
<html lang="en"     class="pb-page"  data-request-id="b70928f2-91e5-4f6e-a83f-bbe2b0139894"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2021.64.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c01940;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model" /></meta><meta name="dc.Creator" content="Feng  He" /></meta><meta name="dc.Creator" content="C. James  Chou" /></meta><meta name="dc.Creator" content="Matthias  Scheiner" /></meta><meta name="dc.Creator" content="Eleonora  Poeta" /></meta><meta name="dc.Creator" content="Natalia  Yuan Chen" /></meta><meta name="dc.Creator" content="Sandra  Gunesch" /></meta><meta name="dc.Creator" content="Matthias  Hoffmann" /></meta><meta name="dc.Creator" content="Christoph  Sotriffer" /></meta><meta name="dc.Creator" content="Barbara  Monti" /></meta><meta name="dc.Creator" content="Tangui  Maurice" /></meta><meta name="dc.Creator" content="Michael  Decker" /></meta><meta name="dc.Description" content="The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative disease..." /></meta><meta name="Description" content="The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative disease..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 26, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01940" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01940" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01940" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01940" /></link>
        
    
    

<title>Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01940" /></meta><meta property="og:title" content="Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0013.jpeg" /></meta><meta property="og:description" content="The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative diseases to incorporate antioxidant effects without losing affinity and selectivity at HDAC6. Structure-activity relationships led to compound 10b as a hybrid molecule showing pronounced and selective inhibition of HDAC6 (IC50 = 30.7 nM, &gt; 25-fold selectivity over other subtypes). This compound shows comparable DPPH radical scavenging ability to ferulic acid, comparable ORAC value to melatonin and comparable Cu2+ chelating ability to EDTA. It also lacks neurotoxicity on HT-22 cells, exhibits a pronounced immunomodulatory effect, and is active in vivo showing significantly higher efficacy in an AD mouse model to prevent both Aβ25−35-induced spatial working and long-term memory dysfunction at lower dose (0.3 mg/kg) compared to positive control HDAC6 inhibitor ACY1215 and an equimolar mixture of the three entities ACY1215, melatonin and ferulic acid, suggesting potentially disease-modifying properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01940"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01940">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01940&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01940&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01940&amp;href=/doi/10.1021/acs.jmedchem.0c01940" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3794-3812</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01937" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01944" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects <i>In Vitro</i> and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Feng He</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Feng He</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Feng++He">Feng He</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">C. James Chou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">C. James Chou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina 29425, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C.+James++Chou">C. James Chou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6808-9089" title="Orcid link">http://orcid.org/0000-0001-6808-9089</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Scheiner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Scheiner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Scheiner">Matthias Scheiner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eleonora Poeta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eleonora Poeta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnologies, University of Bologna, Via Selmi 3, Bologna 40126, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eleonora++Poeta">Eleonora Poeta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Natalia Yuan Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Natalia Yuan Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Natalia++Yuan+Chen">Natalia Yuan Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandra Gunesch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandra Gunesch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Gunesch">Sandra Gunesch</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Hoffmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Hoffmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Hoffmann">Matthias Hoffmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christoph Sotriffer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christoph Sotriffer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christoph++Sotriffer">Christoph Sotriffer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara Monti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara Monti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnologies, University of Bologna, Via Selmi 3, Bologna 40126, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Monti">Barbara Monti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0330-482X" title="Orcid link">http://orcid.org/0000-0003-0330-482X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tangui Maurice</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tangui Maurice</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">MMDN, Univ Montpellier, EPHE, INSERM, Montpellier 34095, France</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4c382d222b392562212d393e252f290c39212322383c29202025293e622a3e"><span class="__cf_email__" data-cfemail="7004111e1705195e1d11050219131530051d1f1e0400151c1c1915025e1602">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tangui++Maurice">Tangui Maurice</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Michael Decker</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Decker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#97fafef4fff6f2fbb9f3f2f4fcf2e5d7e2f9febae0e2f2e5edf5e2e5f0b9f3f2"><span class="__cf_email__" data-cfemail="d6bbbfb5beb7b3baf8b2b3b5bdb3a496a3b8bffba1a3b3a4acb4a3a4b1f8b2b3">[email protected]</span></a>. Phone: +49-93131-89676. Fax: +49-931 31-85494.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Decker">Michael Decker</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6773-6245" title="Orcid link">http://orcid.org/0000-0002-6773-6245</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01940&amp;href=/doi/10.1021%2Facs.jmedchem.0c01940" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3794–3812</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 26, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 November 2020</li><li><span class="item_label"><b>Published</b> online</span>26 March 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 April 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01940</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3794%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFeng%2BHe%252C%2BC.%2BJames%2BChou%252C%2BMatthias%2BScheiner%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D7%26contentID%3Dacs.jmedchem.0c01940%26title%3DMelatonin-%2Band%2BFerulic%2BAcid-Based%2BHDAC6%2BSelective%2BInhibitors%2BExhibit%2BPronounced%2BImmunomodulatory%2BEffects%2BIn%2BVitro%2Band%2BNeuroprotective%2BEffects%2Bin%2Ba%2BPharmacological%2BAlzheimer%25E2%2580%2599s%2BDisease%2BMouse%2BModel%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3812%26publicationDate%3DApril%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01940"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1149</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01940" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;James Chou&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Scheiner&quot;},{&quot;first_name&quot;:&quot;Eleonora&quot;,&quot;last_name&quot;:&quot;Poeta&quot;},{&quot;first_name&quot;:&quot;Natalia&quot;,&quot;last_name&quot;:&quot;Yuan Chen&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Gunesch&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Hoffmann&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;Sotriffer&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Monti&quot;},{&quot;first_name&quot;:&quot;Tangui&quot;,&quot;last_name&quot;:&quot;Maurice&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Decker&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;3794-3812&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01940&quot;},&quot;abstract&quot;:&quot;The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative diseases to incorporate antioxidant effects without losing affinity and selectivity at HDAC6. Structure-activity relationships led to compound 10b as a hybrid molecule showing pronounced and selective inhibition of HDAC6 (IC50 = 30.7 nM, &gt; 25-fold selectivity over other subtypes). This compound shows comparable DPPH radical scavenging ability to ferulic acid, comparable ORAC value to melatonin and comparable Cu2+ chelating ability to EDTA. It also lacks neurotoxicity on HT-22 cells, exhibits a pronounced immunomodulatory effect, and is active in vivo showing significantly higher efficacy in an AD mouse model to prevent both Aβ25−35-induced spatial working and long-term memory dysfunction at lower dose (0.3 mg/kg) compared to positive control HDAC6 inhibitor ACY1215 and an equimolar mixture of the three entities ACY1215, me&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01940&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01940" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01940&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01940" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01940&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01940" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01940&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01940&amp;href=/doi/10.1021/acs.jmedchem.0c01940" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01940" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01940" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01940%26sid%3Dliteratum%253Aachs%26pmid%3D33769811%26genre%3Darticle%26aulast%3DHe%26date%3D2021%26atitle%3DMelatonin-%2Band%2BFerulic%2BAcid-Based%2BHDAC6%2BSelective%2BInhibitors%2BExhibit%2BPronounced%2BImmunomodulatory%2BEffects%2BIn%2BVitro%2Band%2BNeuroprotective%2BEffects%2Bin%2Ba%2BPharmacological%2BAlzheimer%25E2%2580%2599s%2BDisease%2BMouse%2BModel%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D7%26spage%3D3794%26epage%3D3812%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291012" title="Organic acids">Organic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/jmcmar.2021.64.issue-7/20210408/jmcmar.2021.64.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The structures of melatonin and ferulic acid were merged into tertiary amide-based histone deacetylase 6 (HDAC6) inhibitors to develop multi-target-directed inhibitors for neurodegenerative diseases to incorporate antioxidant effects without losing affinity and selectivity at HDAC6. Structure-activity relationships led to compound <b>10b</b> as a hybrid molecule showing pronounced and selective inhibition of HDAC6 (IC50 = 30.7 nM, > 25-fold selectivity over other subtypes). This compound shows comparable DPPH radical scavenging ability to ferulic acid, comparable ORAC value to melatonin and comparable Cu<sup>2+</sup> chelating ability to EDTA. It also lacks neurotoxicity on HT-22 cells, exhibits a pronounced immunomodulatory effect, and is active in vivo showing significantly higher efficacy in an AD mouse model to prevent both Aβ25−35-induced spatial working and long-term memory dysfunction at lower dose (0.3 mg/kg) compared to positive control HDAC6 inhibitor ACY1215 and an equimolar mixture of the three entities ACY1215, melatonin and ferulic acid, suggesting potentially disease-modifying properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Histone deacetylases (HDACs) are responsible for controlling gene expression by modulating the acetylation status of histone and some nonhistone proteins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> HDACs play essential roles in neurodevelopment, memory formation, and cognitive processes, and HDAC inhibitors have been validated as innovative agents for the treatment of neurodegenerative disorders, such as Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Among all 18 subtypes, HDAC6 is of particular interest as it contains two catalytic domains and is mainly cytoplasmic. Moreover, due to its cytoplasmic localization, HDAC6 rather targets nonhistone proteins, such as HSP-90, α-tubulin, β-catenin, and tau protein, which renders HDAC6 to be an interesting target for treatment of neurodegenerative diseases and several rare diseases like Rett syndrome and idiopathic pulmonary fibrosis.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> It is overexpressed in the brain of AD patients, especially in the cortex and hippocampus.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> HDAC6 enables tau protein deacetylation and modulates tau protein phosphorylation, which aggregates to intracellular neurofibrillary tangles (NFTs) in AD patients.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Phenylhydroxamic acid-based selective HDAC6 inhibitors can activate Nrf2 and hypoxic adaptive response, which contribute to neuroprotection <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> 5-Aroylindole-based HDAC6 inhibitors showed neuroprotective activity by triggering ubiquitination and ameliorated the cognition impairment on a scopolamine-induced AD model in rats, a model reflecting the hypocholinergy seen in the pathology.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Lastly, given the importance in AD progression of a sustained immune response (inflammation) and microglia-related mechanisms in Aβ clearance and production,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the potential immunomodulatory activity of HDACs through control of release of cytokines, as well as alteration of activity or function of CNS’ macrophages (microglia) and dendritic cells, has been widely investigated.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Recent studies have demonstrated that manipulation of HDAC6 by tubastatin A (TBSA) alleviates LPS-induced neuroinflammation, representing a new strategy to counteract inflammation and consequently neurodegenerative progression in mice.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Given the multifactorial nature of AD, multitarget compounds being able to simultaneously modulate multiple targets involved in the onset of the disease are promising to restore the physiological balance and generate sufficient therapeutic efficacy. There are several recent reviews covering the design of multitarget compounds.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> As a new approach for AD treatment, the pharmacophore model of HDAC inhibitors has been designed into multitarget compounds addressing several other related targets, which has been extensively discussed in several comprehensive reviews.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17−20)</a> Generally, HDAC inhibitors comprise a zinc binding group (ZBG, <i>e.g.</i>, hydroxamic acid), a linker mimicking the lysine chain, and a cap group, usually an aromatic group that interacts with the external surface of the enzyme.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Due to the high compatibility of the cap group, it can be replaced by different pharmacophores addressing a second target. The Oyarzabal group has reported HDAC and phosphodiesterase 5 (PDE5) dual-target inhibitor CM-414, which can rescue the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice and reverse cognitive deficits in Tg2576 mice.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> Simone <i>et al</i>. designed the first-in-class GSK-3β-HDAC dual inhibitor showing disease-modifying effects <i>in vitro</i> for AD.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The Wu group recently published memantine-based HDAC-NMDAR and tacrine-based HDAC-ChEs multitarget inhibitors, which exhibit potent neuroprotection, antioxidant, and anti-Aβ<i>-</i>aggregation activities.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> Tseng et al. designed HDAC-AChE multitarget inhibitors that enhance neurite outgrowth and show significant anti-Aβ<i>-</i>aggregation activity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Natural products melatonin and ferulic acid have shown promising pharmacological effects potentially beneficial for AD treatment, such as antioxidant effects, neuroprotection, and neurogenesis promotion.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32">(29−32)</a> In the hippocampus of AD patients, increased melatonin receptor 1 (MT1) and decreased melatonin receptor 2 (MT2) expression has been observed.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> However, ferulic acid has low bio-availability and poor blood-brain-barrier penetration, melatonin possesses very short biological half time and lack of selectivity, which are present limitations for further clinical application.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> Nevertheless, pan-HDAC inhibitors based on ferulic acid, tryptamine, or tryptophan all show potent inhibitory activities.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35−38)</a> For instance, the tryptamine-based HDAC inhibitor panobinostat (LBH589) was approved by the FDA for the treatment of multiple myeloma in 2015.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In addition, we have recently reported that hybrids of ferulic and cinnamic acids with flavonoids shown pronounced neuroprotection <i>in vitro</i>, which also translates to <i>in vivo</i> activity. These activities are due to specific interactions with distinct mitochondrial targets.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a></div><div class="NLM_p">In this study, we chemically merged the structures of melatonin and ferulic acid into HDAC6 inhibitor <b>A</b> to develop novel multitarget-directed drug candidates for AD with the aim to combine antioxidant effects in a synergistic manner without losing affinity at and selectivity toward HDAC6. Accordingly, 15 target compounds have been designed (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), synthesized, and bioevaluated. Compounds <b>3a</b> and <b>3b</b> were designed with two aromatic linker groups to replace the acetyl group; similarly, compounds <b>5a–5d</b> incorporate four linker groups in the same position and maintain the amide linkage to study SARs and evaluate the importance of the amide linkage. The linker groups of compounds <b>8a–8c</b> were introduced at the indole nitrogen atom, this design makes the linker groups not as long as the linker group in ethylamine position, and the structures are less flexible, which is supposed to produce higher HDAC6 selective inhibition. Melatonin and ferulic acid as the cap group were merged into one entity for compounds <b>10a–10c</b> and <b>15a–15c</b> aiming to produce stronger HDAC6 selective inhibition and more pronounced antioxidant capacity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of melatonin- and ferulic acid-based HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">In <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the syntheses of target compounds <b>3a</b>, <b>3b</b>, <b>5a–5d</b>, and <b>8a–8c</b> are described starting from 5-methoxytryptamine (<b>1</b>). Corresponding linker groups were introduced to the ethylamine position of 5-methoxytryptamine (<b>1</b>) by stirring with potassium carbonate in a mixture of THF and water to afford intermediates <b>2a</b> and <b>2b</b>. The formation of dual-substituted byproducts lowered the yields of this step, especially the synthesis of intermediate <b>2c</b> presented in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Amide condensation to form intermediates <b>4a</b>–<b>4d</b> were carried out after corresponding carboxylic acids had been activated by TBTU and stirred with compound <b>1</b>, which gave reasonable yields of 60–79%. Melatonin (<b>6</b>) formed by acetylation of compound <b>1</b> was refluxed with corresponding bromides and <i>t</i>-BuOK in THF; meanwhile, the ester groups were hydrolyzed. The obtained crude carboxyl intermediates were therefore esterified in methanol after activation with thionyl chloride to afford intermediates <b>7a–7c</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>3a–3b</b>, <b>5a–5d</b> and <b>8a–8c</b> from 5-Methoxytryptamine (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)acrylate for <b>2a</b>, methyl 4-(bromomethyl)benzoate for <b>2b</b>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, reflux; (b) NH<sub>2</sub>OH·HCl, KOH, MeOH, r.t.; (c) (<i>E</i>)-4-(3-methoxy-3-oxoprop-1-en-1-yl)benzoic acid for <b>4a</b>, 4-(methoxycarbonyl)benzoic acid for <b>4b</b>, (<i>E</i>)-3-(4-(methoxycarbonyl)-phenyl)acrylic acid for <b>4c</b>, 6-methoxy-6-oxohexanoic acid for <b>4d</b>, TBTU, TEA, THF, r.t.; (d) acetic anhydride, DCM, 0 °C to r.t.; (e) (i) methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)acrylate for <b>7a</b>, methyl 4-(bromomethyl)benzoate for <b>7b</b>, methyl 6-bromohexanoate for <b>7c</b>, <i>t</i>-BuOK, THF, reflux; (ii) SOCl<sub>2</sub>, MeOH, r.t.; (f) ferulic acid, ethyl chloroformate, TEA, dried THF, 0 °C; (g) Boc-Gly-OH, EDCI, DMAP, TEA, THF, r.t.; (h) 10% TFA in DCM, r.t.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds <b>10a–10c</b> and <b>15a–15c</b> from 5-Methoxytryptamine (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)acrylate for <b>13a</b>, methyl 4-(bromomethyl)benzoate for <b>13b</b>, methyl 6-bromohexanoate for <b>13c</b>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, reflux; (b) ferulic acid, ethyl chloroformate, TEA, dried THF, 0 °C; (c) NH<sub>2</sub>OH·HCl, KOH, MeOH, r.t.; (d) Boc-Gly-OH, EDCI, DMAP, TEA, THF, r.t.; (e) 10% TFA in DCM, r.t.</p></p></figure><div class="NLM_p">The key step to synthesize compounds <b>10a–10c</b> was the introduction of a ferulic acid moiety, which was introduced into intermediates <b>2a–2c</b> to produce the tertiary amides (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). First, the carboxyl group of ferulic acid was activated by excess ethyl chloroformate; then the phenolic hydroxyl group was esterified and could be hydrolyzed in NH<sub>2</sub>OH-KOH methanol solution during the formation of the hydroxamate group. BOC-Gly-OH reacted with 5-methoxytryptamine (<b>1</b>) after it had been activated with EDCI, and the Boc protecting group was removed in 10% TFA in dichloromethane to afford intermediate <b>12</b>. Subsequently, compounds <b>15a–15c</b> were obtained through procedures similar to the synthesis of compounds <b>10a–10c</b>. All ester intermediates <b>2a</b>, <b>2b</b>, <b>4a–4d</b>, <b>7a–7c</b>, <b>9a–9c</b>, and <b>14a–14c</b> were converted to hydroxamic acid compounds <b>3a</b>, <b>3b</b>, <b>5a–5d</b>, <b>8a–8c</b>, <b>10a–10c</b>, and <b>15a–15c</b>, respectively, by NH<sub>2</sub>OH-KOH in methanol. Purification of target compounds proved challenging because of a carboxylic acid byproduct formed and absorbed on silica gel.</div><div class="NLM_p last">Due to the tertiary amide groups of compounds <b>10a–10c</b> and <b>15a–15c</b>, the occurrence of <i>cis</i>/<i>trans</i> amide bond rotamers was observed, which possess two sets of NMR signals, arising from the restricted rotation around the tertiary amide bond for each rotamer. Since this phenomenon had already been discussed in detail in several publications,<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> variable temperature NMR studies (VT-NMR) for these compounds did not deem necessary.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Inhibition of HDACs</h3><div class="NLM_p">To evaluate selectivity toward HDAC6 and extent of inhibition, a fluorescence assay against HDAC3 and HDAC6 was applied to test the target molecules (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> At 1 μM, compounds <b>3b</b>, <b>5a</b>, <b>5d</b>, and <b>15b</b> show less potent inhibition of both HDAC3 and HDAC6 than all other target compounds. Compounds <b>3b</b>, <b>5a</b>, and <b>5d</b> share similar lengths of linker groups, which are shorter than the cinnamate group in compounds <b>3a</b>, <b>5b</b>, and <b>5c</b>, indicating that the longer linker (like a cinnamate group) is preferable. For comparison, compounds <b>8b</b> and <b>10b</b> show the highest selectivity values regarding HDAC6 inhibition, namely, 57-fold and 53-fold, respectively, over HDAC3. Interestingly, compounds <b>8b</b> and <b>10b</b> share the same phenylhydroxamic acid with different bulky capping groups, being in line with the other reported selective HDAC6 inhibitors.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Also, due to the longer linker and its high flexibility, compounds <b>3a</b>, <b>3b</b>, and <b>5a–5d</b> exhibit less selective inhibition of HDAC6 compared to the other compounds. On the contrary, compounds <b>3a</b> and <b>5b</b> show the most potent inhibition to HDAC3 with IC<sub>50</sub> values of 5.1 and 3.6 nM, respectively, which is more pronounced than their inhibition of HDAC6. Compounds <b>5b</b> and <b>3a</b> with or without the amide linkage showed no differences in the extent of HDAC inhibition.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures, <i>In Vitro</i> HDAC (HDAC3 and HDAC6) Inhibitory, DPPH Radical Scavenging Activities, and ORAC Values of Target Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0011.gif" alt="" id="gr10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data from ref <a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Data are the mean (<i>n</i> = 3) ± SD.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Data are expressed as Trolox equivalents and are the mean (<i>n</i> = 3) ± SD.</p></div></div><div></div></div><div class="NLM_p">To further confirm selective inhibition of compounds <b>8b</b> and <b>10b</b> over other HDACs, their IC<sub>50</sub>s at other Zn<sup>2+</sup>-dependent HDACs (HDAC1– 9) were measured (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Both compounds show highly selective inhibition (more than 23-fold over other subtypes) toward HDAC6, and their selectivity values are higher than those of reference compound ACY1215. The results further validate the importance of phenylhydroxamic acid with bulky capping groups to yield pronounced HDAC6 selective inhibition.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activities of Compounds <b>8b</b> and <b>10b</b> at HDAC1–4 and HDAC6–9</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="("><b>8b</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>10b</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">HDAC classes</th><th class="colsep0 rowsep0" align="center">subtype</th><th class="colsep0 rowsep0" align="center" char="(">IC<sub>50</sub> (nM) (pIC<sub>50</sub> ± SEM) (<i>n</i> = 2)</th><th class="colsep0 rowsep0" align="center">selectivity ratio to HDAC6</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM) (pIC<sub>50</sub> ± SEM) (<i>n</i> = 2)</th><th class="colsep0 rowsep0" align="center">selectivity ratio to HDAC6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="center">class I</td><td class="colsep0 rowsep0" align="left">HDAC1</td><td class="colsep0 rowsep0" align="char" char="(">262 (6.58 ± 0.07)</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">771 (6.11 ± 0.09)</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC2</td><td class="colsep0 rowsep0" align="char" char="(">336 (6.47 ± 0.09)</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">2851 (5.55 ± 0.41)</td><td class="colsep0 rowsep0" align="left">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC3</td><td class="colsep0 rowsep0" align="char" char="(">641 (6.19 ± 0.09)</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">1613 (5.79 ± 0.16)</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC8</td><td class="colsep0 rowsep0" align="char" char="(">838 (6.08 ± 0.23)</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">3590 (5.45 ± 0.54)</td><td class="colsep0 rowsep0" align="left">117</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="center">class IIa</td><td class="colsep0 rowsep0" align="left">HDAC4</td><td class="colsep0 rowsep0" align="char" char="(">3431 (5.47 ± 0.06)</td><td class="colsep0 rowsep0" align="left">306</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>326</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC7</td><td class="colsep0 rowsep0" align="char" char="(">1653 (5.78 ± 0.10)</td><td class="colsep0 rowsep0" align="left">148</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>326</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC9</td><td class="colsep0 rowsep0" align="char" char="(">362 (6.44 ± 0.11)</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left">>326</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">class IIb</td><td class="colsep0 rowsep0" align="left">HDAC6</td><td class="colsep0 rowsep0" align="char" char="(">11.2 (7.59 ± 0.06)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30.7 (7.51 ± 0.06)</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">Computational docking studies were carried out to identify putative binding modes of compounds <b>8b</b> and <b>10b</b> for HDAC6. The protein structure from the crystallographically determined complex of HDAC6 with reference compound <b>A</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DVM">6DVM</a>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was used for this purpose. For compound <b>8b</b>, a well-clustered top-ranked docking result was obtained in which the phenylhydroxamate binds to the deep active-site tunnel in a previously reported conformation.<a onclick="showRef(event, 'ref21 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref21 ref46 ref47">(21,46,47)</a> The hydroxamate shows a monodentate coordination to the zinc-ion at 2.5 Å and a hydrogen-bonding interaction with Gly582 at 2.8 Å distance (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). The phenyl linker is sandwiched in the tunnel between Phe583 and Phe643 at 4.1 and 4.5 Å, respectively. The melatonin-based capping group is positioned in a pocket at the outer rim of the active site, flanked by the L1 loop. The indole moiety is oriented toward His463 and Pro464, while the extended amide might accept a hydrogen bond from Asn457. For compound <b>10b</b>, two binding modes appear feasible for the capping groups, which are placed above the pocket flanked by loop L1 but can be switched in their orientation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B,C). In the best binding pose according to the DSX scoring function<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (cf. the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Supporting Information</a> for further details), aromatic interactions of the indole moiety with His463 appear to be feasible, whereas the hydroxy-methoxyphenyl ring shows van der Waals interactions with Leu712. In the switched orientation, which is somewhat less favorably scored by DSX but found more frequently in the docking runs, the indole is placed above Leu712, whereas the hydroxy group of the ferulic acid-based moiety can reach Asp460 for a hydrogen-bond interaction. Based on the docking results for both compounds, binding of the capping groups to the L1 loop pocket can be assumed to be the likely reason for HDAC6 selectivity, in line with the elegant crystallographic analyses presented by Porter et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed binding modes of compounds <b>8b</b> (A) and <b>10b</b> (B, C) at the active site of HDAC6. The two alternative binding modes shown for <b>10b</b> correspond to the best-ranked result (B) and the most populated cluster of the docking results (C). Distances are given in Å; selected interactions are highlighted with dashed lines. The Zn<sup>2+</sup> ion is represented as a grey sphere. Loops 1 and 2 are denoted as L1 and L2. The deep active-site pocket is visualized with a transparent light-grey surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To examine the cellular potency and selectivity of compounds <b>10b</b> and <b>8b</b>, acetylated tubulin and acetylated histone H3 and H4 were examined in HT-22 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). As expected, <b>10b</b> strongly induced the increase of acetylated tubulin (AcTub), while a little-to-no increase was observed for acetylated histone H3 and H4 (AcHH3 and AcHH4). Compound <b>8b</b> also selectively increases the level of AcTub at 500 μM. The Western blot data indicate that both <b>10b</b> and <b>8b</b> are selectively inhibiting HDAC6 activity but not the class I HDACs targeting histone acetylation.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis of acetylated tubulin (AcTubulin), acetylated histone H3 (AcHH3), acetylated histone H4 (AcHH4), and Hsp90 in HT22 cell lines after 24 h treatment with compounds <b>10b</b> (500, 100, and 20 nM) and <b>8b</b> (500 nM) using ACY1215 (500 nM) as a positive control. Tubulin was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Antioxidant Activities</h3><div class="NLM_p">By combination of antioxidants melatonin and ferulic acid, compounds were designed to maintain their antioxidant capacity. Their antioxidant capacities were evaluated using both 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) and oxygen radical absorbance capacity (ORAC) assays. These assays are well-established techniques for determining the radical scavenging activity (RSA) of a test compound. Reactive oxygen species (ROS), such as the hydroxyl or superoxide radicals, cause lipid peroxidation, protein oxidation, and DNA damage, which can lead to organelles malfunction and further cellular disorders.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Melatonin is inactive regarding inactivation of the DPPH radical, and HDAC6 inhibitor ACY1215 shows only weak scavenging activities. Among all target compounds, tertiary amide-based compounds <b>10a</b>, <b>10c</b>, and <b>15a</b> show the highest radical scavenging ability, and compound <b>10b</b> is comparable to ferulic acid. Various linker groups also affect radical scavenging activities: the compounds bearing the cinnamate group (e.g. compounds <b>3a</b>, <b>5b</b> and <b>8a</b>) exhibit stronger scavenging activities than compounds bearing a phenylene (e.g. compounds <b>3b</b>, <b>5a</b> and <b>8b</b>) or analkylene chain (e.g. compounds <b>5d</b> and <b>8c</b>), respectively. ACY1215 also shows higher radical scavenging activity than melatonin indicating that the hydroxamic acid group is supportive to scavenge the DPPH radical. The ORAC values shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> are expressed as trolox (water-soluble analogue of vitamin E) equivalents (TE), in relation to radical scavenging properties of trolox. Ferulic acid and melatonin were used as positive controls showing ORAC values of 3.1 and 2.0, respectively. All evaluated compounds exhibit strong radical scavenging properties with TE values ranging from 1.0 (<b>10a</b>) to 3.2 (<b>15c</b>). HDAC6 selective compound <b>10b</b> possesses a TE value of 2.1, which is comparable to melatonin. Compounds <b>8a</b>–<b>8c</b> show lower TE values than melatonin and most other compounds tested, indicating the importance of unsubstituted indole-N to maintain the antioxidant capacity of melatonin. There is no obvious effect for amide linkage regarding DPPH scavenging or TE values in compounds <b>5a</b> and <b>3a</b>, <b>5b</b> and <b>3b</b>. Compounds <b>15a–15c</b> show no significant difference to compounds <b>10a–10c</b>, which means that the presence of an acetyl group is not necessary. Introduction of one alkylene chain is much more effective than aromatic linkers, as seen from the TE values of compounds <b>5d</b>, <b>10c</b>, and <b>15c</b>, respectively. Also, the presence of ferulic acid moiety is poorly correlated with the observed TE values unlike for the DPPH radical scavenging capacity.</div><div class="NLM_p">Cerebral biometals (such as copper, zinc, and iron) play crucial roles in Aβ aggregation and neurotoxicity, being a driving force for neurodegeneration in AD.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Figure S1</a>, compounds <b>8b</b>, <b>10b</b>, and ACY1215 exhibit comparable chelating abilities to each other at all concentrations tested and also comparable abilities to EDTA when chelating copper ions. In contrast to nonselective chelation of EDTA, compounds <b>8b</b>, <b>10b</b>, and ACY1215, respectively, show higher selectivity to the copper ion over ferrous and zinc ions, which might render them superior regarding copper-ion dysregulation-related neurodegeneration diseases like AD.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p last">In a summary, compounds <b>8b</b> and <b>10b</b> show the best selective HDAC6 inhibition and additional potent total antioxidant capacities, especially, compound <b>10b</b> exhibits comparable radical scavenging capacities to both ferulic acid and melatonin in DPPH assay and ORAC assay, respectively.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Neurotoxicity</h3><div class="NLM_p">HDAC inhibitors usually possess high cytotoxicity, which might counteract their application as CNS-targeting therapeutics. Hence, it was important to investigate their neurotoxicity profile. A survival assay was performed, treating murine hippocampal neuronal HT-22 cells with 10 μM of each of the target compounds (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Generally, the compounds proved to be safe and showed no neurotoxicity. Compound <b>10b</b> showed no significant neurotoxicity, and slight neurotoxic effects were observed for compound <b>8b</b> and reference compound ACY1215.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Neurotoxicity of target compounds in HT-22 cells at 10 μM. Statistical analysis was performed applying One-way ANOVA followed by Dunnett’s multiple comparison post-test. Levels of significance: ***<i>p</i> < 0.001, *<i>p</i> < 0.05 referring to control cells treated with DMSO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, compounds <b>3a</b> and <b>5b</b> also showed some neurotoxic effects with 50 and 60% cell survival, respectively. This is not too surprising due to their potent inhibition of HDAC3 and might even be beneficial for further anticancer research. With 10 μM, a relatively high concentration was tested and the viability rates should not counteract beneficial effects.</div><div class="NLM_p last">As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Figure S2</a> (cf. <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Supporting Information</a>), the neuroprotection of target compounds against glutamate-induced oxytosis and iodoacetic acid-induced ATP depletion in HT-22 cells has been tested; only compound <b>10a</b> revealed significant neuroprotection at 50 μM.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Immunomodulatory Effect</h3><div class="NLM_p">Activation of microglia cells, <i>i.e.</i>, CNS’ macrophages, is a hallmark of neuroinflammation, a characteristic feature of neurodegenerative conditions. Depending on brain microenvironment, microglia acquire different phenotypes: the neurotoxic M1 phenotype, generally characterized by production of proinflammatory cytokines (TNF-α, IL-1β) or reactive oxygen species (ROS), or the neuroprotective M2 phenotype distinguished by the expression of phagocytic protein TREM2 and of growth factors, such as TGFβ2.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> To analyze the possible immunomodulatory activity, <i>i.e.</i>, the ability to shift the microglial phenotype from the neurotoxic M1 to the neuroprotective M2, of HDACs inhibitors <b>8b</b>, <b>10b</b>, and control ACY1215, N9 microglial cells were treated with increasing concentration of compounds (0.1, 0.5, 1, 2.5, 5 μM) in the presence or absence of 100 ng/mL LPS (lipopolysaccharide), which induces an M1 activation state. After 24 h of treatment, to investigate nitric oxide and IL1β release, markers of M1 microglia, conditioned media were collected and evaluated by a colorimetric assay based on the Griess reaction and Western blot analysis, respectively. In parallel, cell lysates were analyzed by Western blot to measure the expression of the inducible nitric oxide synthase (iNOS, M1 marker), TREM2 and TGFβ2, both markers of M2 microglia. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, compound <b>10b</b> strongly reduces in dose-dependent manner nitrite accumulation (F) and IL1β release (I) compared to compound <b>8b</b> and control ACY1215, as well as iNOS expression induced by LPS-mediated microglia activation (L). Additionally, compound <b>10b</b> leads to an increase in the phagocytic protein TREM2 (O) and TGFβ2 (R) expression, suggesting an immunomodulatory effect, <i>i.e.</i>, a switch from neurotoxic M1 to neuroprotective M2 microglia when cells are treated with high concentration of the compound (2.5, 5 μM). Differently, no change in TREM2 and TGFB2 expression was observed in the presence of increasing concentration of compound <b>8b</b> (E, H, K, N, Q).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compounds <b>8b</b>, <b>10b</b> and control ACY1215 on murine N9 cells induced in a M1 activation state by LPS (100ng/mL) treatment. IL1β release in N9-conditioned medium and expression of iNOS, TREM2 and TGFβ2 were analyzed by western blot after 24h treatment with LPS in presence of increasing concentrations (0.1, 0.5, 1, 2.5 and 5μM) of compounds ACY1215 (A), <b>8a</b> (B) and <b>10b</b> (C). Nitric Oxide release was evaluated through Griess reaction in media conditioned for 24h by microglial cells treated with LPS in presence of compounds ACY1215 (D), <b>8a</b> (E) and <b>10b</b> (F); as shown in figure F, only compound <b>10b</b> induced a significative reduction of NO release, with the strongest effect at 5μM. Additionally, IL1β release and iNOS expression, both markers of M1 neurotoxic microglia, strongly decreased in the presence of increasing concentrations of compound <b>10b</b> compared to LPS-treated control (I, L); conversely, no significant effects where observed on N9 cells following ACY1215 (G, J), and <b>8a</b> (H, K) treatment. In parallel, expression of M2 microglial marker TREM2 increased in cells co-treated by LPS-<b>10b</b> (O) and LPS-ACY1215 (M) compounds, whereas no significant effects in TREM2 expression were obtained following LPS-<b>8a</b> treatment (N). In addition, compared to ACY1215 (P) and <b>8a</b> (Q), in LPS-<b>10b</b> treated cells TGFβ2 expression turned out to increase (R) suggesting, together with TREM expression (O), a shift from neurotoxic M1 to neuroprotective M2 microglia. All quantitative data are presented as means ± S.E. from at last 3 independent experiments. Statistical significance between different treatments was calculated with GRAPHPAD PRISM 6 (La Jolla, California, USA) by using one-way analysis of variance (ANOVA) followed by post-hoc comparison through Bonferroni's test. *p<0.05; **p<0.01 compared to un-treated control; #p<0.05; ##p<0.01compared to LPS-treated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>In Vivo</i> Studies</h3><div class="NLM_p">Due to its promising <i>in vitro</i> properties, compound <b>10b</b> was chosen to evaluate its neuroprotective properties in an <i>in vivo</i> model of AD in mice. The HDAC6 inhibitor ACY1215 was also tested as a comparator. Mice received an intracerebroventricular (icv) injection of theoligomerized Aβ<sub>25–35</sub> peptide into the brain on day 1. Compounds were then injected intraperitoneally (ip) once daily (o.d.) from days 1 to 7. Spatial working memory was evaluated using the spontaneous alternation behavior when mice explored a Y maze, on day 8. Nonspatial long-term memory was analyzed using the step-through passive avoidance response, with training on day 9 and retention on day 10. In this administration scheme, not symptomatic effects, but neuroprotectivity can be assessed <i>in vivo</i>.<a onclick="showRef(event, 'ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57">(54−57)</a></div><div class="NLM_p">As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Figure S3</a> (cf. <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Supporting Information</a>), none of the treatment (DMSO containing a vehicle or each compound) significantly affected the mouse body weight gain during the week of administration showing good tolerability. A transient weight loss was observed on day 2, related to the icv injection of the peptide under light gazeous anesthesia, but animals recovered during the following days.</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,C, compound <b>10b</b> significantly attenuated the Aβ<sub>25–35</sub>-induced spontaneous alternation deficits at a lower dose, 0.3 mg/kg, compared to ACY1215, active at 1 mg/kg. The compound <b>10b</b> was active in the 0.3–1 mg/kg dose-range, reflecting a more potent neuroprotective effect on working memory deficits. The hybrid molecule <b>10b</b> was compared to an equimolar (0.7 μM) mixture of the three entities ACY-1215, melatonin, and ferulic acid (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E). Melatonin did not prevent Aß<sub>25–35</sub>-induced alternation deficits at this low, 0.16 mg/kg dose, and neither did the mixture. None of the treatment affected the exploratory response, measured in terms of number of arms entered during the session (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,D,F).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound on the Aβ<sub>25–35</sub>-induced spontaneous alternation deficit in mice. Mice received Aβ<sub>25–35</sub> (9 nmol icv) or vehicle solution (3 μL icv) on day 1 and compounds (A, B) ACY1215 or (C, D) <b>10b</b>, in the 0.1–3 mg/kg ip dose range, o.d., from days 1 to 7. In (E, F), the effect of a drug combination with equimolar doses of ACY-1215 (0.3 mg/kg), melatonin (0.16 mg/kg), and ferulic acid (0.13 mg/kg) was compared to the efficacy of the hybrid molecule. Mice were then tested for spontaneous alternation performance in the YMT in day 8. Top panel (A, C, and E): spontaneous alternation performance; lower panel (B, D, and F): number of arm entries. Data show mean ± SEM with <i>n</i> = 12–22 per group. ANOVA: <i>F</i><sub>(4,76)</sub> = 2.81, <i>p</i> < 0.05 in (A); <i>F</i><sub>(4,86)</sub> = 2.68, <i>p</i> < 0.05 in (B); <i>F</i><sub>(4,76)</sub> = 1.16, <i>p</i> > 0.05 in (C); <i>F</i><sub>(4,86)</sub> = 0.581, <i>p</i> > 0.05 in (D); <i>F</i><sub>(5,76)</sub> = 6.20, <i>p</i> < 0.0001 in (E); <i>F</i><sub>(5,76)</sub> = 0.554, <i>p</i> > 0.05 in (F). *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs (V + V)-treated group. <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01 vs (Aβ<sub>25–35</sub> + V)-treated group; Dunnett′s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the passive avoidance test, compound ACY1215 attenuated the Aβ<sub>25–35</sub>-induced deficit at all doses tested, but not significantly <i>vs</i> the Aβ<sub>25–35</sub>-injected group (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). Compound <b>10b</b> attenuated the deficit at both 0.1 and 0.3 mg/kg, significantly at the lowest dose tested, but was not active at 1 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). These bell-shaped dose–response effects are commonly observed in cognitive and neuroprotection responses <i>in vivo</i>, as shown recently with the NMDAR antagonist memantine in the same Aß<sub>25–35</sub> mouse model of AD.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> They are here observed in our study for both ACY1215 and <b>10b</b> at the 1 mg/kg dose, suggesting that this biphasic effect relies on HDAC6 inhibition. Melatonin or the equimolar mixture of the three compounds failed to attenuate Aβ<sub>25–35</sub>-induced passive avoidance deficit, again showing the pronounced effect of the hybrid molecule (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). Compound <b>10b</b> therefore exhibited a remarkably effective neuroprotective properties <i>in vivo</i> at sub-mg/kg active dose-range against Aβ<sub>25–35</sub>-induced memory dysfunction, suggesting that HDAC6 inhibition could be an effective neuroprotective strategy for the treatment of AD.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compounds on Aβ<sub>25–35</sub>-induced passive avoidance deficits in mice. Mice received Aβ<sub>25–35</sub> (9 nmol icv) or vehicle solution (3 μL icv) on day 1 and compounds (A) ACY1215 and (B) <b>10b</b>, in the 0.1–3 mg/kg ip dose range, o.d., from days 1 to 7. Animals were trained in the passive avoidance test on day 9, and retention (step-through latency) was analyzed on day 10. Data show the median and interquartile range with <i>n</i> = 10–21 per group. Kruskal–Wallis ANOVA: <i>H</i> = 10.76, <i>p</i> < 0.05 in (A); <i>H</i> = 16.59, <i>p</i> < 0.01 in (B); <i>H</i> = 14.25, <i>p</i> < 0.05 in (C). *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs (V + V)-treated group. <sup>#</sup><i>p</i> < 0.05 vs (Aβ<sub>25–35</sub> + V)-treated group; Dunn’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this work, we designed hybrid HDAC inhibitors by chemically merging the structures of melatonin and ferulic acid into the HDAC6 inhibitor to develop novel multitarget-directed drug candidates for AD with the aim to combine effects in a synergistic manner without losing affinity and selectivity at HDAC6. Altogether, 15 target compounds have been designed, synthesized, and evaluated comprehensively in several <i>in vitro</i> and <i>in vivo</i> assays.</div><div class="NLM_p">The newly synthesized compounds were firstly evaluated for inhibition of HDACs. Melatonin-based compound <b>8b</b> and melatonin-ferulic acid-based compound <b>10b</b> show the highest HDAC6 inhibition with more than 20-fold selectivity over other subtypes and maintaining two-digit nanomolar IC<sub>50</sub>s. Compound <b>8b</b> and <b>10b</b> also maintain the antioxidant capacities from melatonin and ferulic acid, especially compound <b>10b</b>, which scavenges the DPPH radical comparable to ferulic acid and possesses the comparable ORAC value with regard to melatonin. Compound <b>10b</b> does not exhibit neurotoxicity at 10 μM and comparable Cu<sup>2+</sup> chelating ability to the positive control and potent chelator EDTA, which indicates beneficial effects for reduction of metal-mediated oxidative stress, tau, and Aβ aggregation.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p last">Compound <b>10b</b> shows an immunomodulatory effect, leading to a reduction in LPS-induced microglia inflammation and to a switch from neurotoxic M1 to the neuroprotective M2 microglial phenotype. Furthermore, it shows pronounced attenuation of spatial working memory and long-term memory alteration in an <i>in vivo</i> AD mouse model induced by icv Aβ<sub>25–35</sub> peptide injection, at very low doses, thereby proving neuroprotective properties. The superior <i>in vivo</i> efficacy of compound <b>10b</b> may indicate a synergistic effect between HDAC6 inhibition and its antioxidant activities. In addition or alternatively, interaction with MT receptors is possible since expression levels of both MT receptor subtypes are altered in AD and melatonin was reported to rescue neurogenesis impairment by multiple modes of action,<a onclick="showRef(event, 'ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34">(31−34)</a> as well as beneficial pharmacokinetic properties. In any case, the tertiary amide-based HDAC6 selective inhibitor described herein shows that HDAC6 inhibitors cannot only be merged with melatonin and ferulic acid moieties and also maintain potent HDAC6 selective inhibition and the antioxidant properties but also represent a suitable scaffold to develop neuroprotective compounds <i>in vivo</i>, with potentially neurodegenerative disease-modifying properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68320" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68320" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Chemistry</h3><div class="NLM_p">Common reagents and solvents were purchased from commercial suppliers and used without further purification unless otherwise stated. Tetrahydrofuran (THF) was distilled from sodium-benzophenone under an argon atmosphere. Reaction progress was monitored using analytical thin-layer chromatography (TLC) on precoated silica gel GF254 plates (Macherey Nagel GmbH & Co. KG, Düren, Germany), and spots were detected under UV light (254 and 366 nm). Compounds were purified with flash column chromatography with a silica gel and particle size of 40–63 μM (VWR chemicals, Leuven, Belgium) as the stationary phase and petroleum ether/ethyl acetate or dichloromethane/methanol mixtures as eluent systems. Nuclear magnetic resonance spectra were measured on a Bruker AV-400 NMR instrument (Bruker, Karlsruhe, Germany) in deuterated solvents (DMSO-<i>d</i><sub>6</sub>, CDCl<sub>3</sub>, MeOD-<i>d</i><sub>4</sub>). Chemical shifts are expressed in ppm relative to DMSO-<i>d</i><sub>6</sub>, CDCl<sub>3</sub>, or MeOD-<i>d</i><sub>4</sub> (2.50/7.26/3.31 for <sup>1</sup>H; 39.52/77.16/49.00 for <sup>13</sup>C). <sup>1</sup>H NMR signals marked with an asterisk (∗) correspond to peaks assigned to the minor rotamer conformation. Infrared spectra were measured using a Jasco FT/IR-4100, absorption values are expressed as wavenumbers (cm<sup>–1</sup>). Uncorrected melting points were measured using a Stuart melting point apparatus SMP30.</div><div class="NLM_p">Measurements for verification and purity of the compounds were performed by LC/MS (from Shimadzu), comprising a DGU-20A3R controller, pump LC-20AB, degasser DGU-20A, and SPD-20A UV/Vis detector. ESI ionization was accomplished by an LCMS-2020 single quadrupol mass spectrometer. As a stationary phase, for analytical purpose, a Synergi 4U fusion-RP 80 Å (150 × 4.6 mm) column and, for preparative purpose, a Synergi 4 U fusion-RP 80 Å (250 × 10.0 mm) were used. As a mobile phase, a gradient of MeOH/water (both containing 0.1% formic acid) (phase 1/phase 2) was used. The compounds were dissolved in MeOH and filtered through syringe filters. Method A: <i>V</i>(1) / (<i>V</i>(1) + <i>V</i>(2)) = from 0 to 60% over 10 min, <i>V</i>(1) / (<i>V</i>(1) + <i>V</i>(2)) = 60% for 5 min, <i>V</i>(1) / (<i>V</i>(1) + <i>V</i>(2)) = from 60 to 0% over 3 min. Method B: <i>V</i>(1) / (<i>V</i>(1) + <i>V</i>(2)) = from 5 to 90% over 10 min, <i>V</i>(1) / (<i>V</i>(1) + <i>V</i>(2)) = 90% for 5 min, <i>V</i>(1) / (<i>V</i>(1) + <i>V</i>(2)) = from 90 to 5% over 3 min. Methods were performed with a flow rate of 1.0 mL/min. Compounds were detected at λ = 254 nm, and target compounds were ≥95% pure.</div><div class="NLM_p">All designed target compounds did not show any promiscuous moieties in the pan-assay interference compound assay (PAINS) using two different in silico filters (<a href="http://www.cbligand.org/PAINS/" class="extLink">http://www.cbligand.org/PAINS/</a> and <a href="http://fafdrugs4.mti.univ-paris-diderot.fr/" class="extLink">http://fafdrugs4.mti.univ-paris-diderot.fr/</a>).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Methyl (<i>E</i>)-3-(4-(((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)methyl)phenyl)acrylate (<b>2a</b>)</h4><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (0.25 g, 1.78 mmol) and methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)-acrylate (0.23 g, 0.89 mmol) were added in portions to a solution of 5-methoxytryptamine <b>1</b> (0.17 g, 0.89 mmol) in 5 mL of THF and 0.5 mL of H<sub>2</sub>O at 70 °C and stirred for 2 h. Excess MgSO<sub>4</sub> was added to the mixture and stirred for 30 min; the precipitation was filtered out and washed with THF twice. THF solution was combined and concentrated under vacuum and then purified with column chromatography to afford 0.16 g of red oil, yield 49%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.60 (s, 1H), 7.71–7.62 (m, 3H), 7.40 (d, <i>J</i> = 8.1 Hz, 2H), 7.21 (d, <i>J</i> = 8.7 Hz, 1H), 7.08 (d, <i>J</i> = 2.3 Hz, 1H), 6.94 (d, <i>J</i> = 2.4 Hz, 1H), 6.70 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 6.61 (d, <i>J</i> = 16.1 Hz, 1H), 3.80 (s, 2H), 3.73 (s, 6H), 2.86–2.75 (m, 4H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.2, 153.4, 145.0, 132.9, 131.9, 128.9 (2C), 128.8, 128.7 (2C), 128.0, 123.7, 117.6, 112.7, 112.4, 111.5, 100.6, 55.8, 52.8, 51.9, 49.7, 25.8 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub>]<sup>+</sup>: 365.18, found: 365.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 8.71 min.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Methyl 4-(((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)methyl)benzoate (<b>2b</b>)</h4><div class="NLM_p last">Intermediate <b>2b</b> was prepared from 5-methoxytryptamine <b>1</b> and methyl 4-(bromomethyl)benzoate in a similar manner as described for intermediate <b>2a</b>. Brown solid, yield 62%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.59 (s, 1H), 7.90 (d, <i>J</i> = 8.2 Hz, 2H), 7.49 (d, <i>J</i> = 8.2 Hz, 2H), 7.21 (d, <i>J</i> = 8.7 Hz, 1H), 7.08 (d, <i>J</i> = 2.3 Hz, 1H), 6.94 (d, <i>J</i> = 2.4 Hz, 1H), 6.70 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.85 (s, 3H), 3.84 (s, 2H), 3.73 (s, 3H), 2.87–2.74 (m, 4H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.7, 153.3, 147.3, 131.9, 129.5, 128.6, 128.4, 128.0, 123.7, 112.7, 112.4, 111.4, 100.6, 55.8, 52.8, 52.5, 49.9, 25.9 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>]<sup>+</sup>: 339.16, found: 339.15 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 8.05 min.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Methyl 6-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)hexanoate (<b>2c</b>)</h4><div class="NLM_p last">Intermediate <b>2c</b> was prepared from 5-methoxytryptamine <b>1</b> and methyl 6-bromo-hexanoate in a similar manner as described for intermediate <b>2a</b>. Brown solid, yield 35%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.52 (s, 1H), 7.24 (d, <i>J</i> = 8.8 Hz, 1H), 7.08 (d, <i>J</i> = 2.3 Hz, 1H), 7.00 (d, <i>J</i> = 1.3 Hz, 1H), 6.87 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 3.87 (s, 3H), 3.67 (s, 3H), 2.97 (s, 4H), 2.65 (t, <i>J</i> = 7.3 Hz, 2H), 2.30 (t, <i>J</i> = 7.5 Hz, 2H), 1.68–1.58 (m, 2H), 1.56–1.45 (m, 3H), 1.38–1.27 (m, 2H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 174.2, 153.8, 131.5, 127.8, 122.8, 113.3, 112.1, 111.9, 100.7, 56.0, 51.5, 49.8, 49.5, 34.0, 29.6, 26.9, 25.6, 24.8 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub>]<sup>+</sup>: 319.19, found: 319.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 7.52 min.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>E</i>)-<i>N</i>-Hydroxy-3-(4-(((2-(5-methoxy-1<i>H</i>-indol-3-yl)-ethyl)amino)methyl)phenyl)acrylamide (<b>3a</b>)</h4><div class="NLM_p last">To a stirred solution of NH<sub>2</sub>OH·HCl (23.35 g, 343 mmol) in 120 mL of MeOH was added KOH (28 g, 509 mmol) in 70 mL of MeOH at r.t. After 30 min, a white precipitate was filtered out to afford NH<sub>2</sub>OK methanol solution. <b>2a</b> (80 mg, 0.22 mmol) was added to 5 mL of NH<sub>2</sub>OK methanol solution, the mixture was stirred at room temperature for 5 min. The solvent was evaporated under vacuum; the residue was redissolved with 5 mL of water and then adjusted to pH 6–7 by hydrochloric acid. The precipitate was filtered and purified with column chromatography to afford light red solid 44 mg, yield 29%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.88 (brs, 1H) 10.74 (s, 1H), 8.98 (brs, 1H), 7.58 (d, <i>J</i> = 8.1 Hz, 2H), 7.53 (d, <i>J</i> = 8.1 Hz, 2H), 7.45 (d, <i>J</i> = 15.8 Hz, 1H), 7.24 (d, <i>J</i> = 8.7 Hz, 1H), 7.14 (d, <i>J</i> = 2.2 Hz, 1H), 7.03 (d, <i>J</i> = 2.3 Hz, 1H), 6.73 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 6.51 (d, <i>J</i> = 15.8 Hz, 1H), 4.07 (s, 2H), 3.75 (s, 3H), 3.01 (s, 4H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.3, 153.5, 146.3, 137.9, 135.2, 131.9, 130.4 (2C), 127.9 (2C), 127.7, 124.1, 120.0, 112.6, 111.7, 110.6, 100.7, 55.9, 50.9, 48.1, 23.4 ppm. IR (film): ν 3174, 2918, 2823, 1651, 1613, 1579, 1481, 1450, 1435, 1418, 1338, 1288, 1208, 1162, 1064, 1038, 1017, 964, 818, 796, 745, 698 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub>]<sup>+</sup>: 366.17, found: 339.05 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 8.77 min, purity = 96.1%. mp = 166–168 °C.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-Hydroxy-4-(((2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)methyl)benzamide (<b>3b</b>)</h4><div class="NLM_p last">Compound <b>3b</b> was prepared from <b>2b</b> in a similar manner as described for compound <b>3a</b>. Light red solid, yield 48%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.30 (brs, 1H), 10.79 (s, 1H), 9.13 (brs, 1H), 7.80 (d, <i>J</i> = 8.3 Hz, 2H), 7.66 (d, <i>J</i> = 8.3 Hz, 2H), 7.25 (d, <i>J</i> = 8.8 Hz, 1H), 7.17 (d, <i>J</i> = 2.4 Hz, 1H), 7.09 (d, <i>J</i> = 2.4 Hz, 1H), 6.74 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 4.21 (s, 2H), 3.76 (s, 3H), 3.10 (s, 4H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.0, 153.6, 136.2, 133.4, 131.9, 130.3 (2C), 127.6, 127.5 (2C), 124.3, 112.7, 111.7, 109.8, 100.7, 56.0, 50.0, 47.5, 22.4 ppm. IR (film): ν 3197, 2928, 2861, 1623, 1579, 1553, 1487, 1460, 1442, 1384, 1317, 1232, 1210, 1182, 1165, 1111, 1036, 1017, 897, 836, 791, 699 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>]<sup>+</sup>: 340.16, found: 340.10 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 7.50 min, purity = 99.4%. mp = 190–192 °C.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl 4-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-carbamoyl)benzoate (<b>4a</b>)</h4><div class="NLM_p last">TEA (0.48 g, 4.74 mmol) and TBTU (0.51 g, 1.58 mmol) were added to a solution of 4-(methoxycarbonyl)benzoic acid (0.28 g, 1.58 mmol) in 10 mL of THF and then stirred at r.t. for 1 h. 5-Methoxytryptamine <b>1</b> (0.3 g, 1.58 mmol) was added to the mixture and stirred for 2 h. By subsequently washing with water and brine, drying over MgSO<sub>4</sub>, and filtering, then, the solvent was removed under vacuum. The raw product was purified with column chromatography to afford red oil (0.37 g, yield 67%). ESI-MS <i>m</i>/<i>z</i>: 353.14 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.96 (d, <i>J</i> = 8.2 Hz, 2H), 7.64 (d, <i>J</i> = 8.2 Hz, 2H), 7.19 (s, 1H), 7.02–6.94 (m, 2H), 6.80 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.23 (brs, 1H), 3.85 (s, 3H), 3.76–3.68 (m, 5H), 3.00 (t, <i>J</i> = 6.5 Hz, 2H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.6, 166.3, 154.2, 138.6, 132.6, 131.6, 129.8 (2C), 127.7, 126.9 (2C), 122.9, 112.7 (2C), 112.1, 100.4, 55.9, 52.4, 40.5, 25.2 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>: 353.14, found: 353.15 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 11.28 min.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl (<i>E</i>)-3-(4-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-carbamoyl)phenyl)acrylate (<b>4b</b>)</h4><div class="NLM_p last">Intermediate <b>4b</b> was prepared from 5-methoxytryptamine <b>1</b> and (<i>E</i>)-4-(3-methoxy-3-oxoprop-1-en-1-yl)benzoic acid in a similar manner as described for intermediate <b>4a</b>. Faint yellow solid, yield 71%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.69 (s, 1H), 8.72 (t, <i>J</i> = 5.6 Hz, 1H), 7.94 (d, <i>J</i> = 8.3 Hz, 2H), 7.87 (d, <i>J</i> = 8.3 Hz, 2H), 7.75 (d, <i>J</i> = 16.1 Hz, 1H), 7.28 (d, <i>J</i> = 8.7 Hz, 1H), 7.19 (d, <i>J</i> = 2.0 Hz, 1H), 7.11 (d, <i>J</i> = 2.2 Hz, 1H), 6.83–6.74 (m, 2H), 3.80 (s, 3H), 3.77 (s, 3H), 3.60 (q, <i>J</i> = 6.9 Hz, 2H), 2.98 (t, <i>J</i> = 7.4 Hz, 2H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.0, 165.9, 153.5, 144.0, 136.9, 136.5, 131.9, 128.7 (2C), 128.13 (2C), 128.09, 123.8, 119.8, 112.5, 112.2, 111.5, 100.6, 55.8, 52.1, 40.8, 25.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>: 379.16, found: 379.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 11.69 min.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl (<i>E</i>)-4-(3-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)-3-oxoprop-1-en-1-yl)benzoate (<b>4c</b>)</h4><div class="NLM_p last">Intermediate <b>4c</b> was prepared from 5-methoxytryptamine <b>1</b> and (<i>E</i>)-3-(4-(methoxycarbonyl)phenyl)acrylic acid in a similar manner as described for intermediate <b>4a</b>. Yellow solid, yield 79%. ESI-MS <i>m</i>/<i>z</i>: 379.15 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.65 (s, 1H), 8.30 (t, <i>J</i> = 5.7 Hz, 1H), 7.99 (d, <i>J</i> = 8.4 Hz, 2H), 7.70 (d, <i>J</i> = 8.4 Hz, 2H), 7.50 (d, <i>J</i> = 15.8 Hz, 1H), 7.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.14 (d, <i>J</i> = 2.3 Hz, 1H), 7.05 (d, <i>J</i> = 2.4 Hz, 1H), 6.78 (d, <i>J</i> = 15.8 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.87 (s, 3H), 3.76 (s, 3H), 3.49 (q, <i>J</i> = 7.1 Hz, 2H), 2.88 (t, <i>J</i> = 7.2 Hz, 2H), 2.70 (s, 4H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.3, 165.0, 153.5, 140.1, 137.6, 131.9, 130.4, 130.2, 128.2, 128.0, 125.6, 123.9, 112.5, 112.1, 111.6, 100.6, 55.8, 52.7, 38.7, 25.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>: 379.16, found: 379.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 11.81 min.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Methyl 6-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)-6-oxohexanoate (<b>4d</b>)</h4><div class="NLM_p last">Intermediate <b>4d</b> was prepared from 5-methoxytryptamine <b>1</b> and 6-methoxy-6-oxohexanoic acid in a similar manner as described for intermediate <b>4a</b>. Colorless oil, yield 60%. ESI-MS <i>m</i>/<i>z</i>: 319.15 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.62 (s, 1H), 7.88 (t, <i>J</i> = 5.6 Hz, 1H), 7.22 (d, <i>J</i> = 8.7 Hz, 1H), 7.09 (d, <i>J</i> = 2.2 Hz, 1H), 7.02 (d, <i>J</i> = 2.4 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.76 (s, 3H), 3.59 (s, 3H), 3.35–3.27 (m, 2H), 2.77 (t, <i>J</i> = 7.4 Hz, 2H), 2.21 (t, <i>J</i> = 6.9 Hz, 2H), 2.07 (t, <i>J</i> = 7.0 Hz, 2H), 1.54–1.45 (m, 4H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 173.7, 172.2, 153.4, 131.9, 128.0, 123.7, 112.4, 112.1, 111.5, 100.6, 55.8, 51.7, 35.6, 33.5, 25.8, 25.2, 24.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>: 333.17, found: 333.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 10.31 min.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i><sup>1</sup>-Hydroxy-<i>N</i><sup>4</sup>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)-terephthalamide (<b>5a</b>)</h4><div class="NLM_p last">Compound <b>5a</b> was prepared from <b>4a</b> in a similar manner as described for compound <b>3a</b>. Gray solid, yield 19%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.32 (s, 1H), 10.65 (s, 1H), 9.11 (s, 1H), 8.70 (t, <i>J</i> = 5.6 Hz, 1H), 7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.15 (d, <i>J</i> = 2.1 Hz, 1H), 7.06 (d, <i>J</i> = 2.3 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.73 (s, 3H), 3.55 (q, <i>J</i> = 7.3 Hz, 2H), 2.93 (t, <i>J</i> = 7.4 Hz, 2H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.9, 164.0, 153.5, 137.4, 135.4, 131.9, 128.1, 127.7 (2C), 127.3 (2C), 123.8, 112.5, 112.2, 111.5, 100.6, 55.8, 40.8, 25.6 ppm. IR (film): ν 3258, 2921, 2833, 1667, 1608, 1541, 1482, 1443, 1420, 1332, 1303, 1291, 1214, 1178, 1153, 1030, 1013, 838, 795, 723, 692, 677 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 354.14, found: 354.00 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 11.36 min, purity = 99.9%. mp = 179–181 °C.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>E</i>)-4-(3-(Hydroxyamino)-3-oxoprop-1-en-1-yl)-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)benzamide (<b>5b</b>)</h4><div class="NLM_p last">Compound <b>5b</b> was prepared from <b>4b</b> in a similar manner as described for compound <b>3a</b>. Red solid, yield 30%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.82 (brs, 1H), 10.65 (s, 1H), 8.65 (t, <i>J</i> = 5.5 Hz, 1H), 7.88 (d, <i>J</i> = 8.3 Hz, 2H), 7.64 (d, <i>J</i> = 8.2 Hz, 2H), 7.50 (d, <i>J</i> = 15.8 Hz, 1H), 7.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.14 (d, <i>J</i> = 2.0 Hz, 1H), 7.06 (d, <i>J</i> = 2.3 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 6.56 (d, <i>J</i> = 15.8 Hz, 1H), 3.73 (s, 3H), 3.54 (q, <i>J</i> = 6.8 Hz, 2H), 2.93 (t, <i>J</i> = 7.4 Hz, 2H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.0, 162.9, 153.5, 137.8, 137.8, 135.7, 131.9, 128.2 (2C), 128.1, 127.8 (2C), 123.8, 121.2, 112.5, 112.2, 111.5, 100.7, 55.8, 40.7, 25.6 ppm. IR (film): ν 3186, 2883, 2814, 1609, 1525, 1487, 1478, 1440, 1427, 1284, 1207, 1163, 1043, 1021, 974, 831, 792, 755, 704, 660 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 380.15, found: 380.05 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 12.13 min, purity = 99.1%. mp = 90–92 °C.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>E</i>)-<i>N</i>-Hydroxy-4-(3-((2-(5-methoxy-1<i>H</i>-indol-3-yl)-ethyl)amino)-3-oxoprop-1-en-1-yl)benzamide (<b>5c</b>)</h4><div class="NLM_p last">Compound <b>5c</b> was prepared from <b>4c</b> in a similar manner as described for compound <b>3a</b>. Yellow solid, yield 18%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.26 (brs, 1H), 10.65 (s, 1H), 9.07 (brs, 1H), 8.25 (t, <i>J</i> = 5.7 Hz, 1H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.63 (d, <i>J</i> = 8.3 Hz, 2H), 7.47 (d, <i>J</i> = 15.8 Hz, 1H), 7.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.14 (d, <i>J</i> = 2.2 Hz, 1H), 7.05 (d, <i>J</i> = 2.3 Hz, 1H), 6.77–6.65 (m, 2H), 3.76 (s, 3H), 3.48 (q, <i>J</i> = 7.0 Hz, 2H), 2.87 (t, <i>J</i> = 7.2 Hz, 2H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.5, 165.1, 153.5, 138.1, 137.9, 133.7, 131.9, 128.0, 127.92 (2C), 127.87 (2C), 124.5, 123.8, 112.5, 112.1, 111.6, 100.6, 55.8, 49.1, 25.7 ppm. IR (film): ν 3198, 2894, 1659, 1565, 1536, 1491, 1459, 1356, 1317, 1224, 1204, 1174, 1029, 1013, 986, 895, 855, 801, 779, 713, 675 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 380.15, found: 380.10 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 12.24 min, purity = 97.1%. mp = 140–142 °C.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i><sup>1</sup>-Hydroxy-<i>N</i><sup>6</sup>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)-adipamide (<b>5d</b>)</h4><div class="NLM_p last">Compound <b>5d</b> was prepared from <b>4d</b> in a similar manner as described for compound <b>3a</b>. White solid, yield 17%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.62 (s, 1H), 10.33 (s, 1H), 8.65 (s, 1H), 7.87 (t, <i>J</i> = 5.4 Hz, 1H), 7.22 (d, <i>J</i> = 8.7 Hz, 1H), 7.09 (d, <i>J</i> = 2.1 Hz, 1H), 7.02 (d, <i>J</i> = 2.3 Hz, 1H), 6.71 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.76 (s, 3H), 3.31 (q, <i>J</i> = 7.4 Hz, 2H), 2.77 (t, <i>J</i> = 7.4 Hz, 2H), 2.06 (t, <i>J</i> = 8.0 Hz, 2H), 1.94 (t, <i>J</i> = 8.0 Hz, 2H), 1.51–1.43 (m, 4H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.3, 169.5, 153.4, 131.9, 128.0, 123.7, 112.4, 112.1, 111.5, 100.6, 98.7, 55.8, 35.8, 32.6, 25.8, 25.5, 25.4 ppm. IR (film): ν 3386, 3318, 3189, 2972, 2871, 1637, 1616, 1586, 1549, 1485, 1466, 1452, 1434, 1416, 1288, 1213, 1170, 1036, 1020, 951, 923, 840, 812, 773, 702, 667 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>17</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 334.17, found: 334.05 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 10.64 min, purity = 96.5%. mp = 138–139 °C.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)acetamide (Melatonin, <b>6</b>)</h4><div class="NLM_p last">5-Methoxytryptamine <b>1</b> (2.0 g, 10.5 mmol) was suspended in 25 mL of DCM, and acetic anhydride (4.4 g, 42.11 mmol) in 5 mL of DCM was added in drops to the solution at 0 °C and then stirred at r.t. for 2 h. The mixture was washed with sat. NaHCO<sub>3</sub> aq., water, and brine; dried with MgSO<sub>4</sub>; filtered; and removed the solvent to afford brown solid 2.0 g, yield 82%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.00 (brs, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 1H), 6.97 (d, <i>J</i> = 2.3 Hz, 1H), 6.95 (s, 1H), 6.80 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 5.53 (brs, 1H), 3.79 (s, 3H), 3.52 (q, <i>J</i> = 6.4 Hz, 2H), 2.86 (t, <i>J</i> = 6.7 Hz, 2H), 1.86 (s, 3H) ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>13</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>]<sup>+</sup>: 233.12, found: 233.15 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 8.98 min, purity 98.7%.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl (<i>E</i>)-3-(4-((3-(2-Acetamidoethyl)-5-methoxy-1<i>H</i>-indol-1-yl)methyl)phenyl)acrylate (<b>7a</b>)</h4><div class="NLM_p last">Melatonin (0.5 g, 2.2 mmol) and <i>t</i>-BuOK (0.49 g, 4.4 mmol) were stirred in 15 mL of THF at 70 °C for 40 min; then methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)acrylate (0.66 g, 2.6 mmol) was added and stirred for 12 h. The mixture was cooled to r.t. and concentrated under vacuum; the residue was redissolved in DCM and then washed with 0.1 M HCl, water, and brine. The organic phase was dried over MgSO<sub>4</sub> and filtered, the solvent was removed and then redissolved in MeOH, and SOCl<sub>2</sub> (0.79 g, 6.6 mmol) was added in drop with an ice bath and after that stirred at r.t. overnight. The solvent was removed under vacuum and redissolved with DCM, then washed with 0.1 M NaOH, water, and brine and finally purified with column chromatography to afford yellow solid 0.83 g, yield 66%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.94 (t, <i>J</i> = 5.5 Hz, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 2H), 7.61 (d, <i>J</i> = 16.4 Hz, 1H), 7.27 (d, <i>J</i> = 8.8 Hz, 1H), 7.27 (s, 1H), 7.18 (d, <i>J</i> = 8.1 Hz, 2H), 7.06 (d, <i>J</i> = 2.3 Hz, 1H), 6.73 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.58 (d, <i>J</i> = 16.0 Hz, 1H), 5.34 (s, 2H), 3.76 (s, 3H), 3.71 (s, 3H), 3.32 (q, <i>J</i> = 7.4 Hz, 2H), 2.79 (t, <i>J</i> = 7.4 Hz, 2H), 1.81 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.5, 167.1, 153.8, 144.6, 141.6, 133.5, 131.8, 129.0 (2C), 128.7, 127.9 (2C), 127.6, 118.1, 112.2, 111.7, 111.2, 101.2, 55.9, 51.9, 49.3, 25.6, 23.2 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>: 407.19, found: 407.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 12.48 min.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 4-((3-(2-Acetamidoethyl)-5-methoxy-1<i>H</i>-indol-1-yl)methyl)benzoate (<b>7b</b>)</h4><div class="NLM_p last">Intermediate <b>7b</b> was prepared from melatonin and methyl 4-(bromomethyl)-benzoate in a similar manner as described for intermediate <b>7a</b>. Off-white solid, yield 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.93 (t, <i>J</i> = 5.0 Hz, 1H), 7.88 (d, <i>J</i> = 8.3 Hz, 2H), 7.27 (s, 1H), 7.25 (d, <i>J</i> = 8.3 Hz, 2H), 7.24 (d, <i>J</i> = 8.8 Hz, 1H), 7.06 (d, <i>J</i> = 2.4 Hz, 1H), 6.73 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.42 (s, 2H), 3.82 (s, 3H), 3.76 (s, 3H), 3.32 (q, <i>J</i> = 7.4 Hz, 2H), 2.80 (t, <i>J</i> = 7.4 Hz, 2H), 1.80 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.5, 166.4, 153.8, 144.6, 131.8, 129.9, 129.0, 128.7, 127.7, 127.5, 112.3, 111.8, 111.2, 101.2, 55.9, 52.6, 49.2, 25.6, 23.2 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>: 381.17, found: 381.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 12.08 min.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl 6-(3-(2-Acetamidoethyl)-5-methoxy-1<i>H</i>-indol-1-yl)hexanoate (<b>7c</b>)</h4><div class="NLM_p last">Intermediate <b>7c</b> was prepared from melatonin and methyl 6-bromohexanoate in a similar manner as described for intermediate <b>7a</b>. Yellow oil, yield 57%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.13 (d, <i>J</i> = 8.9 Hz, 1H), 6.94 (d, <i>J</i> = 2.1 Hz, 1H), 6.84 (s, 1H), 6.81 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 6.05 (brs, 1H), 3.97 (t, <i>J</i> = 6.9 Hz, 2H), 3.79 (s, 3H), 3.60 (s, 3H), 3.56 (s, 3H), 3.54–3.47 (m, 2H), 2.87 (t, <i>J</i> = 6.0 Hz, 2H), 2.21 (t, <i>J</i> = 7.3 Hz, 2H), 1.78–1.70 (m, 2H), 1.57–1.51 (m, 2H), 1.30–1.20 (m, 2H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 169.2, 165.4, 149.1, 127.0, 123.4, 121.6, 107.2, 106.2, 105.5, 95.9, 51.2, 46.8, 41.4, 35.3, 29.0, 25.2, 21.7, 20.5, 19.7, 18.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>20</sub>H<sub>29</sub>N<sub>2</sub>O<sub>4</sub>]<sup>+</sup>: 361.20, found: 361.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 11.83 min.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>E</i>)-3-(4-((3-(2-Acetamidoethyl)-5-methoxy-1<i>H</i>-indol-1-yl)methyl)phenyl)-<i>N</i>-hydroxyacrylamide (<b>8a</b>)</h4><div class="NLM_p last">Compound <b>8a</b> was prepared from <b>7a</b> in a similar manner as described for compound <b>3a</b>. Red solid, yield 34%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.21 (s, 2H), 7.94 (t, <i>J</i> = 5.3 Hz, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 2H), 7.40 (d, <i>J</i> = 15.8 Hz, 1H), 7.27 (d, <i>J</i> = 7.6 Hz, 1H), 7.26 (s, 1H), 7.18 (d, <i>J</i> = 8.1 Hz, 2H), 7.05 (d, <i>J</i> = 2.3 Hz, 1H), 6.73 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.40 (d, <i>J</i> = 15.8 Hz, 1H), 5.33 (s, 2H), 3.76 (s, 3H), 3.31 (q, <i>J</i> = 7.4 Hz, 2H), 2.79 (t, <i>J</i> = 7.4 Hz, 2H), 1.80 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.5, 165.5, 153.8, 140.4, 138.3, 134.3, 131.8, 128.7, 128.1 (2C), 127.9 (2C), 127.6, 119.4, 112.1, 111.7, 111.2, 101.2, 55.9, 49.3, 39.9, 25.6, 23.2 ppm. IR (film): ν 3276, 2919, 2839, 1662, 1631, 1562, 1492, 1455, 1440, 1358, 1303, 1222, 1178, 1040, 975, 831, 795, 738, 669 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 408.18, found: 408.10 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 13.31 min, purity = 95.2%. mp = 187–189 °C.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-((3-(2-Acetamidoethyl)-5-methoxy-1<i>H</i>-indol-1-yl)-methyl)-<i>N</i>-hydroxybenzamide (<b>8b</b>)</h4><div class="NLM_p last">Compound <b>8b</b> was prepared from <b>7b</b> in a similar manner as described for compound <b>3a</b>. Off-white solid, yield 14%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.13 (s, 1H), 8.99 (s, 1H), 7.94 (t, <i>J</i> = 5.6 Hz, 1H), 7.66 (d, <i>J</i> = 8.2 Hz, 2H), 7.27 (s, 1H), 7.26 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.2 Hz, 2H), 7.05 (d, <i>J</i> = 2.4 Hz, 1H), 6.73 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.36 (s, 2H), 3.76 (s, 3H), 3.31 (q, <i>J</i> = 7.3 Hz, 2H), 2.79 (t, <i>J</i> = 7.4 Hz, 2H), 1.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.5, 164.4, 153.8, 142.2, 132.3, 131.7, 128.7, 127.6, 127.5 (2C), 127.3 (2C), 112.1, 111.7, 111.2, 101.2, 55.9, 49.2, 39.9, 25.6, 23.2. IR (film): ν 3204, 3012, 2812, 2633, 2531, 1646, 1627, 1585, 1574, 1495, 1453, 1411, 1356, 1224, 1040, 1030, 844, 837, 807, 773, 715 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 382.17, found: 382.05 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 12.14 min, purity = 98.0%. mp = 90–92 °C.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-(3-(2-Acetamidoethyl)-5-methoxy-1<i>H</i>-indol-1-yl)-<i>N</i>-hydroxyhexanamide (<b>8c</b>)</h4><div class="NLM_p last">Compound <b>8c</b> was prepared from <b>7c</b> in a similar manner as described for compound <b>3a</b>. Pale yellow solid, yield 26%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.31 (s, 1H), 8.64 (s, 1H), 7.93 (t, <i>J</i> = 5.4 Hz, 1H), 7.30 (d, <i>J</i> = 8.8 Hz, 1H), 7.12 (s, 1H), 7.02 (d, <i>J</i> = 2.3 Hz, 1H), 6.76 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 4.04 (t, <i>J</i> = 7.0 Hz, 2H), 3.77 (s, 3H), 3.31 (q, <i>J</i> = 7.4 Hz, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H), 1.92 (t, <i>J</i> = 7.4 Hz, 2H), 1.81 (s, 3H), 1.74–1.65 (m, 2H), 1.56–1.44 (m, 2H), 1.26–1.15 (m, 2H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.5, 169.4, 153.5, 131.7, 128.4, 127.0, 111.5, 111.3, 110.8, 101.0, 55.9, 45.7, 39.9, 32.6, 30.1, 26.4, 25.6, 25.2, 23.2 ppm. IR (film): ν 3298, 3265, 2933, 2879, 1667, 1659, 1596, 1504, 1461, 1398, 1332, 1231, 1185, 1094, 1040, 966, 849, 791, 769, 676 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>19</sub>H<sub>28</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 362.20, found: 362.10 [M + H]<sup>+</sup>. HPLC (method A): <i>t</i><sub>R</sub> = 12.28 min, purity = 99.5%. mp = 130–131 °C.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl (<i>E</i>)-3-(4-(((<i>E</i>)-3-(4-((Ethoxycarbonyl)oxy)-3-methoxyphenyl)-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)-ethyl)acrylamido)methyl)phenyl)acrylate (<b>9a</b>)</h4><div class="NLM_p last">TEA (0.33 g, 3.3 mmol) and ethyl chloroformate (0.28 g, 2.6 mmol) were added to a solution of ferulic acid (0.26 g, 1.3 mmol) in 15 mL of THF and then stirred at room temperature for 5 min. <b>2a</b> (0.40 g, 1.1 mmol) was added to the mixture in portions and then stirred at r.t. for 30 min. The solvent was removed under vacuum, and the residue was purified with column chromatography to afford pale-yellow solid 0.40 g, yield 60%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.66/10.64* (d, <i>J</i> = 1.6 Hz, 1H), 7.72*/7.71 (d, <i>J</i> = 8.1 Hz, 2H), 7.66/7.64* (d, <i>J</i> = 15.9 Hz, 1H), 7.62*/7.40 (d, <i>J</i> = 15.4 Hz, 1H), 7.46*/7.28 (d, <i>J</i> = 1.9 Hz, 1H), 7.35/7.31* (d, <i>J</i> = 8.1 Hz, 2H), 7.22*/7.18 (d, <i>J</i> = 8.8 Hz, 1H), 7.20*/7.11 (d, <i>J</i> = 8.8 Hz, 1H), 7.09 (d, <i>J</i> = 2.2 Hz, 1H), 7.04*/6.99 (d, <i>J</i> = 2.2 Hz, 1H), 6.85 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 6.82 (d, <i>J</i> = 15.7 Hz, 1H), 6.71 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 6.63/6.62* (d, <i>J</i> = 16.0 Hz, 1H), 4.87*/4.72 (s, 2H), 4.30–4.19 (m, 2H), 3.83*/3.80 (s, 3H), 3.75*/3.73 (s, 3H), 3.71 (s, 3H), 3.71–3.58 (m, 2H), 3.02–2.84 (m, 2H), 1.29/1.27* (t, <i>J</i> = 7.1 Hz, 3H) ppm (the minor rotamer: 35%). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.2, 167.1, 166.3, 153.6, 153.5, 152.8, 151.4, 144.7, 141.6, 140.8, 140.6, 134.8, 133.3, 131.9, 129.2, 129.0, 128.7, 128.0, 127.8, 124.7, 120.4, 119.5, 118.0, 112.9, 112.6, 111.6, 110.9, 100.4, 100.0, 65.2, 56.6, 56.4, 55.79, 55.75, 51.9, 48.5, 48.0, 25.1, 14.5 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>35</sub>H<sub>37</sub>N<sub>2</sub>O<sub>8</sub>]<sup>+</sup>: 613.25, found: 613.30 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 13.33 min.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl (<i>E</i>)-4-((3-(4-((Ethoxycarbonyl)oxy)-3-meth-oxyphenyl)-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)acry-lamido)methyl)benzoate (<b>9b</b>)</h4><div class="NLM_p last">Intermediate <b>9b</b> was prepared from <b>2b</b> and ferulic acid in a similar manner as described for intermediate <b>9a</b>. Yellow solid, yield 90%. <sup>1</sup>H NMR (400 MHz, DMSO<i>-d</i><sub>6</sub>): δ 10.66/10.64* (d, <i>J</i> = 1.5 Hz, 1H), 7.95 (d, <i>J</i> = 8.2 Hz, 2H), 7.62*/7.40 (d, <i>J</i> = 15.2 Hz, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 2H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.28/7.26* (d, <i>J</i> = 1.7 Hz, 1H), 7.24*/6.82 (d, <i>J</i> = 15.6 Hz, 1H) 7.22*/7.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.20*/7.11 (d, <i>J</i> = 8.8 Hz, 1H), 7.08 (d, <i>J</i> = 2.4 Hz, 1H), 7.03*/6.99 (d, <i>J</i> = 2.2 Hz, 1H), 6.85 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 6.71 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 4.93*/4.78 (s, 2H), 4.29–4.20 (m, 2H), 3.85/3.83* (s, 3H), 3.83*/3.80 (s, 3H), 3.74*/3.71 (s, 3H), 3.70–3.58 (m, 2H), 3.00–2.84 (m, 2H), 1.29/1.28* (t, <i>J</i> = 7.0 Hz, 3H) ppm (the minor rotamer: 32%). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.8, 166.7, 166.6, 166.5, 153.7, 153.5, 149.0, 148.8, 148.3, 148.2, 144.9, 144.8, 143.1, 142.5, 131.9, 130.0, 129.8, 129.1, 128.8, 128.3, 128.0, 127.9, 127.6, 127.12, 127.05, 124.6, 123.9, 122.8, 121.9, 116.1, 115.3, 112.6, 112.5, 112.3, 111.9, 111.8, 111.6, 111.0, 100.6, 100.4, 56.2, 56.1, 55.8, 55.4, 52.5, 51.1, 48.7, 48.1, 47.7, 25.2, 23.9, 14.3 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>33</sub>H<sub>35</sub>N<sub>2</sub>O<sub>8</sub>]<sup>+</sup>: 587.23, found: 587.25 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 13.13 min.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl (<i>E</i>)-6-(3-(4-((Ethoxycarbonyl)oxy)-3-meth-oxyphenyl)-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)acry-lamido)hexanoate (<b>9c</b>)</h4><div class="NLM_p last">Intermediate <b>9c</b> was prepared from <b>2c</b> and ferulic acid in a similar manner as described for intermediate <b>9a</b>. Yellow oil, yield 49%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.66/10.64* (d, <i>J</i> = 1.5 Hz, 1H), 7.55*/7.30 (d, <i>J</i> = 15.6 Hz, 1H), 7.48*/7.03 (d, <i>J</i> = 2.2 Hz, 1H), 7.33*/6.82 (dd, <i>J</i> = 8.3, 1.5 Hz, 1H), 7.25–7.22 (m, 1H), 7.18 (d, <i>J</i> = 8.7 Hz, 1H), 7.16–7.11 (m, 2H), 7.09 (d, <i>J</i> = 8.2 Hz, 1H), 6.76–6.69 (m, 1H), 4.25*/4.24 (q, <i>J</i> = 7.1 Hz, 2H), 3.87*/3.79 (s, 3H), 3.77*/3.72 (s, 3H), 3.72*/3.62 (t, <i>J</i> = 7.3 Hz, 2H), 3.59/3.54* (s, 3H), 3.48*/3.39 (t, <i>J</i> = 7.3 Hz, 2H), 2.94/2.92* (t, <i>J</i> = 7.0 Hz, 2H), 2.32/2.27* (t, <i>J</i> = 7.4 Hz, 2H), 1.65–1.48 (m, 4H), 1.36–1.23 (m, 5H) ppm (the minor rotamer: 42%). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 173.8, 173.7, 165.7, 165.6, 153.6, 152.9, 151.5, 151.4, 140.8, 140.5, 139.9, 135.0, 131.8, 127.9, 124.7, 123.8, 122.9, 121.0120.3, 120.1, 119.9, 112.8, 112.6, 112.5, 112.0, 111.54, 111.50, 111.0, 100.8, 100.4, 65.2, 56.5, 56.4, 55.8, 55.7, 51.6, 51.6, 48.2, 45.8, 33.7, 33.6, 29.6, 27.6, 26.5, 26.0, 25.4, 24.7, 24.6, 24.1, 14.5 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>39</sub>N<sub>2</sub>O<sub>8</sub>]<sup>+</sup>: 567.26, found: 567.30 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 12.90 min.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)-<i>N</i>-(4-((<i>E</i>)-3-(hydroxyamino)-3-oxoprop-1-en-1-yl)benzyl)-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)acrylamide (<b>10a</b>)</h4><div class="NLM_p last">Compound <b>10a</b> was prepared from <b>9a</b> in a similar manner as described for compound <b>3a</b>. Gray solid 0.16 g, yield 60%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.75 (s, 1H), 10.67/10.64* (s, 1H), 9.40 (s, 1H), 9.03 (s, 1H), 7.54 (d, <i>J</i> = 7.5 Hz, 2H), 7.45/7.44* (d, <i>J</i> = 15.8 Hz, 1H), 7.38 (d, <i>J</i> = 15.3 Hz, 1H), 7.33/7.29* (d, <i>J</i> = 8.1 Hz, 2H), 7.24 (d, <i>J</i> = 3.5 Hz, 1H), 7.21 (d, <i>J</i> = 8.6 Hz, 1H), 7.12–7.06 (m, 2H), 7.03*/7.00 (d, <i>J</i> = 1.9 Hz, 1H), 6.81–6.64 (m, 3H), 6.45/6.44* (d, <i>J</i> = 15.8 Hz, 1H), 4.83*/4.70 (s, 2H), 3.80*/3.77 (s, 3H), 3.74*/3.73 (s, 3H), 3.68/3.61* (t, <i>J</i> = 6.8 Hz, 2H), 3.01–2.85 (m, 2H) ppm (the minor rotamer: 38%). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.7, 166.6, 163.3, 153.6, 153.5, 149.0, 148.8, 148.3, 148.1, 142.9, 142.3, 140.6, 138.5, 134.1, 131.9, 128.7 (2C), 128.3, 128.1 (2C), 128.0, 127.8, 127.13, 127.07, 124.6, 123.8, 122.8, 121.9, 119.4, 119.2, 116.04, 115.98, 115.5, 112.6, 112.3, 111.9, 111.8, 111.6, 111.0, 100.6, 100.4, 56.24, 56.15, 55.8, 48.4, 47.9, 47.5, 25.1, 23.9 ppm. IR (film): ν 3229, 2952, 2885, 1626, 1572, 1505, 1472, 1450, 1434, 1412, 1352, 1259, 1230, 1204, 1171, 1148, 1120, 1022, 976, 835, 816, 792, 748, 701, 656 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>32</sub>N<sub>3</sub>O<sub>6</sub>]<sup>+</sup>: 542.22, found: 542.30 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 11.20 min, purity = 99.8%. mp = 135–137 °C.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>E</i>)-<i>N</i>-Hydroxy-4-((3-(4-hydroxy-3-methoxyphenyl)-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)acrylamido)-methyl)benzamide (<b>10b</b>)</h4><div class="NLM_p last">Compound <b>10b</b> was prepared from <b>9b</b> in a similar manner as described for compound <b>3a</b>. Orange oil, yield 46%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.18 (s, 1H), 10.68/10.64* (s, 1H), 9.42*/9.40 (s, 1H), 9.01 (brs, 1H), 7.77–7.69 (m, 2H), 7.58–7.16 (m, 5H), 7.12–6.98 (m, 3H), 6.82–6.64 (m, 3H), 4.85*/4.71 (s, 2H), 3.79*/3.77 (s, 3H), 3.74*/3.73 (s, 3H), 3.69/3.61* (t, <i>J</i> = 6.6 Hz, 2H), 3.00–2.85 (m, 2H) ppm (the minor rotamer: 38%). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.2, 166.8, 153.6, 153.49, 153.46, 148.8, 148.1, 147.8, 147.6, 142.4, 142.3, 132.8, 131.9, 128.4, 128.0, 127.6, 127.5, 127.3, 127.3, 127.0, 124.6, 124.1, 123.8, 122.4, 121.9, 116.0, 115.8, 115.4, 113.0, 112.6, 112.3, 111.6, 111.0, 110.9, 100.4, 100.2, 56.2, 56.1, 56.0, 55.9, 55.8, 55.8, 55.4, 49.1, 25.1, 21.0 ppm. IR (film): ν 3201, 2930, 2856, 1639, 1574, 1513, 1482, 1452, 1366, 1268, 1211, 1155, 1124, 1070, 1025, 1013, 973, 894, 815, 796, 747 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>30</sub>N<sub>3</sub>O<sub>6</sub>]<sup>+</sup>: 516.21, found: 516.25 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 10.77 min, purity = 95.7%. mp = 86–88 °C.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>E</i>)-<i>N</i>-Hydroxy-6-(3-(4-hydroxy-3-methoxyphenyl)-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)acrylamido)-hexanamide (<b>10c</b>)</h4><div class="NLM_p last">Compound <b>10c</b> was prepared from <b>9c</b> in a similar manner as described for compound <b>3a</b>. White solid, yield 33%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.67/10.63* (s, 1H), 10.34/10.32* (s, 1H), 9.35 (brs, 1H), 8.66 (s, 1H), 7.48*/7.27 (d, <i>J</i> = 15.2 Hz, 1H), 7.26–7.09 (m, 1H), 7.16–7.10 (s, 1H), 7.03 (s, 1H), 6.91*/6.58 (d, <i>J</i> = 15.3 Hz, 1H), 6.81*/6.73 (d, <i>J</i> = 8.1 Hz, 1H), 6.76–6.67 (m, 2H), 6.18–6.14 (m, 1H), 3.83*/3.77 (s, 3H), 3.75*/3.74 (s, 3H), 3.70/3.60* (t, <i>J</i> = 7.2 Hz 2H), 3.45*/3.36 (t, <i>J</i> = 7.2 Hz 2H), 2.94/2.90* (t, <i>J</i> = 6.80 Hz, 2H), 2.02–1.90 (m, 2H), 1.62–1.46 (m, 4H), 1.34–1.18 (m, 2H) ppm (the minor rotamer: 40%). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.6, 169.5, 166.1, 166.0, 163.0, 153.6, 153.5, 148.8, 148.6, 148.3, 148.1, 142.1, 141.4, 131.9, 127.9, 127.3, 124.6, 123.8, 122.4, 121.7, 116.1, 115.8, 112.6, 112.2, 112.0, 111.5, 111.5, 111.1, 100.8, 100.4, 56.3, 56.1, 55.79, 55.75, 48.2, 47.5, 45.9, 32.7, 29.7, 27.8, 26.7, 26.2, 25.5, 25.3 ppm. IR (film): ν 3304, 3199, 2922, 2851, 1637, 1582, 1513, 1481, 1454, 1427, 1372, 1268, 1214, 1161, 1124, 1101, 1064, 1028, 972, 917, 816, 795 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>27</sub>H<sub>34</sub>N<sub>3</sub>O<sub>6</sub>]<sup>+</sup>: 496.24, found: 496.25 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 10.77 min, purity = 97.6%. mp = 85–87 °C.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>tert</i>-Butyl (2-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)-2-oxoethyl)carbamate (<b>11</b>)</h4><div class="NLM_p last">TEA (1.07 g, 10.50 mmol), EDCI (2.40 g, 12.60 mmol), and DMAP (1.28 g, 10.5 mmol) were added to a solution of Boc-Glu-OH (2.20 g, 12.60 mmol) in 40 mL of THF; then 5-methoxytryptamine <b>1</b> (2.00 g, 10.50 mmol) was added to the mixture and, after that, stirred overnight at r.t. THF was removed, and the residue was redissolved in DCM, washed with 0.1 M HCl, water, and brine, dried over MgSO<sub>4</sub>, and purified with column chromatography to afford a 3.20 g white solid, yield 88%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.99 (brs, 1H), 7.18 (d, <i>J</i> = 7.9 Hz 1H), 6.95 (d, <i>J</i> = 2.3 Hz, 1H), 6.93 (s, 1H), 6.79 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.13 (brs, 1H), 5.03 (brs, 1H), 3.79 (s, 3H), 3.66 (s, 2H), 3.53 (q, <i>J</i> = 6.1 Hz, 2H), 2.87 (t, <i>J</i> = 6.7 Hz, 2H), 1.35 (s, 9H) ppm. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 172.2, 169.3, 154.1, 131.6, 127.7, 122.9, 112.4 (2C), 112.0, 100.5, 56.0, 44.5, 39.5, 28.3 (3C), 25.3 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>18</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 348.18, found: 348.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 10.74 min.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-Amino-<i>N</i>-(2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)acet-amide (<b>12</b>)</h4><div class="NLM_p last"><b>11</b> (2.5 g, 7.20 mmol) was dissolved in 30 mL of DCM; then 8 mL of TFA was added and stirred at r.t. for 30 min. After that, the solvent was removed under vacuum and purified with column chromatography to afford light red oil 1.6 g, yield 90%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.65 (s, 1H), 8.01 (s, 1H), 7.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.12 (d, <i>J</i> = 2.3 Hz, 1H), 7.05 (d, <i>J</i> = 2.4 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.77 (s, 3H), 3.38 (q, <i>J</i> = 7.1 Hz, 2H), 3.11 (s, 2H), 2.81 (t, <i>J</i> = 7.4 Hz, 2H), 2.29 (brs, 2H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 173.0, 153.5, 131.9, 128.0, 123.8, 112.5, 111.9, 111.5, 100.7, 55.8, 55.4, 44.7, 25.7 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>13</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>]<sup>+</sup>: 248.13, found: 248.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 6.15 min.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl (<i>E</i>)-3-(4-(((2-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)-ethyl)amino)-2-oxoethyl)amino)methyl)phenyl)acry-late (<b>13a</b>)</h4><div class="NLM_p last">Intermediate <b>13a</b> was prepared from intermediate <b>12</b> and methyl (<i>E</i>)-3-(4-(bromomethyl)-phenyl)acrylate in a similar manner as described for intermediate <b>2a</b>. Yellow oil, yield 30%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.66 (s, 1H), 7.90 (t, <i>J</i> = 5.7 Hz, 1H), 7.65 (d, <i>J</i> = 15.7 Hz, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 2H), 7.32 (d, <i>J</i> = 8.1 Hz, 2H), 7.24 (d, <i>J</i> = 8.7 Hz, 1H), 7.12 (d, <i>J</i> = 2.3 Hz, 1H), 7.05 (d, <i>J</i> = 2.4 Hz, 1H), 6.73 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 6.62 (d, <i>J</i> = 16.1 Hz, 1H), 3.76 (s, 3H), 3.73 (s, 3H), 3.66 (s, 2H), 3.40 (q, <i>J</i> = 7.0 Hz, 2H), 3.07 (s, 2H), 2.81 (t, <i>J</i> = 7.2 Hz, 2H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.0, 167.2, 153.5, 144.9, 143.3, 133.0, 131.9, 129.0 (2C), 128.7 (2C), 128.0, 123.8, 117.7, 112.5, 111.9, 111.5, 100.7, 55.8, 55.4, 52.7, 51.9, 51.8, 25.7 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>28</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 422.20, found: 422.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 8.69 min.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl 4-(((2-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)-2-oxoethyl)amino)methyl)benzoate (<b>13b</b>)</h4><div class="NLM_p last">Intermediate <b>13b</b> was prepared from intermediate <b>12</b> and methyl 4-(bromomethyl)benzoate in a similar manner as described for intermediate <b>2a</b>. Pale yellow oil, yield 16%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.66 (s, 1H), 7.93–7.84 (m, 3H), 7.41 (d, <i>J</i> = 8.2 Hz, 2H), 7.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.12 (d, <i>J</i> = 2.2 Hz, 1H), 7.05 (d, <i>J</i> = 2.3 Hz, 1H), 6.73 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 3.85 (s, 3H), 3.76 (s, 3H), 3.69 (s, 2H), 3.40 (q, 7.0 Hz, 2H), 3.07 (s, 2H), 2.81 (t, <i>J</i> = 7.2 Hz, 2H) ppm (one exchangeable proton not observed). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.1, 166.7, 153.5, 146.6, 131.9, 129.5 (2C), 128.6 (2C), 128.5, 128.0, 123.8, 112.5, 112.0, 111.5, 100.7, 55.8, 52.7, 52.5, 52.0, 25.7 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>22</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 396.18, found: 396.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 8.30 min.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 6-((2-((2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)-2-oxoethyl)amino)hexanoate (<b>13c</b>)</h4><div class="NLM_p last">Intermediate <b>13c</b> was prepared from intermediate <b>12</b> and methyl 6-bromohexanoate in a similar manner as described for intermediate <b>2a</b>. Yellow oil, yield 42%. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>): δ 7.24 (d, <i>J</i> = 8.8 Hz, 1H), 7.07 (s, 1H), 7.07 (d, <i>J</i> = 2.4 Hz, 1H), 6.77 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 3.84 (s, 3H), 3.74 (s, 2H), 3.67 (s, 3H), 3.61–3.54 (m, 2H), 2.95 (t, <i>J</i> = 7.0 Hz, 2H), 2.77 (t, <i>J</i> = 7.6 Hz, 2H), 2.34 (t, <i>J</i> = 7.3 Hz, 2H), 1.93–1.83 (m, 2H), 1.74–1.52 (m, 2H), 1.43–1.23 (m, 2H) ppm (exchangeable protons not observed). <sup>13</sup>C NMR (101 MHz, MeOD-<i>d</i><sub>4</sub>): δ 174.2, 167.6153.6, 131.0, 127.3, 122.9, 112.2, 111.7, 111.4, 99.8, 54.6, 52.5, 50.7, 49.8, 48.6, 33.2, 28.2, 26.3, 24.9, 24.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>20</sub>H<sub>30</sub>N<sub>3</sub>O<sub>4</sub>]<sup>+</sup>: 376.22, found: 376.20 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 7.96 min.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl (<i>E</i>)-3-(4-(((<i>E</i>)-3-(4-((Ethoxycarbonyl)oxy)-3-methoxyphenyl)-<i>N</i>-(2-((2-(5-methoxy-1<i>H</i>-indol-3-yl)-ethyl)amino)-2-oxoethyl)acrylamido)methyl)phenyl)-acrylate (<b>14a</b>)</h4><div class="NLM_p last">Intermediate <b>14a</b> was prepared from intermediate <b>13a</b> and ferulic acid in a similar manner as described for intermediate <b>9a</b>. White solid, yield 44%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.22/8.20* (s, 1H), 7.73*/7.67 (d, <i>J</i> = 15.2 Hz, 1H), 7.65/7.60* (d, <i>J</i> = 16.0 Hz, 1H), 7.45/7.31* (d, <i>J</i> = 8.0 Hz, 2H), 7.22/7.15* (d, <i>J</i> = 8.8 Hz, 2H), 7.19–7.01 (m, 5H), 6.99/6.95* (s, 1H), 6.88–6.76 (m, 1H), 6.65/6.62* (d, <i>J</i> = 15.2 Hz, 1H), 6.55/6.01* (t, <i>J</i> = 5.4 Hz, 1H), 6.42/6.37* (d, <i>J</i> = 16.1 Hz, 1H), 4.60/4.58* (s, 2H), 4.40–4.28 (m, 2H), 4.03/4.02* (s, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 3.82 (s, 3H), 3.58/3.52* (q, <i>J</i> = 6.4 Hz, 2H), 2.95/2.86* (t, <i>J</i> = 6.6 Hz, 2H), 1.46–1.35 (m, 3H) ppm (the minor rotamer: 31%). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 168.9, 167.7, 167.3, 167.3, 154.1, 153.0, 151.6, 151.5, 143.9, 143.8, 141.5, 138.3, 134.2, 133.8, 128.9, 128.7, 128.5, 127.9, 127.1, 123.2, 122.8, 120.9, 120.6, 118.3, 116.5, 112.3, 112.3, 112.0, 112.0, 100.5, 100.4, 65.2, 65.2, 56.1, 56.0, 55.9, 52.2, 51.8, 51.0, 46.9, 39.7, 39.2, 24.9, 14.2, 8.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>37</sub>H<sub>40</sub>N<sub>3</sub>O<sub>9</sub>]<sup>+</sup>: 670.27, found: 670.30 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 12.72 min.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Methyl (<i>E</i>)-4-((3-(4-((Ethoxycarbonyl)oxy)-3-meth-oxyphenyl)-<i>N</i>-(2-((2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)-2-oxoethyl)acrylamido)methyl)benzoate (<b>14b</b>)</h4><div class="NLM_p last">Intermediate <b>14b</b> was prepared from intermediate <b>13b</b> and ferulic acid in a similar manner as described for intermediate <b>9a</b>. White solid, yield 71%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.05/8.02* (s, 1H), 7.91/7.81* (d, <i>J</i> = 8.1 Hz, 2H), 7.67–7.49 (m, 1H), 7.17–7.08 (m, 3H), 7.08–6.98 (m, 2H), 6.98–6.91 (m, 2H), 6.88 (s, 1H), 6.81–6.69 (m, 1H), 6.52*/6.50 (d, <i>J</i> = 15.3 Hz, 1H), 6.44/5.94* (t, <i>J</i> = 5.1 Hz, 1H), 4.54/4.52* (s, 2H), 4.32–4.15 (m, 2H), 3.95/3.91* (s, 2H), 3.84 (s, 3H), 3.80*/3.76 (s, 3H), 3.77*/3.75 (s, 3H), 3.59–3.39 (m, 2H), 2.87/2.79* (t, <i>J</i> = 6.7 Hz, 2H), 1.36–1.26 (m, 3H) ppm (the minor rotamer: 33%). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 169.3, 168.8, 167.7, 166.5, 154.1, 153.0, 151.5, 143.9, 141.5, 141.3, 133.8, 131.5, 130.3, 130.1, 129.9, 128.2, 126.5, 123.1, 122.9, 122.8, 121.4, 120.6, 118.0, 116.4, 116.2, 112.4, 112.3, 112.0, 111.9, 100.5, 65.2, 65.2, 56.0, 55.9, 52.2, 52.2, 51.2, 46.7, 39.7, 39.3, 24.9, 24.9, 14.2, 8.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>35</sub>H<sub>38</sub>N<sub>3</sub>O<sub>9</sub>]<sup>+</sup>: 644.25, found: 644.30[M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 12.40 min.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Methyl (<i>E</i>)-6-(3-(4-((Ethoxycarbonyl)oxy)-3-meth-oxyphenyl)-<i>N</i>-(2-((2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)-amino)-2-oxoethyl)acrylamido)hexanoate (<b>14c</b>)</h4><div class="NLM_p last">Intermediate <b>14c</b> was prepared from intermediate <b>13c</b> and ferulic acid in a similar manner as described for intermediate <b>9a</b>. Colorless oil, yield 35%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.18/8.16* (brs, 1H), 7.91–7.78 (m, 2H), 7.53–7.40 (m, 1H), 7.20–7.10 (m, 2H), 7.02–6.90 (m, 2H), 6.88–6.78 (m, 1H), 6.75*/6.71 (d, <i>J</i> = 15.2 Hz, 1H), 6.45/6.00* (t, <i>J</i> = 5.2 Hz, 1H), 4.30–4.15 (m, 2H), 3.89/3.86* (s, 2H), 3.82–3.58 (m, 9H), 3.55–3.47 (m, 2H), 2.83–2.67 (m, 4H), 2.52–2.23 (m, 2H), 1.66–1.45 (m, 4H), 1.35–1.20 (m, 5H) ppm (the minor rotamer: 34%). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 173.1, 173.0, 171.2, 168.7, 167.1, 165.2, 153.7, 148.5, 148.1, 143.5, 134.3, 128.2, 127.9, 127.3, 123.12, 123.08, 122.6, 120.4, 116.7, 115.1, 113.4, 112.0, 110.9, 99.3, 63.02, 62.96, 56.2, 55.9, 55.4, 55.2, 41.2, 31.9, 28.2, 27.4, 26.9, 25.9, 25.7, 25.6, 24.9, 24.8, 24.7, 24.6, 14.3, 8.6 ppm. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>33</sub>H<sub>42</sub>N<sub>3</sub>O<sub>9</sub>]<sup>+</sup>: 624.28, found: 624.30[M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 12.19 min.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)-<i>N</i>-(4-((<i>E</i>)-3-(hydroxyamino)-3-oxoprop-1-en-1-yl)benzyl)-<i>N</i>-(2-((2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)amino)-2-oxoethyl)-acrylamide (<b>15a</b>)</h4><div class="NLM_p last">Compound <b>15a</b> was prepared from <b>14a</b> in a similar manner as described for compound <b>3a</b>. Off-white solid, yield 44%. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>): δ 7.67–7.30 (m, 4H), 7.27–7.12 (m, 3H), 7.12–6.93 (m, 4H), 6.90–6.60 (m, 3H), 6.54–6.36 (m, 1H), 4.75–4.50 (m, 2H), 4.17–3.91 (m, 2H), 3.89–3.73 (m, 6H), 3.51/3.47* (t, <i>J</i> = 7.3 Hz, 1H), 3.00–2.82 (m, 2H) ppm (exchangeable protons not observed) (the minor rotamer: 22%). <sup>13</sup>C NMR (101 MHz, MeOD-<i>d</i><sub>4</sub>): δ 171.2, 169.5, 169.3, 168.9, 164.9, 153.6, 148.9, 147.9, 144.3, 144.2, 139.7, 138.8, 134.3, 132.0, 128.7, 128.3, 127.9, 127.8, 127.7, 127.3, 126.9, 123.1, 122.9, 122.4, 117.3, 115.1, 113.5, 113.3, 111.8, 111.6, 111.5, 111.2, 110.5, 110.5, 100.0, 55.1, 54.98, 54.95, 51.9, 50.0, 49.6, 39.9, 39.8, 24.7, 24.6 ppm. IR (film): ν 3222, 2934, 2831, 1644, 1591, 1516, 1489, 1459, 1444, 1423, 1279, 1208, 1174, 1126, 1029, 972, 792, 743, 706, 662 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>33</sub>H<sub>35</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>: 599.24, found: 599.30 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 10.38 min, purity = 98.9%. mp = 140–142 °C.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>E</i>)-<i>N</i>-Hydroxy-4-((3-(4-hydroxy-3-methoxyphenyl)-<i>N</i>-(2-((2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)amino)-2-oxoethyl)acrylamido)methyl)benzamide (<b>15b</b>)</h4><div class="NLM_p last">Compound <b>15b</b> was prepared from <b>14b</b> in a similar manner as described for compound <b>3a</b>. Golden yellow solid, yield 22%. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>): δ 8.15–7.54 (m, 3H), 7.50–7.19 (m, 3H), 7.19–6.92 (m, 4H), 6.88–6.48 (m, 3H), 4.80–4.54 (m, 2H), 4.23–3.92 (m, 2H), 3.91–3.68 (m, 6H), 3.52/3.47* (t, <i>J</i> = 6.8 Hz, 2H), 2.99–2.82 (m, 2H) ppm (exchangeable protons not observed) (the minor rotamer: 19%). <sup>13</sup>C NMR (101 MHz, MeOD-<i>d</i><sub>4</sub>): δ 171.5, 171.3, 169.6, 169.1, 168.5, 166.7, 153.6, 149.0, 148.9, 147.9, 147.4, 144.7, 144.4, 141.3, 134.8, 132.0, 130.9, 129.3, 128.3, 128.0, 127.82, 127.75, 127.5, 127.4, 127.23, 127.15, 126.8, 123.1, 123.0, 122.9, 122.5, 122.0, 119.3, 115.1, 114.8, 113.0, 111.9, 111.62, 111.60, 111.4, 111.1, 110.5, 100.0, 55.2, 55.1, 55.03, 54.99, 52.6, 51.9, 50.5, 50.1, 40.1, 39.9, 24.8, 24.6 ppm. IR (film): ν 3229, 2933, 2830, 1641, 1595, 1581, 1521, 1491, 1462, 1447, 1283, 1253, 1211, 1173, 1127, 1024, 1013, 894, 793, 708 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>33</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>: 573.23, found: 573.30 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 9.91 min, purity = 97.0%. mp = 98–100 °C.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>E</i>)-<i>N</i>-Hydroxy-6-(3-(4-hydroxy-3-methoxyphenyl)-<i>N</i>-(2-((2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl)amino)-2-oxoethyl)acrylamido)hexanamide (<b>15c</b>)</h4><div class="NLM_p last">Compound <b>15c</b> was prepared from <b>14c</b> in a similar manner as described for compound <b>3a</b>. Red solid, yield 60%. <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>): δ 7.57–7.18 (m, 2H), 7.17–7.03 (m, 3H), 7.01–6.41 (m, 4H), 4.24–3.75 (m, 8H), 3.60–3.50 (m, 2H), 2.95/2.90* (t, <i>J</i> = 6.6 Hz, 2H), 2.12/2.00* (t, <i>J</i> = 7.0 Hz, 2H) 1.74–1.43 (m, 4H), 1.41–1.04 (m, 4H) ppm (exchangeable protons not observed) (the minor rotamer: 17%). <sup>13</sup>C NMR (101 MHz, MeOD-<i>d</i><sub>4</sub>): δ 171.0, 170.1, 170.0, 167.7, 167.0, 164.7, 153.6, 148.8, 147.9, 143.8, 132.0, 127.81, 127.77, 127.0, 123.1, 122.2, 119.1, 115.1, 114.0, 111.6, 111.2, 110.7, 99.9, 63.0, 62.9, 55.2, 55.1, 55.01, 54.97, 40.0, 32.1, 28.3, 27.4, 26.6, 25.9, 25.72, 25.66, 24.91, 24.85, 24.7, 24.6 ppm. IR (film): ν 3174, 3074, 3020, 2936, 2881, 1632, 1575, 1511, 1480, 1450, 1433, 1370, 1273, 1209, 1195, 1162, 1123, 1070, 1024, 996, 974, 815, 792, 663 cm<sup>–1</sup>. LRMS (ESI+) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>37</sub>N<sub>4</sub>O<sub>7</sub>]<sup>+</sup>: 553.26, found: 553.25 [M + H]<sup>+</sup>. HPLC (method B): <i>t</i><sub>R</sub> = 9.97 min, purity = 97.7%. mp = 55–58 °C.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>In Vitro</i> HDAC Inhibition Fluorescence Assay</h3><div class="NLM_p last">All the HDAC enzymes were bought from BPS Bioscience. <i>In vitro</i> HDAC inhibition assays were conducted as previously described with minor modifications.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In brief, 20 μL of recombinant HDAC enzyme solution (HDAC1–4, 6–9) was mixed with various concentrations of tested compound (20 μL). The mixture was incubated at 30 °C for 1 h; then 10 μL of fluorogenic substrate (Boc-Lys (acetyl)-AMC for HDAC1, 2, 3, and 6, Boc-Lys (trifluoroacetyl)-AMC for HDAC 4, 7, 8 and 9) was added. After incubation at 30 °C for 2 h, the catalysis was stopped by the addition of 10 μL of developer containing trypsin. Thirty minutes later, fluorescence intensity was measured using a microplate reader at excitation and emission wavelengths of 360 and 460 nm, respectively. All samples were prepared in duplicate, and the minimum of two independent assays was performed for each compound. The inhibition ratios were calculated from the fluorescence intensity readings of tested wells relative to those of control wells, and the IC50 curves and values were determined by GraphPad Prism 7.0, using the “log(inhibitor) versus normalized response - variable slope” function.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Western Blot Analysis of Cellular HDAC Inhibition</h3><div class="NLM_p last">HT22 cells (1,500,000 per well) were plated in flat-bottom six-well plates and allowed to grow for 12 h and then treated with different concentrations of compounds. Twenty-four hours later, cells were harvested, washed by PBS, and lysed with RIPA buffer, which comprised 50 mM Tris base, 150 mM NaCl, 5 mM EDTA, 0.1% (v/v) SDS, 0.5% (v/v) sodium deoxycholate, and 1% (v/v) Triton-x-100. After lysing, the suspension was ultrasonicated and centrifuged at 14,000 rpm for 15 min at 4 °C. The mixture of 75 μL of the supernatant and 25 μL of β-mercaptoethanol/LDS solution (15:85) was heated at 90 °C for 15 min and normalization according to BCA test carried out before loading. Lysates were run on Invitrogen NuPAGE 4–12% Bis-Tris 15 well gels at 170 V for approximately 60 min in MES buffer. Gels were transferred to methylcellulose and run at 30 V for 3 h. Membranes were incubated at 4 °C overnight with 1/1000 primary antibodies, which were diluted in 2.5% (w/v) milk or 5% (w/v) bovine serum albumin. The membrane was washed twice with TBST buffer before being incubated with secondary antibodies. Images were acquired using a GE ImageQuant LAS 4000.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Computational Docking</h3><div class="NLM_p last">Docking studies for compounds <b>8b</b> and <b>10b</b> were conducted based on the crystal structure of HDAC6 complexed with compound <b>A</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DVM">6DVM</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The preparation of the structures and the setup of the docking calculations with GOLD<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> are described in detail in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Supporting Information</a>. Figures were prepared with the PyMOL molecular graphics system (Schrödinger-LLC, version 2.4.1).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> DPPH Assay</h3><div class="NLM_p last">For determination of antioxidative properties, a 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical assay was used as previously described.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> A stock solution (200 μM) of DPPH was freshly prepared in MeOH. Compounds were dissolved in MeOH (5 mM) as stock solution. To start the reaction, 50 μL of the DPPH stock solution was added to a 100 μL diluted compound or pure methanol as a negative control. The 96-well plate was incubated at room temperature in the dark for 30 min, and absorbance was then determined with a microplate reader at 517 nm. The experiments were performed in triplicates. A dilution series of compound served as a blank to the particular compound and was subtracted from each measurement point. The scavenging potency is expressed as the concentration that scavenged 50% of the DPPH free radicals (EC<sub>50</sub>) determined <i>via</i> a nonlinear regression curve. Ferulic acid was used as references under the same assay conditions.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> ORAC Assay</h3><div class="NLM_p last">To study the antioxidant capacities of target compounds and the SAR of melatonin, we used the ORAC-Fluorescein method of Ou <i>et al</i>.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> partially modified by Dávalos <i>et al</i>.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> that uses fluorescein (FL) as a fluorescent probe, (±)-6-hydroxy-2,5,7,8-tetramethyl-chromane-2-carboxylic acid (Trolox) as a reference, and compound 2,2′-azobis(amidinopropane) dihydrochloride (AAPH) as a free-radical generator. When the free-radical generator is added, production of free radicals starts, and those oxidize fluorescein decreasing its fluorescence. When an antioxidant is present, the scavenger traps free radicals and the fluorescence remains unchanged. Reactions were performed in 75 mM PBS (pH 7.4), and the final reaction mixture volume was 200 μL at 37 °C. Derivatives at the desired concentrations (20 μL) and FL (120 μL, 70 nM, final concentration) solutions were mixed in a black 96-well microplate (SARSTEDT) and preincubated for 15 min at 37 °C. Subsequently, AAPH solution (60 μL, 12 mM, final concentration) was added rapidly and the plate was placed in a TECAN microplate reader to measure the fluorescence (485 nm excitation and 510 nm emission filters) intensity every 2 min for 90 min. Samples were measured at two different concentrations (2 and 4 μM). A blank (FL + AAPH in PBS) and a calibration curve of Trolox (1, 2, 4, 6, 8, 10, 12, and 15 μM) were included in each experiment. All samples were prepared in duplicate, and three independent assays were performed for each compound. The area under the fluorescence decay curve (fluorescence <i>vs</i> time) (AUC) was calculated as<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_m001.gif" alt="" id="_i59" /></img></span>where <i>f</i><sub>0</sub> is the initial fluorescence reading at 0 min and <i>f</i><sub>i</sub> is the fluorescence reading at time 2<i>i</i>. The net AUC corresponding to a sample was calculated by subtracting the AUC corresponding to the blank (Net AUC = AUC<sub>antioxidant</sub> – AUC<sub>blank</sub>). Linear regression equations were calculated by plotting the net AUC against the trolox antioxidant standard concentration (<i>R</i><sup>2</sup> > 0.99). ORAC-FL values were expressed as trolox equivalents by using the standard curve calculated for each assay, where the ORAC-FL value of Trolox was taken as 1, plot the Trolox standard curve, and interpolate it to determine sample ORAC values.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Metal Chelating Assays</h3><div class="NLM_p">The chelating ability to the ferrous ion was carried out as Santos <i>et al</i>.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> described and partially modified. The ferrous ion in ferrous sulfate readily reacts with ferrozoine (3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-<i>p</i>,<i>p′</i>-disulfonic acid monosodium salt hydrate) to form a Fe<sup>2+</sup>-ferrozoine complex, a purple-colored chromogen whose intensity is measured at 562 nm. The presence of antioxidant chelators reduces the formation of Fe<sup>2+</sup>-ferrozoine complex. Lower absorbance indicates higher metal-chelating activity. NaAc buffer was prepared (50 mM, pH 6.0). To start the reaction, 50 μL of Fe<sup>2+</sup> aq. (80 μM in buffer) was added to 100 μL diluted compounds-MeOH solution or pure methanol as a negative control. The 96-well plate was incubated at room temperature for 2 min, 50 μL of ferrozine aq. (250 μM in buffer) was added to each well and then incubated at room temperature for 10 min, and absorbance was then determined with a microplate reader at 562 nm. The experiments were performed in duplicates. The mixture of a dilution series of compound and Fe<sup>2+</sup> aq. served as a blank to the particular compound and was subtracted from each measurement point. EDTA·2Na in water was diluted with MeOH, which was served as a reference under the same assay conditions.</div><div class="NLM_p">The ability of compounds to chelate Cu<sup>2+</sup> was assessed using the method as Santos <i>et al</i>.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> described and partially modified that employs pyrocatechol violet (PV) as the chromogen agent. In aqueous medium buffered at slightly acidic medium (pH 6.0). There is usually a leftover of Cu<sup>2+</sup> in the reactional medium because not all the copper is bound by chemical compounds present in a test sample. Thereafter, the remaining Cu<sup>2+</sup> reacts with pyrocatechol violet at a proportion of 2:1, forming a blue-colored complex that can be monitored at 632 nm. However, the dark color turns into yellow in the presence of chelating agents that dissociate the complex, and the chelating activity can thus be estimated by the measurement of the rate of color reduction. Briefly, in each well, 50 μL of Cu<sup>2+</sup> aq. (400 μM in buffer) was added to 100 μL diluted compounds-MeOH solution or pure methanol as negative control. The 96-well-plate was incubated at room temperature for 2 min, 50 μL of PV aq. (400 μM in buffer) was added to each well (avoid the light) and then incubated at room temperature for 10 min, and absorbance was then determined with a microplate reader at 632 nm. The experiments were performed in duplicates. EDTA·2Na in water was diluted with MeOH, which was served as a reference under the same assay conditions.</div><div class="NLM_p">The chelating ability to zinc ions was carried out as Catapano <i>et al</i>.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> described and partially modified. Stock solutions of target compounds (10 mM) were prepared in DMSO, whereas that of zinc chloride (10 mM) and EDTA (10 mM) were prepared in ultrapure water. Dithizone (10 mM) as the chromogen agent was prepared in DMSO. NaAc buffer was prepared (50 mM, pH 6.0). Firstly, zinc-ion solutions (50 μL, 60 μM) or water was added to the buffers (150 μL). Thereafter, 50 μL of diluted compounds-DMSO solution or pure DMSO was added. After 2 min of mixing, 50 μL of dithizone-DMSO solution (250 μM) was added, and the absorbance was measured immediately at 540 nm.</div><div class="NLM_p last">The chelation ratios were calculated from the absorbance intensity readings of tested wells relative to those of control wells, data are expressed as means ± SEM of two different independent experiments.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Neurotoxicity Assay</h3><div class="NLM_p">HT-22 cells were grown in Dulbecco’s modified Eagle medium (DMEM, Sigma-Aldrich, Munich Germany) supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS) and 1% (v/v) penicillin–streptomycin. Cells were subcultured every 2 days and incubated at 37 °C with 5% CO<sub>2</sub> in a humidified incubator. Compounds were dissolved in DMSO (Sigma-Aldrich, Munich, Germany) and diluted with a medium. Generally, 80% confluent cells were seeded with 5000 cells per well into sterile 96-well plates and were incubated for 24 h. For the neurotoxicity assay, the previous medium was removed and 10 μM of the compound was added to the wells, DMSO (0.05%) in DMEM served as a control. Cells were incubated for 24 h. MTT solution (4 mg/mL in PBS) was diluted 1:10 with medium and added to the wells after the removal of the previous medium. Cells were incubated for 3 h when the supernatant was removed, and lysis buffer (10% SDS) was applied. The next day, absorbance at 560 nm was determined with a multiwell plate photometer (Tecan–SpectraMax 250). Experiments were performed in triplicates. Results are presented as percentage to untreated control cells. Data are expressed as means ± SD of three different independent experiments. Analysis was accomplished using GraphPad Prism 7 Software applying oneway ANOVA followed by Dunnett’s multiple comparison posttest. Levels of significance: *<i>p</i> < 0.05; **<i>p</i> < 0.01; ***<i>p</i> < 0.001.</div><div class="NLM_p">For the oxytosis assay, 5 mM glutamate (monosodium-<span class="smallcaps smallerCapital">l</span>-glutamate, Sigma-Aldrich, Munich, Germany) together with respective compounds was added to the cells and incubated for 24 h. Quercetin (25 μM) (Sigma-Aldrich, Munich, Germany) together with 5 mM glutamate served as a positive control. After 24 h incubation, cell viability was determined using a colorimetric MTT assay as described above. Results are presented as percentage of untreated control cells. Data is expressed as means ± SEM of two independent experiments. Analysis was accomplished using GraphPad Prism 7 Software applying Oneway ANOVA followed by Dunnett’s multiple comparison posttest. Levels of significance: ***<i>p</i> < 0.001.</div><div class="NLM_p last">For the ATP depletion assay, 3 × 10<sup>3</sup> cells per well were seeded into sterile 96-well plates and incubated overnight. The next day medium was exchanged with fresh medium. Iodoacetic acid (20 μM) (IAA) was added with a vehicle (DMSO) as a negative control, or together with respective compounds for protection. After 2 h incubation at 37 °C in the incubator, the medium was aspirated, the fresh medium was applied, and only the compounds at the same respective concentrations were added without IAA. After 24 h, cell viability was determined using a colorimetric MTT assay. Results are presented as percentage of untreated control cells.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Immunomodulation Analysis</h3><div class="NLM_p">Mouse N9-microglial cells were cultured in Dulbecco modified eagle medium (DMEM) supplemented with 10% heat inactivated Fetal Bovine Serum (FBS), 1% penicillin/streptomycin, and 2 mM glutamine (all from Aurogene Srl, Rome, Italy). To evaluate the immunomodulatory effect, 2.5 × 10<sup>5</sup> microglial cells were plated in a 35 mm dish in the presence or absence of 100 ng/mL LPS (lipopolysaccharide) with increasing concentrations of compounds. After 24 h of treatment, the microglial conditioned medium was collected and used for nitrite measurement, or concentrated using Microcon YM-3 (Millipore, Billerica, MA), and resuspended in 4× loading buffer (0.2 M Tris–HCL pH 6.8; sodium dodecyl sulfate; 40% glycerol; 0.4% bromophenol blue and 0.4 M dithiothreitol; Sigma-Aldrich) for Western blot analysis. In parallel, microglial cells were collected in lysis buffer (1% SDS, 50 Mm Tris pH 7.4, 1 mM EDTA, 10 μL/mL protease inhibitors and 10 μL/mL phosphatase inhibitors), and protein content was determined by using the Lowry protein assay.</div><div class="NLM_p">For Western blot analysis, media and cell samples were briefly sonicated and loaded into 12% sodium-dodecyl sulfate-polyacrylamide gels (SDS-PAGE; Bio-Rad). After electrophoresis and transfer onto nitrocellulose membranes (GE Healthcare, Milano, Italy), membranes were blocked 1 h in blocking solution PBS-0.1% Tween-20 (Sigma-Aldrich), 4% non-fat dry milk (Bio-Rad), and incubated overnight at 4 °C with primary antibodies in PBS-0.1% Tween-20: rabbit anti-iNOS (1:1000, Cell Signaling Technology, Danvers, Massachusetts, USA), rabbit anti-TREM2 (1:1000, Cell Signaling Technology), mouse anti-TGFβ2 (1:1000 Abcam, Cambridge, UK), and mouse anti-GAPDH (1:20,000, Dako North America, Agilent Technologies, USA). The next day, membranes were then incubated with specific antibodies conjugated to horseradish peroxidase (goat anti-rabbit and goat-anti mouse, 1:5000, Jackson ImmunoResearch, Cambridge, UK) for 90 min at RT in PBS-0.1% Tween-20. Proteins were visualized by using the Clarity Western ECL Substrate (Bio-Rad) and detected using Bio-Rad Image Lab Software with a ChemiDoc imaging system (Bio-Rad).</div><div class="NLM_p">For nitrite measurement, accumulation of NO in microglial conditioned media was quantified by a colorimetric assay based on Greiss reaction in a 96-well-plate. A nitrate standard curve was performed with NaNO<sub>2</sub> at known concentrations. To start the reaction, 5 mM sulfanilamide (Sigma-Aldrich) was added to the culture medium and standard curve; it reacts with nitrite under acidic conditions to form a diazonium cation, which subsequently couples to <i>N</i>-1-naphthylethylenediamine dihydrochloride 40 mM (NEDA; Sigma-Aldrich) to produce a colored azo dye. After 15 min of incubation at RT in the dark, absorbance was read at 540 nm with a multiplate spectrophotometric reader (Bio-rad Laboratories Srl, Milano, Italy).</div><div class="NLM_p last">All quantitative data are presented as means ± S.E. from at last three independent experiments. Statistical significance between different treatments was calculated with GRAPHPAD PRISM6 (L Jolla, California, USA) using one-way analysis of variance (ANOVA) followed by post-hoc comparison Bonferroni’s test. A value of <i>p</i> < 0.05 was considered statistically significant.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>In Vivo</i> Studies</h3><div class="NLM_p">Protocols for the behavioral experiments were established previously.<a onclick="showRef(event, 'ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57">(54−57)</a> Compound <b>10b</b> and the control ACY1215 were tested for their neuroprotective properties in the <i>in vivo</i> pharmacological model of Alzheimer’s disease induced by intracerebroventricular (icv) injection of the oligomerized Aβ<sub>25–35</sub> peptide in the mouse. Compounds were injected intraperitoneally (ip) o.d. between days 1 and 7, the oligomerized Aβ<sub>25–35</sub> peptide was injected icv on the first day of the study, and behavioral evaluation was performed between days 8 and 10 followed by sacrifice on day 11. Brain samples were collected and stored at −80 °C awaiting further biochemical analyses.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Animals</h4><div class="NLM_p last">Male Swiss mice, 6 weeks old, weighing 31–36 g, from JANVIER (Saint Berthevin, France), were kept for housing, and experiments took place within the animal facility building of the University of Montpellier (CECEMA, Office of Veterinary Services agreement # B-34-172-23). Upon arrival, animals were divided into groups and housed with access to food and water <i>ad libitum</i>, except during behavioral experiments. Mice were kept in a temperature- and humidity-controlled animal facility on a 12 h/12 h light/dark cycle (lights off at 07:00 PM). All animal procedures were conducted in strict adherence to the European Union directive of September 22, 2010 (2010/63/UE) and the ARRIVE guidelines. The project was authorized by the French National Ethic Committee (APAFIS #1485-15034).</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Preparation of Compound Injection</h4><div class="NLM_p last">Compounds were weighed, dissolved in pure DMSO at a concentration of 1 mg/mL, and diluted into final test concentrations with saline. The final percentage of DMSO in saline was 60% for all compounds. Vehicle solution used for control groups was 60% DMSO in saline. General behavior of the mice in the home cage was checked visually after injections. In particular, weight gain was checked every day. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">Figure S2</a>, the icv injection affected animals on day 1, but then weight gain was regular and not significantly different from control. All treatments showed good compound and vehicle solution tolerability. Moreover, animals were tested in behavioral tests 24 h after the last compound/vehicle administration.</div></div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Amyloid Peptide Preparation and icv Injection</h4><div class="NLM_p last">Mice were anesthetized with isoflurane (2.5%) and icv injected with the Aβ<sub>25–35</sub> peptide (9 nmol/mouse), and homogeneous oligomeric preparation of the Aβ<sub>25–35</sub> peptide was performed as described by Maurice <i>et al.</i><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The control group received bidistilled water icv as we previously reported that injection of a control peptide does not result in memory deficits or toxicity.</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Spontaneous Alternation Performances in the Y Maze</h4><div class="NLM_p last">On day 8, all animals were tested for spontaneous alternation performance in the Y maze to evaluate their spatial working memory. The Y maze is made of gray poly(vinyl chloride). Each arm is 40 cm long, 13 cm high, 3 cm wide at the bottom, 10 cm wide at the top, and converging at an equal angle. Each mouse is placed at the end of one arm and allowed to explore the maze freely for 8 min. The sequence of arm entries (including possible returns into the same arm) was checked visually and noted down. If the mouse enters all three arms on consecutive occasion, this is defined as an alternation. Therefore, the total number of arm entries minus two is also the maximum number of alternations. The percentage of alternation was calculated as (actual alternations/maximum alternations) × 100. Parameters for the evaluation of behavior are given as the percentage of alternation (memory index) and the total number of arm entries (exploration index). When an extreme behavior (alternation percentage < 20% or > 90% or a number of arm entries of <10) was observed, animals were excluded from the calculations, which corresponded to a 4.7% attrition in this study.</div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Passive Avoidance Test</h4><div class="NLM_p last">On days 9 and 10 of the study, a passive avoidance test was performed to measure nonspatial long-term memory, as described previously.<a onclick="showRef(event, 'ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57">(54−57)</a> The setup for the experiment consists of a two-compartment (15 × 20 × 15 cm high) poly(vinyl chloride) box, whereas one compartment is white and illuminated with a bulb (60 W, 40 cm above the apparatus), and the other is black with a cover and grid floor. A guillotine door separates the two compartments. On day 9, during the training session, each animal was placed in the white compartment with the door closed. After 5 s, the door was opened, and the mouse was allowed to enter the dark compartment. When it had placed all its paws on the grid floor, the door was closed, and a foot shock was delivered (0.3 mA) for 3 s using a scrambled shock generator (Lafayette Instruments, Lafayette, USA). The time spent to enter the dark compartment (step-through latency) and the level of sensitivity to the shock were evaluated (no sign = 0, flinching reactions = 1, vocalizations = 2). None of the treatments affected the step-through latency or shock sensitivity in the present study (data not shown). The retention test was carried out on day 10. Five seconds after the mouse was placed in the white compartment, the door was opened, and the mouse was allowed to explore the box. The time spent to enter the dark compartment (step-through latency) was measured up to 300 s. Animals showing latencies during the training and retention session lower than 10 s and shock sensitivity = 0 were considered as failing to learn the task and discarded from calculations. In this study, it corresponded to 0.6% attrition.</div></div><div id="sec4_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Statistical Analyses</h4><div class="NLM_p last">All values, except passive avoidance latencies, are expressed as mean ± SEM. Statistical analyses were performed on the different conditions using one-way ANOVA (F value), followed by Dunnett’s post hoc multiple comparison test. Passive avoidance latencies do not follow a Gaussian distribution since upper cutoff times (300 s) are defined. Therefore, they were analyzed using a Kruskal–Wallis nonparametric ANOVA (H value) followed by Dunn’s multiple comparison test. <i>p</i> < 0.05 was considered as statistically significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01940" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01940?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01940</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC-chromatograms of target compounds, details of computational docking, metal chelation, neuroprotection against oxytosis and ATP depletion, and weight of animals during <i>in vivo</i> studies (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_002.csv" class="ext-link">CVS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf">jm0c01940_si_001.pdf (1.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_002.csv">jm0c01940_si_002.csv (3.99 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01940" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tangui Maurice</span> - <span class="hlFld-Affiliation affiliation">MMDN,
Univ Montpellier, EPHE, INSERM, Montpellier 34095, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6f1b0e01081a0641020e1a1d060c0a2f1a0200011b1f0a0303060a1d41091d"><span class="__cf_email__" data-cfemail="7602171811031f581b1703041f151336031b19180206131a1a1f1304581004">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Decker</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6773-6245" title="Orcid link">http://orcid.org/0000-0002-6773-6245</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0d60646e656c68612369686e66687f4d786364207a78687f776f787f6a236968"><span class="__cf_email__" data-cfemail="036e6a606b62666f2d67666068667143766d6a2e7476667179617671642d6766">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng He</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. James Chou</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Discovery and Biomedical Sciences, South Carolina College
of Pharmacy, Medical University of South
Carolina, Charleston, South Carolina 29425, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6808-9089" title="Orcid link">http://orcid.org/0000-0001-6808-9089</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Scheiner</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eleonora Poeta</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnologies, University
of Bologna, Via Selmi 3, Bologna 40126, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalia Yuan Chen</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Gunesch</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Hoffmann</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph Sotriffer</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry, Julius Maximilian University of Würzburg, Am Hubland, Würzburg 97074, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Monti</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnologies, University
of Bologna, Via Selmi 3, Bologna 40126, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0330-482X" title="Orcid link">http://orcid.org/0000-0003-0330-482X</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through the contributions of all authors. Synthesis of the target compounds, DPPH assay, ORAC assay, and metal chelation assay were performed by F.H. HDAC inhibition assay was performed by C.J.C. The docking study was conducted by N.Y.C. and C.S. The neurotoxicity experiment was performed by S.G. The immunomodulation study was performed by E.P. and B.M. In vivo experiments were performed by M.S., M.H., and T.M. M.D. was responsible for the oversight and development of the whole project.</p></li><li><span class="author-information-subsection-header">Funding</span><p>M.D. acknowledges the German Research Council (Deutsche Forschungsgemeinschaft) under DFG DE 1546/6-3. M.D. and T.M. acknowledge support from Campus France (PHC Procope) and the German Academic Exchange Service (DAAD) with funds of the Federal Ministry of Education and Research (BMBF) under Grant # 57387204, as well as support from BayFrance (Franco-Bavarian University cooperation center) under Grant # FK03-2020. F.H. acknowledges the Ph.D. scholarship from the China Scholarship Council (CSC). N.Y.C. acknowledges support from the German Academic Exchange Service (DAAD). M.H. acknowledges the German Academic Scholarship Foundation (“Studienstiftung des deutschen Volkes”) for a Ph.D. fellowship and the Elite Network of Bavaria (International Doctoral Program “Receptor Dynamics”) for support.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AAPH</td><td class="NLM_def"><p class="first last">2,2′-azobis(amidinopropane) dihydrochloride</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-beta</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ANOVA</td><td class="NLM_def"><p class="first last">analysis of variance</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">ChEs</td><td class="NLM_def"><p class="first last">cholinesterases</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">FL</td><td class="NLM_def"><p class="first last">fluorescein</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HSP-90</td><td class="NLM_def"><p class="first last">hot shock protein 90</p></td></tr><tr><td class="NLM_term">Il-1β</td><td class="NLM_def"><p class="first last">interleukin 1 beta</p></td></tr><tr><td class="NLM_term">iNOS</td><td class="NLM_def"><p class="first last">inducible nitric oxide synthase</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharides</p></td></tr><tr><td class="NLM_term">MIF</td><td class="NLM_def"><p class="first last">macrophage migration inhibitory factor</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">M.P.</td><td class="NLM_def"><p class="first last">melting point</p></td></tr><tr><td class="NLM_term">NFTs</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">NMDAR</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-D-aspartate receptor</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PDE5</td><td class="NLM_def"><p class="first last">phosphodiesterase 5 (PDE5)</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetra-methyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">trimethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TGF β2</td><td class="NLM_def"><p class="first last">transforming growth factor beta-2</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TREM2</td><td class="NLM_def"><p class="first last">triggering receptor expressed on myeloid cells 2</p></td></tr><tr><td class="NLM_term">Trolox</td><td class="NLM_def"><p class="first last">(±)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid</p></td></tr><tr><td class="NLM_term">TSA</td><td class="NLM_def"><p class="first last">trichostatin A</p></td></tr><tr><td class="NLM_term">YMT</td><td class="NLM_def"><p class="first last">Y-maze test</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc binding group;</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 65 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Thirty years of HDAC inhibitors: 2020 insight and hindsight</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">12460</span>– <span class="NLM_lpage">12484</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00830</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlSisrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=12460-12484&author=T.+C.+S.+Hoauthor=A.+H.+Y.+Chanauthor=A.+Ganesan&title=Thirty+years+of+HDAC+inhibitors%3A+2020+insight+and+hindsight&doi=10.1021%2Facs.jmedchem.0c00830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight</span></div><div class="casAuthors">Ho, Terence C. S.; Chan, Alex H. Y.; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12460-12484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now 30 years since the first report of a potent zinc-dependent histone deacetylase (HDAC) inhibitor appeared.  Since then, five HDAC inhibitors have received regulatory approval for cancer chemotherapy while many others are in clin. development for oncol. as well as other therapeutic indications.  This Perspective reviews the biol. and medicinal chem. advances over the past 3 decades with an emphasis on the design of selective inhibitors that discriminate between the 11 human HDAC isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrES4d2gbkB17Vg90H21EOLACvtfcHk0ligZGcUA3hLEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlSisrzP&md5=1deb2ad5787797a9ee98dcf7bdade52c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00830%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DT.%2BC.%2BS.%26aulast%3DChan%26aufirst%3DA.%2BH.%2BY.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThirty%2520years%2520of%2520HDAC%2520inhibitors%253A%25202020%2520insight%2520and%2520hindsight%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D12460%26epage%3D12484%26doi%3D10.1021%2Facs.jmedchem.0c00830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L.-H.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases in memory and cognition</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">re12</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aaa0069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1126%2Fscisignal.aaa0069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=25492968" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=re12&author=J.+Penneyauthor=L.-H.+Tsai&title=Histone+deacetylases+in+memory+and+cognition&doi=10.1126%2Fscisignal.aaa0069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aaa0069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aaa0069%26sid%3Dliteratum%253Aachs%26aulast%3DPenney%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DL.-H.%26atitle%3DHistone%2520deacetylases%2520in%2520memory%2520and%2520cognition%26jtitle%3DSci.%2520Signaling%26date%3D2014%26volume%3D7%26spage%3Dre12%26doi%3D10.1126%2Fscisignal.aaa0069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. V. W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2119</span>– <span class="NLM_lpage">2130</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05564.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fj.1471-4159.2008.05564.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=18636984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=2119-2130&author=H.+Dingauthor=P.+J.+Dolanauthor=G.+V.+W.+Johnson&title=Histone+deacetylase+6+interacts+with+the+microtubule-associated+protein+tau&doi=10.1111%2Fj.1471-4159.2008.05564.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span></div><div class="casAuthors">Ding, Huiping; Dolan, Philip J.; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2119-2130</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6), a unique cytoplasmic deacetylase, likely plays a role in neurodegeneration by coordinating cell responses to abnormal protein aggregation.  Here, we provide in vitro and in vivo evidence that HDAC6 interacts with tau, a microtubule-assocd. protein that forms neurofibrillary tangles in Alzheimer's disease.  This interaction is mediated by the microtubule-binding domain on tau and the Ser/Glu tetradecapeptide domain on HDAC6.  Treatment with tubacin, a selective inhibitor of tubulin deacetylation activity of HDAC6, did not disrupt HDAC6-tau interaction.  Nonetheless tubacin treatment attenuated site-specific tau phosphorylation, as did shRNA-mediated knockdown of HDAC6.  Proteasome inhibition potentiated HDAC6-tau interactions and facilitated the concn. and co-localization of HDAC6 and tau in a perinuclear aggresome-like compartment, independent of HDAC6 tubulin deacetylase activity.  Furthermore, we obsd. that in Alzheimer's disease brains the protein level of HDAC6 was significantly increased.  These findings establish HDAC6 as a tau-interacting protein and as a potential modulator of tau phosphorylation and accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9OtxbhpBU9LVg90H21EOLACvtfcHk0ligZGcUA3hLEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM&md5=cf63da19f8f887459227b620d9a0898b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05564.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05564.x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DDolan%26aufirst%3DP.%2BJ.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%2BW.%26atitle%3DHistone%2520deacetylase%25206%2520interacts%2520with%2520the%2520microtubule-associated%2520protein%2520tau%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D2119%26epage%3D2130%26doi%3D10.1111%2Fj.1471-4159.2008.05564.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1080/13543776.2019.1708901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1080%2F13543776.2019.1708901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31865813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVKnsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=121-136&author=S.+Shenauthor=A.+P.+Kozikowski&title=A+patent+review+of+histone+deacetylase+6+inhibitors+in+neurodegenerative+diseases+%282014-2019%29&doi=10.1080%2F13543776.2019.1708901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)</span></div><div class="casAuthors">Shen, Sida; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-136</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase 6 (HDAC6) is unique in comparison with other zinc-dependent HDAC family members.  An increasing amt. of evidence from clin. and preclin. research demonstrates the potential of HDAC6 inhibition as an effective therapeutic approach for the treatment of cancer, autoimmune diseases, as well as neurol. disorders.  The recently disclosed crystal structures of HDAC6-ligand complexes offer further means for achieving pharmacophore refinement, thus further accelerating the pace of HDAC6 inhibitor discovery in the last few years.: This review summarizes the latest clin. status of HDAC6 inhibitors, discusses pharmacol. applications of selective HDAC6 inhibitors in neurodegenerative diseases, and describes the patent applications dealing with HDAC6 inhibitors from 2014-2019 that have not been reported in research articles.: Phenylhydroxamate has proven a very useful scaffold in the discovery of potent and selective HDAC6 inhibitors.  However, weaknesses of the hydroxamate function such as metabolic instability and mutagenic potential limit its application in the neurol. field, where long-term administration is required.  The recent invention of oxadiazole-based ligands by pharmaceutical companies may provide a new opportunity to optimize the druglike properties of HDAC6 inhibitors for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCWThC7SH8r7Vg90H21EOLACvtfcHk0lh3CfRNifD20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVKnsb3J&md5=926d00ce3a0153953eb2f933599500b9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F13543776.2019.1708901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2019.1708901%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DS.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DA%2520patent%2520review%2520of%2520histone%2520deacetylase%25206%2520inhibitors%2520in%2520neurodegenerative%2520diseases%2520%25282014-2019%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D30%26spage%3D121%26epage%3D136%26doi%3D10.1080%2F13543776.2019.1708901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraswati, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span> <span> </span><span class="NLM_article-title">Old but gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFymtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=23-39&author=M.+Brindisiauthor=A.+P.+Saraswatiauthor=S.+Brogiauthor=S.+Gemmaauthor=S.+Butiniauthor=G.+Campiani&title=Old+but+gold%3A+tracking+the+new+guise+of+histone+deacetylase+6+%28HDAC6%29+enzyme+as+a+biomarker+and+therapeutic+target+in+rare+diseases&doi=10.1021%2Facs.jmedchem.9b00924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases</span></div><div class="casAuthors">Brindisi, Margherita; Saraswati, A. Prasanth; Brogi, Simone; Gemma, Sandra; Butini, Stefania; Campiani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-39</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Epigenetic regulation orchestrates many cellular processes and greatly influences key disease mechanisms.  Histone deacetylase (HDAC) enzymes play a crucial role either as biomarkers or therapeutic targets owing to their involvement in specific pathophysiol. pathways.  Beyond their well-characterized role as histone modifiers, HDACs also interact with several non-histone substrates and their increased expression has been highlighted in specific diseases.  HDAC6 isoform, due to its unique cytoplasmic localization, modulates the acetylation status of tubulin, HSP90, TGF-β and peroxiredoxins.  HDAC6 also exerts non-catalytic activities, through its interaction with ubiquitin.  Both catalytic and non-catalytic functions of HDACs are being actively studied in the field of specific rare disorders, beyond the well-established role in carcinogenesis.  This perspective outlines the application of HDAC(6) inhibitors in rare diseases, such as Rett syndrome, inherited retinal disorders, idiopathic pulmonary fibrosis and Charcot-Marie-Tooth disease, highlighting their therapeutic potential as innovative and targeted disease-modifying agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kzJmRToypbVg90H21EOLACvtfcHk0lh3CfRNifD20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFymtbrK&md5=688368246471313ed025f0c230167052</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00924%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DSaraswati%26aufirst%3DA.%2BP.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26atitle%3DOld%2520but%2520gold%253A%2520tracking%2520the%2520new%2520guise%2520of%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520enzyme%2520as%2520a%2520biomarker%2520and%2520therapeutic%2520target%2520in%2520rare%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D23%26epage%3D39%26doi%3D10.1021%2Facs.jmedchem.9b00924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Mello, S. R.</span></span> <span> </span><span class="NLM_article-title">Complex neuroprotective and neurotoxic effects of histone deacetylases</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1111/jnc.14309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fjnc.14309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29355955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvFKgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=96-110&author=E.+A.+Thomasauthor=S.+R.+D%E2%80%99Mello&title=Complex+neuroprotective+and+neurotoxic+effects+of+histone+deacetylases&doi=10.1111%2Fjnc.14309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Complex neuroprotective and neurotoxic effects of histone deacetylases</span></div><div class="casAuthors">Thomas, Elizabeth A.; D'Mello, Santosh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">96-110</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  By their ability to shatter quality of life for both patients and caregivers, neurodegenerative diseases are the most devastating of human disorders.  Unfortunately, there are no effective or long-terms treatments capable of slowing down the relentless loss of neurons in any of these diseases.  One impediment is the lack of detailed knowledge of the mol. mechanisms underlying the processes of neurodegeneration.  While some neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, are mostly sporadic in nature, driven by both environment and genetic susceptibility, many others, including Huntington's disease, spinocerebellar ataxias, and spinal-bulbar muscular atrophy, are genetically inherited disorders.  Surprisingly, given their different roots and etiologies, both sporadic and genetic neurodegenerative disorders have been linked to disease mechanisms involving histone deacetylase (HDAC) proteins, which consists of 18 family members with diverse functions.  While most studies have implicated certain HDAC subtypes in promoting neurodegeneration, a substantial body of literature suggests that other HDAC proteins can preserve neuronal viability.  Of particular interest, however, is the recent realization that a single HDAC subtype can have both neuroprotective and neurotoxic effects.  Diverse mechanisms, beyond transcriptional regulation have been linked to these effects, including deacetylation of non-histone proteins, protein-protein interactions, post-translational modifications of the HDAC proteins themselves and direct interactions with disease proteins.  The roles of these HDACs in both sporadic and genetic neurodegenerative diseases will be discussed in the current review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov484p4J5yKLVg90H21EOLACvtfcHk0lh3CfRNifD20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvFKgtL0%253D&md5=6e7e414940a7148cf9c8a52365df3403</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fjnc.14309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.14309%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DE.%2BA.%26aulast%3DD%25E2%2580%2599Mello%26aufirst%3DS.%2BR.%26atitle%3DComplex%2520neuroprotective%2520and%2520neurotoxic%2520effects%2520of%2520histone%2520deacetylases%26jtitle%3DJ.%2520Neurochem.%26date%3D2018%26volume%3D145%26spage%3D96%26epage%3D110%26doi%3D10.1111%2Fjnc.14309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span> <span> </span><span class="NLM_article-title">The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">655</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-0688-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1038%2Fs41419-018-0688-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29844403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=655&author=S.+J.+Fanauthor=F.+I.+Huangauthor=J.+P.+Liouauthor=C.+R.+Yang&title=The+novel+histone+de+acetylase+6+inhibitor%2C+MPT0G211%2C+ameliorates+tau+phosphorylation+and+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1038%2Fs41419-018-0688-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Fan Sheng-Jun; Huang Fang-I; Yang Chia-Ron; Liou Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">655</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a dreadful neurodegenerative disease that leads to severe impairment of cognitive function, leading to a drastic decline in the quality of life.  The primary pathological features of AD include senile plaques (SPs) and intracellular neurofibrillary tangles (NFTs), comprising aggregated amyloid β (Aβ) and hyperphosphorylated tau protein, respectively, in the hippocampus of AD patients.  Histone deacetylase 6 (HDAC6) is a key enzyme in this neurodegenerative disease, in particular, as it relates to tau hyperphosphorylation.  This study aimed to investigate the protective effects and mechanism of the novel HDAC6 inhibitor, MPT0G211, using an AD model.  Our results indicated that MPT0G211 significantly reduced tau phosphorylation and aggregation, the processes highly correlated with the formation of NFTs.  This HDAC6 inhibitory activity resulted in an increase in acetylated Hsp90, which decreased Hsp90 and HDAC6 binding, causing ubiquitination of phosphorylated tau proteins.  In addition, a significant increase of phospho-glycogen synthase kinase-3β (phospho-GSK3β) on Ser9 (the inactive form) through Akt phosphorylation was associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment.  In AD in vivo models, MPT0G211 appeared to ameliorate learning and memory impairment in animals.  Furthermore, MPT0G211 treatment reduced the amount of phosphorylated tau in the hippocampal CA1 region.  In summary, MPT0G211 treatment appears to be a promising strategy for improving the AD phenotypes, including tau hyperphosphorylation and aggregation, neurodegeneration, and learning and memory impairment, making it a valuable agent for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThODJPxWFHy0EgZCMqtRBifW6udTcc2ea5NOR09xhM8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D&md5=5b9b227e4df99bd8150004e7342c214c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-0688-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-0688-5%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DF.%2BI.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DC.%2BR.%26atitle%3DThe%2520novel%2520histone%2520de%2520acetylase%25206%2520inhibitor%252C%2520MPT0G211%252C%2520ameliorates%2520tau%2520phosphorylation%2520and%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D655%26doi%3D10.1038%2Fs41419-018-0688-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaisina, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaidery, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Aissa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnova, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaisin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourassa, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratan, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikulin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poloznikov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazaryan, I. G.</span></span> <span> </span><span class="NLM_article-title">Activation of Nrf2 and hypoxic adaptive response contribute to neuroprotection elicited by phenylhydroxamic acid selective HDAC6 inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=894-900&author=I.+N.+Gaisinaauthor=S.+H.+Leeauthor=N.+A.+Kaideryauthor=M.+Ben+Aissaauthor=M.+Ahujaauthor=N.+N.+Smirnovaauthor=S.+Wakadeauthor=A.+Gaisinauthor=M.+W.+Bourassaauthor=R.+R.+Ratanauthor=S.+V.+Nikulinauthor=A.+A.+Poloznikovauthor=B.+Thomasauthor=G.+R.+J.+Thatcherauthor=I.+G.+Gazaryan&title=Activation+of+Nrf2+and+hypoxic+adaptive+response+contribute+to+neuroprotection+elicited+by+phenylhydroxamic+acid+selective+HDAC6+inhibitors&doi=10.1021%2Facschemneuro.7b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors</span></div><div class="casAuthors">Gaisina, Irina N.; Lee, Sue H.; Kaidery, Navneet A.; Ben Aissa, Manel; Ahuja, Manuj; Smirnova, Natalya N.; Wakade, Sushama; Gaisin, Arsen; Bourassa, Megan W.; Ratan, Rajiv R.; Nikulin, Sergey V.; Poloznikov, Andrey A.; Thomas, Bobby; Thatcher, Gregory R. J.; Gazaryan, Irina G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">894-900</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of HIF-1α and Nrf2 is a primary component of cellular response to oxidative stress, and activation of HIF-1α and Nrf2 provides neuroprotection in models of neurodegenerative disorders, including ischemic stroke, Alzheimer's and Parkinson's diseases.  Screening a library of CNS-targeted drugs using novel reporters for HIF-1α and Nrf2 elevation in neuronal cells revealed histone deacetylase (HDAC) inhibitors as potential activators of these pathways.  We report the identification of phenylhydroxamates as single agents exhibiting tripartite inhibition of HDAC6, inhibition of HIF-1 prolyl hydroxylase (PHD), and activation of Nrf2.  Two superior tripartite agents, ING-6 and ING-66, showed neuroprotection against various cellular insults, assocd. with stabilization of both Nrf2 and HIF-1, and expression of their resp. target genes in vitro and in vivo.  Discovery of the innate ability of phenylhydroxamate HDAC inhibitors to activate Nrf2 and HIF provides a novel route to multifunctional neuroprotective agents and cautions against HDAC6 selective inhibitors as chem. probes of specific HDAC isoform function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEVdjIPEJsurVg90H21EOLACvtfcHk0lj_5FSkdxb0HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFOhsw%253D%253D&md5=6977da6ac81dd5fc7f07c3dccbb1d4b2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00435%26sid%3Dliteratum%253Aachs%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKaidery%26aufirst%3DN.%2BA.%26aulast%3DBen%2BAissa%26aufirst%3DM.%26aulast%3DAhuja%26aufirst%3DM.%26aulast%3DSmirnova%26aufirst%3DN.%2BN.%26aulast%3DWakade%26aufirst%3DS.%26aulast%3DGaisin%26aufirst%3DA.%26aulast%3DBourassa%26aufirst%3DM.%2BW.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26aulast%3DNikulin%26aufirst%3DS.%2BV.%26aulast%3DPoloznikov%26aufirst%3DA.%2BA.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DGazaryan%26aufirst%3DI.%2BG.%26atitle%3DActivation%2520of%2520Nrf2%2520and%2520hypoxic%2520adaptive%2520response%2520contribute%2520to%2520neuroprotection%2520elicited%2520by%2520phenylhydroxamic%2520acid%2520selective%2520HDAC6%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D894%26epage%3D900%26doi%3D10.1021%2Facschemneuro.7b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span> <span> </span><span class="NLM_article-title">5-Aroylindoles act as selective histone deacetylase 6 inhibitors ameliorating Alzheimer’s disease phenotypes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7087</span>– <span class="NLM_lpage">7102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKmsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7087-7102&author=H.-Y.+Leeauthor=S.-J.+Fanauthor=F.-I.+Huangauthor=H.-Y.+Chaoauthor=K.-C.+Hsuauthor=T.+E.+Linauthor=T.-K.+Yehauthor=M.-J.+Laiauthor=Y.-H.+Liauthor=H.-L.+Huangauthor=C.-R.+Yangauthor=J.-P.+Liou&title=5-Aroylindoles+act+as+selective+histone+deacetylase+6+inhibitors+ameliorating+Alzheimer%E2%80%99s+disease+phenotypes&doi=10.1021%2Facs.jmedchem.8b00151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes</span></div><div class="casAuthors">Lee, Hsueh-Yun; Fan, Sheng-Jun; Huang, Fang-I.; Chao, Hsin-Yi; Hsu, Kai-Cheng; Lin, Tony Eight; Yeh, Teng-Kuang; Lai, Mei-Jung; Li, Yu-Hsuan; Huang, Hsiang-Ling; Yang, Chia-Ron; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7087-7102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper reports the development of a series of 5-aroylindolyl-substituted hydroxamic acids.  N-Hydroxy-4-((5-(4-methoxybenzoyl)-1H-indol-1-yl)methyl)benzamide (6) has potent inhibitory selectivity against histone deacetylase 6 (HDAC6) with an IC50 value of 3.92 nM.  It decreases not only the level of phosphorylation of tau proteins but also the aggregation of tau proteins.  Compd. 6 also shows neuroprotective activity by triggering ubiquitination.  In animal models, compd. 6 is able to ameliorate the impaired learning and memory, and it crosses the blood-brain barrier after oral administration.  Compd. 6 can be developed as a potential treatment for Alzheimer's disease in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJdt1D5uVurVg90H21EOLACvtfcHk0lj_5FSkdxb0HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKmsL3L&md5=6065438bfabec38e1f8fa4b5ea47e3ce</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00151%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DFan%26aufirst%3DS.-J.%26aulast%3DHuang%26aufirst%3DF.-I.%26aulast%3DChao%26aufirst%3DH.-Y.%26aulast%3DHsu%26aufirst%3DK.-C.%26aulast%3DLin%26aufirst%3DT.%2BE.%26aulast%3DYeh%26aufirst%3DT.-K.%26aulast%3DLai%26aufirst%3DM.-J.%26aulast%3DLi%26aufirst%3DY.-H.%26aulast%3DHuang%26aufirst%3DH.-L.%26aulast%3DYang%26aufirst%3DC.-R.%26aulast%3DLiou%26aufirst%3DJ.-P.%26atitle%3D5-Aroylindoles%2520act%2520as%2520selective%2520histone%2520deacetylase%25206%2520inhibitors%2520ameliorating%2520Alzheimer%25E2%2580%2599s%2520disease%2520phenotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7087%26epage%3D7102%26doi%3D10.1021%2Facs.jmedchem.8b00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bemiller, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtishaw, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leisgang, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, B. T.</span></span> <span> </span><span class="NLM_article-title">Inflammation as a central mechanism in Alzheimer’s disease</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2018.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.trci.2018.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BB3cvnvVSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=575-590&author=J.+W.+Kinneyauthor=S.+M.+Bemillerauthor=A.+S.+Murtishawauthor=A.+M.+Leisgangauthor=A.+M.+Salazarauthor=B.+T.+Lamb&title=Inflammation+as+a+central+mechanism+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.trci.2018.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation as a central mechanism in Alzheimer's disease</span></div><div class="casAuthors">Kinney Jefferson W; Murtishaw Andrew S; Leisgang Amanda M; Salazar Arnold M; Bemiller Shane M; Lamb Bruce T</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">575-590</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles.  Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD.  The sustained activation of the brain's resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder.  In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia-related signaling mechanisms that have been implicated in AD.  Additional information on microglia signaling and a number of cytokines in AD are also reviewed.  We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0qVKieHI_a-dfST00W0BcfW6udTcc2eZb8Nm2ZIWyjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvnvVSltA%253D%253D&md5=cf1cea8f5c84010fd13daebab3094edf</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2018.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2018.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DJ.%2BW.%26aulast%3DBemiller%26aufirst%3DS.%2BM.%26aulast%3DMurtishaw%26aufirst%3DA.%2BS.%26aulast%3DLeisgang%26aufirst%3DA.%2BM.%26aulast%3DSalazar%26aufirst%3DA.%2BM.%26aulast%3DLamb%26aufirst%3DB.%2BT.%26atitle%3DInflammation%2520as%2520a%2520central%2520mechanism%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2018%26volume%3D4%26spage%3D575%26epage%3D590%26doi%3D10.1016%2Fj.trci.2018.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schotterl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennenstuhl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumann, U.</span></span> <span> </span><span class="NLM_article-title">Modulation of immune responses by histone deacetylase inhibitors</span>. <i>Crit. Rev. Oncog.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1615/CritRevOncog.2014012393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1615%2FCritRevOncog.2014012393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=25746108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhslCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=139-154&author=S.+Schotterlauthor=H.+Brennenstuhlauthor=U.+Naumann&title=Modulation+of+immune+responses+by+histone+deacetylase+inhibitors&doi=10.1615%2FCritRevOncog.2014012393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of immune responses by histone deacetylase inhibitors</span></div><div class="casAuthors">Schotterl Sonja; Brennenstuhl Heiko; Naumann Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncogenesis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">139-54</span>
        ISSN:<span class="NLM_cas:issn">0893-9675</span>.
    </div><div class="casAbstract">Recent studies have demonstrated that histone deacetylase (HDAC) inhibitors (HDACi) have potential immunomodulatory activity since they affect the immune surveillance by regulating the production of cytokines, alter the activity and function of macrophages and dendritic cells (DC), regulate the transcription of a variety of immune-stimulating genes, and can modulate the activity of immune effector cells of both the innate and adaptive immune system.  Besides their immunostimulatory activity, HDACi can induce growth arrest and cell death, and modulate a subset of cellular functions such as cell motility or differentiation.  This makes HDACi interesting therapeutic candidates for the treatment of a variety of human diseases like cancer, autoimmune, and graft versus host diseases.  Besides these, HDACs have been shown to be involved in virus replication and pathogenesis, and it was recently shown that HDACi provide therapeutic effects in the treatment of oncogenic virus infections and associated malignancies.  This review will further give information about the different families of HDACs and their opponents, the histone acetylases (HATs), about the classes and function of specific HDACi, and their use in the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe2viLetAEXv6AExegM5LLfW6udTcc2eaYO8l4e2mk47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhslCgtw%253D%253D&md5=7fd1a3ce494b8f8f85520eba76e54fae</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1615%2FCritRevOncog.2014012393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevOncog.2014012393%26sid%3Dliteratum%253Aachs%26aulast%3DSchotterl%26aufirst%3DS.%26aulast%3DBrennenstuhl%26aufirst%3DH.%26aulast%3DNaumann%26aufirst%3DU.%26atitle%3DModulation%2520of%2520immune%2520responses%2520by%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DCrit.%2520Rev.%2520Oncog.%26date%3D2015%26volume%3D20%26spage%3D139%26epage%3D154%26doi%3D10.1615%2FCritRevOncog.2014012393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenechukwu, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice</span>. <i>Pharm. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1080/13880209.2018.1563620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1080%2F13880209.2018.1563620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31124385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BB3M7ptlWntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2019&pages=263-268&author=Y.+Songauthor=L.+Qinauthor=R.+Yangauthor=F.+Yangauthor=N.+A.+Kenechukwuauthor=X.+Zhaoauthor=X.+Zhouauthor=X.+Wenauthor=L.+Li&title=Inhibition+of+HDAC6+alleviating+lipopolysaccharide-induced+p38MAPK+phosphorylation+and+neuroinflammation+in+mice&doi=10.1080%2F13880209.2018.1563620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice</span></div><div class="casAuthors">Song Yuanjian; Yang Fan; Kenechukwu Nwobodo Alexander; Zhao Xiaofang; Li Lei; Song Yuanjian; Yang Fan; Kenechukwu Nwobodo Alexander; Wen Xiangru; Li Lei; Song Yuanjian; Qin Li; Yang Rongli; Li Lei; Zhou Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-268</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Context: Researchers in a variety of fields have extensively focused on histone deacetylase 6 (HDAC6) due to its aggravation of inflammatory reaction.  However, relevant studies examining whether HDAC6 could exacerbate lipopolysaccharide (LPS)-induced inflammation are still lacking.  Objective: We assessed the role of HDAC6 in LPS-induced brain inflammation and used the HDAC6-selective inhibitor Tubastatin A (TBSA) to investigate the potential mechanisms further.  Materials and methods: Brain inflammation was induced in Kunming (KM) mice via intraperitoneal (I.P.), injection of Lipopolysaccharide (LPS) (1 mg/kg), the TBSA (0.5 mg/kg) was delivered via intraperitoneal.  The phosphorylated p38 (p-p38) Mitogen-activated protein kinases (MAPK) and expression of typical inflammatory mediators, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both the hippocampus and cortex, were examined by immunoblotting.  Nissl staining was used to detect the neuronal damage in the hippocampus and the cortex.  Results: About 1 mg/kg LPS via daily intraperitoneal (I.P.) injections for 12 days significantly increased p38 MAPK phosphorylation, TNF-α and IL-6 expression, and neuronal loss.  However, 0.5 mg/kg TBSA (three days before LPS treatment) by I.P. injections for 15 days could reverse the above results.  Conclusions: This present study provided evidence that TBSA significantly suppressed LPS-induced neuroinflammation and the expression of p-p38.  Results derived from our study might help reveal the effective targeting strategies of LPS-induced brain inflammation through inhibiting HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuCv_wHdytl5HZzFRCXxVKfW6udTcc2eaYO8l4e2mk47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7ptlWntg%253D%253D&md5=ce35a28b2a3843f2ca7cc306cee0e2bd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1080%2F13880209.2018.1563620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13880209.2018.1563620%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DKenechukwu%26aufirst%3DN.%2BA.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520HDAC6%2520alleviating%2520lipopolysaccharide-induced%2520p38MAPK%2520phosphorylation%2520and%2520neuroinflammation%2520in%2520mice%26jtitle%3DPharm.%2520Biol.%26date%3D2019%26volume%3D57%26spage%3D263%26epage%3D268%26doi%3D10.1080%2F13880209.2018.1563620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology by design: a medicinal chemist’s perspective on multitargeting compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=420-444&author=E.+Proschakauthor=H.+Starkauthor=D.+Merk&title=Polypharmacology+by+design%3A+a+medicinal+chemist%E2%80%99s+perspective+on+multitargeting+compounds&doi=10.1021%2Facs.jmedchem.8b00760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds</span></div><div class="casAuthors">Proschak, Ewgenij; Stark, Holger; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">420-444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multitargeting compds. comprising activity on more than a single biol. target have gained remarkable relevance in drug discovery owing to the complexity of multifactorial diseases such as cancer, inflammation, or the metabolic syndrome.  Polypharmacol. drug profiles can produce additive or synergistic effects while reducing side effects and significantly contribute to the high therapeutic success of indispensable drugs such as aspirin.  While their identification has long been the result of serendipity, medicinal chem. now tends to design polypharmacol.  Modern in vitro pharmacol. methods and chem. probes allow a systematic search for rational target combinations and recent innovations in computational technologies, crystallog., or fragment-based design equip multitarget compd. development with valuable tools.  In this Perspective, we analyze the relevance of multiple ligands in drug discovery and the versatile toolbox to design polypharmacol.  We conclude that despite some characteristic challenges remaining unresolved, designed polypharmacol. holds enormous potential to secure future therapeutic innovation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEwJSxWw3vbVg90H21EOLACvtfcHk0lizGcU1qHotCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fE&md5=6dc4b8e1c4777372396626140a302663</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00760%26sid%3Dliteratum%253Aachs%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DPolypharmacology%2520by%2520design%253A%2520a%2520medicinal%2520chemist%25E2%2580%2599s%2520perspective%2520on%2520multitargeting%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D420%26epage%3D444%26doi%3D10.1021%2Facs.jmedchem.8b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of multitarget-directed ligands: strategies and emerging paradigms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8881</span>– <span class="NLM_lpage">8914</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8881-8914&author=J.+Zhouauthor=X.+Jiangauthor=S.+Heauthor=H.+Jiangauthor=F.+Fengauthor=W.+Liuauthor=W.+Quauthor=H.+Sun&title=Rational+design+of+multitarget-directed+ligands%3A+strategies+and+emerging+paradigms&doi=10.1021%2Facs.jmedchem.9b00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms</span></div><div class="casAuthors">Zhou, Junting; Jiang, Xueyang; He, Siyu; Jiang, Hongli; Feng, Feng; Liu, Wenyuan; Qu, Wei; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8881-8914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit satisfactory efficacy.  Recently, increasing evidence indicates that simultaneous modulation of multiple targets may improve both therapeutic safety and efficacy, compared with single-target drugs.  However, few multitarget drugs are on market or in clin. trials, despite the best efforts of medicinal chemists.  This article discusses the systematic establishment of target combination, lead generation, and optimization of multitarget-directed ligands (MTDLs).  Moreover, we analyze some MTDLs research cases for several complex diseases in recent years and the physicochem. properties of 117 clin. multitarget drugs, with the aim to reveal the trends and insights of the potential use of MTDLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLqk7hMZnoLVg90H21EOLACvtfcHk0lhmDEB9wQ3d9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D&md5=37adb9bc31802e62fd7f8d0d6e7697e3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520multitarget-directed%2520ligands%253A%2520strategies%2520and%2520emerging%2520paradigms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8881%26epage%3D8914%26doi%3D10.1021%2Facs.jmedchem.9b00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Harnessing polypharmacology with medicinal chemistry</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=273-275&author=M.+L.+Bolognesi&title=Harnessing+polypharmacology+with+medicinal+chemistry&doi=10.1021%2Facsmedchemlett.9b00039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing Polypharmacology with Medicinal Chemistry</span></div><div class="casAuthors">Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-275</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Polypharmacol. has expanded enormously over the last ten years, with several multitarget drugs (MTDs) already in the market.  This Viewpoint provides a basis for a discussion about the crit. need to develop MTDs in a more rationale and conscious way.  A checklist to maximize success in polypharmacol. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4yXxJ_uU72bVg90H21EOLACvtfcHk0lhmDEB9wQ3d9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVWjt7g%253D&md5=28a8cc47ae2966a2ecd8a411adfb1ef5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00039%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DHarnessing%2520polypharmacology%2520with%2520medicinal%2520chemistry%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D273%26epage%3D275%26doi%3D10.1021%2Facsmedchemlett.9b00039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albertini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sena
Murteira Pinheiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1002/med.21699.</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fmed.21699." title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1&author=C.+Albertiniauthor=A.+Salernoauthor=P.+de+Sena%0AMurteira+Pinheiroauthor=M.+L.+Bolognesi&title=From+combinations+to+multitarget-directed+ligands%3A+A+continuum+in+Alzheimer%E2%80%99s+disease+polypharmacology&doi=10.1002%2Fmed.21699."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fmed.21699.&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21699.%26sid%3Dliteratum%253Aachs%26aulast%3DAlbertini%26aufirst%3DC.%26aulast%3DSalerno%26aufirst%3DA.%26aulast%3Dde%2BSena%2BMurteira%2BPinheiro%26aufirst%3DP.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DFrom%2520combinations%2520to%2520multitarget-directed%2520ligands%253A%2520A%2520continuum%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520polypharmacology%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2020%26spage%3D1%26doi%3D10.1002%2Fmed.21699." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors as multitarget ligands: new players in Alzheimer’s disease drug discovery?</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fcmdc.201900174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=30958639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos1Wiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1067-1073&author=A.+De%0ASimoneauthor=A.+Milelli&title=Histone+deacetylase+inhibitors+as+multitarget+ligands%3A+new+players+in+Alzheimer%E2%80%99s+disease+drug+discovery%3F&doi=10.1002%2Fcmdc.201900174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors as multitarget ligands: new players in Alzheimer's disease drug discovery?</span></div><div class="casAuthors">De Simone, Angela; Milelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACIs) are responsible for controlling gene expression by modulating the acetylation status of histone proteins.  Furthermore, they modulate the activity of cytoplasmic non-histone proteins.  Due to the involvement of HDACs in neurodevelopment, memory formation, and cognitive processes, HDACIs have been suggested as innovative agents for the treatment of neurodegenerative disorders such as Alzheimer's disease (AD).  Given their mechanisms of action and the complex nature of AD, HDACIs have been proposed for the design of novel multitarget ligands (MTLs).  To this aim, the fragment responsible for HDAC inhibition has been coupled with other structures that are able to provide addnl. biol. actions, such as antioxidant activity or the inhibition of phosphodiesterase 5, transglutaminase 2, and glycogen synthase kinase 3β.  Herein we discuss recent efforts to design HDACI-based MTLs as potential disease-modifying entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotgFDwLEiUt7Vg90H21EOLACvtfcHk0ljfAQIoHW442A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos1Wiurc%253D&md5=191fca2c9334551a52be5c13bf71cf90</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900174%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DMilelli%26aufirst%3DA.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520as%2520multitarget%2520ligands%253A%2520new%2520players%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%253F%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1067%26epage%3D1073%26doi%3D10.1002%2Fcmdc.201900174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Two-hit wonders: the expanding universe of multitargeting epigenetic agents</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2020.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.cbpa.2020.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32784072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKnsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2020&pages=135-154&author=A.+R.+de%0ALeraauthor=A.+Ganesan&title=Two-hit+wonders%3A+the+expanding+universe+of+multitargeting+epigenetic+agents&doi=10.1016%2Fj.cbpa.2020.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Two-hit wonders: The expanding universe of multitargeting epigenetic agents</span></div><div class="casAuthors">de Lera, Angel R.; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-154</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multitargeting involves the application of mols. that are deliberately intended to bind to two or more unrelated cellular targets with high affinity.  In epigenetic chem. biol. and drug discovery, the rational design of multitargeting agents has evolved to a sophisticated level, and there are now five examples that have reached clin. trials.  This review covers recent developments in the field and future prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwQn-GXR3grVg90H21EOLACvtfcHk0ljfAQIoHW442A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKnsbvO&md5=b5383c9c221fbcb6dcf7483d98aa7b78</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2020.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2020.05.009%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%26aufirst%3DA.%2BR.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DTwo-hit%2520wonders%253A%2520the%2520expanding%2520universe%2520of%2520multitargeting%2520epigenetic%2520agents%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2020%26volume%3D57%26spage%3D135%26epage%3D154%26doi%3D10.1016%2Fj.cbpa.2020.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smalley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, J. T.</span></span> <span> </span><span class="NLM_article-title">Bifunctional HDAC therapeutics: one drug to rule them all?</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4394</span>, <span class="refDoi"> DOI: 10.3390/molecules25194394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.3390%2Fmolecules25194394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVOjtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=4394&author=J.+P.+Smalleyauthor=S.+M.+Cowleyauthor=J.+T.+Hodgkinson&title=Bifunctional+HDAC+therapeutics%3A+one+drug+to+rule+them+all%3F&doi=10.3390%2Fmolecules25194394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional HDAC therapeutics: one drug to rule them all?</span></div><div class="casAuthors">Smalley, Joshua P.; Cowley, Shaun M.; Hodgkinson, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4394</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) enzymes play crucial roles in epigenetic gene expression and are an attractive therapeutic target.  Five HDAC inhibitors have been approved for cancer treatment to date, however, clin. applications have been limited due to poor single-agent drug efficacy and side effects assocd. with a lack of HDAC isoform or complex selectivity.  An emerging strategy aiming to address these limitations is the development of bifunctional HDAC therapeutics-single mols. comprising a HDAC inhibitor conjugated to another specificity targeting moiety.  This review summarizes the recent advancements in novel types of dual-targeting HDAC modulators, including proteolysis-targeting chimeras (PROTACs), with a focus on HDAC isoform and complex selectivity, and the future potential of such bifunctional mols. in achieving enhanced drug efficacy and therapeutic benefits in treating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMU3F42ROLKLVg90H21EOLACvtfcHk0lhYxwWENL5a0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVOjtbnJ&md5=a4aa1f08b4450f6d71ec5fdc6e13ca75</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25194394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25194394%26sid%3Dliteratum%253Aachs%26aulast%3DSmalley%26aufirst%3DJ.%2BP.%26aulast%3DCowley%26aufirst%3DS.%2BM.%26aulast%3DHodgkinson%26aufirst%3DJ.%2BT.%26atitle%3DBifunctional%2520HDAC%2520therapeutics%253A%2520one%2520drug%2520to%2520rule%2520them%2520all%253F%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D4394%26doi%3D10.3390%2Fmolecules25194394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Epigenetic polypharmacology: a new frontier for epi-drug discovery</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1002/med.21600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fmed.21600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31218726" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=190-244&author=D.+Tomaselliauthor=A.+Lucidiauthor=D.+Rotiliauthor=A.+Mai&title=Epigenetic+polypharmacology%3A+a+new+frontier+for+epi-drug+discovery&doi=10.1002%2Fmed.21600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fmed.21600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21600%26sid%3Dliteratum%253Aachs%26aulast%3DTomaselli%26aufirst%3DD.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DEpigenetic%2520polypharmacology%253A%2520a%2520new%2520frontier%2520for%2520epi-drug%2520discovery%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D40%26spage%3D190%26epage%3D244%26doi%3D10.1002%2Fmed.21600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osko, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6-selective inhibitors and the influence of capping groups on hydroxamate-zinc denticity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8054</span>– <span class="NLM_lpage">8060</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFansLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8054-8060&author=N.+J.+Porterauthor=J.+D.+Oskoauthor=D.+Diedrichauthor=T.+Kurzauthor=J.+M.+Hookerauthor=F.+K.+Hansenauthor=D.+W.+Christianson&title=Histone+deacetylase+6-selective+inhibitors+and+the+influence+of+capping+groups+on+hydroxamate-zinc+denticity&doi=10.1021%2Facs.jmedchem.8b01013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity</span></div><div class="casAuthors">Porter, Nicholas J.; Osko, Jeremy D.; Diedrich, Daniela; Kurz, Thomas; Hooker, Jacob M.; Hansen, Finn K.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8054-8060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four crystal structures are presented of histone deacetylase 6 (HDAC6) complexes with para-substituted phenylhydromaxamate inhibitors, including bulky peptoids.  These structures provide insight regarding the design of capping groups that confer selectivity for binding to HDAC6, specifically with regard to interactions in a pocket formed by the L1 loop.  Capping group interactions may also influence hydroxamate-Zn2+ coordination with monodentate or bidentate geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq54PM6p6wpnrVg90H21EOLACvtfcHk0lh26i1hjWEoKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFansLnE&md5=f1d227d7668d09e121e5967b2d65f1a5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01013%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DOsko%26aufirst%3DJ.%2BD.%26aulast%3DDiedrich%26aufirst%3DD.%26aulast%3DKurz%26aufirst%3DT.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DHansen%26aufirst%3DF.%2BK.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHistone%2520deacetylase%25206-selective%2520inhibitors%2520and%2520the%2520influence%2520of%2520capping%2520groups%2520on%2520hydroxamate-zinc%2520denticity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8054%26epage%3D8060%26doi%3D10.1021%2Facs.jmedchem.8b01013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mendoza, A. E.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of first-in-class dual acting histone deacetylases (HDACs) and phosphodiesterase 5 (PDE5) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8967</span>– <span class="NLM_lpage">9004</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00908</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8967-9004&author=O.+Rabalauthor=J.+A.+S%C3%A1nchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=C.+Garc%C3%ADa-Barrosoauthor=A.+Ugarteauthor=A.+E.-H.+de+Mendozaauthor=E.+S%C3%A1ezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Design%2C+synthesis%2C+and+biological+evaluation+of+first-in-class+dual+acting+histone+deacetylases+%28HDACs%29+and+phosphodiesterase+5+%28PDE5%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8967-9004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simultaneous inhibition of phosphodiesterase 5 (PDE5) and histone deacetylases (HDAC) has recently been validated as a potentially novel therapeutic approach for Alzheimer's Disease (AD).  To further extend this concept, the authors designed and synthesized the first chem. series of dual acting PDE5 and HDAC inhibitors, and the authors validated this systems therapeutics approach.  Following the implementation of structure- and knowledge-based approaches, initial hits were designed and were shown to validate the hypothesis of dual in vitro inhibition.  Then, an optimization strategy was pursued to obtain a proper tool compd. for in vivo testing in AD models.  Initial hits were translated into mols. with adequate cellular functional responses (histone acetylation and cAMP/cGMP response element-binding (CREB) phosphorylation in the nanomolar range), an acceptable therapeutic window (>1 log unit) and the ability to cross the blood-brain barrier, leading to the identification of 7 as a candidate for in vivo proof-of-concept testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbHBoJlefNEbVg90H21EOLACvtfcHk0lgg0DHI-ZWEcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O&md5=756a252809f05f5d7fc59e828736cfba</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00908%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3Dde%2BMendoza%26aufirst%3DA.%2BE.-H.%26aulast%3DS%25C3%25A1ez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520first-in-class%2520dual%2520acting%2520histone%2520deacetylases%2520%2528HDACs%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8967%26epage%3D9004%26doi%3D10.1021%2Facs.jmedchem.6b00908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s disease mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1038%2Fnpp.2016.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=27550730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=524-539&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+A.+S%C3%A1nchez-Ariasauthor=O.+Rabalauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=S.+Mederosauthor=A.+Ugarteauthor=R.+Francoauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=A+first-in-class+small-molecule+that+acts+as+a+dual+inhibitor+of+HDAC+and+PDE5+and+that+rescues+hippocampal+synaptic+impairment+in+Alzheimer%E2%80%99s+disease+mice&doi=10.1038%2Fnpp.2016.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice</span></div><div class="casAuthors">Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Sanchez-Arias, Juan A.; Rabal, Obdulia; Perez-Gonzalez, Marta; Mederos, Sara; Ugarte, Ana; Franco, Rafael; Segura, Victor; Perea, Gertrudis; Oyarzabal, Julen; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-539</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The targeting of two independent but synergistic enzymic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD).  Here we report the discovery of a new first-in-class small-mol. (CM-414) that acts as a dual inhibitor of PDE5 and HDACs.  We have used this compd. as a chem. probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation.  This mol. rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice.  Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine d. on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.  Thus, CM-414 may serve as the starting point to discover balanced dual inhibitors with an optimal efficacy and safety profile for clin. testing on AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrel_KiPL5177Vg90H21EOLACvtfcHk0lgg0DHI-ZWEcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP&md5=26482df7c58696a362ca1e73bab12264</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.163%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DA%2520first-in-class%2520small-molecule%2520that%2520acts%2520as%2520a%2520dual%2520inhibitor%2520of%2520HDAC%2520and%2520PDE5%2520and%2520that%2520rescues%2520hippocampal%2520synaptic%2520impairment%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D524%26epage%3D539%26doi%3D10.1038%2Fnpp.2016.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mendoza, A. E.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda-Lucena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Multitarget approach for the treatment of Alzheimer’s disease: inhibition of phosphodiesterase 9 (PDE9) and histone deacetylases (HDACs) covering diverse selectivity profiles</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4076</span>– <span class="NLM_lpage">4101</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1egu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4076-4101&author=O.+Rabalauthor=J.+A.+S%C3%A1nchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=C.+Garc%C3%ADa-Barrosoauthor=A.+Ugarteauthor=A.+E.-H.+de+Mendozaauthor=E.+S%C3%A1ezauthor=M.+Espelosinauthor=S.+Ursuaauthor=H.+Tanauthor=W.+Wuauthor=M.+Xuauthor=A.+Pineda-Lucenaauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Multitarget+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+inhibition+of+phosphodiesterase+9+%28PDE9%29+and+histone+deacetylases+%28HDACs%29+covering+diverse+selectivity+profiles&doi=10.1021%2Facschemneuro.9b00303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Tan, Haizhong; Wu, Wei; Xu, Musheng; Pineda-Lucena, Antonio; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4076-4101</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present a series of dual-target phosphodiesterase 9 (PDE9) and histone deacetylase (HDAC) inhibitors devised as pharmacol. tool compds. for assessing the implications of these two targets in Alzheimer's disease (AD).  These novel inhibitors were designed taking into account the key pharmacophoric features of known selective PDE9 inhibitors as well as privileged chem. structures, bearing zinc binding groups (hydroxamic acids and ortho-amino anilides) that hit HDAC targets.  These substituents were selected according to rational criteria and previous knowledge from our group to explore diverse HDAC selectivity profiles (pan-HDAC, HDAC6 selective, and class I selective) that were confirmed in biochem. screens.  Their functional response in inducing acetylation of histone and tubulin and phosphorylation of cAMP response element binding (CREB) was measured as a requisite for further progression into complete in vitro absorption, distribution, metab. and excretion (ADME) and in vivo brain penetration profiling.  Compd. 31b, a selective HDAC6 inhibitor with acceptable brain permeability, was chosen for assessing in vivo efficacy of these first-in-class inhibitors, as well as studying their mode of action (MoA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9GkgLW75qELVg90H21EOLACvtfcHk0lg5p1lRao7MaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1egu7rF&md5=be57148d4b99a7e517c51142a1908fb8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00303%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3Dde%2BMendoza%26aufirst%3DA.%2BE.-H.%26aulast%3DS%25C3%25A1ez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DPineda-Lucena%26aufirst%3DA.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DMultitarget%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520inhibition%2520of%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520and%2520histone%2520deacetylases%2520%2528HDACs%2529%2520covering%2520diverse%2520selectivity%2520profiles%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D4076%26epage%3D4101%26doi%3D10.1021%2Facschemneuro.9b00303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Pietra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petragnani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrobono, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frabetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russomanno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballerini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebbioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of the first-in-class GSK-3β/HDAC dual inhibitor as disease-modifying agent to combat Alzheimer’s disease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=469-474&author=A.+De%0ASimoneauthor=V.+La+Pietraauthor=N.+Betariauthor=N.+Petragnaniauthor=M.+Conteauthor=S.+Danieleauthor=D.+Pietrobonoauthor=C.+Martiniauthor=S.+Petrallaauthor=R.+Casadeiauthor=L.+Davaniauthor=F.+Frabettiauthor=P.+Russomannoauthor=E.+Novellinoauthor=S.+Montanariauthor=V.+Tumiattiauthor=P.+Balleriniauthor=F.+Sarnoauthor=A.+Nebbiosoauthor=L.+Altucciauthor=B.+Montiauthor=V.+Andrisanoauthor=A.+Milelli&title=Discovery+of+the+first-in-class+GSK-3%CE%B2%2FHDAC+dual+inhibitor+as+disease-modifying+agent+to+combat+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facsmedchemlett.8b00507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease</span></div><div class="casAuthors">De Simone, Angela; La Pietra, Valeria; Betari, Nibal; Petragnani, Nicola; Conte, Mariarosaria; Daniele, Simona; Pietrobono, Deborah; Martini, Claudia; Petralla, Sabrina; Casadei, Raffaella; Davani, Lara; Frabetti, Flavia; Russomanno, Pasquale; Novellino, Ettore; Montanari, Serena; Tumiatti, Vincenzo; Ballerini, Patrizia; Sarno, Federica; Nebbioso, Angela; Altucci, Lucia; Monti, Barbara; Andrisano, Vincenza; Milelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-474</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several evidence pointed out the role of epigenetics in Alzheimer's disease (AD) revealing strictly relationships between epigenetic and "classical" AD targets.  Based on the reported connection among histone deacetylases (HDACs) and glycogen synthase kinase 3β (GSK-3β), herein we present the discovery and the biochem. characterization of the first-in-class hit compd. able to exert promising anti-AD effects by modulating the targeted proteins in the low micromolar range of concn.  Compd. 11 induces an increase in histone acetylation and a redn. of tau phosphorylation.  It is nontoxic and protective against H2O2 and 6-OHDA stimuli in SH-SY5Y and in CGN cell lines, resp.  Moreover, it promotes neurogenesis and displays immunomodulatory effects.  Compd. 11 shows no lethality in a wt-zebrafish model (<100 μM) and high water soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFpd6rQuX3jrVg90H21EOLACvtfcHk0lhgCllJhVY4GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSqtbs%253D&md5=c57168700a73c70eafa747add137cac1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00507%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DBetari%26aufirst%3DN.%26aulast%3DPetragnani%26aufirst%3DN.%26aulast%3DConte%26aufirst%3DM.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DPietrobono%26aufirst%3DD.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DCasadei%26aufirst%3DR.%26aulast%3DDavani%26aufirst%3DL.%26aulast%3DFrabetti%26aufirst%3DF.%26aulast%3DRussomanno%26aufirst%3DP.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DBallerini%26aufirst%3DP.%26aulast%3DSarno%26aufirst%3DF.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DMilelli%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520the%2520first-in-class%2520GSK-3%25CE%25B2%252FHDAC%2520dual%2520inhibitor%2520as%2520disease-modifying%2520agent%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D469%26epage%3D474%26doi%3D10.1021%2Facsmedchemlett.8b00507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer’s disease</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">104109</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.104109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bioorg.2020.104109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32768741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKgsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2020&pages=104109&author=F.+Heauthor=Y.+Ranauthor=X.+Liauthor=D.+Wangauthor=Q.+Zhangauthor=J.+Lvauthor=C.+Yuauthor=Y.+Quauthor=X.+Zhangauthor=A.+Xuauthor=C.+Weiauthor=C.+J.+Chouauthor=J.+Wu&title=Design%2C+synthesis+and+biological+evaluation+of+dual-function+inhibitors+targeting+NMDAR+and+HDAC+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bioorg.2020.104109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's disease</span></div><div class="casAuthors">He, Feng; Ran, Yingying; Li, Xiaoyang; Wang, Defeng; Zhang, Qiuqiong; Lv, Jiahui; Yu, Chenggong; Qu, Ying; Zhang, Xiangna; Xu, Ana; Wei, Chao; Chou, C. James; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104109</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) have been indicated important roles in neurodegenerative disorders including Alzheimer's disease (AD).  Herein, a series of novel compds. that contain a memantine moiety were designed to target HDACs and N-methyl-D-aspartate receptor (NMDAR) which are related to the treatment of AD.  Biol. characterization established that compd. 9d exhibited a balanced inhibitory activity on NMDAR and HDACs.  This compd. is relatively selective to HDAC6 with IC50 of 0.18 μM and also maintains comparable activity on NMDAR (Ki = 0.59 μM) as memantine.  Functionally, treatment with 9d (I) increased the level of AcTubulin in MV4-11 cells and rescued PC-12 cells from H2O2-induced cytotoxicity with EC50 of 0.94 μM.  Studies in mice also demonstrated that compd. I efficiently penetrates the blood brain barrier to reach the brain tissue.  Collectively, the results strongly encourage further development of 9d as a potential therapeutic agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxsMkyhmn3l7Vg90H21EOLACvtfcHk0libZsQC-yP1Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKgsLbF&md5=0d2c7f6afe4f6ec0a2eae238084a622c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.104109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.104109%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DF.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520dual-function%2520inhibitors%2520targeting%2520NMDAR%2520and%2520HDAC%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D103%26spage%3D104109%26doi%3D10.1016%2Fj.bioorg.2020.104109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: Design, synthesis, and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">103721</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bioorg.2020.103721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32193030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&pages=103721&author=A.+Xuauthor=F.+Heauthor=X.+Zhangauthor=X.+Liauthor=Y.+Ranauthor=C.+Weiauthor=C.+J.+Chouauthor=R.+Zhangauthor=J.+Wu&title=Tacrine-hydroxamate+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+Design%2C+synthesis%2C+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation</span></div><div class="casAuthors">Xu, Ana; He, Feng; Zhang, Xiangna; Li, Xiaoyang; Ran, Yingying; Wei, Chao; James Chou, C.; Zhang, Rui; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103721</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop multitarget-directed ligands as potential treatments for Alzheimer's disease, twenty-eight new tacrine-hydroxamate derivs. were designed, synthesized, and biol. evaluated.  As expected, most of the compds. exhibited inhibitory activities against cholinesterases (ChEs) and histone deacetylase (HDACs).  Among the tested compds., I showed not only potent and selective inhibition on AChE at sub-nanomolar potency (AChEIC50 = 0.12 nM, BChEIC50 = 361.52 nM) but also potent inhibition on HDAC (IC50 = 0.23 nM).  Moreover, I exhibited inhibitory activity on Aβ1-42 self-aggregation as well as disaggregation activity on pre-formed Aβ fibrils.  Furthermore, I exhibited antioxidant activity and metal chelating properties.  Further mechanistic studies demonstrated that I is a pan-inhibitor of HDACs and a mixed-type inhibitor for AChE.  It was shown that I is a BBB penetrant by online prediction.  Taken together, the results indicate that I can serve as a lead compd. to develop promising candidate analogs as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLE3wLayb4i7Vg90H21EOLACvtfcHk0libZsQC-yP1Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D&md5=e2b820af806ce7651f90fc66d4a1f1cb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103721%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTacrine-hydroxamate%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26spage%3D103721%26doi%3D10.1016%2Fj.bioorg.2020.103721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiao, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.-J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">112193</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.ejmech.2020.112193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32151835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2020&pages=112193&author=H.-J.+Tsengauthor=M.-H.+Linauthor=Y.-J.+Shiaoauthor=Y.-C.+Yangauthor=J.-C.+Chuauthor=C.-Y.+Chenauthor=Y.-Y.+Chenauthor=T.+E.+Linauthor=C.-J.+Suauthor=S.-L.+Panauthor=L.-C.+Chenauthor=C.-Y.+Wangauthor=K.-C.+Hsuauthor=W.-J.+Huang&title=Synthesis+and+biological+evaluation+of+acridine-based+histone+deacetylase+inhibitors+as+multitarget+agents+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2020.112193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease</span></div><div class="casAuthors">Tseng, Hui-Ju; Lin, Mei-Hsiang; Shiao, Young-Ji; Yang, Ying-Chen; Chu, Jung-Chun; Chen, Chun-Yung; Chen, Yi-Ying; Lin, Tony Eight; Su, Chih-Jou; Pan, Shiow-Lin; Chen, Liang-Chieh; Wang, Chen-Yu; Hsu, Kai-Cheng; Huang, Wei-Jan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112193</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multitarget agents simultaneously trigger mols. in functionally complementary pathways, and are therefore considered to have potential in effectively treating Alzheimer's disease (AD), which has a complex pathogenetic mechanism.  In this study, the HDAC inhibitor core is incorporated into the acetylcholine esterase (ACE) inhibitor acridine-derived moiety and resulted in compds. that exhibited higher class IIa HDAC (4, 5, 7, and 9)- and class IIb HDAC6-inhibiting activity when compared to the pan-HDAC inhibitor SAHA in clin. practice.  One of these compds., I, displayed greater selectivity toward HDAC6 than other isoform enzymes.  In contrast, the activity of compd. II was selective toward class IIa HDAC and HDAC6.  These two compds. exhibited strong activity against Aβ-aggregation as well as significantly disrupted Aβ-oligomer.  Addnl., I and II strongly inhibited AChE.  These exptl. findings demonstrate that the above two are HDAC-Aβ-aggregation-AChE inhibitors.  Notably, they can enhance neurite outgrowth, but with no significant neurotoxicity.  Further biol. evaluation revealed the various cellular effects of multitarget compds. I and II, which have the potential to treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqexIdMql7N8bVg90H21EOLACvtfcHk0lhufJTT_WK2yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFels70%253D&md5=f4dd58408b6092ade3b9183065014f33</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112193%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DH.-J.%26aulast%3DLin%26aufirst%3DM.-H.%26aulast%3DShiao%26aufirst%3DY.-J.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DChu%26aufirst%3DJ.-C.%26aulast%3DChen%26aufirst%3DC.-Y.%26aulast%3DChen%26aufirst%3DY.-Y.%26aulast%3DLin%26aufirst%3DT.%2BE.%26aulast%3DSu%26aufirst%3DC.-J.%26aulast%3DPan%26aufirst%3DS.-L.%26aulast%3DChen%26aufirst%3DL.-C.%26aulast%3DWang%26aufirst%3DC.-Y.%26aulast%3DHsu%26aufirst%3DK.-C.%26aulast%3DHuang%26aufirst%3DW.-J.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520acridine-based%2520histone%2520deacetylase%2520inhibitors%2520as%2520multitarget%2520agents%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D192%26spage%3D112193%26doi%3D10.1016%2Fj.ejmech.2020.112193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosales-Corral, S. A.</span>; <span class="NLM_string-name">Reiter, R. J.</span>; <span class="NLM_string-name">Tan, D.-X.</span>; <span class="NLM_string-name">Manchester, L. C.</span>; <span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and Anti-Inflammatory Role of Melatonin in Alzheimer’s Neurodegeneration</span>. In  <i>Aging</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preedy, V. R.</span></span>, Ed. <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2014</span>; pp.  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">193</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2FB978-0-12-405933-7.00018-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=177-193&author=S.+A.+Rosales-Corral&author=R.+J.+Reiter&author=D.-X.+Tan&author=L.+C.+Manchester&author=X.+Liuauthor=V.+R.+Preedy&title=Aging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-405933-7.00018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-405933-7.00018-4%26sid%3Dliteratum%253Aachs%26aulast%3DRosales-Corral%26aufirst%3DS.%2BA.%26atitle%3DAntioxidant%2520and%2520Anti-Inflammatory%2520Role%2520of%2520Melatonin%2520in%2520Alzheimer%25E2%2580%2599s%2520Neurodegeneration%26btitle%3DAging%26aulast%3DPreedy%26aufirst%3DV.%2BR.%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D177%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malar, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span> <span> </span><span class="NLM_article-title">Ferulic acid and Alzheimer’s disease: promises and pitfalls</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.2174/1389557515666150522102545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.2174%2F1389557515666150522102545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=26002710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=776-788&author=S.+F.+Nabaviauthor=K.+P.+Deviauthor=D.+S.+Malarauthor=A.+Suredaauthor=M.+Dagliaauthor=S.+M.+Nabavi&title=Ferulic+acid+and+Alzheimer%E2%80%99s+disease%3A+promises+and+pitfalls&doi=10.2174%2F1389557515666150522102545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ferulic Acid and Alzheimer's Disease: Promises and Pitfalls</span></div><div class="casAuthors">Nabavi, Seyed Fazel; Devi, Kasi Pandima; Malar, Dicson Sheeja; Sureda, Antoni; Daglia, Maria; Nabavi, Seyed Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">776-788</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress plays an important role in both initiation and progression of neurodegenerative diseases, such as Alzheimer and Parkinson.  Therefore, much attention has been paid to antioxidants for developing therapeutic strategies for the neurodegenerative diseases.  However, as serious adverse effects are related to synthetic antioxidants, recent research has been focused on natural products esp. phenolic antioxidants.  In the present article, we critically review the available literature related to the beneficial role of ferulic acid on Alzheimer's disease, since it is a natural antioxidant which is widely found in different fruits and vegetables.  We also provide some informations about sources, chem. structure, bioavailability and clin. impacts of ferulic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ2BkYCOLYprVg90H21EOLACvtfcHk0ljav8FJ-IbCEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVWns70%253D&md5=abebf633cb2168eda2aefd3fb61dc16f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F1389557515666150522102545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666150522102545%26sid%3Dliteratum%253Aachs%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DDevi%26aufirst%3DK.%2BP.%26aulast%3DMalar%26aufirst%3DD.%2BS.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3DDaglia%26aufirst%3DM.%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26atitle%3DFerulic%2520acid%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520promises%2520and%2520pitfalls%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D776%26epage%3D788%26doi%3D10.2174%2F1389557515666150522102545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mihardja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, L. W.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer’s disease</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1478</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1111/nyas.14436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fnyas.14436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32700392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1eltbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1478&publication_year=2020&pages=43-62&author=M.+Mihardjaauthor=J.+Royauthor=K.+Y.+Wongauthor=L.+Aquiliauthor=B.+C.+Hengauthor=Y.-S.+Chanauthor=M.+L.+Fungauthor=L.+W.+Lim&title=Therapeutic+potential+of+neurogenesis+and+melatonin+regulation+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fnyas.14436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease</span></div><div class="casAuthors">Mihardja, Mazel; Roy, Jaydeep; Wong, Kan Yin; Aquili, Luca; Heng, Boon Chin; Chan, Ying-Shing; Fung, Man Lung; Lim, Lee Wei</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1478</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-62</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by the hallmark pathologies of amyloid-beta plaques and neurofibrillary tangles.  Symptoms of this devastating disease include behavioral changes and deterioration of higher cognitive functions.  Impairment of neurogenesis has also been shown to occur in AD, which adversely impacts new neuronal cell growth, differentiation, and survival.  This impairment possibly results from the cumulative effects of the various pathologies of AD.  Preclin. studies have suggested that the administration of melatonin-the pineal hormone primarily responsible for the regulation of the circadian rhythm-targets the effects of AD pathologies and improves cognitive impairment.  It is postulated that by mitigating the effect of these pathologies, melatonin can also rescue neurogenesis impairment.  This review aims to explore the effect of AD pathologies on neurogenesis, as well as the mechanisms by which melatonin is able to ameliorate AD pathologies to potentially promote neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGZ2acFPj9uLVg90H21EOLACvtfcHk0ljav8FJ-IbCEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1eltbzN&md5=682afdba5a53dbafde56b2f076decaed</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fnyas.14436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.14436%26sid%3Dliteratum%253Aachs%26aulast%3DMihardja%26aufirst%3DM.%26aulast%3DRoy%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DK.%2BY.%26aulast%3DAquili%26aufirst%3DL.%26aulast%3DHeng%26aufirst%3DB.%2BC.%26aulast%3DChan%26aufirst%3DY.-S.%26aulast%3DFung%26aufirst%3DM.%2BL.%26aulast%3DLim%26aufirst%3DL.%2BW.%26atitle%3DTherapeutic%2520potential%2520of%2520neurogenesis%2520and%2520melatonin%2520regulation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2020%26volume%3D1478%26spage%3D43%26epage%3D62%26doi%3D10.1111%2Fnyas.14436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Ferulic acid promotes survival and differentiation of neural stem cells to prevent gentamicin-induced neuronal hearing loss</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2017.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.yexcr.2017.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=28916193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFentb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2017&pages=257-263&author=L.+Guauthor=X.+Cuiauthor=W.+Weiauthor=J.+Yangauthor=X.+Li&title=Ferulic+acid+promotes+survival+and+differentiation+of+neural+stem+cells+to+prevent+gentamicin-induced+neuronal+hearing+loss&doi=10.1016%2Fj.yexcr.2017.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ferulic acid promotes survival and differentiation of neural stem cells to prevent gentamicin-induced neuronal hearing loss</span></div><div class="casAuthors">Gu, Lintao; Cui, Xinhua; Wei, Wei; Yang, Jia; Li, Xuezhong</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-263</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neural stem cells (NSCs) have exhibited promising potential in therapies against neuronal hearing loss.  Ferulic acid (FA) has been widely reported to enhance neurogenic differentiation of different stem cells.  We investigated the role of FA in promoting NSC transplant therapy to prevent gentamicin-induced neuronal hearing loss.  NSCs were isolated from mouse cochlear tissues to establish in vitro culture, which were then treated with FA.  The survival and differentiation of NSCs were evaluated.  Subsequently, neurite outgrowth and excitability of the in vitro neuronal network were assessed.  Gentamicin was used to induce neuronal hearing loss in mice, in the presence and absence of FA, followed by assessments of auditory brainstem response (ABR) and distortion product optoacoustic emissions (DPOAE) amplitude.  FA promoted survival, neurosphere formation and differentiation of NSCs, as well as neurite outgrowth and excitability of in vitro neuronal network.  Furthermore, FA restored ABR threshold shifts and DPOAE in gentamicin-induced neuronal hearing loss mouse model in vivo.  Our data, for the first time, support potential therapeutic efficacy of FA in promoting survival and differentiation of NSCs to prevent gentamicin-induced neuronal hearing loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwcriugCFzrVg90H21EOLACvtfcHk0lgpFTvZz2vHaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFentb7M&md5=952efbd6fd44147aace258f8af3bd399</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2017.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2017.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DFerulic%2520acid%2520promotes%2520survival%2520and%2520differentiation%2520of%2520neural%2520stem%2520cells%2520to%2520prevent%2520gentamicin-induced%2520neuronal%2520hearing%2520loss%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D360%26spage%3D257%26epage%3D263%26doi%3D10.1016%2Fj.yexcr.2017.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savaskan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brydon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jockers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirz-Justice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Spahn, F.</span></span> <span> </span><span class="NLM_article-title">Increased melatonin <b>1a</b>-receptor immunoreactivity in the hippocampus of Alzheimer’s disease patients</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1034/j.1600-079x.2002.00841.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1034%2Fj.1600-079x.2002.00841.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=11841602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BD387islahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=59-62&author=E.+Savaskanauthor=G.+Olivieriauthor=F.+Meierauthor=L.+Brydonauthor=R.+Jockersauthor=R.+Ravidauthor=A.+Wirz-Justiceauthor=F.+M%C3%BCller-Spahn&title=Increased+melatonin+1a-receptor+immunoreactivity+in+the+hippocampus+of+Alzheimer%E2%80%99s+disease+patients&doi=10.1034%2Fj.1600-079x.2002.00841.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients</span></div><div class="casAuthors">Savaskan Egemen; Olivieri Gianfranco; Meier Fides; Brydon Lena; Jockers Ralf; Ravid Rivka; Wirz-Justice Anna; Muller-Spahn Franz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pineal research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-62</span>
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    </div><div class="casAbstract">The pineal secretory product melatonin has, in addition to regulating retinal, circadian and vascular functions, neuroprotective effects.  Blood melatonin levels are often decreased in Alzheimer's disease (AD), a progressively disabling neurodegenerative disorder.  In this study we provide the first immunohistochemical evidence for the localization of melatonin 1a-receptor (MT(1)) in aged human hippocampus and a comparison of AD cases.  MT(1) was localized to pyramidal neurons in the hippocampal cornu ammonis (CA)1-4 subfields.  There was a distinct increase in staining intensity in all AD cases indicating an up-regulation of the receptor, possibly as a compensatory response to impaired melatonin levels in order to augment melatonin's neuroprotective effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6Ck1VE4rdR4McDoIzZtNkfW6udTcc2ebKdsNeHj9qobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387islahsQ%253D%253D&md5=4e76a18b508363d11f37209fa7631acc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-079x.2002.00841.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-079x.2002.00841.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavaskan%26aufirst%3DE.%26aulast%3DOlivieri%26aufirst%3DG.%26aulast%3DMeier%26aufirst%3DF.%26aulast%3DBrydon%26aufirst%3DL.%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DRavid%26aufirst%3DR.%26aulast%3DWirz-Justice%26aufirst%3DA.%26aulast%3DM%25C3%25BCller-Spahn%26aufirst%3DF.%26atitle%3DIncreased%2520melatonin%25201a-receptor%2520immunoreactivity%2520in%2520the%2520hippocampus%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2002%26volume%3D32%26spage%3D59%26epage%3D62%26doi%3D10.1034%2Fj.1600-079x.2002.00841.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savaskan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayoub, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeloni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraschini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Spahn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jockers, R.</span></span> <span> </span><span class="NLM_article-title">Reduced hippocampal MT<sub>2</sub> melatonin receptor expression in Alzheimer’s disease</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1111/j.1600-079X.2004.00169.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fj.1600-079X.2004.00169.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=15617532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=10-16&author=E.+Savaskanauthor=M.+A.+Ayoubauthor=R.+Ravidauthor=D.+Angeloniauthor=F.+Fraschiniauthor=F.+Meierauthor=A.+Eckertauthor=F.+M%C3%BCller-Spahnauthor=R.+Jockers&title=Reduced+hippocampal+MT2+melatonin+receptor+expression+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1600-079X.2004.00169.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease</span></div><div class="casAuthors">Savaskan, Egemen; Ayoub, Mohammed A.; Ravid, Rivka; Angeloni, Debora; Fraschini, Franco; Meier, Fides; Eckert, Anne; Mueller-Spahn, Franz; Jockers, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-16</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to identify the distribution of the second melatonin receptor (MT2) in the human hippocampus of elderly controls and Alzheimer's disease (AD) patients.  This is the first report of immunohistochem. MT2 localization in the human hippocampus both in control and AD cases.  The specificity of the MT2 antibody was ascertained by fluorescence microscopy using the anti-MT2 antibody in HEK 293 cells expressing recombinant MT2, in immunoblot expts. on membranes from MT2 expressing cells, and, finally, by immunopptn. expts. of the native MT2.  MT2 immunoreactivity was studied in the hippocampus of 16 elderly control and 16 AD cases.  In controls, MT2 was localized in pyramidal neurons of the hippocampal subfields CA1-4 and in some granular neurons of the stratum granulosum.  The overall intensity of the MT2 staining was distinctly decreased in AD cases.  The results indicate that MT2 may be involved in mediating the effects of melatonin in the human hippocampus, and this mechanism may be heavily impaired in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpigcEioiTbQ7Vg90H21EOLACvtfcHk0lhWcxdH2OqE2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFekuw%253D%253D&md5=b0ee16e371274611634c958690af71c3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2004.00169.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2004.00169.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavaskan%26aufirst%3DE.%26aulast%3DAyoub%26aufirst%3DM.%2BA.%26aulast%3DRavid%26aufirst%3DR.%26aulast%3DAngeloni%26aufirst%3DD.%26aulast%3DFraschini%26aufirst%3DF.%26aulast%3DMeier%26aufirst%3DF.%26aulast%3DEckert%26aufirst%3DA.%26aulast%3DM%25C3%25BCller-Spahn%26aufirst%3DF.%26aulast%3DJockers%26aufirst%3DR.%26atitle%3DReduced%2520hippocampal%2520MT2%2520melatonin%2520receptor%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2005%26volume%3D38%26spage%3D10%26epage%3D16%26doi%3D10.1111%2Fj.1600-079X.2004.00169.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smil, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantigny, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahhab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panetta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déziel, R.</span></span> <span> </span><span class="NLM_article-title">Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bmcl.2008.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=19111466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2isrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=688-692&author=D.+V.+Smilauthor=S.+Mankuauthor=Y.+A.+Chantignyauthor=S.+Leitauthor=A.+Wahhabauthor=T.+P.+Yanauthor=M.+Fournelauthor=C.+Marounauthor=Z.+Liauthor=A.-M.+Lemieuxauthor=A.+Nicolescuauthor=J.+Rahilauthor=S.+Lefebvreauthor=A.+Panettaauthor=J.+M.+Bestermanauthor=R.+D%C3%A9ziel&title=Novel+HDAC6+isoform+selective+chiral+small+molecule+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bmcl.2008.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors</span></div><div class="casAuthors">Smil, David V.; Manku, Sukhdev; Chantigny, Yves A.; Leit, Silvana; Wahhab, Amal; Yan, Theresa P.; Fournel, Marielle; Maroun, Christiane; Li, Zuomei; Lemieux, Anne-Marie; Nicolescu, Alina; Rahil, Jubrail; Lefebvre, Sylvain; Panetta, Anthony; Besterman, Jeffrey M.; Deziel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">688-692</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to identify HDAC isoform selective inhibitors, we designed and synthesized chiral 3,4-dihydroquinoxalin-2(1H)-one and piperazine-2,5-dione aryl hydroxamates showing selectivity (up to 40-fold) for human HDAC6 over other class I/IIa HDACs.  The obsd. selectivity and potency (IC50 values 10-200 nM against HDAC6) is markedly dependent on the abs. configuration of the chiral moiety, and suggests possibilities for use of chiral compds. in selective HDAC isoform inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UIfh9LXgp7Vg90H21EOLACvtfcHk0lhWcxdH2OqE2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2isrY%253D&md5=b85a35bb0061a0200d74be630cef5d95</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DSmil%26aufirst%3DD.%2BV.%26aulast%3DManku%26aufirst%3DS.%26aulast%3DChantigny%26aufirst%3DY.%2BA.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DWahhab%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DT.%2BP.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DMaroun%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLemieux%26aufirst%3DA.-M.%26aulast%3DNicolescu%26aufirst%3DA.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPanetta%26aufirst%3DA.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DD%25C3%25A9ziel%26aufirst%3DR.%26atitle%3DNovel%2520HDAC6%2520isoform%2520selective%2520chiral%2520small%2520molecule%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D688%26epage%3D692%26doi%3D10.1016%2Fj.bmcl.2008.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9891</span>– <span class="NLM_lpage">9899</span>, <span class="refDoi"> DOI: 10.1021/jm301098e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9891-9899&author=J.+A.+Bergmanauthor=K.+Woanauthor=P.+Perez-Villarroelauthor=A.+Villagraauthor=E.+M.+Sotomayorauthor=A.+P.+Kozikowski&title=Selective+histone+deacetylase+6+inhibitors+bearing+substituted+urea+linkers+inhibit+melanoma+cell+growth&doi=10.1021%2Fjm301098e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span></div><div class="casAuthors">Bergman, Joel A.; Woan, Karrune; Perez-Villarroel, Patricio; Villagra, Alejandro; Sotomayor, Eduardo M.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9891-9899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incidence of malignant melanoma has dramatically increased in recent years thus requiring the need for improved therapeutic strategies.  In our efforts to design selective histone deactylase inhibitors (HDACI), we discovered that the aryl urea 1 is a modestly potent yet nonselective inhibitor.  Structure-activity relationship studies revealed that adding substituents to the nitrogen atom of the urea so as to generate compds. bearing a branched linker group results in increased potency and selectivity for HDAC6.  Compd. 5g shows low nanomolar inhibitory potency against HDAC6 and a selectivity of ∼600-fold relative to the inhibition of HDAC1.  These HDACIs were evaluated for their ability to inhibit the growth of B16 melanoma cells with the most potent and selective HDAC6I being found to decrease tumor cell growth.  To the best of our knowledge, this work constitutes the first report of HDAC6-selective inhibitors that possess antiproliferative effects against melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkTtPLqvwsrVg90H21EOLACvtfcHk0ljMo_7au25VBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ&md5=d6be4c0efb3922fc35d814ba00ae9ed1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm301098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301098e%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DWoan%26aufirst%3DK.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DVillagra%26aufirst%3DA.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%2520histone%2520deacetylase%25206%2520inhibitors%2520bearing%2520substituted%2520urea%2520linkers%2520inhibit%2520melanoma%2520cell%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9891%26epage%3D9899%26doi%3D10.1021%2Fjm301098e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6973</span>– <span class="NLM_lpage">6980</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bmc.2013.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=24095016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6973-6980&author=F.+Wangauthor=W.+Luauthor=T.+Zhangauthor=J.+Dongauthor=H.+Gaoauthor=P.+Liauthor=S.+Wangauthor=J.+Zhang&title=Development+of+novel+ferulic+acid+derivatives+as+potent+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bmc.2013.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors</span></div><div class="casAuthors">Wang, Fang; Lu, Wen; Zhang, Tao; Dong, Jinyun; Gao, Hongping; Li, Pengfei; Wang, Sicen; Zhang, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6973-6980</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACIs) offer a promising strategy for cancer therapy.  The discovery of potent ferulic acid-based HDACIs with hydroxamic acid or 2-aminobenzamide group as zinc binding group was reported.  The halogeno-acetanilide was introduced as novel surface recognition moiety (SRM).  The majority of title compds. displayed potent HDAC inhibitory activity.  In particular, I and II [R = 3-F] exhibited significant enzymic inhibitory activities, with IC50 values of 3.94 and 2.82 μM, resp.  Furthermore, these compds. showed moderate antiproliferative activity against a panel of human cancer cells.  II [R = 3,5-CF3] displayed promising profile as an antitumor candidate.  The results indicated that these ferulic acid derivs. could serve as promising lead compds. for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrSn4Cn__K7Vg90H21EOLACvtfcHk0ligI4lNMD3kEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrJ&md5=8c3ddd718130cc659f4f4b3d9c7056ff</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520novel%2520ferulic%2520acid%2520derivatives%2520as%2520potent%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6973%26epage%3D6980%26doi%3D10.1016%2Fj.bmc.2013.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and preliminary bioactivity evaluation of N<sup>1</sup>-hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fcbdd.12819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=27416889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslaltLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=38-46&author=X.+Wangauthor=X.+Liauthor=J.+Liauthor=J.+Houauthor=Y.+Quauthor=C.+Yuauthor=F.+Heauthor=W.+Xuauthor=J.+Wu&title=Design%2C+synthesis%2C+and+preliminary+bioactivity+evaluation+of+N1-hydroxyterephthalamide+derivatives+with+indole+cap+as+novel+histone+deacetylase+inhibitors&doi=10.1111%2Fcbdd.12819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and preliminary bioactivity evaluation of N1-hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors</span></div><div class="casAuthors">Wang, Xue; Li, Xiaoyang; Li, Jingyao; Hou, Jinning; Qu, Ying; Yu, Chenggong; He, Feng; Xu, Wenfang; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylases inhibitors (HDACIs) have been widely recognized as significant therapeutic approach to cancers.  In the efforts to develop novel histone deacetylases inhibitors (HDACIs) as potential anticancer agents, a series of N1-hydroxyterephthalamide derivs. with an indole cap group were designed and synthesized.  Compd. I was identified to be the most potent one (IC50 = 0.074 μM against HeLa nuclear ext.) and showed higher inhibitory activity than the pos. control SAHA (IC50 = 0.131 μM), which was also verified by further mol. docking studies into active site of HDAC2.  The results of selectivity on the inhibition of HDACs exhibited I being with similar isoform selective profile with PXD101.  In addn., four representative compds. including I based on the outcomes of preliminary tumor cell screening demonstrated more potent or comparable to SAHA in the next antiproliferative activity assays.  Collectively, the results encouraged further development of this chem. template to provide more potent analogs as HDACIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKCHMkmNNjrVg90H21EOLACvtfcHk0ligI4lNMD3kEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslaltLfI&md5=f30df66e963648c419fed8c96c2baf43</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12819%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preliminary%2520bioactivity%2520evaluation%2520of%2520N1-hydroxyterephthalamide%2520derivatives%2520with%2520indole%2520cap%2520as%2520novel%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D89%26spage%3D38%26epage%3D46%26doi%3D10.1111%2Fcbdd.12819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, J.</span></span> <span> </span><span class="NLM_article-title">Panobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myeloma</span>. <i>Drugs Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1358/dot.2015.51.8.2362311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1358%2Fdot.2015.51.8.2362311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BC283js1WlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=491-504&author=T.+Chengauthor=L.+Grasseauthor=J.+Shahauthor=J.+Chandra&title=Panobinostat%2C+a+pan-histone+deacetylase+inhibitor%3A+rationale+for+and+application+to+treatment+of+multiple+myeloma&doi=10.1358%2Fdot.2015.51.8.2362311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Panobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myeloma</span></div><div class="casAuthors">Cheng T; Grasse L; Chandra J; Shah J</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of today (Barcelona, Spain : 1998)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">491-504</span>
        ISSN:<span class="NLM_cas:issn">1699-3993</span>.
    </div><div class="casAbstract">Histone deacetylase inhibitors (HDACis) have emerged as novel therapeutic agents for cancer.  Currently, four HDACis are approved by the Food and Drug Administration (FDA) to treat various hematologic malignancies.  Panobinostat (LBH-589, trade name Farydak®, developed and marketed by Novartis) is a potent pan-HDACi with demonstrated anticancer activities against multiple myeloma, a B-cell malignancy, at a low nanomolar range in preclinical settings, and in 2015 was granted FDA approval for the treatment of relapsed and refractory multiple myeloma.  Here, we review the development of HDACis, the unique features of panobinostat, and the rationale for developing panobinostat in a combination setting for the treatment of multiple myeloma.  We also review the completed and ongoing clinical trials testing the efficacy of panobinostat in combination therapies and highlight future therapeutically relevant strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdrHqiOVCAxdts4TFFB11gfW6udTcc2eZF1j5Y861akbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283js1WlsA%253D%253D&md5=6840a213c7bcd49b260ad853d1c66fcc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1358%2Fdot.2015.51.8.2362311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2015.51.8.2362311%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DGrasse%26aufirst%3DL.%26aulast%3DShah%26aufirst%3DJ.%26aulast%3DChandra%26aufirst%3DJ.%26atitle%3DPanobinostat%252C%2520a%2520pan-histone%2520deacetylase%2520inhibitor%253A%2520rationale%2520for%2520and%2520application%2520to%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DDrugs%2520Today%26date%3D2015%26volume%3D51%26spage%3D491%26epage%3D504%26doi%3D10.1358%2Fdot.2015.51.8.2362311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiermeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">101378</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.redox.2019.101378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31926632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFemt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2020&pages=101378&author=S.+Guneschauthor=M.+Hoffmannauthor=C.+Kiermeierauthor=W.+Fischerauthor=A.+F.+M.+Pintoauthor=T.+Mauriceauthor=P.+Maherauthor=M.+Decker&title=7-O-Esters+of+taxifolin+with+pronounced+and+overadditive+effects+in+neuroprotection%2C+anti-neuroinflammation%2C+and+amelioration+of+short-term+memory+impairment+in+vivo&doi=10.1016%2Fj.redox.2019.101378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo</span></div><div class="casAuthors">Gunesch, Sandra; Hoffmann, Matthias; Kiermeier, Carolina; Fischer, Wolfgang; Pinto, Antonio F. M.; Maurice, Tangui; Maher, Pamela; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101378</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial disease and the most common form of dementia.  There are no treatments to cure, prevent or slow down the progression of the disease.  Natural products hold considerable interest for the development of preventive neuroprotectants to treat neurodegenerative disorders like AD, due to their low toxicity and general beneficial effects on human health with their anti-inflammatory and antioxidant features.  In this work we describe regioselective synthesis of 7-O-ester hybrids of the flavonoid taxifolin with the phenolic acids cinnamic and ferulic acid, namely 7-O-cinnamoyltaxifolin and 7-O-feruloyltaxifolin.  The compds. show pronounced overadditive neuroprotective effects against oxytosis, ferroptosis and ATP depletion in the murine hippocampal neuron HT22 cell model.  Furthermore, 7-O-cinnamoyltaxifolin and 7-O-feruloyltaxifolin reduced LPS-induced neuroinflammation in BV-2 microglia cells as assessed by effects on the levels of NO, IL6 and TNFa.  In all in vitro assays the 7-O-esters of taxifolin and ferulic or cinnamic acid showed strong overadditive activity, significantly exceeding the effects of the individual components and the equimolar mixts. thereof, which were almost inactive in all of the assays at the tested concns.  In vivo studies confirmed this overadditive effect.  Treatment of an AD mouse model based on the injection of oligomerized Aβ25-35 peptide into the brain to cause neurotoxicity and subsequently memory deficits with 7-O-cinnamoyltaxifolin or 7-O-feruloyltaxifolin resulted in improved performance in an assay for short-term memory as compared to vehicle and mice treated with the resp. equimolar mixts.  These results highlight the benefits of natural product hybrids as a novel compd. class with potential use for drug discovery in neurodegenerative diseases due to their pharmacol. profile that is distinct from the individual natural components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxRqkt587okbVg90H21EOLACvtfcHk0lizWojt9UYvPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFemt7k%253D&md5=84206a34fa10317bc63f84492e42479f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101378%26sid%3Dliteratum%253Aachs%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DKiermeier%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DPinto%26aufirst%3DA.%2BF.%2BM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DMaher%26aufirst%3DP.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3D7-O-Esters%2520of%2520taxifolin%2520with%2520pronounced%2520and%2520overadditive%2520effects%2520in%2520neuroprotection%252C%2520anti-neuroinflammation%252C%2520and%2520amelioration%2520of%2520short-term%2520memory%2520impairment%2520in%2520vivo%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D29%26spage%3D101378%26doi%3D10.1016%2Fj.redox.2019.101378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano-Castell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlosser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Development and application of a chemical probe based on a neuroprotective flavonoid hybrid for target identification using activity-based protein profiling</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3823</span>– <span class="NLM_lpage">3837</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.0c00589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.0c00589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitF2iurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=3823-3837&author=S.+Guneschauthor=D.+Soriano-Castellauthor=S.+Lamerauthor=A.+Schlosserauthor=P.+Maherauthor=M.+Decker&title=Development+and+application+of+a+chemical+probe+based+on+a+neuroprotective+flavonoid+hybrid+for+target+identification+using+activity-based+protein+profiling&doi=10.1021%2Facschemneuro.0c00589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Application of a Chemical Probe Based on a Neuroprotective Flavonoid Hybrid for Target Identification Using Activity-Based Protein Profiling</span></div><div class="casAuthors">Gunesch, Sandra; Soriano-Castell, David; Lamer, Stephanie; Schlosser, Andreas; Maher, Pamela; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3823-3837</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of dementia, and up to now, there are no disease-modifying drugs available.  Natural product hybrids based on the flavonoid taxifolin and phenolic acids have shown a promising pleiotropic neuroprotective profile in cell culture assays and even disease-modifying effects in vivo.  However, the detailed mechanisms of action remain unclear.  To elucidate the distinct intracellular targets of 7-O-esters of taxifolin, we present in this work the development and application of a chem. probe, 7-O-cinnamoyltaxifolin-alkyne, for target identification using activity-based protein profiling. 7-O-Cinnamoyltaxifolin-alkyne remained neuroprotective in all cell culture assays.  Western blot anal. showed a comparable influence on the same intracellular pathways as that of the lead compd. 7-O-cinnamoyltaxifolin, thereby confirming its suitability as a probe for target identification expts.  Affinity pulldown and MS anal. revealed adenine nucleotide translocase 1 (ANT-1) and sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) as intracellular interaction partners of 7-O-cinnamoyltaxifolin-alkyne and thus of 7-O-esters of taxifolin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxBnMLkEUbF7Vg90H21EOLACvtfcHk0lhU_1CxkKp6pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitF2iurrK&md5=612e740bb463418a6591aef1acf40c0b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.0c00589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.0c00589%26sid%3Dliteratum%253Aachs%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DSoriano-Castell%26aufirst%3DD.%26aulast%3DLamer%26aufirst%3DS.%26aulast%3DSchlosser%26aufirst%3DA.%26aulast%3DMaher%26aufirst%3DP.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520application%2520of%2520a%2520chemical%2520probe%2520based%2520on%2520a%2520neuroprotective%2520flavonoid%2520hybrid%2520for%2520target%2520identification%2520using%2520activity-based%2520protein%2520profiling%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2020%26volume%3D11%26spage%3D3823%26epage%3D3837%26doi%3D10.1021%2Facschemneuro.0c00589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertzen, C. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves Avelar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span> <span> </span><span class="NLM_article-title">Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3219</span>– <span class="NLM_lpage">3222</span>, <span class="refDoi"> DOI: 10.1039/C5CC10301K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1039%2FC5CC10301K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=26810607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Ohsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=3219-3222&author=D.+Diedrichauthor=A.+Hamacherauthor=C.+G.+W.+Gertzenauthor=L.+A.+Alves+Avelarauthor=G.+J.+Reissauthor=T.+Kurzauthor=H.+Gohlkeauthor=M.+U.+Kassackauthor=F.+K.+Hansen&title=Rational+design+and+diversity-oriented+synthesis+of+peptoid-based+selective+HDAC6+inhibitors&doi=10.1039%2FC5CC10301K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors</span></div><div class="casAuthors">Diedrich, D.; Hamacher, A.; Gertzen, C. G. W.; Alves Avelar, L. A.; Reiss, G. J.; Kurz, T.; Gohlke, H.; Kassack, M. U.; Hansen, F. K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3219-3222</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A mini library of HDAC inhibitors with peptoid-based cap groups was synthesized using an efficient multicomponent approach.  Four compds. were identified as potent HDAC6 inhibitors with a selectivity over other HDAC isoforms.  The most potent HDAC6 inhibitor revealed remarkable chemosensitizing properties and completely reverted the cisplatin resistance in Cal27 CisR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOpBEaojI1W7Vg90H21EOLACvtfcHk0lhLiM9jRKQA9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Ohsg%253D%253D&md5=3175aed0befb813805c973cfb24e72ce</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2FC5CC10301K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC10301K%26sid%3Dliteratum%253Aachs%26aulast%3DDiedrich%26aufirst%3DD.%26aulast%3DHamacher%26aufirst%3DA.%26aulast%3DGertzen%26aufirst%3DC.%2BG.%2BW.%26aulast%3DAlves%2BAvelar%26aufirst%3DL.%2BA.%26aulast%3DReiss%26aufirst%3DG.%2BJ.%26aulast%3DKurz%26aufirst%3DT.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DHansen%26aufirst%3DF.%2BK.%26atitle%3DRational%2520design%2520and%2520diversity-oriented%2520synthesis%2520of%2520peptoid-based%2520selective%2520HDAC6%2520inhibitors%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D3219%26epage%3D3222%26doi%3D10.1039%2FC5CC10301K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertzen, C. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwinderman, M. R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span> <span> </span><span class="NLM_article-title">Design, multicomponent synthesis, and anticancer activity of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5493</span>– <span class="NLM_lpage">5506</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Knt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5493-5506&author=V.+Kriegerauthor=A.+Hamacherauthor=C.+G.+W.+Gertzenauthor=J.+Sengerauthor=M.+R.+H.+Zwindermanauthor=M.+Marekauthor=C.+Romierauthor=F.+J.+Dekkerauthor=T.+Kurzauthor=M.+Jungauthor=H.+Gohlkeauthor=M.+U.+Kassackauthor=F.+K.+Hansen&title=Design%2C+multicomponent+synthesis%2C+and+anticancer+activity+of+a+focused+histone+deacetylase+%28HDAC%29+inhibitor+library+with+peptoid-based+cap+groups&doi=10.1021%2Facs.jmedchem.7b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, multicomponent synthesis, and anticancer activity of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups</span></div><div class="casAuthors">Krieger, Viktoria; Hamacher, Alexandra; Gertzen, Christoph G. W.; Senger, Johanna; Zwinderman, Martijn R. H.; Marek, Martin; Romier, Christophe; Dekker, Frank J.; Kurz, Thomas; Jung, Manfred; Gohlke, Holger; Kassack, Matthias U.; Hansen, Finn K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5493-5506</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work, we report the multicomponent synthesis of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups and different zinc-binding groups.  All synthesized compds. were tested in a cellular HDAC inhibition assay and an MTT assay for cytotoxicity.  On the basis of their noteworthy activity in the cellular HDAC assays, four compds. were further screened for their inhibitory activity against recombinant HDAC1-3, HDAC6, and HDAC8.  All four compds. showed potent inhibition of HDAC1-3 as well as significant inhibition of HDAC6 with IC50 values in the submicromolar concn. range.  Compd. (I), the most potent HDAC inhibitor in the cellular HDAC assay, revealed remarkable chemosensitizing properties and enhanced the cisplatin sensitivity of the cisplatin-resistant head-neck cancer cell line Cal27CisR by almost 7-fold.  Furthermore, I almost completely reversed the cisplatin resistance in Cal27CisR.  This effect is related to a synergistic induction of apoptosis as seen in the combination of I with cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr43qPA21H-mLVg90H21EOLACvtfcHk0lhLiM9jRKQA9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Knt7c%253D&md5=8a101145194f8188522438b61756f3e9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00197%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DV.%26aulast%3DHamacher%26aufirst%3DA.%26aulast%3DGertzen%26aufirst%3DC.%2BG.%2BW.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DZwinderman%26aufirst%3DM.%2BR.%2BH.%26aulast%3DMarek%26aufirst%3DM.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DDekker%26aufirst%3DF.%2BJ.%26aulast%3DKurz%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DHansen%26aufirst%3DF.%2BK.%26atitle%3DDesign%252C%2520multicomponent%2520synthesis%252C%2520and%2520anticancer%2520activity%2520of%2520a%2520focused%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitor%2520library%2520with%2520peptoid-based%2520cap%2520groups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5493%26epage%3D5506%26doi%3D10.1021%2Facs.jmedchem.7b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span> <span> </span><span class="NLM_article-title">Peptoid architectures: elaboration, actuation, and application</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2008.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.cbpa.2008.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=18786652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajs7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=714-721&author=B.+Yooauthor=K.+Kirshenbaum&title=Peptoid+architectures%3A+elaboration%2C+actuation%2C+and+application&doi=10.1016%2Fj.cbpa.2008.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Peptoid architectures: elaboration, actuation, and application</span></div><div class="casAuthors">Yoo, Barney; Kirshenbaum, Kent</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">714-721</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peptoids are peptidomimetic oligomers composed of N-substituted glycine units.  Their convenient synthesis enables strict control over the sequence of highly diverse monomers and is capable of generating extensive compd. libraries.  Recent studies are beginning to explore the relation between peptoid sequence, structure, and function.  The authors describe new approaches to direct the conformation of the peptoid backbone, leading to secondary structures, such as helixes, loops, and turns.  These advances are enabling the discovery of bioactive peptoids and will establish modules for the design and assembly of protein mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGSLBbf_-kbVg90H21EOLACvtfcHk0ljNrNS5B7G64g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajs7%252FF&md5=a46631e9c62143af12f90e5d710a196e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DB.%26aulast%3DKirshenbaum%26aufirst%3DK.%26atitle%3DPeptoid%2520architectures%253A%2520elaboration%252C%2520actuation%252C%2520and%2520application%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D714%26epage%3D721%26doi%3D10.1016%2Fj.cbpa.2008.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inks, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. J.</span></span> <span> </span><span class="NLM_article-title">Class I HDAC inhibitors display different antitumor mechanism in leukemia and prostatic cancer cells depending on their p53 status</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2603</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2589-2603&author=X.+Liauthor=Y.+K.+Petersonauthor=E.+S.+Inksauthor=R.+A.+Himesauthor=J.+Liauthor=Y.+Zhangauthor=X.+Kongauthor=C.+J.+Chou&title=Class+I+HDAC+inhibitors+display+different+antitumor+mechanism+in+leukemia+and+prostatic+cancer+cells+depending+on+their+p53+status&doi=10.1021%2Facs.jmedchem.8b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status</span></div><div class="casAuthors">Li, Xiaoyang; Peterson, Yuri K.; Inks, Elizabeth S.; Himes, Richard A.; Li, Jiaying; Zhang, Yingjie; Kong, Xiujie; Chou, C. James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2589-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously, we designed and synthesized a series of o-aminobenzamide-based histone deacetylase (HDAC) inhibitors, among which the representative compd. I exhibited potent inhibitory activity against class I HDACs.  In this study, we report the development of more potent hydrazide-based class I selective HDAC inhibitors using II as a lead.  Representative compd. 13b showed a mixed, slow, and tight binding inhibition mechanism for HDAC1, 2, and 3.  The most potent compd. 13e exhibited low nanomolar IC50s toward HDAC1, 2, and 3 and could down-regulate HDAC6 in acute myeloid leukemia MV4-11 cells.  The EC50 of 13e against MV4-11 cells was 34.7 nM, which is 26 times lower than its parent compd. 11a.  In vitro responses to 13e vary significantly and interestingly based on cell type: in p53 wild-type MV4-11 cells, 13e induced cell death via apoptosis and G1/S cell cycle arrest, which is likely mediated by a p53-dependent pathway, while in p53-null PC-3 cells, 13e caused G2/M arrest and inhibited cell proliferation without inducing caspase-3-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNn9M1ceDMg7Vg90H21EOLACvtfcHk0ljNrNS5B7G64g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKrs7w%253D&md5=36fcd594770688e5dcbbdbd3c8619b89</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00136%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DInks%26aufirst%3DE.%2BS.%26aulast%3DHimes%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26atitle%3DClass%2520I%2520HDAC%2520inhibitors%2520display%2520different%2520antitumor%2520mechanism%2520in%2520leukemia%2520and%2520prostatic%2520cancer%2520cells%2520depending%2520on%2520their%2520p53%2520status%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2589%26epage%3D2603%26doi%3D10.1021%2Facs.jmedchem.8b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osko, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayana
Reddy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Exploring structural determinants of inhibitor affinity and selectivity in complexes with histone deacetylase 6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01540</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01540" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit12jsr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=295-308&author=J.+D.+Oskoauthor=N.+J.+Porterauthor=P.+A.+Narayana%0AReddyauthor=Y.-C.+Xiaoauthor=J.+Rokkaauthor=M.+Jungauthor=J.+M.+Hookerauthor=J.+M.+Salvinoauthor=D.+W.+Christianson&title=Exploring+structural+determinants+of+inhibitor+affinity+and+selectivity+in+complexes+with+histone+deacetylase+6&doi=10.1021%2Facs.jmedchem.9b01540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6</span></div><div class="casAuthors">Osko, Jeremy D.; Porter, Nicholas J.; Narayana Reddy, Poli Adi; Xiao, You-Cai; Rokka, Johanna; Jung, Manfred; Hooker, Jacob M.; Salvino, Joseph M.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">295-308</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of histone deacetylase 6 (HDAC6) has emerged as a promising therapeutic strategy for the treatment of cancer, chemotherapy-induced peripheral neuropathy, and neurodegenerative disease.  The recent X-ray crystal structure detn. of HDAC6 enables an understanding of structural features directing affinity and selectivity in the active site.  Here, we present the X-ray crystal structures of five HDAC6-inhibitor complexes that illuminate key mol. features of the inhibitor linker and capping groups that facilitate and differentiate binding to HDAC6.  In particular, arom. and heteroarom. linkers nestle within an arom. cleft defined by F583 and F643, and different arom. linkers direct the capping group toward shallow pockets defined by the L1 loop, the L2 loop, or somewhere in between these pockets.  These results expand our understanding of factors contributing to the selective inhibition of HDAC6, particularly regarding interactions that can be targeted in the region of the L2 pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBosfiCC-DubVg90H21EOLACvtfcHk0li7kS-hwh2NVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit12jsr3N&md5=0ebd3729b8a0ed03629c4ecca475b02e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01540%26sid%3Dliteratum%253Aachs%26aulast%3DOsko%26aufirst%3DJ.%2BD.%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DNarayana%2BReddy%26aufirst%3DP.%2BA.%26aulast%3DXiao%26aufirst%3DY.-C.%26aulast%3DRokka%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DExploring%2520structural%2520determinants%2520of%2520inhibitor%2520affinity%2520and%2520selectivity%2520in%2520complexes%2520with%2520histone%2520deacetylase%25206%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D295%26epage%3D308%26doi%3D10.1021%2Facs.jmedchem.9b01540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahendran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breslow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">13459</span>– <span class="NLM_lpage">13464</span>, <span class="refDoi"> DOI: 10.1073/pnas.1718823114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1073%2Fpnas.1718823114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29203661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=13459-13464&author=N.+J.+Porterauthor=A.+Mahendranauthor=R.+Breslowauthor=D.+W.+Christianson&title=Unusual+zinc-binding+mode+of+HDAC6-selective+hydroxamate+inhibitors&doi=10.1073%2Fpnas.1718823114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors</span></div><div class="casAuthors">Porter, Nicholas J.; Mahendran, Adaickapillai; Breslow, Ronald; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">13459-13464</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) regulate myriad cellular processes by catalyzing the hydrolysis of acetyl-L-lysine residues in histone and nonhistone proteins.  The Zn2+-dependent class IIb enzyme HDAC6 regulates microtubule function by deacetylating α-tubulin, which suppresses microtubule dynamics and leads to cell cycle arrest and apoptosis.  Accordingly, HDAC6 is a target for the development of selective inhibitors that might be useful in new therapeutic approaches for the treatment of cancer, neurodegenerative diseases, and other disorders.  Here, we present high-resoln. structures of catalytic domain 2 from Danio rerio HDAC6 (henceforth simply "HDAC6") complexed with compds. that selectively inhibit HDAC6 while maintaining nanomolar inhibitory potency: N-hydroxy-4-((N(2-hydroxyethyl)-2-phenylacetamido)methyl)-benzamide (HPB), ACY-1215 (Ricolinostat), and ACY-1083.  These structures reveal that an unusual monodentate Zn2+ coordination mode is exploited by sterically bulky HDAC6-selective phenylhydroxamate inhibitors.  We addnl. report the ultrahigh-resoln. structure of the HDAC6-trichostatin A complex, which reveals two Zn2+-binding conformers for the inhibitor: a major conformer (70%) with canonical bidentate hydroxamate-Zn2+ coordination geometry and a minor conformer (30%) with monodentate hydroxamate-Zn2+ coordination geometry, reflecting a free energy difference of only 0.5 kcal/mol.  The minor conformer is not visible in lower resoln. structure detns.  Structural comparisons of HDAC6-inhibitor complexes with class I HDACs suggest active site features that contribute to the isoenzyme selectivity obsd. in biochem. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0oUH1X_04p7Vg90H21EOLACvtfcHk0likBvIa4r7J7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrbI&md5=07180756239eac4891642cf59a2e6992</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1718823114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1718823114%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DMahendran%26aufirst%3DA.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DUnusual%2520zinc-binding%2520mode%2520of%2520HDAC6-selective%2520hydroxamate%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D13459%26epage%3D13464%26doi%3D10.1073%2Fpnas.1718823114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duzer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirstea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canavese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span> <span> </span><span class="NLM_article-title">Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2589</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-10-387365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1182%2Fblood-2011-10-387365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=22262760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2579-2589&author=L.+Santoauthor=T.+Hideshimaauthor=A.+L.+Kungauthor=J.+C.+Tsengauthor=D.+Tamangauthor=M.+Yangauthor=M.+Jarpeauthor=J.+H.+van+Duzerauthor=R.+Mazitschekauthor=W.+C.+Ogierauthor=D.+Cirsteaauthor=S.+Rodigauthor=H.+Edaauthor=T.+Scullenauthor=M.+Canaveseauthor=J.+Bradnerauthor=K.+C.+Andersonauthor=S.+S.+Jonesauthor=N.+Raje&title=Preclinical+activity%2C+pharmacodynamic%2C+and+pharmacokinetic+properties+of+a+selective+HDAC6+inhibitor%2C+ACY-1215%2C+in+combination+with+bortezomib+in+multiple+myeloma&doi=10.1182%2Fblood-2011-10-387365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma</span></div><div class="casAuthors">Santo, Loredana; Hideshima, Teru; Kung, Andrew L.; Tseng, Jen-Chieh; Tamang, David; Yang, Min; Jarpe, Matthew; van Duzer, John H.; Mazitschek, Ralph; Ogier, Walter C.; Cirstea, Diana; Rodig, Scott; Eda, Homare; Scullen, Tyler; Canavese, Miriam; Bradner, James; Anderson, Kenneth C.; Jones, Simon S.; Raje, Noopur</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2579-2589</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) enzymic activity has been linked to the transcription of DNA in cancers including multiple myeloma (MM).  Therefore, HDAC inhibitors used alone and in combination are being actively studied as novel therapies in MM.  In the present study, we investigated the preclin. activity of ACY-1215, an HDAC6-selective inhibitor, alone and in combination with bortezomib in MM.  Low doses of ACY-1215 combined with bortezomib triggered synergistic anti-MM activity, resulting in protracted endoplasmic reticulum stress and apoptosis via activation of caspase-3, caspase-8, and caspase-9 and poly (ADP) ribosome polymerase.  In vivo, the anti-MM activity of ACY-1215 in combination with bortezomib was confirmed using 2 different xenograft SCID mouse models: human MM injected s.c. (the plasmacytoma model) and luciferase-expressing human MM injected i.v. (the disseminated MM model).  Tumor growth was significantly delayed and overall survival was significantly prolonged in animals treated with the combination therapy.  Pharmacokinetic data showed peak plasma levels of ACY-1215 at 4 h after treatment coincident with an increase in acetylated α-tubulin, a marker of HDAC6 inhibition, by immunohistochem. and Western blot anal.  These studies provide preclin. rationale for acetylated α-tubulin use as a pharmacodynamic biomarker in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoelmsk1wo_LVg90H21EOLACvtfcHk0likBvIa4r7J7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D&md5=094298bdd3d5b91c7060d8b294857846</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-10-387365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-10-387365%26sid%3Dliteratum%253Aachs%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DTseng%26aufirst%3DJ.%2BC.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3Dvan%2BDuzer%26aufirst%3DJ.%2BH.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DOgier%26aufirst%3DW.%2BC.%26aulast%3DCirstea%26aufirst%3DD.%26aulast%3DRodig%26aufirst%3DS.%26aulast%3DEda%26aufirst%3DH.%26aulast%3DScullen%26aufirst%3DT.%26aulast%3DCanavese%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DRaje%26aufirst%3DN.%26atitle%3DPreclinical%2520activity%252C%2520pharmacodynamic%252C%2520and%2520pharmacokinetic%2520properties%2520of%2520a%2520selective%2520HDAC6%2520inhibitor%252C%2520ACY-1215%252C%2520in%2520combination%2520with%2520bortezomib%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2579%26epage%3D2589%26doi%3D10.1182%2Fblood-2011-10-387365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neudert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">DSX: a knowledge-based scoring function for the assessment of protein-ligand complexes</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2731</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/ci200274q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200274q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ggtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2731-2745&author=G.+Neudertauthor=G.+Klebe&title=DSX%3A+a+knowledge-based+scoring+function+for+the+assessment+of+protein-ligand+complexes&doi=10.1021%2Fci200274q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">DSX: A Knowledge-Based Scoring Function for the Assessment of Protein-Ligand Complexes</span></div><div class="casAuthors">Neudert, Gerd; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2731-2745</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We introduce the new knowledge-based scoring function DSX that consists of distance-dependent pair potentials, novel torsion angle potentials, and newly defined solvent accessible surface-dependent potentials.  DSX pair potentials are based on the statistical formalism of DrugScore, extended by a much more specialized set of atom types.  The original DrugScore-like ref. state is rather unstable with respect to modifications in the used atom types.  Therefore, an important method to overcome this problem and to allow for robust results when deriving pair potentials for arbitrary sets of atom types is presented.  A validation based on a carefully prepd. test set is shown, enabling direct comparison to the majority of other popular scoring functions.  Here, DSX features superior performance with respect to docking- and ranking power and runtime requirements.  Furthermore, the beneficial combination with torsion angle-dependent and desolvation-dependent potentials is demonstrated.  DSX is robust, flexible, and capable of working together with special features of popular docking engines, e.g., flexible protein residues in AutoDock or GOLD.  The program is freely available to the scientific community and can be downloaded from our Web site www.agklebe.de.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvQyrP7qPi5bVg90H21EOLACvtfcHk0lj2_3YnriRU4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ggtb3K&md5=c90af0aa9af9ae15d458d9ba759163bb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fci200274q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200274q%26sid%3Dliteratum%253Aachs%26aulast%3DNeudert%26aufirst%3DG.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DDSX%253A%2520a%2520knowledge-based%2520scoring%2520function%2520for%2520the%2520assessment%2520of%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2731%26epage%3D2745%26doi%3D10.1021%2Fci200274q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span> <span> </span><span class="NLM_article-title">Glutathione and thioredoxin dependent systems in neurodegenerative disease: what can be learned from reverse genetics in mice</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2013.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.neuint.2013.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=23333338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=738-749&author=M.+Conradauthor=J.+Schickauthor=J.+P.+F.+Angeli&title=Glutathione+and+thioredoxin+dependent+systems+in+neurodegenerative+disease%3A+what+can+be+learned+from+reverse+genetics+in+mice&doi=10.1016%2Fj.neuint.2013.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione and thioredoxin dependent systems in neurodegenerative disease: What can be learned from reverse genetics in mice</span></div><div class="casAuthors">Conrad, Marcus; Schick, Joel; Angeli, Jose Pedro Friedmann</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">738-749</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is a major common hallmark of many neurodegenerative disease such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and stroke.  Novel concepts in our understanding of oxidative stress indicate that a perturbed redox circuitry could be strongly linked with the onset of such diseases.  In this respect, glutathione and thioredoxin dependent antioxidant enzymes play a central role as key regulators due to the fact that a slight dysfunction of any of these enzymes leads to sustained reactive oxygen species (ROS) prodn.  Apart from their classical role as ROS scavengers, some of these enzymes are also able to control post-translational modifications.  Therefore, efficient control of ROS prodn. and reversibility of post-translational modifications are crit. as improper control of such events may lead to the activation of pathol. redox circuits that eventually culminate in neuronal cell death.  To dissect the apparently opposing functions of ROS in cell physiol. and pathophysiol., a proper working toolkit is mandatory.  In vivo modeling is an abs. requirement due to the complexity of redox signaling systems that often contradict data obtained from in vitro approaches.  Hence, inducible/conditional knockout mouse models for key redox enzymes are emerging as powerful tools to perturb redox circuitries in a temporal and spatial manner.  In this review we address the basics of ROS generation, chem. and detoxification as well as examples in where applications of mouse models of important enzymes have been successfully applied in the study of neurodegenerative processes.  We also highlight the importance of new models to overcome present tech. limitations in order to advance in the study of redox processes in the role of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCUAZhQc1wbVg90H21EOLACvtfcHk0lji5-g0W9O6GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ylt7g%253D&md5=d60ecf990c569709840303865afd172b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DSchick%26aufirst%3DJ.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26atitle%3DGlutathione%2520and%2520thioredoxin%2520dependent%2520systems%2520in%2520neurodegenerative%2520disease%253A%2520what%2520can%2520be%2520learned%2520from%2520reverse%2520genetics%2520in%2520mice%26jtitle%3DNeurochem.%2520Int.%26date%3D2013%26volume%3D62%26spage%3D738%26epage%3D749%26doi%3D10.1016%2Fj.neuint.2013.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Biological metals and Alzheimer’s disease: implications for therapeutics and diagnostics</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.pneurobio.2010.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=20444428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1-18&author=J.+A.+Duceauthor=A.+I.+Bush&title=Biological+metals+and+Alzheimer%E2%80%99s+disease%3A+implications+for+therapeutics+and+diagnostics&doi=10.1016%2Fj.pneurobio.2010.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics</span></div><div class="casAuthors">Duce, James A.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The equil. of metal ions is crit. for many physiol. functions, particularly in the central nervous system, where metals are essential for development and maintenance of enzymic activities, mitochondrial function, myelination, neurotransmission as well as learning and memory.  Due to their importance, cells have evolved complex machinery for controlling metal-ion homeostasis.  However, disruption of these mechanisms, or absorption of detrimental metals with no known biol. function, alter the ionic balance and can result in a disease state, including several neurodegenerative disorders such as Alzheimer's disease.  Understanding the complex structural and functional interactions of metal ions with the various intracellular and extracellular components of the central nervous system, under normal conditions and during neurodegeneration, is essential for the development of effective therapies.  Accordingly, assisting the balance of metal ions back to homeostatic levels has been proposed as a disease-modifying therapeutic strategy for Alzheimer's disease as well as other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHRXNaNohExLVg90H21EOLACvtfcHk0lji5-g0W9O6GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D&md5=2aa9da17774b3da9f6118f0ce3f122ae</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DBiological%2520metals%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520therapeutics%2520and%2520diagnostics%26jtitle%3DProg.%2520Neurobiol.%26date%3D2010%26volume%3D92%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.pneurobio.2010.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, B.</span></span> <span> </span><span class="NLM_article-title">Metal ions in Alzheimer’s disease: a key role or not?</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2026</span>– <span class="NLM_lpage">2035</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.9b00248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.9b00248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlShs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=2026-2035&author=Y.+Liuauthor=M.+Nguyenauthor=A.+Robertauthor=B.+Meunier&title=Metal+ions+in+Alzheimer%E2%80%99s+disease%3A+a+key+role+or+not%3F&doi=10.1021%2Facs.accounts.9b00248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Metal Ions in Alzheimer's Disease: A Key Role or Not?</span></div><div class="casAuthors">Liu, Yan; Nguyen, Michel; Robert, Anne; Meunier, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2026-2035</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Despite tremendous research efforts in universities and pharmaceutical companies, effective drugs are still lacking for the treatment of Alzheimer's disease (AD).  The biochem. mechanisms of this devastating neurodegenerative disease have not yet been clearly understood.  Besides a small percentage of cases with early onset disease having a genetic origin (<5%, familial AD), most cases develop in the elderly as a sporadic form due to multiple and complex parameters of aging.  Consequently, AD is spreading in all countries with a long life expectancy.  AD is characterized by deposition of senile plaques made of β-amyloid proteins (Aβ) and by hyperphosphorylation of tau proteins, which have been considered as the main drug targets up to now.  However, antibodies targeting amyloid aggregates, as well as enzyme inhibitors aiming to modify the amyloid precursor protein processing, have failed to improve cognition in clin. trials.  Thus, to set up effective drugs, it is urgent to enlarge the panel of drug targets.  Evidence of the link between AD and redox metal dysregulation has also been supported by post-mortem analyses of amyloid plaques, which revealed accumulation of copper, iron, and zinc by 5.7, 2.8, and 3.1 times, resp., the levels obsd. in normal brains.  Copper-amyloid complexes, in the presence of endogenous reductants, are able to catalyze the redn. of dioxygen and to produce reduced, reactive oxygen species (ROS), leading to neuron death.  The possibility of using metal chelators to regenerate normal trafficking of metal ions has been considered as a promising strategy in order to reduce the redox stress lethal for neurons.  However, most attempts to use metal chelators as therapeutic agents have been limited to existing mols. available from the shelves.  Very few chelators have resulted from a rational design aiming to create drugs with a safety profile and able to cross the blood-brain barrier after an oral administration.  In the human body, metals are handled by a sophisticated protein network to strictly control their transport and reactivity.  Abnormal concns. of certain metals may lead to pathol. events due to misaccumulation and irregular reactivity.  Consequently, therapeutic attempts to restore metal homeostasis should carefully take into account the coordination chem. specificities of the concerned redox-active metal ions.  This Account is focused on the role of the main biol. redox-active transition metals, iron and copper.  For iron, the recent debate on the possible role of magnetite in AD pathogenesis is presented.  The section devoted to copper is focused on the design of specific copper chelators as drug candidates able to regulate copper homeostasis and to reduce the oxidative damage responsible for the neuron death obsd. in AD brains.  A short survey on non-redox-active metal ions is also included at the beginning, such as aluminum and its controversial role in AD and zinc which is a key metal ion in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkifxcw4n0LVg90H21EOLACvtfcHk0lgzvEC31KQzTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlShs7%252FO&md5=1b5557cc504fe48a31223b39ed765b4f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.9b00248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.9b00248%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DA.%26aulast%3DMeunier%26aufirst%3DB.%26atitle%3DMetal%2520ions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520key%2520role%2520or%2520not%253F%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2019%26volume%3D52%26spage%3D2026%26epage%3D2035%26doi%3D10.1021%2Facs.accounts.9b00248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span> <span> </span><span class="NLM_article-title">Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease</span>. <i>Ann. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">136</span>, <span class="refDoi"> DOI: 10.3978/j.issn.2305-5839.2015.03.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.3978%2Fj.issn.2305-5839.2015.03.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=26207229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFequrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=136&author=W.-Y.+Wangauthor=M.-S.+Tanauthor=J.-T.+Yuauthor=L.+Tan&title=Role+of+pro-inflammatory+cytokines+released+from+microglia+in+Alzheimer%E2%80%99s+disease&doi=10.3978%2Fj.issn.2305-5839.2015.03.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease</span></div><div class="casAuthors">Wang, Wen-Ying; Tan, Meng-Shan; Yu, Jin-Tai; Tan, Lan</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Translational Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">136/1-136/15</span>CODEN:
                <span class="NLM_cas:coden">ATMNDX</span>;
        ISSN:<span class="NLM_cas:issn">2305-5847</span>.
    
            (<span class="NLM_cas:orgname">AME Publishing Co.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain, which is characterized by the formation of extracellular amyloid plaques (or senile plaques) and intracellular neurofibrillary tangles.  However, increasing evidences demonstrated that neuroinflammatory changes, including chronic microgliosis are key pathol. components of AD.  Microglia, the resident immune cells of the brain, is constantly survey the microenvironment under physiol. conditions.  In AD, deposition of β-amyliod (Aβ) peptide initiates a spectrum of cerebral neuroinflammation mediated by activating microglia.  Activated microglia may play a potentially detrimental role by eliciting the expression of pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) influencing the surrounding brain tissue.  Emerging studies have demonstrated that up-regulation of pro-inflammatory cytokines play multiple roles in both neurodegeneration and neuroprotection.  Understanding the pro-inflammatory cytokines signaling pathways involved in the regulation of AD is crucial to the development of strategies for therapy.  This review will discuss the mechanisms and important role of pro-inflammatory cytokines in the pathogenesis of AD, and the ongoing drug targeting pro-inflammatory cytokine for therapeutic modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrydEyb_SUzbbVg90H21EOLACvtfcHk0lgzvEC31KQzTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFequrk%253D&md5=21894d5d8de838c4137bfc5ebcd35218</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2305-5839.2015.03.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2305-5839.2015.03.49%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.-Y.%26aulast%3DTan%26aufirst%3DM.-S.%26aulast%3DYu%26aufirst%3DJ.-T.%26aulast%3DTan%26aufirst%3DL.%26atitle%3DRole%2520of%2520pro-inflammatory%2520cytokines%2520released%2520from%2520microglia%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Transl.%2520Med.%26date%3D2015%26volume%3D3%26spage%3D136%26doi%3D10.3978%2Fj.issn.2305-5839.2015.03.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>706</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(95)01032-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2F0006-8993%2895%2901032-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=8822355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=706&publication_year=1996&pages=181-193&author=T.+Mauriceauthor=B.+P.+Lockhartauthor=A.+Privat&title=Amnesia+induced+in+mice+by+centrally+administered+%CE%B2-amyloid+peptides+involves+cholinergic+dysfunction&doi=10.1016%2F0006-8993%2895%2901032-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span></div><div class="casAuthors">Maurice, Tangui; Lockhart, Brian P.; Privat, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">706</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-93</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Substantial evidences suggest that the increased cerebral deposition, and neurotoxic action of the β-amyloid peptide, the major constituent of senile plaques, may represent the underlying cause of the cognitive deficits obsd. in Alzheimer's disease.  Herein, the authors attempted to verify this hypothesis by inducing a potential Alzheimer's-type amnesia after direct intracerebroventricular administration of aggregated β25-35-amyloid peptide in mice.  In this aim, amnesic capacities were evaluated after 6 to 13 days, using spontaneous alternation in the Y-maze, step-down type passive avoidance and place learning in a water-maze.  Pre-training administration of aggregated β25-35 peptide induced dose-dependent decreases in both alternation behavior and passive avoidance, at doses of 3 and 9 nmol/mouse.  A reduced but still significant impairment was obsd. when the peptide was not aggregated, or 'aged', by preincubation for 4 days at 37°.  The β1-28 peptide, at 3 nmol/mouse, also induced a marked decrease in step-down latency.  Post-training, but not pre-retention, administration of β25-35 peptide also significantly impaired learning.  The beneficial effects of cholinergic agents on β25-35-induced amnesia was examd. using the cholinesterase inhibitor tacrine (THA, 1.3 and 4.3 μmol/kg i.p.) and the nicotinic receptor agonist (-)-nicotine (NIC, 0.06 and 0.2 μmol/kg i.p.).  Both drugs induced a dose-dependent abrogation of the β25-35-induced decreases in alternation behavior and passive avoidance.  Furthermore, THA, at 1.3 μmol/kg, and NIC, at 0.2 μmol/kg, also reversed the β25-35-induced impairment of place learning and retention in the water-maze.  Histol. examn. of Cresyl violet-stained brain sections indicated a moderate but significant cell loss within the frontoparietal cortex and the hippocampal formation of mice treated with aged β25-35 peptide (9 nmol).  Examn. of Congo red-stained sections in the same animals demonstrated the presence of numerous amyloid deposits throughout these brain areas.  These results confirm that the deposition of β-amyloid peptide in the brain is in some way related to impairment of learning and cholinergic degeneration and suggest that the [25-35] fragment of the β-amyloid protein, sufficient to induce neuronal death in cultures, also induces an Alzheimer's-type amnesia in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsjUgNl1iVLVg90H21EOLACvtfcHk0lju8RTfVE5crw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D&md5=5a0465719e2a405fcc1c6aae31ad0367</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2895%2901032-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252895%252901032-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DLockhart%26aufirst%3DB.%2BP.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DAmnesia%2520induced%2520in%2520mice%2520by%2520centrally%2520administered%2520%25CE%25B2-amyloid%2520peptides%2520involves%2520cholinergic%2520dysfunction%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D706%26spage%3D181%26epage%3D193%26doi%3D10.1016%2F0006-8993%2895%2901032-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkeis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Dual-acting cholinesterase-human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9078</span>– <span class="NLM_lpage">9102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9078-9102&author=M.+Scheinerauthor=D.+Dollesauthor=S.+Guneschauthor=M.+Hoffmannauthor=M.+Nabissiauthor=O.+Marinelliauthor=M.+Naldiauthor=M.+Bartoliniauthor=S.+Petrallaauthor=E.+Poetaauthor=B.+Montiauthor=C.+Falkeisauthor=M.+Viethauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=R.+Maitraauthor=T.+Mauriceauthor=M.+Decker&title=Dual-acting+cholinesterase-human+cannabinoid+receptor+2+ligands+show+pronounced+neuroprotection+in+vitro+and+overadditive+and+disease-modifying+neuroprotective+effects+in+vivo&doi=10.1021%2Facs.jmedchem.9b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo</span></div><div class="casAuthors">Scheiner, Matthias; Dolles, Dominik; Gunesch, Sandra; Hoffmann, Matthias; Nabissi, Massimo; Marinelli, Oliviero; Naldi, Marina; Bartolini, Manuela; Petralla, Sabrina; Poeta, Eleonora; Monti, Barbara; Falkeis, Christina; Vieth, Michael; Huebner, Harald; Gmeiner, Peter; Maitra, Rangan; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9078-9102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a series of 14 hybrid mols. out of the cholinesterase (ChE) inhibitor tacrine and a benzimidazole-based human cannabinoid receptor subtype 2 (hCB2R) agonist and investigated them in vitro and in vivo.  The compds. are potent ChE inhibitors, and for the most promising hybrids, the mechanism of human acetylcholinesterase (hAChE) inhibition as well as their ability to interfere with AChE-induced aggregation of β-amyloid (Aβ), and Aβ self-aggregation was assessed.  All hybrids were evaluated for affinity and selectivity for hCB1R and hCB2R.  To ensure that the hybrids retained their agonist character, the expression of cAMP-regulated genes was quantified, and potency and efficacy were detd.  Addnl., the effects of the hybrids on microglia activation and neuroprotection on HT-22 cells were investigated.  The most promising in vitro hybrids showed pronounced neuroprotection in an Alzheimer's mouse model at low dosage (0.1 mg/kg, i.p.), lacking hepatotoxicity even at high dose (3 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRfz6xatTXLVg90H21EOLACvtfcHk0liG_hZ3fbG72A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM&md5=f0148c8ba51a2d0cbe83a26bb388a446</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DPoeta%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DFalkeis%26aufirst%3DC.%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDual-acting%2520cholinesterase-human%2520cannabinoid%2520receptor%25202%2520ligands%2520show%2520pronounced%2520neuroprotection%2520in%2520vitro%2520and%2520overadditive%2520and%2520disease-modifying%2520neuroprotective%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9078%26epage%3D9102%26doi%3D10.1021%2Facs.jmedchem.9b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer’s disease mouse model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9116</span>– <span class="NLM_lpage">9140</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9116-9140&author=M.+Hoffmannauthor=C.+Stillerauthor=E.+Endresauthor=M.+Scheinerauthor=S.+Guneschauthor=C.+Sotrifferauthor=T.+Mauriceauthor=M.+Decker&title=Highly+selective+butyrylcholinesterase+inhibitors+with+tunable+duration+of+action+by+chemical+modification+of+transferable+carbamate+units+exhibit+pronounced+neuroprotective+effect+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1021%2Facs.jmedchem.9b01012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Hoffmann, Matthias; Stiller, Carina; Endres, Erik; Scheiner, Matthias; Gunesch, Sandra; Sotriffer, Christoph; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9116-9140</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the carbamate structure of pseudo-irreversible butyrylcholinesterase (BChE) inhibitors was optimized with regard to a longer binding to the enzyme.  A set of compds. bearing different heterocycles (e.g., morpholine, tetrahydroisoquinoline, benzimidazole, piperidine) and alkylene spacers (2 to 10 methylene groups between carbamate and heterocycle) in the carbamate residue was synthesized and characterized in vitro for their binding affinity, binding kinetics, and carbamate hydrolysis.  These novel BChE inhibitors are highly selective for hBChE over human acetycholinesterase (hAChE), yielding short-, medium-, and long-acting nanomolar hBChE inhibitors (with a half-life of the carbamoylated enzyme ranging from 1 to 28 h).  The inhibitors show neuroprotective properties in a murine hippocampal cell line and a pharmacol. mouse model of Alzheimer's disease (AD), suggesting a significant benefit of BChE inhibition for a disease-modifying treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXA4e0pcqAhrVg90H21EOLACvtfcHk0liG_hZ3fbG72A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO&md5=458d5ab7ffce4864702a39d981b6dc29</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01012%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DStiller%26aufirst%3DC.%26aulast%3DEndres%26aufirst%3DE.%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DHighly%2520selective%2520butyrylcholinesterase%2520inhibitors%2520with%2520tunable%2520duration%2520of%2520action%2520by%2520chemical%2520modification%2520of%2520transferable%2520carbamate%2520units%2520exhibit%2520pronounced%2520neuroprotective%2520effect%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9116%26epage%3D9140%26doi%3D10.1021%2Facs.jmedchem.9b01012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstenn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Anti-amnesic and neuroprotective effects of fluoroethylnormemantine in a pharmacological mouse model of Alzheimer’s disease</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1093/ijnp/pyaa075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1093%2Fijnp%2Fpyaa075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32977336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BB3s%252FjsFOktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2021&pages=142-157&author=S.+Coulyauthor=M.+Denusauthor=M.+Bouchetauthor=G.+Rubinstennauthor=T.+Maurice&title=Anti-amnesic+and+neuroprotective+effects+of+fluoroethylnormemantine+in+a+pharmacological+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fijnp%2Fpyaa075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Couly Simon; Denus Morgane; Bouchet Melanie; Maurice Tangui; Rubinstenn Gilles</div><div class="citationInfo"><span class="NLM_cas:title">The international journal of neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-157</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Current therapies in Alzheimer's disease (AD), including Memantine, have proven to be only symptomatic but not curative or disease modifying.  Fluoroethylnormemantine (FENM) is a structural analogue of Memantine, functionalized with a fluorine group that allowed its use as a positron emission tomography tracer.  We here analyzed FENM neuroprotective potential in a pharmacological model of AD compared with Memantine.  METHODS:  Swiss mice were treated intracerebroventricularly with aggregated Aβ 25-35 peptide and examined after 1 week in a battery of memory tests (spontaneous alternation, passive avoidance, object recognition, place learning in the water-maze, topographic memory in the Hamlet).  Toxicity induced in the mouse hippocampus or cortex was analyzed biochemically or morphologically.  RESULTS:  Both Memantine and FENM showed symptomatic anti-amnesic effects in Aβ 25-35-treated mice.  Interestingly, FENM was not amnesic when tested alone at 10 mg/kg, contrarily to Memantine.  Drugs injected once per day prevented Aβ 25-35-induced memory deficits, oxidative stress (lipid peroxidation, cytochrome c release), inflammation (interleukin-6, tumor necrosis factor-α increases; glial fibrillary acidic protein and Iba1 immunoreactivity in the hippocampus and cortex), and apoptosis and cell loss (Bcl-2-associated X/B-cell lymphoma 2 ratio; cell loss in the hippocampus CA1 area).  However, FENM effects were more robust than observed with Memantine, with significant attenuations vs the Aβ 25-35-treated group.  CONCLUSIONS:  FENM therefore appeared as a potent neuroprotective drug in an AD model, with a superior efficacy compared with Memantine and an absence of direct amnesic effect at higher doses.  These results open the possibility to use the compound at more relevant dosages than those actually proposed in Memantine treatment for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMr7FgOxQEcBLDWw4HIq2sfW6udTcc2eYVa8EckzBSTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s%252FjsFOktw%253D%253D&md5=6e674d4e52a7c8391391204544166af4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyaa075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyaa075%26sid%3Dliteratum%253Aachs%26aulast%3DCouly%26aufirst%3DS.%26aulast%3DDenus%26aufirst%3DM.%26aulast%3DBouchet%26aufirst%3DM.%26aulast%3DRubinstenn%26aufirst%3DG.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DAnti-amnesic%2520and%2520neuroprotective%2520effects%2520of%2520fluoroethylnormemantine%2520in%2520a%2520pharmacological%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2021%26volume%3D24%26spage%3D142%26epage%3D157%26doi%3D10.1093%2Fijnp%2Fpyaa075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heltweg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span> <span> </span><span class="NLM_article-title">In vitro assays for the determination of histone deacetylase activity</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2005.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.ymeth.2005.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=16087348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1ahs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=332-337&author=B.+Heltwegauthor=J.+Trappauthor=M.+Jung&title=In+vitro+assays+for+the+determination+of+histone+deacetylase+activity&doi=10.1016%2Fj.ymeth.2005.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro assays for the determination of histone deacetylase activity</span></div><div class="casAuthors">Heltweg, Birgit; Trapp, Johannes; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-337</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone deacetylases are important regulators of transcription and an emerging target for anticancer drugs.  We present an overview over various assay formats that include radiolabeled histones, oligopeptides, and small mols. as substrates.  The advantages and disadvantages of the various formats in terms of, e.g., substrate availability, throughput or subtype selectivity are discussed.  Detailed procedures for various assay types that can be used for different problems, such as library screening or fluorescent inhibitor testing, are given.  We present a new protocol for a simple high-throughput assay for NAD+-dependent (class III) histone deacetylases, also termed sirtuins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEetxUXugzbbVg90H21EOLACvtfcHk0lgGKScXcB2s0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1ahs74%253D&md5=acdab3410a71c11ba6a2835d1e7378c0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2005.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2005.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DHeltweg%26aufirst%3DB.%26aulast%3DTrapp%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520assays%2520for%2520the%2520determination%2520of%2520histone%2520deacetylase%2520activity%26jtitle%3DMethods%26date%3D2005%26volume%3D36%26spage%3D332%26epage%3D337%26doi%3D10.1016%2Fj.ymeth.2005.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgooyNV2x2L4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonk, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartshorn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. D.</span></span> <span> </span><span class="NLM_article-title">Improved protein–ligand docking using GOLD</span>. <i>Proteins: Struct., Funct., Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1002/prot.10465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein%E2%80%93ligand+docking+using+GOLD&doi=10.1002%2Fprot.10465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0lgooyNV2x2L4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein%25E2%2580%2593ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623%26doi%3D10.1002%2Fprot.10465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. K.</span></span> <span> </span><span class="NLM_article-title">DPPH antioxidant assay revisited</span>. <i>Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1202</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.foodchem.2008.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.foodchem.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1202-1205&author=O.+P.+Sharmaauthor=T.+K.+Bhat&title=DPPH+antioxidant+assay+revisited&doi=10.1016%2Fj.foodchem.2008.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">DPPH antioxidant assay revisited</span></div><div class="casAuthors">Sharma, Om P.; Bhat, Tej K.</div><div class="citationInfo"><span class="NLM_cas:title">Food Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1202-1205</span>CODEN:
                <span class="NLM_cas:coden">FOCHDJ</span>;
        ISSN:<span class="NLM_cas:issn">0308-8146</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Scavenging of DPPH free radical is the basis of a common antioxidant assay.  A no. of protocols have been followed for this assay resulting in variation in the results of different labs.  We present a perspective of the protocols followed by different workers with incongruity in their results and recommend a std. procedure within the sensitivity range of spectrophotometry.  Three common std. antioxidants viz. ascorbic acid, BHT and Pr gallate have been used in this study.  The IC50 values for ascorbic acid and Pr gallate were 11.8 μM and 4.4 μM in methanol and 11.5 μM and 4.7 μM in buffered methanol as reaction medium, resp.  The free radical scavenging by BHT was markedly influenced by the reaction medium.  The IC50 values were 60.0 μM and 9.7 μM when the reaction was done in methanol and buffered methanol, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKousJor6cObVg90H21EOLACvtfcHk0lizgK3nC9aMnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsbrK&md5=23ff778dd3e2a174133b430f933301a3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.foodchem.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.foodchem.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DO.%2BP.%26aulast%3DBhat%26aufirst%3DT.%2BK.%26atitle%3DDPPH%2520antioxidant%2520assay%2520revisited%26jtitle%3DFood%2520Chem.%26date%3D2009%26volume%3D113%26spage%3D1202%26epage%3D1205%26doi%3D10.1016%2Fj.foodchem.2008.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampsch-Woodill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R. L.</span></span> <span> </span><span class="NLM_article-title">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4619</span>– <span class="NLM_lpage">4626</span>, <span class="refDoi"> DOI: 10.1021/jf010586o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+validation+of+an+improved+oxygen+radical+absorbance+capacity+assay+using+fluorescein+as+the+fluorescent+probe&doi=10.1021%2Fjf010586o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0lizgK3nC9aMnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520an%2520improved%2520oxygen%2520radical%2520absorbance%2520capacity%2520assay%2520using%2520fluorescein%2520as%2520the%2520fluorescent%2520probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26spage%3D4619%26epage%3D4626%26doi%3D10.1021%2Fjf010586o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dávalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Cordovés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomé, B.</span></span> <span> </span><span class="NLM_article-title">Extending applicability of the oxygen radical absorbance capacity (ORAC–fluorescein) assay</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1021/jf0305231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&author=A.+D%C3%A1valosauthor=C.+G%C3%B3mez-Cordov%C3%A9sauthor=B.+Bartolom%C3%A9&title=Extending+applicability+of+the+oxygen+radical+absorbance+capacity+%28ORAC%E2%80%93fluorescein%29+assay&doi=10.1021%2Fjf0305231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC-Fluorescein) Assay</span></div><div class="casAuthors">Davalos, Alberto; Gomez-Cordoves, Carmen; Bartolome, Begona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ORAC-fluorescein (ORAC-FL) method recently validated using automatic liq. handling systems has been adapted to manual handling and using a conventional fluorescence microplate reader.  As calcd. for Trolox, the precision of the method was <3.0, expressed as percent coeff. of variation.  The accuracy of the method was <2.3, expressed as percent variation of the mean.  The detection and quantification limits were those corresponding to 0.5- and 1-μM Trolox std. solns., resp.  The method has been applied to 10 pure compds. (benzoic and cinnamic acids and aldehydes, flavonoids, and butylated hydroxyanisole), to 30 white, rose, and bottled- and oak-aged red wines, and to 7 com. dietary antioxidant supplements.  All samples exhibited a good linear response with concn.  As seen by other methodologies, the chem. structure of a compd. dets. its antioxidant activity (ORAC-FL value).  Of particular interest were the results with oak-aged red wines from different vintages (1989-2002) that confirm influence of vintage, but not origin of the oak, in the antioxidant activity of wines from the same variety.  Dietary antioxidant supplements presented a great variability (170-fold difference) in their antioxidant potency.  This work proves applicability of the ORAC-FL assay in evaluating the antioxidant activity of diverse food samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MQ8zab9ce7Vg90H21EOLACvtfcHk0lhIsCljdVoI-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D&md5=c08c16818b9c32fc87b46570b26544f9</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A1valos%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Cordov%25C3%25A9s%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DExtending%2520applicability%2520of%2520the%2520oxygen%2520radical%2520absorbance%2520capacity%2520%2528ORAC%25E2%2580%2593fluorescein%2529%2520assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26spage%3D48%26epage%3D54%26doi%3D10.1021%2Fjf0305231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarenga Brizola, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granato, D.</span></span> <span> </span><span class="NLM_article-title">High-throughput assay comparison and standardization for metal chelating capacity screening: A proposal and application</span>. <i>Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/j.foodchem.2016.07.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.foodchem.2016.07.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=27507505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ahs7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2017&pages=515-522&author=J.+S.+Santosauthor=V.+R.+Alvarenga+Brizolaauthor=D.+Granato&title=High-throughput+assay+comparison+and+standardization+for+metal+chelating+capacity+screening%3A+A+proposal+and+application&doi=10.1016%2Fj.foodchem.2016.07.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput assay comparison and standardization for metal chelating capacity screening: A proposal and application</span></div><div class="casAuthors">Santos, Janio Sousa; Alvarenga Brizola, Vitor Rafael; Granato, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Food Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">515-522</span>CODEN:
                <span class="NLM_cas:coden">FOCHDJ</span>;
        ISSN:<span class="NLM_cas:issn">0308-8146</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aiming to standardize the exptl. protocols to assess the ability to chelate Fe2+ and Cu2+ using 96-well microplates, we analyzed Brazilian coffees (n = 20) as a study-case in relation to their antioxidant activity using conventional methods (DPPH and FRAP assays) and correlated the results with the total phenolic content (TPC) using bivariate and multivariate statistical approaches.  Complementarily, we assessed the repeatability, reproducibility, recovery, and linearity of both methods.  Data showed that the proposed assays presented a good repeatability and reproducibility (<7% RSD) and mean recovery values of 96.66% and 98.91% for the iron and copper assays, resp.  Both methods were linear in the range of 0-100 mg EDTA equiv./L.  Cu2+-chelating ability was significantly correlated to FRAP, DPPH, and TPC, while sparse (p < 0.05) correlations were obtained with Fe2+-chelating ability.  Overall, both micro assays can be used to assess the ability of plant-based exts. to chelate Fe2+ and Cu2+in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzN3-RTiFq4LVg90H21EOLACvtfcHk0lhIsCljdVoI-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ahs7nF&md5=d031983e0ebbd4e761086c06390010ec</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.foodchem.2016.07.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.foodchem.2016.07.091%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DJ.%2BS.%26aulast%3DAlvarenga%2BBrizola%26aufirst%3DV.%2BR.%26aulast%3DGranato%26aufirst%3DD.%26atitle%3DHigh-throughput%2520assay%2520comparison%2520and%2520standardization%2520for%2520metal%2520chelating%2520capacity%2520screening%253A%2520A%2520proposal%2520and%2520application%26jtitle%3DFood%2520Chem.%26date%3D2017%26volume%3D214%26spage%3D515%26epage%3D522%26doi%3D10.1016%2Fj.foodchem.2016.07.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tvrdý, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlíčková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercolini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mladěnka, P.</span></span> <span> </span><span class="NLM_article-title">A simple, cheap but reliable method for evaluation of zinc chelating properties</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2018.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bioorg.2018.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29421704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFais7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2018&pages=287-292&author=M.+C.+Catapanoauthor=V.+Tvrd%C3%BDauthor=J.+Karl%C3%AD%C4%8Dkov%C3%A1author=L.+Mercoliniauthor=P.+Mlad%C4%9Bnka&title=A+simple%2C+cheap+but+reliable+method+for+evaluation+of+zinc+chelating+properties&doi=10.1016%2Fj.bioorg.2018.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A simple, cheap but reliable method for evaluation of zinc chelating properties</span></div><div class="casAuthors">Catapano, Maria Carmen; Tvrdy, Vaclav; Karlickova, Jana; Mercolini, Laura; Mladenka, Premysl</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">287-292</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Zinc is an essential trace element.  Both its lack and excess are assocd. with pathol. states.  The former is more common and can ensue from the excessive treatment with clin. used iron/copper chelators.  The aim of this work was to prep. a reliable, rapid and cheap method for the screening of zinc chelation.  Spectrophotometric assessment using a known zinc indicator dithizone was selected.  Initial screening performed by comparison of spectra of dithizone and its complex with zinc suggested 530 and 570nm as suitable wavelengths for detn. of zinc at pH 4.5 while 540 and 590nm for pH 5.5-7.5.  Addnl. research showed the lower wavelengths to be more suitable.  The sensitivity of the method was always bellow 1μM with good linearity relationship between absorbance and zinc concn.  The method suitability was confirmed by use of two known zinc chelators, EDTA and N,N,N',N'-tetrakis(2-pyridylmethyl)-1,2-ethylenediamine (TPEN).  This method represents a sufficiently precise method for zinc chelation screening usable at pathophysiol. relevant pH conditions.  Such method can be employed for both screening of novel zinc chelators and for testing affinity of other metal chelators for zinc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGratUaOy8CxYLVg90H21EOLACvtfcHk0li-LcfEYkxyHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFais7o%253D&md5=77678e7f351a4bc01ea2ffeef9b50f20</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCatapano%26aufirst%3DM.%2BC.%26aulast%3DTvrd%25C3%25BD%26aufirst%3DV.%26aulast%3DKarl%25C3%25AD%25C4%258Dkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DMercolini%26aufirst%3DL.%26aulast%3DMlad%25C4%259Bnka%26aufirst%3DP.%26atitle%3DA%2520simple%252C%2520cheap%2520but%2520reliable%2520method%2520for%2520evaluation%2520of%2520zinc%2520chelating%2520properties%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D77%26spage%3D287%26epage%3D292%26doi%3D10.1016%2Fj.bioorg.2018.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javier  Cifuentes</span>, <span class="hlFld-ContribAuthor ">Vivian A.  Salazar</span>, <span class="hlFld-ContribAuthor ">Mónica  Cuellar</span>, <span class="hlFld-ContribAuthor ">María Claudia  Castellanos</span>, <span class="hlFld-ContribAuthor ">Jader  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Juan C.  Cruz</span>, <span class="hlFld-ContribAuthor ">Carolina  Muñoz-Camargo</span>. </span><span class="cited-content_cbyCitation_article-title">Antioxidant and Neuroprotective Properties of Non-Centrifugal Cane Sugar and Other Sugarcane Derivatives in an In Vitro Induced Parkinson’s Model. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 1040. <a href="https://doi.org/10.3390/antiox10071040" title="DOI URL">https://doi.org/10.3390/antiox10071040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox10071040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox10071040%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DAntioxidant%252Band%252BNeuroprotective%252BProperties%252Bof%252BNon-Centrifugal%252BCane%252BSugar%252Band%252BOther%252BSugarcane%252BDerivatives%252Bin%252Ban%252BIn%252BVitro%252BInduced%252BParkinson%2525E2%252580%252599s%252BModel%26aulast%3DCifuentes%26aufirst%3DJavier%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wamidh H.  Talib</span>, <span class="hlFld-ContribAuthor ">Ahmad Riyad  Alsayed</span>, <span class="hlFld-ContribAuthor ">Alaa  Abuawad</span>, <span class="hlFld-ContribAuthor ">Safa  Daoud</span>, <span class="hlFld-ContribAuthor ">Asma Ismail  Mahmod</span>. </span><span class="cited-content_cbyCitation_article-title">Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2506. <a href="https://doi.org/10.3390/molecules26092506" title="DOI URL">https://doi.org/10.3390/molecules26092506</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092506%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMelatonin%252Bin%252BCancer%252BTreatment%25253A%252BCurrent%252BKnowledge%252Band%252BFuture%252BOpportunities%26aulast%3DTalib%26aufirst%3DWamidh%2BH.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of melatonin- and ferulic acid-based HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds <b>3a–3b</b>, <b>5a–5d</b> and <b>8a–8c</b> from 5-Methoxytryptamine (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)acrylate for <b>2a</b>, methyl 4-(bromomethyl)benzoate for <b>2b</b>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, reflux; (b) NH<sub>2</sub>OH·HCl, KOH, MeOH, r.t.; (c) (<i>E</i>)-4-(3-methoxy-3-oxoprop-1-en-1-yl)benzoic acid for <b>4a</b>, 4-(methoxycarbonyl)benzoic acid for <b>4b</b>, (<i>E</i>)-3-(4-(methoxycarbonyl)-phenyl)acrylic acid for <b>4c</b>, 6-methoxy-6-oxohexanoic acid for <b>4d</b>, TBTU, TEA, THF, r.t.; (d) acetic anhydride, DCM, 0 °C to r.t.; (e) (i) methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)acrylate for <b>7a</b>, methyl 4-(bromomethyl)benzoate for <b>7b</b>, methyl 6-bromohexanoate for <b>7c</b>, <i>t</i>-BuOK, THF, reflux; (ii) SOCl<sub>2</sub>, MeOH, r.t.; (f) ferulic acid, ethyl chloroformate, TEA, dried THF, 0 °C; (g) Boc-Gly-OH, EDCI, DMAP, TEA, THF, r.t.; (h) 10% TFA in DCM, r.t.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds <b>10a–10c</b> and <b>15a–15c</b> from 5-Methoxytryptamine (<b>1</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl (<i>E</i>)-3-(4-(bromomethyl)phenyl)acrylate for <b>13a</b>, methyl 4-(bromomethyl)benzoate for <b>13b</b>, methyl 6-bromohexanoate for <b>13c</b>, K<sub>2</sub>CO<sub>3</sub>, THF, H<sub>2</sub>O, reflux; (b) ferulic acid, ethyl chloroformate, TEA, dried THF, 0 °C; (c) NH<sub>2</sub>OH·HCl, KOH, MeOH, r.t.; (d) Boc-Gly-OH, EDCI, DMAP, TEA, THF, r.t.; (e) 10% TFA in DCM, r.t.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Proposed binding modes of compounds <b>8b</b> (A) and <b>10b</b> (B, C) at the active site of HDAC6. The two alternative binding modes shown for <b>10b</b> correspond to the best-ranked result (B) and the most populated cluster of the docking results (C). Distances are given in Å; selected interactions are highlighted with dashed lines. The Zn<sup>2+</sup> ion is represented as a grey sphere. Loops 1 and 2 are denoted as L1 and L2. The deep active-site pocket is visualized with a transparent light-grey surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot analysis of acetylated tubulin (AcTubulin), acetylated histone H3 (AcHH3), acetylated histone H4 (AcHH4), and Hsp90 in HT22 cell lines after 24 h treatment with compounds <b>10b</b> (500, 100, and 20 nM) and <b>8b</b> (500 nM) using ACY1215 (500 nM) as a positive control. Tubulin was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Neurotoxicity of target compounds in HT-22 cells at 10 μM. Statistical analysis was performed applying One-way ANOVA followed by Dunnett’s multiple comparison post-test. Levels of significance: ***<i>p</i> < 0.001, *<i>p</i> < 0.05 referring to control cells treated with DMSO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compounds <b>8b</b>, <b>10b</b> and control ACY1215 on murine N9 cells induced in a M1 activation state by LPS (100ng/mL) treatment. IL1β release in N9-conditioned medium and expression of iNOS, TREM2 and TGFβ2 were analyzed by western blot after 24h treatment with LPS in presence of increasing concentrations (0.1, 0.5, 1, 2.5 and 5μM) of compounds ACY1215 (A), <b>8a</b> (B) and <b>10b</b> (C). Nitric Oxide release was evaluated through Griess reaction in media conditioned for 24h by microglial cells treated with LPS in presence of compounds ACY1215 (D), <b>8a</b> (E) and <b>10b</b> (F); as shown in figure F, only compound <b>10b</b> induced a significative reduction of NO release, with the strongest effect at 5μM. Additionally, IL1β release and iNOS expression, both markers of M1 neurotoxic microglia, strongly decreased in the presence of increasing concentrations of compound <b>10b</b> compared to LPS-treated control (I, L); conversely, no significant effects where observed on N9 cells following ACY1215 (G, J), and <b>8a</b> (H, K) treatment. In parallel, expression of M2 microglial marker TREM2 increased in cells co-treated by LPS-<b>10b</b> (O) and LPS-ACY1215 (M) compounds, whereas no significant effects in TREM2 expression were obtained following LPS-<b>8a</b> treatment (N). In addition, compared to ACY1215 (P) and <b>8a</b> (Q), in LPS-<b>10b</b> treated cells TGFβ2 expression turned out to increase (R) suggesting, together with TREM expression (O), a shift from neurotoxic M1 to neuroprotective M2 microglia. All quantitative data are presented as means ± S.E. from at last 3 independent experiments. Statistical significance between different treatments was calculated with GRAPHPAD PRISM 6 (La Jolla, California, USA) by using one-way analysis of variance (ANOVA) followed by post-hoc comparison through Bonferroni's test. *p<0.05; **p<0.01 compared to un-treated control; #p<0.05; ##p<0.01compared to LPS-treated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound on the Aβ<sub>25–35</sub>-induced spontaneous alternation deficit in mice. Mice received Aβ<sub>25–35</sub> (9 nmol icv) or vehicle solution (3 μL icv) on day 1 and compounds (A, B) ACY1215 or (C, D) <b>10b</b>, in the 0.1–3 mg/kg ip dose range, o.d., from days 1 to 7. In (E, F), the effect of a drug combination with equimolar doses of ACY-1215 (0.3 mg/kg), melatonin (0.16 mg/kg), and ferulic acid (0.13 mg/kg) was compared to the efficacy of the hybrid molecule. Mice were then tested for spontaneous alternation performance in the YMT in day 8. Top panel (A, C, and E): spontaneous alternation performance; lower panel (B, D, and F): number of arm entries. Data show mean ± SEM with <i>n</i> = 12–22 per group. ANOVA: <i>F</i><sub>(4,76)</sub> = 2.81, <i>p</i> < 0.05 in (A); <i>F</i><sub>(4,86)</sub> = 2.68, <i>p</i> < 0.05 in (B); <i>F</i><sub>(4,76)</sub> = 1.16, <i>p</i> > 0.05 in (C); <i>F</i><sub>(4,86)</sub> = 0.581, <i>p</i> > 0.05 in (D); <i>F</i><sub>(5,76)</sub> = 6.20, <i>p</i> < 0.0001 in (E); <i>F</i><sub>(5,76)</sub> = 0.554, <i>p</i> > 0.05 in (F). *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs (V + V)-treated group. <sup>#</sup><i>p</i> < 0.05, <sup>##</sup><i>p</i> < 0.01 vs (Aβ<sub>25–35</sub> + V)-treated group; Dunnett′s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/medium/jm0c01940_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compounds on Aβ<sub>25–35</sub>-induced passive avoidance deficits in mice. Mice received Aβ<sub>25–35</sub> (9 nmol icv) or vehicle solution (3 μL icv) on day 1 and compounds (A) ACY1215 and (B) <b>10b</b>, in the 0.1–3 mg/kg ip dose range, o.d., from days 1 to 7. Animals were trained in the passive avoidance test on day 9, and retention (step-through latency) was analyzed on day 10. Data show the median and interquartile range with <i>n</i> = 10–21 per group. Kruskal–Wallis ANOVA: <i>H</i> = 10.76, <i>p</i> < 0.05 in (A); <i>H</i> = 16.59, <i>p</i> < 0.01 in (B); <i>H</i> = 14.25, <i>p</i> < 0.05 in (C). *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs (V + V)-treated group. <sup>#</sup><i>p</i> < 0.05 vs (Aβ<sub>25–35</sub> + V)-treated group; Dunn’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c01940/20210331/images/large/jm0c01940_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01940&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 65 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Thirty years of HDAC inhibitors: 2020 insight and hindsight</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">12460</span>– <span class="NLM_lpage">12484</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00830</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlSisrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=12460-12484&author=T.+C.+S.+Hoauthor=A.+H.+Y.+Chanauthor=A.+Ganesan&title=Thirty+years+of+HDAC+inhibitors%3A+2020+insight+and+hindsight&doi=10.1021%2Facs.jmedchem.0c00830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight</span></div><div class="casAuthors">Ho, Terence C. S.; Chan, Alex H. Y.; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">12460-12484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now 30 years since the first report of a potent zinc-dependent histone deacetylase (HDAC) inhibitor appeared.  Since then, five HDAC inhibitors have received regulatory approval for cancer chemotherapy while many others are in clin. development for oncol. as well as other therapeutic indications.  This Perspective reviews the biol. and medicinal chem. advances over the past 3 decades with an emphasis on the design of selective inhibitors that discriminate between the 11 human HDAC isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrES4d2gbkB17Vg90H21EOLACvtfcHk0li1xf84tnEX3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlSisrzP&md5=1deb2ad5787797a9ee98dcf7bdade52c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00830%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DT.%2BC.%2BS.%26aulast%3DChan%26aufirst%3DA.%2BH.%2BY.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThirty%2520years%2520of%2520HDAC%2520inhibitors%253A%25202020%2520insight%2520and%2520hindsight%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D12460%26epage%3D12484%26doi%3D10.1021%2Facs.jmedchem.0c00830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, L.-H.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases in memory and cognition</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">re12</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aaa0069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1126%2Fscisignal.aaa0069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=25492968" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=re12&author=J.+Penneyauthor=L.-H.+Tsai&title=Histone+deacetylases+in+memory+and+cognition&doi=10.1126%2Fscisignal.aaa0069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aaa0069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aaa0069%26sid%3Dliteratum%253Aachs%26aulast%3DPenney%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DL.-H.%26atitle%3DHistone%2520deacetylases%2520in%2520memory%2520and%2520cognition%26jtitle%3DSci.%2520Signaling%26date%3D2014%26volume%3D7%26spage%3Dre12%26doi%3D10.1126%2Fscisignal.aaa0069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. V. W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">2119</span>– <span class="NLM_lpage">2130</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05564.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fj.1471-4159.2008.05564.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=18636984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=2119-2130&author=H.+Dingauthor=P.+J.+Dolanauthor=G.+V.+W.+Johnson&title=Histone+deacetylase+6+interacts+with+the+microtubule-associated+protein+tau&doi=10.1111%2Fj.1471-4159.2008.05564.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase 6 interacts with the microtubule-associated protein tau</span></div><div class="casAuthors">Ding, Huiping; Dolan, Philip J.; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2119-2130</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylase 6 (HDAC6), a unique cytoplasmic deacetylase, likely plays a role in neurodegeneration by coordinating cell responses to abnormal protein aggregation.  Here, we provide in vitro and in vivo evidence that HDAC6 interacts with tau, a microtubule-assocd. protein that forms neurofibrillary tangles in Alzheimer's disease.  This interaction is mediated by the microtubule-binding domain on tau and the Ser/Glu tetradecapeptide domain on HDAC6.  Treatment with tubacin, a selective inhibitor of tubulin deacetylation activity of HDAC6, did not disrupt HDAC6-tau interaction.  Nonetheless tubacin treatment attenuated site-specific tau phosphorylation, as did shRNA-mediated knockdown of HDAC6.  Proteasome inhibition potentiated HDAC6-tau interactions and facilitated the concn. and co-localization of HDAC6 and tau in a perinuclear aggresome-like compartment, independent of HDAC6 tubulin deacetylase activity.  Furthermore, we obsd. that in Alzheimer's disease brains the protein level of HDAC6 was significantly increased.  These findings establish HDAC6 as a tau-interacting protein and as a potential modulator of tau phosphorylation and accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9OtxbhpBU9LVg90H21EOLACvtfcHk0li1xf84tnEX3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7fM&md5=cf63da19f8f887459227b620d9a0898b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05564.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05564.x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DDolan%26aufirst%3DP.%2BJ.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%2BW.%26atitle%3DHistone%2520deacetylase%25206%2520interacts%2520with%2520the%2520microtubule-associated%2520protein%2520tau%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D2119%26epage%3D2130%26doi%3D10.1111%2Fj.1471-4159.2008.05564.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1080/13543776.2019.1708901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1080%2F13543776.2019.1708901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31865813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVKnsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=121-136&author=S.+Shenauthor=A.+P.+Kozikowski&title=A+patent+review+of+histone+deacetylase+6+inhibitors+in+neurodegenerative+diseases+%282014-2019%29&doi=10.1080%2F13543776.2019.1708901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)</span></div><div class="casAuthors">Shen, Sida; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-136</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase 6 (HDAC6) is unique in comparison with other zinc-dependent HDAC family members.  An increasing amt. of evidence from clin. and preclin. research demonstrates the potential of HDAC6 inhibition as an effective therapeutic approach for the treatment of cancer, autoimmune diseases, as well as neurol. disorders.  The recently disclosed crystal structures of HDAC6-ligand complexes offer further means for achieving pharmacophore refinement, thus further accelerating the pace of HDAC6 inhibitor discovery in the last few years.: This review summarizes the latest clin. status of HDAC6 inhibitors, discusses pharmacol. applications of selective HDAC6 inhibitors in neurodegenerative diseases, and describes the patent applications dealing with HDAC6 inhibitors from 2014-2019 that have not been reported in research articles.: Phenylhydroxamate has proven a very useful scaffold in the discovery of potent and selective HDAC6 inhibitors.  However, weaknesses of the hydroxamate function such as metabolic instability and mutagenic potential limit its application in the neurol. field, where long-term administration is required.  The recent invention of oxadiazole-based ligands by pharmaceutical companies may provide a new opportunity to optimize the druglike properties of HDAC6 inhibitors for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCWThC7SH8r7Vg90H21EOLACvtfcHk0lhCjPhFexAJPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVKnsb3J&md5=926d00ce3a0153953eb2f933599500b9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F13543776.2019.1708901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2019.1708901%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DS.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DA%2520patent%2520review%2520of%2520histone%2520deacetylase%25206%2520inhibitors%2520in%2520neurodegenerative%2520diseases%2520%25282014-2019%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2020%26volume%3D30%26spage%3D121%26epage%3D136%26doi%3D10.1080%2F13543776.2019.1708901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraswati, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span> <span> </span><span class="NLM_article-title">Old but gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFymtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=23-39&author=M.+Brindisiauthor=A.+P.+Saraswatiauthor=S.+Brogiauthor=S.+Gemmaauthor=S.+Butiniauthor=G.+Campiani&title=Old+but+gold%3A+tracking+the+new+guise+of+histone+deacetylase+6+%28HDAC6%29+enzyme+as+a+biomarker+and+therapeutic+target+in+rare+diseases&doi=10.1021%2Facs.jmedchem.9b00924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases</span></div><div class="casAuthors">Brindisi, Margherita; Saraswati, A. Prasanth; Brogi, Simone; Gemma, Sandra; Butini, Stefania; Campiani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-39</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Epigenetic regulation orchestrates many cellular processes and greatly influences key disease mechanisms.  Histone deacetylase (HDAC) enzymes play a crucial role either as biomarkers or therapeutic targets owing to their involvement in specific pathophysiol. pathways.  Beyond their well-characterized role as histone modifiers, HDACs also interact with several non-histone substrates and their increased expression has been highlighted in specific diseases.  HDAC6 isoform, due to its unique cytoplasmic localization, modulates the acetylation status of tubulin, HSP90, TGF-β and peroxiredoxins.  HDAC6 also exerts non-catalytic activities, through its interaction with ubiquitin.  Both catalytic and non-catalytic functions of HDACs are being actively studied in the field of specific rare disorders, beyond the well-established role in carcinogenesis.  This perspective outlines the application of HDAC(6) inhibitors in rare diseases, such as Rett syndrome, inherited retinal disorders, idiopathic pulmonary fibrosis and Charcot-Marie-Tooth disease, highlighting their therapeutic potential as innovative and targeted disease-modifying agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kzJmRToypbVg90H21EOLACvtfcHk0lhCjPhFexAJPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFymtbrK&md5=688368246471313ed025f0c230167052</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00924%26sid%3Dliteratum%253Aachs%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DSaraswati%26aufirst%3DA.%2BP.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26atitle%3DOld%2520but%2520gold%253A%2520tracking%2520the%2520new%2520guise%2520of%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520enzyme%2520as%2520a%2520biomarker%2520and%2520therapeutic%2520target%2520in%2520rare%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D23%26epage%3D39%26doi%3D10.1021%2Facs.jmedchem.9b00924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Mello, S. R.</span></span> <span> </span><span class="NLM_article-title">Complex neuroprotective and neurotoxic effects of histone deacetylases</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1111/jnc.14309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fjnc.14309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29355955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvFKgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=96-110&author=E.+A.+Thomasauthor=S.+R.+D%E2%80%99Mello&title=Complex+neuroprotective+and+neurotoxic+effects+of+histone+deacetylases&doi=10.1111%2Fjnc.14309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Complex neuroprotective and neurotoxic effects of histone deacetylases</span></div><div class="casAuthors">Thomas, Elizabeth A.; D'Mello, Santosh R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">96-110</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  By their ability to shatter quality of life for both patients and caregivers, neurodegenerative diseases are the most devastating of human disorders.  Unfortunately, there are no effective or long-terms treatments capable of slowing down the relentless loss of neurons in any of these diseases.  One impediment is the lack of detailed knowledge of the mol. mechanisms underlying the processes of neurodegeneration.  While some neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, are mostly sporadic in nature, driven by both environment and genetic susceptibility, many others, including Huntington's disease, spinocerebellar ataxias, and spinal-bulbar muscular atrophy, are genetically inherited disorders.  Surprisingly, given their different roots and etiologies, both sporadic and genetic neurodegenerative disorders have been linked to disease mechanisms involving histone deacetylase (HDAC) proteins, which consists of 18 family members with diverse functions.  While most studies have implicated certain HDAC subtypes in promoting neurodegeneration, a substantial body of literature suggests that other HDAC proteins can preserve neuronal viability.  Of particular interest, however, is the recent realization that a single HDAC subtype can have both neuroprotective and neurotoxic effects.  Diverse mechanisms, beyond transcriptional regulation have been linked to these effects, including deacetylation of non-histone proteins, protein-protein interactions, post-translational modifications of the HDAC proteins themselves and direct interactions with disease proteins.  The roles of these HDACs in both sporadic and genetic neurodegenerative diseases will be discussed in the current review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov484p4J5yKLVg90H21EOLACvtfcHk0lhCjPhFexAJPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvFKgtL0%253D&md5=6e7e414940a7148cf9c8a52365df3403</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fjnc.14309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.14309%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DE.%2BA.%26aulast%3DD%25E2%2580%2599Mello%26aufirst%3DS.%2BR.%26atitle%3DComplex%2520neuroprotective%2520and%2520neurotoxic%2520effects%2520of%2520histone%2520deacetylases%26jtitle%3DJ.%2520Neurochem.%26date%3D2018%26volume%3D145%26spage%3D96%26epage%3D110%26doi%3D10.1111%2Fjnc.14309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span> <span> </span><span class="NLM_article-title">The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">655</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-0688-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1038%2Fs41419-018-0688-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29844403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=655&author=S.+J.+Fanauthor=F.+I.+Huangauthor=J.+P.+Liouauthor=C.+R.+Yang&title=The+novel+histone+de+acetylase+6+inhibitor%2C+MPT0G211%2C+ameliorates+tau+phosphorylation+and+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1038%2Fs41419-018-0688-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Fan Sheng-Jun; Huang Fang-I; Yang Chia-Ron; Liou Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cell death & disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">655</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a dreadful neurodegenerative disease that leads to severe impairment of cognitive function, leading to a drastic decline in the quality of life.  The primary pathological features of AD include senile plaques (SPs) and intracellular neurofibrillary tangles (NFTs), comprising aggregated amyloid β (Aβ) and hyperphosphorylated tau protein, respectively, in the hippocampus of AD patients.  Histone deacetylase 6 (HDAC6) is a key enzyme in this neurodegenerative disease, in particular, as it relates to tau hyperphosphorylation.  This study aimed to investigate the protective effects and mechanism of the novel HDAC6 inhibitor, MPT0G211, using an AD model.  Our results indicated that MPT0G211 significantly reduced tau phosphorylation and aggregation, the processes highly correlated with the formation of NFTs.  This HDAC6 inhibitory activity resulted in an increase in acetylated Hsp90, which decreased Hsp90 and HDAC6 binding, causing ubiquitination of phosphorylated tau proteins.  In addition, a significant increase of phospho-glycogen synthase kinase-3β (phospho-GSK3β) on Ser9 (the inactive form) through Akt phosphorylation was associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment.  In AD in vivo models, MPT0G211 appeared to ameliorate learning and memory impairment in animals.  Furthermore, MPT0G211 treatment reduced the amount of phosphorylated tau in the hippocampal CA1 region.  In summary, MPT0G211 treatment appears to be a promising strategy for improving the AD phenotypes, including tau hyperphosphorylation and aggregation, neurodegeneration, and learning and memory impairment, making it a valuable agent for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThODJPxWFHy0EgZCMqtRBifW6udTcc2ebV5z12SbUyxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbhsFejtQ%253D%253D&md5=5b9b227e4df99bd8150004e7342c214c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-0688-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-0688-5%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DF.%2BI.%26aulast%3DLiou%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DC.%2BR.%26atitle%3DThe%2520novel%2520histone%2520de%2520acetylase%25206%2520inhibitor%252C%2520MPT0G211%252C%2520ameliorates%2520tau%2520phosphorylation%2520and%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2018%26volume%3D9%26spage%3D655%26doi%3D10.1038%2Fs41419-018-0688-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaisina, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaidery, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Aissa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnova, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaisin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourassa, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratan, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikulin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poloznikov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatcher, G. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazaryan, I. G.</span></span> <span> </span><span class="NLM_article-title">Activation of Nrf2 and hypoxic adaptive response contribute to neuroprotection elicited by phenylhydroxamic acid selective HDAC6 inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovFOhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=894-900&author=I.+N.+Gaisinaauthor=S.+H.+Leeauthor=N.+A.+Kaideryauthor=M.+Ben+Aissaauthor=M.+Ahujaauthor=N.+N.+Smirnovaauthor=S.+Wakadeauthor=A.+Gaisinauthor=M.+W.+Bourassaauthor=R.+R.+Ratanauthor=S.+V.+Nikulinauthor=A.+A.+Poloznikovauthor=B.+Thomasauthor=G.+R.+J.+Thatcherauthor=I.+G.+Gazaryan&title=Activation+of+Nrf2+and+hypoxic+adaptive+response+contribute+to+neuroprotection+elicited+by+phenylhydroxamic+acid+selective+HDAC6+inhibitors&doi=10.1021%2Facschemneuro.7b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors</span></div><div class="casAuthors">Gaisina, Irina N.; Lee, Sue H.; Kaidery, Navneet A.; Ben Aissa, Manel; Ahuja, Manuj; Smirnova, Natalya N.; Wakade, Sushama; Gaisin, Arsen; Bourassa, Megan W.; Ratan, Rajiv R.; Nikulin, Sergey V.; Poloznikov, Andrey A.; Thomas, Bobby; Thatcher, Gregory R. J.; Gazaryan, Irina G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">894-900</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activation of HIF-1α and Nrf2 is a primary component of cellular response to oxidative stress, and activation of HIF-1α and Nrf2 provides neuroprotection in models of neurodegenerative disorders, including ischemic stroke, Alzheimer's and Parkinson's diseases.  Screening a library of CNS-targeted drugs using novel reporters for HIF-1α and Nrf2 elevation in neuronal cells revealed histone deacetylase (HDAC) inhibitors as potential activators of these pathways.  We report the identification of phenylhydroxamates as single agents exhibiting tripartite inhibition of HDAC6, inhibition of HIF-1 prolyl hydroxylase (PHD), and activation of Nrf2.  Two superior tripartite agents, ING-6 and ING-66, showed neuroprotection against various cellular insults, assocd. with stabilization of both Nrf2 and HIF-1, and expression of their resp. target genes in vitro and in vivo.  Discovery of the innate ability of phenylhydroxamate HDAC inhibitors to activate Nrf2 and HIF provides a novel route to multifunctional neuroprotective agents and cautions against HDAC6 selective inhibitors as chem. probes of specific HDAC isoform function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEVdjIPEJsurVg90H21EOLACvtfcHk0ligpwJEZkBVKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovFOhsw%253D%253D&md5=6977da6ac81dd5fc7f07c3dccbb1d4b2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00435%26sid%3Dliteratum%253Aachs%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKaidery%26aufirst%3DN.%2BA.%26aulast%3DBen%2BAissa%26aufirst%3DM.%26aulast%3DAhuja%26aufirst%3DM.%26aulast%3DSmirnova%26aufirst%3DN.%2BN.%26aulast%3DWakade%26aufirst%3DS.%26aulast%3DGaisin%26aufirst%3DA.%26aulast%3DBourassa%26aufirst%3DM.%2BW.%26aulast%3DRatan%26aufirst%3DR.%2BR.%26aulast%3DNikulin%26aufirst%3DS.%2BV.%26aulast%3DPoloznikov%26aufirst%3DA.%2BA.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DGazaryan%26aufirst%3DI.%2BG.%26atitle%3DActivation%2520of%2520Nrf2%2520and%2520hypoxic%2520adaptive%2520response%2520contribute%2520to%2520neuroprotection%2520elicited%2520by%2520phenylhydroxamic%2520acid%2520selective%2520HDAC6%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D894%26epage%3D900%26doi%3D10.1021%2Facschemneuro.7b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span> <span> </span><span class="NLM_article-title">5-Aroylindoles act as selective histone deacetylase 6 inhibitors ameliorating Alzheimer’s disease phenotypes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7087</span>– <span class="NLM_lpage">7102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00151</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00151" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKmsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7087-7102&author=H.-Y.+Leeauthor=S.-J.+Fanauthor=F.-I.+Huangauthor=H.-Y.+Chaoauthor=K.-C.+Hsuauthor=T.+E.+Linauthor=T.-K.+Yehauthor=M.-J.+Laiauthor=Y.-H.+Liauthor=H.-L.+Huangauthor=C.-R.+Yangauthor=J.-P.+Liou&title=5-Aroylindoles+act+as+selective+histone+deacetylase+6+inhibitors+ameliorating+Alzheimer%E2%80%99s+disease+phenotypes&doi=10.1021%2Facs.jmedchem.8b00151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes</span></div><div class="casAuthors">Lee, Hsueh-Yun; Fan, Sheng-Jun; Huang, Fang-I.; Chao, Hsin-Yi; Hsu, Kai-Cheng; Lin, Tony Eight; Yeh, Teng-Kuang; Lai, Mei-Jung; Li, Yu-Hsuan; Huang, Hsiang-Ling; Yang, Chia-Ron; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7087-7102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper reports the development of a series of 5-aroylindolyl-substituted hydroxamic acids.  N-Hydroxy-4-((5-(4-methoxybenzoyl)-1H-indol-1-yl)methyl)benzamide (6) has potent inhibitory selectivity against histone deacetylase 6 (HDAC6) with an IC50 value of 3.92 nM.  It decreases not only the level of phosphorylation of tau proteins but also the aggregation of tau proteins.  Compd. 6 also shows neuroprotective activity by triggering ubiquitination.  In animal models, compd. 6 is able to ameliorate the impaired learning and memory, and it crosses the blood-brain barrier after oral administration.  Compd. 6 can be developed as a potential treatment for Alzheimer's disease in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrJdt1D5uVurVg90H21EOLACvtfcHk0lhzX9H3Wd0vyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKmsL3L&md5=6065438bfabec38e1f8fa4b5ea47e3ce</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00151%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DFan%26aufirst%3DS.-J.%26aulast%3DHuang%26aufirst%3DF.-I.%26aulast%3DChao%26aufirst%3DH.-Y.%26aulast%3DHsu%26aufirst%3DK.-C.%26aulast%3DLin%26aufirst%3DT.%2BE.%26aulast%3DYeh%26aufirst%3DT.-K.%26aulast%3DLai%26aufirst%3DM.-J.%26aulast%3DLi%26aufirst%3DY.-H.%26aulast%3DHuang%26aufirst%3DH.-L.%26aulast%3DYang%26aufirst%3DC.-R.%26aulast%3DLiou%26aufirst%3DJ.-P.%26atitle%3D5-Aroylindoles%2520act%2520as%2520selective%2520histone%2520deacetylase%25206%2520inhibitors%2520ameliorating%2520Alzheimer%25E2%2580%2599s%2520disease%2520phenotypes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7087%26epage%3D7102%26doi%3D10.1021%2Facs.jmedchem.8b00151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bemiller, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtishaw, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leisgang, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salazar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, B. T.</span></span> <span> </span><span class="NLM_article-title">Inflammation as a central mechanism in Alzheimer’s disease</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2018.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.trci.2018.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BB3cvnvVSltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=575-590&author=J.+W.+Kinneyauthor=S.+M.+Bemillerauthor=A.+S.+Murtishawauthor=A.+M.+Leisgangauthor=A.+M.+Salazarauthor=B.+T.+Lamb&title=Inflammation+as+a+central+mechanism+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.trci.2018.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation as a central mechanism in Alzheimer's disease</span></div><div class="casAuthors">Kinney Jefferson W; Murtishaw Andrew S; Leisgang Amanda M; Salazar Arnold M; Bemiller Shane M; Lamb Bruce T</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">575-590</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles.  Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD.  The sustained activation of the brain's resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder.  In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia-related signaling mechanisms that have been implicated in AD.  Additional information on microglia signaling and a number of cytokines in AD are also reviewed.  We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0qVKieHI_a-dfST00W0BcfW6udTcc2ea-HF1cjm0-t7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvnvVSltA%253D%253D&md5=cf1cea8f5c84010fd13daebab3094edf</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2018.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2018.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DJ.%2BW.%26aulast%3DBemiller%26aufirst%3DS.%2BM.%26aulast%3DMurtishaw%26aufirst%3DA.%2BS.%26aulast%3DLeisgang%26aufirst%3DA.%2BM.%26aulast%3DSalazar%26aufirst%3DA.%2BM.%26aulast%3DLamb%26aufirst%3DB.%2BT.%26atitle%3DInflammation%2520as%2520a%2520central%2520mechanism%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2018%26volume%3D4%26spage%3D575%26epage%3D590%26doi%3D10.1016%2Fj.trci.2018.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schotterl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennenstuhl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumann, U.</span></span> <span> </span><span class="NLM_article-title">Modulation of immune responses by histone deacetylase inhibitors</span>. <i>Crit. Rev. Oncog.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1615/CritRevOncog.2014012393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1615%2FCritRevOncog.2014012393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=25746108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhslCgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=139-154&author=S.+Schotterlauthor=H.+Brennenstuhlauthor=U.+Naumann&title=Modulation+of+immune+responses+by+histone+deacetylase+inhibitors&doi=10.1615%2FCritRevOncog.2014012393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of immune responses by histone deacetylase inhibitors</span></div><div class="casAuthors">Schotterl Sonja; Brennenstuhl Heiko; Naumann Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncogenesis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">139-54</span>
        ISSN:<span class="NLM_cas:issn">0893-9675</span>.
    </div><div class="casAbstract">Recent studies have demonstrated that histone deacetylase (HDAC) inhibitors (HDACi) have potential immunomodulatory activity since they affect the immune surveillance by regulating the production of cytokines, alter the activity and function of macrophages and dendritic cells (DC), regulate the transcription of a variety of immune-stimulating genes, and can modulate the activity of immune effector cells of both the innate and adaptive immune system.  Besides their immunostimulatory activity, HDACi can induce growth arrest and cell death, and modulate a subset of cellular functions such as cell motility or differentiation.  This makes HDACi interesting therapeutic candidates for the treatment of a variety of human diseases like cancer, autoimmune, and graft versus host diseases.  Besides these, HDACs have been shown to be involved in virus replication and pathogenesis, and it was recently shown that HDACi provide therapeutic effects in the treatment of oncogenic virus infections and associated malignancies.  This review will further give information about the different families of HDACs and their opponents, the histone acetylases (HATs), about the classes and function of specific HDACi, and their use in the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe2viLetAEXv6AExegM5LLfW6udTcc2ea-HF1cjm0-t7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhslCgtw%253D%253D&md5=7fd1a3ce494b8f8f85520eba76e54fae</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1615%2FCritRevOncog.2014012393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevOncog.2014012393%26sid%3Dliteratum%253Aachs%26aulast%3DSchotterl%26aufirst%3DS.%26aulast%3DBrennenstuhl%26aufirst%3DH.%26aulast%3DNaumann%26aufirst%3DU.%26atitle%3DModulation%2520of%2520immune%2520responses%2520by%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DCrit.%2520Rev.%2520Oncog.%26date%3D2015%26volume%3D20%26spage%3D139%26epage%3D154%26doi%3D10.1615%2FCritRevOncog.2014012393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenechukwu, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice</span>. <i>Pharm. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1080/13880209.2018.1563620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1080%2F13880209.2018.1563620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31124385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BB3M7ptlWntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2019&pages=263-268&author=Y.+Songauthor=L.+Qinauthor=R.+Yangauthor=F.+Yangauthor=N.+A.+Kenechukwuauthor=X.+Zhaoauthor=X.+Zhouauthor=X.+Wenauthor=L.+Li&title=Inhibition+of+HDAC6+alleviating+lipopolysaccharide-induced+p38MAPK+phosphorylation+and+neuroinflammation+in+mice&doi=10.1080%2F13880209.2018.1563620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice</span></div><div class="casAuthors">Song Yuanjian; Yang Fan; Kenechukwu Nwobodo Alexander; Zhao Xiaofang; Li Lei; Song Yuanjian; Yang Fan; Kenechukwu Nwobodo Alexander; Wen Xiangru; Li Lei; Song Yuanjian; Qin Li; Yang Rongli; Li Lei; Zhou Xiaoyan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-268</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Context: Researchers in a variety of fields have extensively focused on histone deacetylase 6 (HDAC6) due to its aggravation of inflammatory reaction.  However, relevant studies examining whether HDAC6 could exacerbate lipopolysaccharide (LPS)-induced inflammation are still lacking.  Objective: We assessed the role of HDAC6 in LPS-induced brain inflammation and used the HDAC6-selective inhibitor Tubastatin A (TBSA) to investigate the potential mechanisms further.  Materials and methods: Brain inflammation was induced in Kunming (KM) mice via intraperitoneal (I.P.), injection of Lipopolysaccharide (LPS) (1 mg/kg), the TBSA (0.5 mg/kg) was delivered via intraperitoneal.  The phosphorylated p38 (p-p38) Mitogen-activated protein kinases (MAPK) and expression of typical inflammatory mediators, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both the hippocampus and cortex, were examined by immunoblotting.  Nissl staining was used to detect the neuronal damage in the hippocampus and the cortex.  Results: About 1 mg/kg LPS via daily intraperitoneal (I.P.) injections for 12 days significantly increased p38 MAPK phosphorylation, TNF-α and IL-6 expression, and neuronal loss.  However, 0.5 mg/kg TBSA (three days before LPS treatment) by I.P. injections for 15 days could reverse the above results.  Conclusions: This present study provided evidence that TBSA significantly suppressed LPS-induced neuroinflammation and the expression of p-p38.  Results derived from our study might help reveal the effective targeting strategies of LPS-induced brain inflammation through inhibiting HDAC6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuCv_wHdytl5HZzFRCXxVKfW6udTcc2ebx8VtFQz7cDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7ptlWntg%253D%253D&md5=ce35a28b2a3843f2ca7cc306cee0e2bd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1080%2F13880209.2018.1563620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13880209.2018.1563620%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DKenechukwu%26aufirst%3DN.%2BA.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520HDAC6%2520alleviating%2520lipopolysaccharide-induced%2520p38MAPK%2520phosphorylation%2520and%2520neuroinflammation%2520in%2520mice%26jtitle%3DPharm.%2520Biol.%26date%3D2019%26volume%3D57%26spage%3D263%26epage%3D268%26doi%3D10.1080%2F13880209.2018.1563620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology by design: a medicinal chemist’s perspective on multitargeting compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">420</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=420-444&author=E.+Proschakauthor=H.+Starkauthor=D.+Merk&title=Polypharmacology+by+design%3A+a+medicinal+chemist%E2%80%99s+perspective+on+multitargeting+compounds&doi=10.1021%2Facs.jmedchem.8b00760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds</span></div><div class="casAuthors">Proschak, Ewgenij; Stark, Holger; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">420-444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multitargeting compds. comprising activity on more than a single biol. target have gained remarkable relevance in drug discovery owing to the complexity of multifactorial diseases such as cancer, inflammation, or the metabolic syndrome.  Polypharmacol. drug profiles can produce additive or synergistic effects while reducing side effects and significantly contribute to the high therapeutic success of indispensable drugs such as aspirin.  While their identification has long been the result of serendipity, medicinal chem. now tends to design polypharmacol.  Modern in vitro pharmacol. methods and chem. probes allow a systematic search for rational target combinations and recent innovations in computational technologies, crystallog., or fragment-based design equip multitarget compd. development with valuable tools.  In this Perspective, we analyze the relevance of multiple ligands in drug discovery and the versatile toolbox to design polypharmacol.  We conclude that despite some characteristic challenges remaining unresolved, designed polypharmacol. holds enormous potential to secure future therapeutic innovation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEwJSxWw3vbVg90H21EOLACvtfcHk0ljxHXckNI9haw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlKms7fE&md5=6dc4b8e1c4777372396626140a302663</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00760%26sid%3Dliteratum%253Aachs%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DPolypharmacology%2520by%2520design%253A%2520a%2520medicinal%2520chemist%25E2%2580%2599s%2520perspective%2520on%2520multitargeting%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D420%26epage%3D444%26doi%3D10.1021%2Facs.jmedchem.8b00760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of multitarget-directed ligands: strategies and emerging paradigms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8881</span>– <span class="NLM_lpage">8914</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8881-8914&author=J.+Zhouauthor=X.+Jiangauthor=S.+Heauthor=H.+Jiangauthor=F.+Fengauthor=W.+Liuauthor=W.+Quauthor=H.+Sun&title=Rational+design+of+multitarget-directed+ligands%3A+strategies+and+emerging+paradigms&doi=10.1021%2Facs.jmedchem.9b00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms</span></div><div class="casAuthors">Zhou, Junting; Jiang, Xueyang; He, Siyu; Jiang, Hongli; Feng, Feng; Liu, Wenyuan; Qu, Wei; Sun, Haopeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8881-8914</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit satisfactory efficacy.  Recently, increasing evidence indicates that simultaneous modulation of multiple targets may improve both therapeutic safety and efficacy, compared with single-target drugs.  However, few multitarget drugs are on market or in clin. trials, despite the best efforts of medicinal chemists.  This article discusses the systematic establishment of target combination, lead generation, and optimization of multitarget-directed ligands (MTDLs).  Moreover, we analyze some MTDLs research cases for several complex diseases in recent years and the physicochem. properties of 117 clin. multitarget drugs, with the aim to reveal the trends and insights of the potential use of MTDLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLqk7hMZnoLVg90H21EOLACvtfcHk0ljxHXckNI9haw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlKrt7k%253D&md5=37adb9bc31802e62fd7f8d0d6e7697e3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520multitarget-directed%2520ligands%253A%2520strategies%2520and%2520emerging%2520paradigms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8881%26epage%3D8914%26doi%3D10.1021%2Facs.jmedchem.9b00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Harnessing polypharmacology with medicinal chemistry</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00039</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=273-275&author=M.+L.+Bolognesi&title=Harnessing+polypharmacology+with+medicinal+chemistry&doi=10.1021%2Facsmedchemlett.9b00039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing Polypharmacology with Medicinal Chemistry</span></div><div class="casAuthors">Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-275</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Polypharmacol. has expanded enormously over the last ten years, with several multitarget drugs (MTDs) already in the market.  This Viewpoint provides a basis for a discussion about the crit. need to develop MTDs in a more rationale and conscious way.  A checklist to maximize success in polypharmacol. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4yXxJ_uU72bVg90H21EOLACvtfcHk0ljxHXckNI9haw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVWjt7g%253D&md5=28a8cc47ae2966a2ecd8a411adfb1ef5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00039%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DHarnessing%2520polypharmacology%2520with%2520medicinal%2520chemistry%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D273%26epage%3D275%26doi%3D10.1021%2Facsmedchemlett.9b00039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albertini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sena
Murteira Pinheiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1002/med.21699.</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fmed.21699." title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=1&author=C.+Albertiniauthor=A.+Salernoauthor=P.+de+Sena%0AMurteira+Pinheiroauthor=M.+L.+Bolognesi&title=From+combinations+to+multitarget-directed+ligands%3A+A+continuum+in+Alzheimer%E2%80%99s+disease+polypharmacology&doi=10.1002%2Fmed.21699."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fmed.21699.&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21699.%26sid%3Dliteratum%253Aachs%26aulast%3DAlbertini%26aufirst%3DC.%26aulast%3DSalerno%26aufirst%3DA.%26aulast%3Dde%2BSena%2BMurteira%2BPinheiro%26aufirst%3DP.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DFrom%2520combinations%2520to%2520multitarget-directed%2520ligands%253A%2520A%2520continuum%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520polypharmacology%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2020%26spage%3D1%26doi%3D10.1002%2Fmed.21699." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors as multitarget ligands: new players in Alzheimer’s disease drug discovery?</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1067</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201900174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fcmdc.201900174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=30958639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos1Wiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1067-1073&author=A.+De%0ASimoneauthor=A.+Milelli&title=Histone+deacetylase+inhibitors+as+multitarget+ligands%3A+new+players+in+Alzheimer%E2%80%99s+disease+drug+discovery%3F&doi=10.1002%2Fcmdc.201900174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors as multitarget ligands: new players in Alzheimer's disease drug discovery?</span></div><div class="casAuthors">De Simone, Angela; Milelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACIs) are responsible for controlling gene expression by modulating the acetylation status of histone proteins.  Furthermore, they modulate the activity of cytoplasmic non-histone proteins.  Due to the involvement of HDACs in neurodevelopment, memory formation, and cognitive processes, HDACIs have been suggested as innovative agents for the treatment of neurodegenerative disorders such as Alzheimer's disease (AD).  Given their mechanisms of action and the complex nature of AD, HDACIs have been proposed for the design of novel multitarget ligands (MTLs).  To this aim, the fragment responsible for HDAC inhibition has been coupled with other structures that are able to provide addnl. biol. actions, such as antioxidant activity or the inhibition of phosphodiesterase 5, transglutaminase 2, and glycogen synthase kinase 3β.  Herein we discuss recent efforts to design HDACI-based MTLs as potential disease-modifying entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotgFDwLEiUt7Vg90H21EOLACvtfcHk0lgfD3ESGeiZ6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos1Wiurc%253D&md5=191fca2c9334551a52be5c13bf71cf90</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201900174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201900174%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DMilelli%26aufirst%3DA.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520as%2520multitarget%2520ligands%253A%2520new%2520players%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%253F%26jtitle%3DChemMedChem%26date%3D2019%26volume%3D14%26spage%3D1067%26epage%3D1073%26doi%3D10.1002%2Fcmdc.201900174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Lera, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">Two-hit wonders: the expanding universe of multitargeting epigenetic agents</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2020.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.cbpa.2020.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32784072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKnsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2020&pages=135-154&author=A.+R.+de%0ALeraauthor=A.+Ganesan&title=Two-hit+wonders%3A+the+expanding+universe+of+multitargeting+epigenetic+agents&doi=10.1016%2Fj.cbpa.2020.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Two-hit wonders: The expanding universe of multitargeting epigenetic agents</span></div><div class="casAuthors">de Lera, Angel R.; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">135-154</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multitargeting involves the application of mols. that are deliberately intended to bind to two or more unrelated cellular targets with high affinity.  In epigenetic chem. biol. and drug discovery, the rational design of multitargeting agents has evolved to a sophisticated level, and there are now five examples that have reached clin. trials.  This review covers recent developments in the field and future prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwQn-GXR3grVg90H21EOLACvtfcHk0lgfD3ESGeiZ6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKnsbvO&md5=b5383c9c221fbcb6dcf7483d98aa7b78</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2020.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2020.05.009%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%26aufirst%3DA.%2BR.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DTwo-hit%2520wonders%253A%2520the%2520expanding%2520universe%2520of%2520multitargeting%2520epigenetic%2520agents%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2020%26volume%3D57%26spage%3D135%26epage%3D154%26doi%3D10.1016%2Fj.cbpa.2020.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smalley, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkinson, J. T.</span></span> <span> </span><span class="NLM_article-title">Bifunctional HDAC therapeutics: one drug to rule them all?</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4394</span>, <span class="refDoi"> DOI: 10.3390/molecules25194394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.3390%2Fmolecules25194394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVOjtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=4394&author=J.+P.+Smalleyauthor=S.+M.+Cowleyauthor=J.+T.+Hodgkinson&title=Bifunctional+HDAC+therapeutics%3A+one+drug+to+rule+them+all%3F&doi=10.3390%2Fmolecules25194394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional HDAC therapeutics: one drug to rule them all?</span></div><div class="casAuthors">Smalley, Joshua P.; Cowley, Shaun M.; Hodgkinson, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4394</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase (HDAC) enzymes play crucial roles in epigenetic gene expression and are an attractive therapeutic target.  Five HDAC inhibitors have been approved for cancer treatment to date, however, clin. applications have been limited due to poor single-agent drug efficacy and side effects assocd. with a lack of HDAC isoform or complex selectivity.  An emerging strategy aiming to address these limitations is the development of bifunctional HDAC therapeutics-single mols. comprising a HDAC inhibitor conjugated to another specificity targeting moiety.  This review summarizes the recent advancements in novel types of dual-targeting HDAC modulators, including proteolysis-targeting chimeras (PROTACs), with a focus on HDAC isoform and complex selectivity, and the future potential of such bifunctional mols. in achieving enhanced drug efficacy and therapeutic benefits in treating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMU3F42ROLKLVg90H21EOLACvtfcHk0lgfD3ESGeiZ6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVOjtbnJ&md5=a4aa1f08b4450f6d71ec5fdc6e13ca75</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25194394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25194394%26sid%3Dliteratum%253Aachs%26aulast%3DSmalley%26aufirst%3DJ.%2BP.%26aulast%3DCowley%26aufirst%3DS.%2BM.%26aulast%3DHodgkinson%26aufirst%3DJ.%2BT.%26atitle%3DBifunctional%2520HDAC%2520therapeutics%253A%2520one%2520drug%2520to%2520rule%2520them%2520all%253F%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D4394%26doi%3D10.3390%2Fmolecules25194394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomaselli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucidi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span> <span> </span><span class="NLM_article-title">Epigenetic polypharmacology: a new frontier for epi-drug discovery</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1002/med.21600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fmed.21600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31218726" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=190-244&author=D.+Tomaselliauthor=A.+Lucidiauthor=D.+Rotiliauthor=A.+Mai&title=Epigenetic+polypharmacology%3A+a+new+frontier+for+epi-drug+discovery&doi=10.1002%2Fmed.21600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fmed.21600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21600%26sid%3Dliteratum%253Aachs%26aulast%3DTomaselli%26aufirst%3DD.%26aulast%3DLucidi%26aufirst%3DA.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMai%26aufirst%3DA.%26atitle%3DEpigenetic%2520polypharmacology%253A%2520a%2520new%2520frontier%2520for%2520epi-drug%2520discovery%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D40%26spage%3D190%26epage%3D244%26doi%3D10.1002%2Fmed.21600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osko, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase 6-selective inhibitors and the influence of capping groups on hydroxamate-zinc denticity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8054</span>– <span class="NLM_lpage">8060</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFansLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8054-8060&author=N.+J.+Porterauthor=J.+D.+Oskoauthor=D.+Diedrichauthor=T.+Kurzauthor=J.+M.+Hookerauthor=F.+K.+Hansenauthor=D.+W.+Christianson&title=Histone+deacetylase+6-selective+inhibitors+and+the+influence+of+capping+groups+on+hydroxamate-zinc+denticity&doi=10.1021%2Facs.jmedchem.8b01013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity</span></div><div class="casAuthors">Porter, Nicholas J.; Osko, Jeremy D.; Diedrich, Daniela; Kurz, Thomas; Hooker, Jacob M.; Hansen, Finn K.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8054-8060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four crystal structures are presented of histone deacetylase 6 (HDAC6) complexes with para-substituted phenylhydromaxamate inhibitors, including bulky peptoids.  These structures provide insight regarding the design of capping groups that confer selectivity for binding to HDAC6, specifically with regard to interactions in a pocket formed by the L1 loop.  Capping group interactions may also influence hydroxamate-Zn2+ coordination with monodentate or bidentate geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq54PM6p6wpnrVg90H21EOLACvtfcHk0lhdv-YCjNuGyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFansLnE&md5=f1d227d7668d09e121e5967b2d65f1a5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01013%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DOsko%26aufirst%3DJ.%2BD.%26aulast%3DDiedrich%26aufirst%3DD.%26aulast%3DKurz%26aufirst%3DT.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DHansen%26aufirst%3DF.%2BK.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DHistone%2520deacetylase%25206-selective%2520inhibitors%2520and%2520the%2520influence%2520of%2520capping%2520groups%2520on%2520hydroxamate-zinc%2520denticity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8054%26epage%3D8060%26doi%3D10.1021%2Facs.jmedchem.8b01013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mendoza, A. E.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of first-in-class dual acting histone deacetylases (HDACs) and phosphodiesterase 5 (PDE5) inhibitors for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8967</span>– <span class="NLM_lpage">9004</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00908</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8967-9004&author=O.+Rabalauthor=J.+A.+S%C3%A1nchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=C.+Garc%C3%ADa-Barrosoauthor=A.+Ugarteauthor=A.+E.-H.+de+Mendozaauthor=E.+S%C3%A1ezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Design%2C+synthesis%2C+and+biological+evaluation+of+first-in-class+dual+acting+histone+deacetylases+%28HDACs%29+and+phosphodiesterase+5+%28PDE5%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8967-9004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simultaneous inhibition of phosphodiesterase 5 (PDE5) and histone deacetylases (HDAC) has recently been validated as a potentially novel therapeutic approach for Alzheimer's Disease (AD).  To further extend this concept, the authors designed and synthesized the first chem. series of dual acting PDE5 and HDAC inhibitors, and the authors validated this systems therapeutics approach.  Following the implementation of structure- and knowledge-based approaches, initial hits were designed and were shown to validate the hypothesis of dual in vitro inhibition.  Then, an optimization strategy was pursued to obtain a proper tool compd. for in vivo testing in AD models.  Initial hits were translated into mols. with adequate cellular functional responses (histone acetylation and cAMP/cGMP response element-binding (CREB) phosphorylation in the nanomolar range), an acceptable therapeutic window (>1 log unit) and the ability to cross the blood-brain barrier, leading to the identification of 7 as a candidate for in vivo proof-of-concept testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbHBoJlefNEbVg90H21EOLACvtfcHk0lhdv-YCjNuGyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyqtL7O&md5=756a252809f05f5d7fc59e828736cfba</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00908%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3Dde%2BMendoza%26aufirst%3DA.%2BE.-H.%26aulast%3DS%25C3%25A1ez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520first-in-class%2520dual%2520acting%2520histone%2520deacetylases%2520%2528HDACs%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8967%26epage%3D9004%26doi%3D10.1021%2Facs.jmedchem.6b00908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s disease mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1038%2Fnpp.2016.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=27550730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=524-539&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+A.+S%C3%A1nchez-Ariasauthor=O.+Rabalauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=S.+Mederosauthor=A.+Ugarteauthor=R.+Francoauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=A+first-in-class+small-molecule+that+acts+as+a+dual+inhibitor+of+HDAC+and+PDE5+and+that+rescues+hippocampal+synaptic+impairment+in+Alzheimer%E2%80%99s+disease+mice&doi=10.1038%2Fnpp.2016.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice</span></div><div class="casAuthors">Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Sanchez-Arias, Juan A.; Rabal, Obdulia; Perez-Gonzalez, Marta; Mederos, Sara; Ugarte, Ana; Franco, Rafael; Segura, Victor; Perea, Gertrudis; Oyarzabal, Julen; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-539</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The targeting of two independent but synergistic enzymic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD).  Here we report the discovery of a new first-in-class small-mol. (CM-414) that acts as a dual inhibitor of PDE5 and HDACs.  We have used this compd. as a chem. probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation.  This mol. rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice.  Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine d. on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.  Thus, CM-414 may serve as the starting point to discover balanced dual inhibitors with an optimal efficacy and safety profile for clin. testing on AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrel_KiPL5177Vg90H21EOLACvtfcHk0lgQLU7w6YtvhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP&md5=26482df7c58696a362ca1e73bab12264</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.163%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DA%2520first-in-class%2520small-molecule%2520that%2520acts%2520as%2520a%2520dual%2520inhibitor%2520of%2520HDAC%2520and%2520PDE5%2520and%2520that%2520rescues%2520hippocampal%2520synaptic%2520impairment%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D524%26epage%3D539%26doi%3D10.1038%2Fnpp.2016.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-González, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mendoza, A. E.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineda-Lucena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Multitarget approach for the treatment of Alzheimer’s disease: inhibition of phosphodiesterase 9 (PDE9) and histone deacetylases (HDACs) covering diverse selectivity profiles</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4076</span>– <span class="NLM_lpage">4101</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1egu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4076-4101&author=O.+Rabalauthor=J.+A.+S%C3%A1nchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+P%C3%A9rez-Gonz%C3%A1lezauthor=C.+Garc%C3%ADa-Barrosoauthor=A.+Ugarteauthor=A.+E.-H.+de+Mendozaauthor=E.+S%C3%A1ezauthor=M.+Espelosinauthor=S.+Ursuaauthor=H.+Tanauthor=W.+Wuauthor=M.+Xuauthor=A.+Pineda-Lucenaauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Multitarget+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+inhibition+of+phosphodiesterase+9+%28PDE9%29+and+histone+deacetylases+%28HDACs%29+covering+diverse+selectivity+profiles&doi=10.1021%2Facschemneuro.9b00303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Tan, Haizhong; Wu, Wei; Xu, Musheng; Pineda-Lucena, Antonio; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4076-4101</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present a series of dual-target phosphodiesterase 9 (PDE9) and histone deacetylase (HDAC) inhibitors devised as pharmacol. tool compds. for assessing the implications of these two targets in Alzheimer's disease (AD).  These novel inhibitors were designed taking into account the key pharmacophoric features of known selective PDE9 inhibitors as well as privileged chem. structures, bearing zinc binding groups (hydroxamic acids and ortho-amino anilides) that hit HDAC targets.  These substituents were selected according to rational criteria and previous knowledge from our group to explore diverse HDAC selectivity profiles (pan-HDAC, HDAC6 selective, and class I selective) that were confirmed in biochem. screens.  Their functional response in inducing acetylation of histone and tubulin and phosphorylation of cAMP response element binding (CREB) was measured as a requisite for further progression into complete in vitro absorption, distribution, metab. and excretion (ADME) and in vivo brain penetration profiling.  Compd. 31b, a selective HDAC6 inhibitor with acceptable brain permeability, was chosen for assessing in vivo efficacy of these first-in-class inhibitors, as well as studying their mode of action (MoA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9GkgLW75qELVg90H21EOLACvtfcHk0lgQLU7w6YtvhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1egu7rF&md5=be57148d4b99a7e517c51142a1908fb8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00303%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DS%25C3%25A1nchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Gonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3Dde%2BMendoza%26aufirst%3DA.%2BE.-H.%26aulast%3DS%25C3%25A1ez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DPineda-Lucena%26aufirst%3DA.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DMultitarget%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520inhibition%2520of%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520and%2520histone%2520deacetylases%2520%2528HDACs%2529%2520covering%2520diverse%2520selectivity%2520profiles%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D4076%26epage%3D4101%26doi%3D10.1021%2Facschemneuro.9b00303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Pietra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petragnani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrobono, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frabetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russomanno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballerini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebbioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of the first-in-class GSK-3β/HDAC dual inhibitor as disease-modifying agent to combat Alzheimer’s disease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=469-474&author=A.+De%0ASimoneauthor=V.+La+Pietraauthor=N.+Betariauthor=N.+Petragnaniauthor=M.+Conteauthor=S.+Danieleauthor=D.+Pietrobonoauthor=C.+Martiniauthor=S.+Petrallaauthor=R.+Casadeiauthor=L.+Davaniauthor=F.+Frabettiauthor=P.+Russomannoauthor=E.+Novellinoauthor=S.+Montanariauthor=V.+Tumiattiauthor=P.+Balleriniauthor=F.+Sarnoauthor=A.+Nebbiosoauthor=L.+Altucciauthor=B.+Montiauthor=V.+Andrisanoauthor=A.+Milelli&title=Discovery+of+the+first-in-class+GSK-3%CE%B2%2FHDAC+dual+inhibitor+as+disease-modifying+agent+to+combat+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facsmedchemlett.8b00507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease</span></div><div class="casAuthors">De Simone, Angela; La Pietra, Valeria; Betari, Nibal; Petragnani, Nicola; Conte, Mariarosaria; Daniele, Simona; Pietrobono, Deborah; Martini, Claudia; Petralla, Sabrina; Casadei, Raffaella; Davani, Lara; Frabetti, Flavia; Russomanno, Pasquale; Novellino, Ettore; Montanari, Serena; Tumiatti, Vincenzo; Ballerini, Patrizia; Sarno, Federica; Nebbioso, Angela; Altucci, Lucia; Monti, Barbara; Andrisano, Vincenza; Milelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-474</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several evidence pointed out the role of epigenetics in Alzheimer's disease (AD) revealing strictly relationships between epigenetic and "classical" AD targets.  Based on the reported connection among histone deacetylases (HDACs) and glycogen synthase kinase 3β (GSK-3β), herein we present the discovery and the biochem. characterization of the first-in-class hit compd. able to exert promising anti-AD effects by modulating the targeted proteins in the low micromolar range of concn.  Compd. 11 induces an increase in histone acetylation and a redn. of tau phosphorylation.  It is nontoxic and protective against H2O2 and 6-OHDA stimuli in SH-SY5Y and in CGN cell lines, resp.  Moreover, it promotes neurogenesis and displays immunomodulatory effects.  Compd. 11 shows no lethality in a wt-zebrafish model (<100 μM) and high water soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFpd6rQuX3jrVg90H21EOLACvtfcHk0lgQLU7w6YtvhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSqtbs%253D&md5=c57168700a73c70eafa747add137cac1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00507%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DBetari%26aufirst%3DN.%26aulast%3DPetragnani%26aufirst%3DN.%26aulast%3DConte%26aufirst%3DM.%26aulast%3DDaniele%26aufirst%3DS.%26aulast%3DPietrobono%26aufirst%3DD.%26aulast%3DMartini%26aufirst%3DC.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DCasadei%26aufirst%3DR.%26aulast%3DDavani%26aufirst%3DL.%26aulast%3DFrabetti%26aufirst%3DF.%26aulast%3DRussomanno%26aufirst%3DP.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMontanari%26aufirst%3DS.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DBallerini%26aufirst%3DP.%26aulast%3DSarno%26aufirst%3DF.%26aulast%3DNebbioso%26aufirst%3DA.%26aulast%3DAltucci%26aufirst%3DL.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DMilelli%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520the%2520first-in-class%2520GSK-3%25CE%25B2%252FHDAC%2520dual%2520inhibitor%2520as%2520disease-modifying%2520agent%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D469%26epage%3D474%26doi%3D10.1021%2Facsmedchemlett.8b00507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer’s disease</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">104109</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.104109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bioorg.2020.104109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32768741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKgsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2020&pages=104109&author=F.+Heauthor=Y.+Ranauthor=X.+Liauthor=D.+Wangauthor=Q.+Zhangauthor=J.+Lvauthor=C.+Yuauthor=Y.+Quauthor=X.+Zhangauthor=A.+Xuauthor=C.+Weiauthor=C.+J.+Chouauthor=J.+Wu&title=Design%2C+synthesis+and+biological+evaluation+of+dual-function+inhibitors+targeting+NMDAR+and+HDAC+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bioorg.2020.104109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's disease</span></div><div class="casAuthors">He, Feng; Ran, Yingying; Li, Xiaoyang; Wang, Defeng; Zhang, Qiuqiong; Lv, Jiahui; Yu, Chenggong; Qu, Ying; Zhang, Xiangna; Xu, Ana; Wei, Chao; Chou, C. James; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104109</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) have been indicated important roles in neurodegenerative disorders including Alzheimer's disease (AD).  Herein, a series of novel compds. that contain a memantine moiety were designed to target HDACs and N-methyl-D-aspartate receptor (NMDAR) which are related to the treatment of AD.  Biol. characterization established that compd. 9d exhibited a balanced inhibitory activity on NMDAR and HDACs.  This compd. is relatively selective to HDAC6 with IC50 of 0.18 μM and also maintains comparable activity on NMDAR (Ki = 0.59 μM) as memantine.  Functionally, treatment with 9d (I) increased the level of AcTubulin in MV4-11 cells and rescued PC-12 cells from H2O2-induced cytotoxicity with EC50 of 0.94 μM.  Studies in mice also demonstrated that compd. I efficiently penetrates the blood brain barrier to reach the brain tissue.  Collectively, the results strongly encourage further development of 9d as a potential therapeutic agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxsMkyhmn3l7Vg90H21EOLACvtfcHk0liGfly9Pe7mpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKgsLbF&md5=0d2c7f6afe4f6ec0a2eae238084a622c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.104109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.104109%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DF.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520dual-function%2520inhibitors%2520targeting%2520NMDAR%2520and%2520HDAC%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D103%26spage%3D104109%26doi%3D10.1016%2Fj.bioorg.2020.104109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: Design, synthesis, and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">103721</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bioorg.2020.103721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32193030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&pages=103721&author=A.+Xuauthor=F.+Heauthor=X.+Zhangauthor=X.+Liauthor=Y.+Ranauthor=C.+Weiauthor=C.+J.+Chouauthor=R.+Zhangauthor=J.+Wu&title=Tacrine-hydroxamate+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+Design%2C+synthesis%2C+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation</span></div><div class="casAuthors">Xu, Ana; He, Feng; Zhang, Xiangna; Li, Xiaoyang; Ran, Yingying; Wei, Chao; James Chou, C.; Zhang, Rui; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103721</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop multitarget-directed ligands as potential treatments for Alzheimer's disease, twenty-eight new tacrine-hydroxamate derivs. were designed, synthesized, and biol. evaluated.  As expected, most of the compds. exhibited inhibitory activities against cholinesterases (ChEs) and histone deacetylase (HDACs).  Among the tested compds., I showed not only potent and selective inhibition on AChE at sub-nanomolar potency (AChEIC50 = 0.12 nM, BChEIC50 = 361.52 nM) but also potent inhibition on HDAC (IC50 = 0.23 nM).  Moreover, I exhibited inhibitory activity on Aβ1-42 self-aggregation as well as disaggregation activity on pre-formed Aβ fibrils.  Furthermore, I exhibited antioxidant activity and metal chelating properties.  Further mechanistic studies demonstrated that I is a pan-inhibitor of HDACs and a mixed-type inhibitor for AChE.  It was shown that I is a BBB penetrant by online prediction.  Taken together, the results indicate that I can serve as a lead compd. to develop promising candidate analogs as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLE3wLayb4i7Vg90H21EOLACvtfcHk0liGfly9Pe7mpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D&md5=e2b820af806ce7651f90fc66d4a1f1cb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103721%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTacrine-hydroxamate%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26spage%3D103721%26doi%3D10.1016%2Fj.bioorg.2020.103721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiao, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.-J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">112193</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.ejmech.2020.112193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32151835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2020&pages=112193&author=H.-J.+Tsengauthor=M.-H.+Linauthor=Y.-J.+Shiaoauthor=Y.-C.+Yangauthor=J.-C.+Chuauthor=C.-Y.+Chenauthor=Y.-Y.+Chenauthor=T.+E.+Linauthor=C.-J.+Suauthor=S.-L.+Panauthor=L.-C.+Chenauthor=C.-Y.+Wangauthor=K.-C.+Hsuauthor=W.-J.+Huang&title=Synthesis+and+biological+evaluation+of+acridine-based+histone+deacetylase+inhibitors+as+multitarget+agents+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2020.112193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease</span></div><div class="casAuthors">Tseng, Hui-Ju; Lin, Mei-Hsiang; Shiao, Young-Ji; Yang, Ying-Chen; Chu, Jung-Chun; Chen, Chun-Yung; Chen, Yi-Ying; Lin, Tony Eight; Su, Chih-Jou; Pan, Shiow-Lin; Chen, Liang-Chieh; Wang, Chen-Yu; Hsu, Kai-Cheng; Huang, Wei-Jan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112193</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multitarget agents simultaneously trigger mols. in functionally complementary pathways, and are therefore considered to have potential in effectively treating Alzheimer's disease (AD), which has a complex pathogenetic mechanism.  In this study, the HDAC inhibitor core is incorporated into the acetylcholine esterase (ACE) inhibitor acridine-derived moiety and resulted in compds. that exhibited higher class IIa HDAC (4, 5, 7, and 9)- and class IIb HDAC6-inhibiting activity when compared to the pan-HDAC inhibitor SAHA in clin. practice.  One of these compds., I, displayed greater selectivity toward HDAC6 than other isoform enzymes.  In contrast, the activity of compd. II was selective toward class IIa HDAC and HDAC6.  These two compds. exhibited strong activity against Aβ-aggregation as well as significantly disrupted Aβ-oligomer.  Addnl., I and II strongly inhibited AChE.  These exptl. findings demonstrate that the above two are HDAC-Aβ-aggregation-AChE inhibitors.  Notably, they can enhance neurite outgrowth, but with no significant neurotoxicity.  Further biol. evaluation revealed the various cellular effects of multitarget compds. I and II, which have the potential to treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqexIdMql7N8bVg90H21EOLACvtfcHk0lio4G3vDsDCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFels70%253D&md5=f4dd58408b6092ade3b9183065014f33</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112193%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DH.-J.%26aulast%3DLin%26aufirst%3DM.-H.%26aulast%3DShiao%26aufirst%3DY.-J.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DChu%26aufirst%3DJ.-C.%26aulast%3DChen%26aufirst%3DC.-Y.%26aulast%3DChen%26aufirst%3DY.-Y.%26aulast%3DLin%26aufirst%3DT.%2BE.%26aulast%3DSu%26aufirst%3DC.-J.%26aulast%3DPan%26aufirst%3DS.-L.%26aulast%3DChen%26aufirst%3DL.-C.%26aulast%3DWang%26aufirst%3DC.-Y.%26aulast%3DHsu%26aufirst%3DK.-C.%26aulast%3DHuang%26aufirst%3DW.-J.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520acridine-based%2520histone%2520deacetylase%2520inhibitors%2520as%2520multitarget%2520agents%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D192%26spage%3D112193%26doi%3D10.1016%2Fj.ejmech.2020.112193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosales-Corral, S. A.</span>; <span class="NLM_string-name">Reiter, R. J.</span>; <span class="NLM_string-name">Tan, D.-X.</span>; <span class="NLM_string-name">Manchester, L. C.</span>; <span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and Anti-Inflammatory Role of Melatonin in Alzheimer’s Neurodegeneration</span>. In  <i>Aging</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preedy, V. R.</span></span>, Ed. <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2014</span>; pp.  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">193</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2FB978-0-12-405933-7.00018-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=177-193&author=S.+A.+Rosales-Corral&author=R.+J.+Reiter&author=D.-X.+Tan&author=L.+C.+Manchester&author=X.+Liuauthor=V.+R.+Preedy&title=Aging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-405933-7.00018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-405933-7.00018-4%26sid%3Dliteratum%253Aachs%26aulast%3DRosales-Corral%26aufirst%3DS.%2BA.%26atitle%3DAntioxidant%2520and%2520Anti-Inflammatory%2520Role%2520of%2520Melatonin%2520in%2520Alzheimer%25E2%2580%2599s%2520Neurodegeneration%26btitle%3DAging%26aulast%3DPreedy%26aufirst%3DV.%2BR.%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D177%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malar, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span> <span> </span><span class="NLM_article-title">Ferulic acid and Alzheimer’s disease: promises and pitfalls</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">776</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.2174/1389557515666150522102545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.2174%2F1389557515666150522102545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=26002710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=776-788&author=S.+F.+Nabaviauthor=K.+P.+Deviauthor=D.+S.+Malarauthor=A.+Suredaauthor=M.+Dagliaauthor=S.+M.+Nabavi&title=Ferulic+acid+and+Alzheimer%E2%80%99s+disease%3A+promises+and+pitfalls&doi=10.2174%2F1389557515666150522102545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ferulic Acid and Alzheimer's Disease: Promises and Pitfalls</span></div><div class="casAuthors">Nabavi, Seyed Fazel; Devi, Kasi Pandima; Malar, Dicson Sheeja; Sureda, Antoni; Daglia, Maria; Nabavi, Seyed Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">776-788</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress plays an important role in both initiation and progression of neurodegenerative diseases, such as Alzheimer and Parkinson.  Therefore, much attention has been paid to antioxidants for developing therapeutic strategies for the neurodegenerative diseases.  However, as serious adverse effects are related to synthetic antioxidants, recent research has been focused on natural products esp. phenolic antioxidants.  In the present article, we critically review the available literature related to the beneficial role of ferulic acid on Alzheimer's disease, since it is a natural antioxidant which is widely found in different fruits and vegetables.  We also provide some informations about sources, chem. structure, bioavailability and clin. impacts of ferulic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ2BkYCOLYprVg90H21EOLACvtfcHk0lio4G3vDsDCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVWns70%253D&md5=abebf633cb2168eda2aefd3fb61dc16f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F1389557515666150522102545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557515666150522102545%26sid%3Dliteratum%253Aachs%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DDevi%26aufirst%3DK.%2BP.%26aulast%3DMalar%26aufirst%3DD.%2BS.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3DDaglia%26aufirst%3DM.%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26atitle%3DFerulic%2520acid%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520promises%2520and%2520pitfalls%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D776%26epage%3D788%26doi%3D10.2174%2F1389557515666150522102545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mihardja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, L. W.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer’s disease</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1478</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1111/nyas.14436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fnyas.14436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32700392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1eltbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1478&publication_year=2020&pages=43-62&author=M.+Mihardjaauthor=J.+Royauthor=K.+Y.+Wongauthor=L.+Aquiliauthor=B.+C.+Hengauthor=Y.-S.+Chanauthor=M.+L.+Fungauthor=L.+W.+Lim&title=Therapeutic+potential+of+neurogenesis+and+melatonin+regulation+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fnyas.14436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease</span></div><div class="casAuthors">Mihardja, Mazel; Roy, Jaydeep; Wong, Kan Yin; Aquili, Luca; Heng, Boon Chin; Chan, Ying-Shing; Fung, Man Lung; Lim, Lee Wei</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1478</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-62</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by the hallmark pathologies of amyloid-beta plaques and neurofibrillary tangles.  Symptoms of this devastating disease include behavioral changes and deterioration of higher cognitive functions.  Impairment of neurogenesis has also been shown to occur in AD, which adversely impacts new neuronal cell growth, differentiation, and survival.  This impairment possibly results from the cumulative effects of the various pathologies of AD.  Preclin. studies have suggested that the administration of melatonin-the pineal hormone primarily responsible for the regulation of the circadian rhythm-targets the effects of AD pathologies and improves cognitive impairment.  It is postulated that by mitigating the effect of these pathologies, melatonin can also rescue neurogenesis impairment.  This review aims to explore the effect of AD pathologies on neurogenesis, as well as the mechanisms by which melatonin is able to ameliorate AD pathologies to potentially promote neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGZ2acFPj9uLVg90H21EOLACvtfcHk0lio4G3vDsDCpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1eltbzN&md5=682afdba5a53dbafde56b2f076decaed</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fnyas.14436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.14436%26sid%3Dliteratum%253Aachs%26aulast%3DMihardja%26aufirst%3DM.%26aulast%3DRoy%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DK.%2BY.%26aulast%3DAquili%26aufirst%3DL.%26aulast%3DHeng%26aufirst%3DB.%2BC.%26aulast%3DChan%26aufirst%3DY.-S.%26aulast%3DFung%26aufirst%3DM.%2BL.%26aulast%3DLim%26aufirst%3DL.%2BW.%26atitle%3DTherapeutic%2520potential%2520of%2520neurogenesis%2520and%2520melatonin%2520regulation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2020%26volume%3D1478%26spage%3D43%26epage%3D62%26doi%3D10.1111%2Fnyas.14436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Ferulic acid promotes survival and differentiation of neural stem cells to prevent gentamicin-induced neuronal hearing loss</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2017.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.yexcr.2017.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=28916193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFentb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2017&pages=257-263&author=L.+Guauthor=X.+Cuiauthor=W.+Weiauthor=J.+Yangauthor=X.+Li&title=Ferulic+acid+promotes+survival+and+differentiation+of+neural+stem+cells+to+prevent+gentamicin-induced+neuronal+hearing+loss&doi=10.1016%2Fj.yexcr.2017.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ferulic acid promotes survival and differentiation of neural stem cells to prevent gentamicin-induced neuronal hearing loss</span></div><div class="casAuthors">Gu, Lintao; Cui, Xinhua; Wei, Wei; Yang, Jia; Li, Xuezhong</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">257-263</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neural stem cells (NSCs) have exhibited promising potential in therapies against neuronal hearing loss.  Ferulic acid (FA) has been widely reported to enhance neurogenic differentiation of different stem cells.  We investigated the role of FA in promoting NSC transplant therapy to prevent gentamicin-induced neuronal hearing loss.  NSCs were isolated from mouse cochlear tissues to establish in vitro culture, which were then treated with FA.  The survival and differentiation of NSCs were evaluated.  Subsequently, neurite outgrowth and excitability of the in vitro neuronal network were assessed.  Gentamicin was used to induce neuronal hearing loss in mice, in the presence and absence of FA, followed by assessments of auditory brainstem response (ABR) and distortion product optoacoustic emissions (DPOAE) amplitude.  FA promoted survival, neurosphere formation and differentiation of NSCs, as well as neurite outgrowth and excitability of in vitro neuronal network.  Furthermore, FA restored ABR threshold shifts and DPOAE in gentamicin-induced neuronal hearing loss mouse model in vivo.  Our data, for the first time, support potential therapeutic efficacy of FA in promoting survival and differentiation of NSCs to prevent gentamicin-induced neuronal hearing loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwcriugCFzrVg90H21EOLACvtfcHk0lg5GDyBj_83nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFentb7M&md5=952efbd6fd44147aace258f8af3bd399</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2017.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2017.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DFerulic%2520acid%2520promotes%2520survival%2520and%2520differentiation%2520of%2520neural%2520stem%2520cells%2520to%2520prevent%2520gentamicin-induced%2520neuronal%2520hearing%2520loss%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D360%26spage%3D257%26epage%3D263%26doi%3D10.1016%2Fj.yexcr.2017.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savaskan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brydon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jockers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirz-Justice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Spahn, F.</span></span> <span> </span><span class="NLM_article-title">Increased melatonin <b>1a</b>-receptor immunoreactivity in the hippocampus of Alzheimer’s disease patients</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1034/j.1600-079x.2002.00841.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1034%2Fj.1600-079x.2002.00841.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=11841602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BD387islahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=59-62&author=E.+Savaskanauthor=G.+Olivieriauthor=F.+Meierauthor=L.+Brydonauthor=R.+Jockersauthor=R.+Ravidauthor=A.+Wirz-Justiceauthor=F.+M%C3%BCller-Spahn&title=Increased+melatonin+1a-receptor+immunoreactivity+in+the+hippocampus+of+Alzheimer%E2%80%99s+disease+patients&doi=10.1034%2Fj.1600-079x.2002.00841.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients</span></div><div class="casAuthors">Savaskan Egemen; Olivieri Gianfranco; Meier Fides; Brydon Lena; Jockers Ralf; Ravid Rivka; Wirz-Justice Anna; Muller-Spahn Franz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pineal research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-62</span>
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    </div><div class="casAbstract">The pineal secretory product melatonin has, in addition to regulating retinal, circadian and vascular functions, neuroprotective effects.  Blood melatonin levels are often decreased in Alzheimer's disease (AD), a progressively disabling neurodegenerative disorder.  In this study we provide the first immunohistochemical evidence for the localization of melatonin 1a-receptor (MT(1)) in aged human hippocampus and a comparison of AD cases.  MT(1) was localized to pyramidal neurons in the hippocampal cornu ammonis (CA)1-4 subfields.  There was a distinct increase in staining intensity in all AD cases indicating an up-regulation of the receptor, possibly as a compensatory response to impaired melatonin levels in order to augment melatonin's neuroprotective effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6Ck1VE4rdR4McDoIzZtNkfW6udTcc2ebhXfqwDKP0cLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387islahsQ%253D%253D&md5=4e76a18b508363d11f37209fa7631acc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-079x.2002.00841.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-079x.2002.00841.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavaskan%26aufirst%3DE.%26aulast%3DOlivieri%26aufirst%3DG.%26aulast%3DMeier%26aufirst%3DF.%26aulast%3DBrydon%26aufirst%3DL.%26aulast%3DJockers%26aufirst%3DR.%26aulast%3DRavid%26aufirst%3DR.%26aulast%3DWirz-Justice%26aufirst%3DA.%26aulast%3DM%25C3%25BCller-Spahn%26aufirst%3DF.%26atitle%3DIncreased%2520melatonin%25201a-receptor%2520immunoreactivity%2520in%2520the%2520hippocampus%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2002%26volume%3D32%26spage%3D59%26epage%3D62%26doi%3D10.1034%2Fj.1600-079x.2002.00841.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savaskan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayoub, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeloni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraschini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller-Spahn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jockers, R.</span></span> <span> </span><span class="NLM_article-title">Reduced hippocampal MT<sub>2</sub> melatonin receptor expression in Alzheimer’s disease</span>. <i>J. Pineal Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1111/j.1600-079X.2004.00169.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fj.1600-079X.2004.00169.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=15617532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2005&pages=10-16&author=E.+Savaskanauthor=M.+A.+Ayoubauthor=R.+Ravidauthor=D.+Angeloniauthor=F.+Fraschiniauthor=F.+Meierauthor=A.+Eckertauthor=F.+M%C3%BCller-Spahnauthor=R.+Jockers&title=Reduced+hippocampal+MT2+melatonin+receptor+expression+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1600-079X.2004.00169.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease</span></div><div class="casAuthors">Savaskan, Egemen; Ayoub, Mohammed A.; Ravid, Rivka; Angeloni, Debora; Fraschini, Franco; Meier, Fides; Eckert, Anne; Mueller-Spahn, Franz; Jockers, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-16</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to identify the distribution of the second melatonin receptor (MT2) in the human hippocampus of elderly controls and Alzheimer's disease (AD) patients.  This is the first report of immunohistochem. MT2 localization in the human hippocampus both in control and AD cases.  The specificity of the MT2 antibody was ascertained by fluorescence microscopy using the anti-MT2 antibody in HEK 293 cells expressing recombinant MT2, in immunoblot expts. on membranes from MT2 expressing cells, and, finally, by immunopptn. expts. of the native MT2.  MT2 immunoreactivity was studied in the hippocampus of 16 elderly control and 16 AD cases.  In controls, MT2 was localized in pyramidal neurons of the hippocampal subfields CA1-4 and in some granular neurons of the stratum granulosum.  The overall intensity of the MT2 staining was distinctly decreased in AD cases.  The results indicate that MT2 may be involved in mediating the effects of melatonin in the human hippocampus, and this mechanism may be heavily impaired in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpigcEioiTbQ7Vg90H21EOLACvtfcHk0lg5GDyBj_83nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFekuw%253D%253D&md5=b0ee16e371274611634c958690af71c3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2004.00169.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2004.00169.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavaskan%26aufirst%3DE.%26aulast%3DAyoub%26aufirst%3DM.%2BA.%26aulast%3DRavid%26aufirst%3DR.%26aulast%3DAngeloni%26aufirst%3DD.%26aulast%3DFraschini%26aufirst%3DF.%26aulast%3DMeier%26aufirst%3DF.%26aulast%3DEckert%26aufirst%3DA.%26aulast%3DM%25C3%25BCller-Spahn%26aufirst%3DF.%26aulast%3DJockers%26aufirst%3DR.%26atitle%3DReduced%2520hippocampal%2520MT2%2520melatonin%2520receptor%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2005%26volume%3D38%26spage%3D10%26epage%3D16%26doi%3D10.1111%2Fj.1600-079X.2004.00169.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smil, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantigny, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahhab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolescu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panetta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Déziel, R.</span></span> <span> </span><span class="NLM_article-title">Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bmcl.2008.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=19111466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2isrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=688-692&author=D.+V.+Smilauthor=S.+Mankuauthor=Y.+A.+Chantignyauthor=S.+Leitauthor=A.+Wahhabauthor=T.+P.+Yanauthor=M.+Fournelauthor=C.+Marounauthor=Z.+Liauthor=A.-M.+Lemieuxauthor=A.+Nicolescuauthor=J.+Rahilauthor=S.+Lefebvreauthor=A.+Panettaauthor=J.+M.+Bestermanauthor=R.+D%C3%A9ziel&title=Novel+HDAC6+isoform+selective+chiral+small+molecule+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bmcl.2008.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors</span></div><div class="casAuthors">Smil, David V.; Manku, Sukhdev; Chantigny, Yves A.; Leit, Silvana; Wahhab, Amal; Yan, Theresa P.; Fournel, Marielle; Maroun, Christiane; Li, Zuomei; Lemieux, Anne-Marie; Nicolescu, Alina; Rahil, Jubrail; Lefebvre, Sylvain; Panetta, Anthony; Besterman, Jeffrey M.; Deziel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">688-692</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to identify HDAC isoform selective inhibitors, we designed and synthesized chiral 3,4-dihydroquinoxalin-2(1H)-one and piperazine-2,5-dione aryl hydroxamates showing selectivity (up to 40-fold) for human HDAC6 over other class I/IIa HDACs.  The obsd. selectivity and potency (IC50 values 10-200 nM against HDAC6) is markedly dependent on the abs. configuration of the chiral moiety, and suggests possibilities for use of chiral compds. in selective HDAC isoform inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UIfh9LXgp7Vg90H21EOLACvtfcHk0lheuyHhvT8XWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2isrY%253D&md5=b85a35bb0061a0200d74be630cef5d95</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DSmil%26aufirst%3DD.%2BV.%26aulast%3DManku%26aufirst%3DS.%26aulast%3DChantigny%26aufirst%3DY.%2BA.%26aulast%3DLeit%26aufirst%3DS.%26aulast%3DWahhab%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DT.%2BP.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DMaroun%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLemieux%26aufirst%3DA.-M.%26aulast%3DNicolescu%26aufirst%3DA.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DPanetta%26aufirst%3DA.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DD%25C3%25A9ziel%26aufirst%3DR.%26atitle%3DNovel%2520HDAC6%2520isoform%2520selective%2520chiral%2520small%2520molecule%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D688%26epage%3D692%26doi%3D10.1016%2Fj.bmcl.2008.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Villarroel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villagra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotomayor, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9891</span>– <span class="NLM_lpage">9899</span>, <span class="refDoi"> DOI: 10.1021/jm301098e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9891-9899&author=J.+A.+Bergmanauthor=K.+Woanauthor=P.+Perez-Villarroelauthor=A.+Villagraauthor=E.+M.+Sotomayorauthor=A.+P.+Kozikowski&title=Selective+histone+deacetylase+6+inhibitors+bearing+substituted+urea+linkers+inhibit+melanoma+cell+growth&doi=10.1021%2Fjm301098e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth</span></div><div class="casAuthors">Bergman, Joel A.; Woan, Karrune; Perez-Villarroel, Patricio; Villagra, Alejandro; Sotomayor, Eduardo M.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9891-9899</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The incidence of malignant melanoma has dramatically increased in recent years thus requiring the need for improved therapeutic strategies.  In our efforts to design selective histone deactylase inhibitors (HDACI), we discovered that the aryl urea 1 is a modestly potent yet nonselective inhibitor.  Structure-activity relationship studies revealed that adding substituents to the nitrogen atom of the urea so as to generate compds. bearing a branched linker group results in increased potency and selectivity for HDAC6.  Compd. 5g shows low nanomolar inhibitory potency against HDAC6 and a selectivity of ∼600-fold relative to the inhibition of HDAC1.  These HDACIs were evaluated for their ability to inhibit the growth of B16 melanoma cells with the most potent and selective HDAC6I being found to decrease tumor cell growth.  To the best of our knowledge, this work constitutes the first report of HDAC6-selective inhibitors that possess antiproliferative effects against melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTkTtPLqvwsrVg90H21EOLACvtfcHk0lheuyHhvT8XWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsrbJ&md5=d6be4c0efb3922fc35d814ba00ae9ed1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm301098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301098e%26sid%3Dliteratum%253Aachs%26aulast%3DBergman%26aufirst%3DJ.%2BA.%26aulast%3DWoan%26aufirst%3DK.%26aulast%3DPerez-Villarroel%26aufirst%3DP.%26aulast%3DVillagra%26aufirst%3DA.%26aulast%3DSotomayor%26aufirst%3DE.%2BM.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%2520histone%2520deacetylase%25206%2520inhibitors%2520bearing%2520substituted%2520urea%2520linkers%2520inhibit%2520melanoma%2520cell%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9891%26epage%3D9899%26doi%3D10.1021%2Fjm301098e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6973</span>– <span class="NLM_lpage">6980</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bmc.2013.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=24095016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6973-6980&author=F.+Wangauthor=W.+Luauthor=T.+Zhangauthor=J.+Dongauthor=H.+Gaoauthor=P.+Liauthor=S.+Wangauthor=J.+Zhang&title=Development+of+novel+ferulic+acid+derivatives+as+potent+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bmc.2013.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors</span></div><div class="casAuthors">Wang, Fang; Lu, Wen; Zhang, Tao; Dong, Jinyun; Gao, Hongping; Li, Pengfei; Wang, Sicen; Zhang, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6973-6980</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylase inhibitors (HDACIs) offer a promising strategy for cancer therapy.  The discovery of potent ferulic acid-based HDACIs with hydroxamic acid or 2-aminobenzamide group as zinc binding group was reported.  The halogeno-acetanilide was introduced as novel surface recognition moiety (SRM).  The majority of title compds. displayed potent HDAC inhibitory activity.  In particular, I and II [R = 3-F] exhibited significant enzymic inhibitory activities, with IC50 values of 3.94 and 2.82 μM, resp.  Furthermore, these compds. showed moderate antiproliferative activity against a panel of human cancer cells.  II [R = 3,5-CF3] displayed promising profile as an antitumor candidate.  The results indicated that these ferulic acid derivs. could serve as promising lead compds. for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrSn4Cn__K7Vg90H21EOLACvtfcHk0lheuyHhvT8XWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrJ&md5=8c3ddd718130cc659f4f4b3d9c7056ff</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520novel%2520ferulic%2520acid%2520derivatives%2520as%2520potent%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6973%26epage%3D6980%26doi%3D10.1016%2Fj.bmc.2013.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and preliminary bioactivity evaluation of N<sup>1</sup>-hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1111%2Fcbdd.12819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=27416889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslaltLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=38-46&author=X.+Wangauthor=X.+Liauthor=J.+Liauthor=J.+Houauthor=Y.+Quauthor=C.+Yuauthor=F.+Heauthor=W.+Xuauthor=J.+Wu&title=Design%2C+synthesis%2C+and+preliminary+bioactivity+evaluation+of+N1-hydroxyterephthalamide+derivatives+with+indole+cap+as+novel+histone+deacetylase+inhibitors&doi=10.1111%2Fcbdd.12819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and preliminary bioactivity evaluation of N1-hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors</span></div><div class="casAuthors">Wang, Xue; Li, Xiaoyang; Li, Jingyao; Hou, Jinning; Qu, Ying; Yu, Chenggong; He, Feng; Xu, Wenfang; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Histone deacetylases inhibitors (HDACIs) have been widely recognized as significant therapeutic approach to cancers.  In the efforts to develop novel histone deacetylases inhibitors (HDACIs) as potential anticancer agents, a series of N1-hydroxyterephthalamide derivs. with an indole cap group were designed and synthesized.  Compd. I was identified to be the most potent one (IC50 = 0.074 μM against HeLa nuclear ext.) and showed higher inhibitory activity than the pos. control SAHA (IC50 = 0.131 μM), which was also verified by further mol. docking studies into active site of HDAC2.  The results of selectivity on the inhibition of HDACs exhibited I being with similar isoform selective profile with PXD101.  In addn., four representative compds. including I based on the outcomes of preliminary tumor cell screening demonstrated more potent or comparable to SAHA in the next antiproliferative activity assays.  Collectively, the results encouraged further development of this chem. template to provide more potent analogs as HDACIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKCHMkmNNjrVg90H21EOLACvtfcHk0lhSt3lqAYTSgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslaltLfI&md5=f30df66e963648c419fed8c96c2baf43</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12819%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520preliminary%2520bioactivity%2520evaluation%2520of%2520N1-hydroxyterephthalamide%2520derivatives%2520with%2520indole%2520cap%2520as%2520novel%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D89%26spage%3D38%26epage%3D46%26doi%3D10.1111%2Fcbdd.12819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, J.</span></span> <span> </span><span class="NLM_article-title">Panobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myeloma</span>. <i>Drugs Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1358/dot.2015.51.8.2362311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1358%2Fdot.2015.51.8.2362311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BC283js1WlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=491-504&author=T.+Chengauthor=L.+Grasseauthor=J.+Shahauthor=J.+Chandra&title=Panobinostat%2C+a+pan-histone+deacetylase+inhibitor%3A+rationale+for+and+application+to+treatment+of+multiple+myeloma&doi=10.1358%2Fdot.2015.51.8.2362311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Panobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myeloma</span></div><div class="casAuthors">Cheng T; Grasse L; Chandra J; Shah J</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of today (Barcelona, Spain : 1998)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">491-504</span>
        ISSN:<span class="NLM_cas:issn">1699-3993</span>.
    </div><div class="casAbstract">Histone deacetylase inhibitors (HDACis) have emerged as novel therapeutic agents for cancer.  Currently, four HDACis are approved by the Food and Drug Administration (FDA) to treat various hematologic malignancies.  Panobinostat (LBH-589, trade name Farydak®, developed and marketed by Novartis) is a potent pan-HDACi with demonstrated anticancer activities against multiple myeloma, a B-cell malignancy, at a low nanomolar range in preclinical settings, and in 2015 was granted FDA approval for the treatment of relapsed and refractory multiple myeloma.  Here, we review the development of HDACis, the unique features of panobinostat, and the rationale for developing panobinostat in a combination setting for the treatment of multiple myeloma.  We also review the completed and ongoing clinical trials testing the efficacy of panobinostat in combination therapies and highlight future therapeutically relevant strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdrHqiOVCAxdts4TFFB11gfW6udTcc2eZuQxn2eXxZNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283js1WlsA%253D%253D&md5=6840a213c7bcd49b260ad853d1c66fcc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1358%2Fdot.2015.51.8.2362311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2015.51.8.2362311%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DGrasse%26aufirst%3DL.%26aulast%3DShah%26aufirst%3DJ.%26aulast%3DChandra%26aufirst%3DJ.%26atitle%3DPanobinostat%252C%2520a%2520pan-histone%2520deacetylase%2520inhibitor%253A%2520rationale%2520for%2520and%2520application%2520to%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DDrugs%2520Today%26date%3D2015%26volume%3D51%26spage%3D491%26epage%3D504%26doi%3D10.1358%2Fdot.2015.51.8.2362311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiermeier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">101378</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2019.101378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.redox.2019.101378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=31926632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFemt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2020&pages=101378&author=S.+Guneschauthor=M.+Hoffmannauthor=C.+Kiermeierauthor=W.+Fischerauthor=A.+F.+M.+Pintoauthor=T.+Mauriceauthor=P.+Maherauthor=M.+Decker&title=7-O-Esters+of+taxifolin+with+pronounced+and+overadditive+effects+in+neuroprotection%2C+anti-neuroinflammation%2C+and+amelioration+of+short-term+memory+impairment+in+vivo&doi=10.1016%2Fj.redox.2019.101378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo</span></div><div class="casAuthors">Gunesch, Sandra; Hoffmann, Matthias; Kiermeier, Carolina; Fischer, Wolfgang; Pinto, Antonio F. M.; Maurice, Tangui; Maher, Pamela; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101378</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial disease and the most common form of dementia.  There are no treatments to cure, prevent or slow down the progression of the disease.  Natural products hold considerable interest for the development of preventive neuroprotectants to treat neurodegenerative disorders like AD, due to their low toxicity and general beneficial effects on human health with their anti-inflammatory and antioxidant features.  In this work we describe regioselective synthesis of 7-O-ester hybrids of the flavonoid taxifolin with the phenolic acids cinnamic and ferulic acid, namely 7-O-cinnamoyltaxifolin and 7-O-feruloyltaxifolin.  The compds. show pronounced overadditive neuroprotective effects against oxytosis, ferroptosis and ATP depletion in the murine hippocampal neuron HT22 cell model.  Furthermore, 7-O-cinnamoyltaxifolin and 7-O-feruloyltaxifolin reduced LPS-induced neuroinflammation in BV-2 microglia cells as assessed by effects on the levels of NO, IL6 and TNFa.  In all in vitro assays the 7-O-esters of taxifolin and ferulic or cinnamic acid showed strong overadditive activity, significantly exceeding the effects of the individual components and the equimolar mixts. thereof, which were almost inactive in all of the assays at the tested concns.  In vivo studies confirmed this overadditive effect.  Treatment of an AD mouse model based on the injection of oligomerized Aβ25-35 peptide into the brain to cause neurotoxicity and subsequently memory deficits with 7-O-cinnamoyltaxifolin or 7-O-feruloyltaxifolin resulted in improved performance in an assay for short-term memory as compared to vehicle and mice treated with the resp. equimolar mixts.  These results highlight the benefits of natural product hybrids as a novel compd. class with potential use for drug discovery in neurodegenerative diseases due to their pharmacol. profile that is distinct from the individual natural components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxRqkt587okbVg90H21EOLACvtfcHk0lhSt3lqAYTSgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFemt7k%253D&md5=84206a34fa10317bc63f84492e42479f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2019.101378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2019.101378%26sid%3Dliteratum%253Aachs%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DKiermeier%26aufirst%3DC.%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DPinto%26aufirst%3DA.%2BF.%2BM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DMaher%26aufirst%3DP.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3D7-O-Esters%2520of%2520taxifolin%2520with%2520pronounced%2520and%2520overadditive%2520effects%2520in%2520neuroprotection%252C%2520anti-neuroinflammation%252C%2520and%2520amelioration%2520of%2520short-term%2520memory%2520impairment%2520in%2520vivo%26jtitle%3DRedox%2520Biol.%26date%3D2020%26volume%3D29%26spage%3D101378%26doi%3D10.1016%2Fj.redox.2019.101378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano-Castell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlosser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Development and application of a chemical probe based on a neuroprotective flavonoid hybrid for target identification using activity-based protein profiling</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3823</span>– <span class="NLM_lpage">3837</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.0c00589</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.0c00589" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitF2iurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=3823-3837&author=S.+Guneschauthor=D.+Soriano-Castellauthor=S.+Lamerauthor=A.+Schlosserauthor=P.+Maherauthor=M.+Decker&title=Development+and+application+of+a+chemical+probe+based+on+a+neuroprotective+flavonoid+hybrid+for+target+identification+using+activity-based+protein+profiling&doi=10.1021%2Facschemneuro.0c00589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Application of a Chemical Probe Based on a Neuroprotective Flavonoid Hybrid for Target Identification Using Activity-Based Protein Profiling</span></div><div class="casAuthors">Gunesch, Sandra; Soriano-Castell, David; Lamer, Stephanie; Schlosser, Andreas; Maher, Pamela; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3823-3837</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common form of dementia, and up to now, there are no disease-modifying drugs available.  Natural product hybrids based on the flavonoid taxifolin and phenolic acids have shown a promising pleiotropic neuroprotective profile in cell culture assays and even disease-modifying effects in vivo.  However, the detailed mechanisms of action remain unclear.  To elucidate the distinct intracellular targets of 7-O-esters of taxifolin, we present in this work the development and application of a chem. probe, 7-O-cinnamoyltaxifolin-alkyne, for target identification using activity-based protein profiling. 7-O-Cinnamoyltaxifolin-alkyne remained neuroprotective in all cell culture assays.  Western blot anal. showed a comparable influence on the same intracellular pathways as that of the lead compd. 7-O-cinnamoyltaxifolin, thereby confirming its suitability as a probe for target identification expts.  Affinity pulldown and MS anal. revealed adenine nucleotide translocase 1 (ANT-1) and sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) as intracellular interaction partners of 7-O-cinnamoyltaxifolin-alkyne and thus of 7-O-esters of taxifolin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxBnMLkEUbF7Vg90H21EOLACvtfcHk0lhMcJHcxtvNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitF2iurrK&md5=612e740bb463418a6591aef1acf40c0b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.0c00589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.0c00589%26sid%3Dliteratum%253Aachs%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DSoriano-Castell%26aufirst%3DD.%26aulast%3DLamer%26aufirst%3DS.%26aulast%3DSchlosser%26aufirst%3DA.%26aulast%3DMaher%26aufirst%3DP.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520application%2520of%2520a%2520chemical%2520probe%2520based%2520on%2520a%2520neuroprotective%2520flavonoid%2520hybrid%2520for%2520target%2520identification%2520using%2520activity-based%2520protein%2520profiling%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2020%26volume%3D11%26spage%3D3823%26epage%3D3837%26doi%3D10.1021%2Facschemneuro.0c00589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertzen, C. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves Avelar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span> <span> </span><span class="NLM_article-title">Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3219</span>– <span class="NLM_lpage">3222</span>, <span class="refDoi"> DOI: 10.1039/C5CC10301K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1039%2FC5CC10301K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=26810607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xos1Ohsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=3219-3222&author=D.+Diedrichauthor=A.+Hamacherauthor=C.+G.+W.+Gertzenauthor=L.+A.+Alves+Avelarauthor=G.+J.+Reissauthor=T.+Kurzauthor=H.+Gohlkeauthor=M.+U.+Kassackauthor=F.+K.+Hansen&title=Rational+design+and+diversity-oriented+synthesis+of+peptoid-based+selective+HDAC6+inhibitors&doi=10.1039%2FC5CC10301K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors</span></div><div class="casAuthors">Diedrich, D.; Hamacher, A.; Gertzen, C. G. W.; Alves Avelar, L. A.; Reiss, G. J.; Kurz, T.; Gohlke, H.; Kassack, M. U.; Hansen, F. K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3219-3222</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A mini library of HDAC inhibitors with peptoid-based cap groups was synthesized using an efficient multicomponent approach.  Four compds. were identified as potent HDAC6 inhibitors with a selectivity over other HDAC isoforms.  The most potent HDAC6 inhibitor revealed remarkable chemosensitizing properties and completely reverted the cisplatin resistance in Cal27 CisR cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOpBEaojI1W7Vg90H21EOLACvtfcHk0lhMcJHcxtvNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xos1Ohsg%253D%253D&md5=3175aed0befb813805c973cfb24e72ce</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2FC5CC10301K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC10301K%26sid%3Dliteratum%253Aachs%26aulast%3DDiedrich%26aufirst%3DD.%26aulast%3DHamacher%26aufirst%3DA.%26aulast%3DGertzen%26aufirst%3DC.%2BG.%2BW.%26aulast%3DAlves%2BAvelar%26aufirst%3DL.%2BA.%26aulast%3DReiss%26aufirst%3DG.%2BJ.%26aulast%3DKurz%26aufirst%3DT.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DHansen%26aufirst%3DF.%2BK.%26atitle%3DRational%2520design%2520and%2520diversity-oriented%2520synthesis%2520of%2520peptoid-based%2520selective%2520HDAC6%2520inhibitors%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D3219%26epage%3D3222%26doi%3D10.1039%2FC5CC10301K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertzen, C. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwinderman, M. R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassack, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F. K.</span></span> <span> </span><span class="NLM_article-title">Design, multicomponent synthesis, and anticancer activity of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5493</span>– <span class="NLM_lpage">5506</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1Knt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5493-5506&author=V.+Kriegerauthor=A.+Hamacherauthor=C.+G.+W.+Gertzenauthor=J.+Sengerauthor=M.+R.+H.+Zwindermanauthor=M.+Marekauthor=C.+Romierauthor=F.+J.+Dekkerauthor=T.+Kurzauthor=M.+Jungauthor=H.+Gohlkeauthor=M.+U.+Kassackauthor=F.+K.+Hansen&title=Design%2C+multicomponent+synthesis%2C+and+anticancer+activity+of+a+focused+histone+deacetylase+%28HDAC%29+inhibitor+library+with+peptoid-based+cap+groups&doi=10.1021%2Facs.jmedchem.7b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, multicomponent synthesis, and anticancer activity of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups</span></div><div class="casAuthors">Krieger, Viktoria; Hamacher, Alexandra; Gertzen, Christoph G. W.; Senger, Johanna; Zwinderman, Martijn R. H.; Marek, Martin; Romier, Christophe; Dekker, Frank J.; Kurz, Thomas; Jung, Manfred; Gohlke, Holger; Kassack, Matthias U.; Hansen, Finn K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5493-5506</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this work, we report the multicomponent synthesis of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups and different zinc-binding groups.  All synthesized compds. were tested in a cellular HDAC inhibition assay and an MTT assay for cytotoxicity.  On the basis of their noteworthy activity in the cellular HDAC assays, four compds. were further screened for their inhibitory activity against recombinant HDAC1-3, HDAC6, and HDAC8.  All four compds. showed potent inhibition of HDAC1-3 as well as significant inhibition of HDAC6 with IC50 values in the submicromolar concn. range.  Compd. (I), the most potent HDAC inhibitor in the cellular HDAC assay, revealed remarkable chemosensitizing properties and enhanced the cisplatin sensitivity of the cisplatin-resistant head-neck cancer cell line Cal27CisR by almost 7-fold.  Furthermore, I almost completely reversed the cisplatin resistance in Cal27CisR.  This effect is related to a synergistic induction of apoptosis as seen in the combination of I with cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr43qPA21H-mLVg90H21EOLACvtfcHk0lhMcJHcxtvNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1Knt7c%253D&md5=8a101145194f8188522438b61756f3e9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00197%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DV.%26aulast%3DHamacher%26aufirst%3DA.%26aulast%3DGertzen%26aufirst%3DC.%2BG.%2BW.%26aulast%3DSenger%26aufirst%3DJ.%26aulast%3DZwinderman%26aufirst%3DM.%2BR.%2BH.%26aulast%3DMarek%26aufirst%3DM.%26aulast%3DRomier%26aufirst%3DC.%26aulast%3DDekker%26aufirst%3DF.%2BJ.%26aulast%3DKurz%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DKassack%26aufirst%3DM.%2BU.%26aulast%3DHansen%26aufirst%3DF.%2BK.%26atitle%3DDesign%252C%2520multicomponent%2520synthesis%252C%2520and%2520anticancer%2520activity%2520of%2520a%2520focused%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitor%2520library%2520with%2520peptoid-based%2520cap%2520groups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5493%26epage%3D5506%26doi%3D10.1021%2Facs.jmedchem.7b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span> <span> </span><span class="NLM_article-title">Peptoid architectures: elaboration, actuation, and application</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2008.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.cbpa.2008.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=18786652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajs7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=714-721&author=B.+Yooauthor=K.+Kirshenbaum&title=Peptoid+architectures%3A+elaboration%2C+actuation%2C+and+application&doi=10.1016%2Fj.cbpa.2008.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Peptoid architectures: elaboration, actuation, and application</span></div><div class="casAuthors">Yoo, Barney; Kirshenbaum, Kent</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">714-721</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peptoids are peptidomimetic oligomers composed of N-substituted glycine units.  Their convenient synthesis enables strict control over the sequence of highly diverse monomers and is capable of generating extensive compd. libraries.  Recent studies are beginning to explore the relation between peptoid sequence, structure, and function.  The authors describe new approaches to direct the conformation of the peptoid backbone, leading to secondary structures, such as helixes, loops, and turns.  These advances are enabling the discovery of bioactive peptoids and will establish modules for the design and assembly of protein mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGSLBbf_-kbVg90H21EOLACvtfcHk0lifYZ373prw5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajs7%252FF&md5=a46631e9c62143af12f90e5d710a196e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DB.%26aulast%3DKirshenbaum%26aufirst%3DK.%26atitle%3DPeptoid%2520architectures%253A%2520elaboration%252C%2520actuation%252C%2520and%2520application%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D714%26epage%3D721%26doi%3D10.1016%2Fj.cbpa.2008.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inks, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. J.</span></span> <span> </span><span class="NLM_article-title">Class I HDAC inhibitors display different antitumor mechanism in leukemia and prostatic cancer cells depending on their p53 status</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2603</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2589-2603&author=X.+Liauthor=Y.+K.+Petersonauthor=E.+S.+Inksauthor=R.+A.+Himesauthor=J.+Liauthor=Y.+Zhangauthor=X.+Kongauthor=C.+J.+Chou&title=Class+I+HDAC+inhibitors+display+different+antitumor+mechanism+in+leukemia+and+prostatic+cancer+cells+depending+on+their+p53+status&doi=10.1021%2Facs.jmedchem.8b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status</span></div><div class="casAuthors">Li, Xiaoyang; Peterson, Yuri K.; Inks, Elizabeth S.; Himes, Richard A.; Li, Jiaying; Zhang, Yingjie; Kong, Xiujie; Chou, C. James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2589-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously, we designed and synthesized a series of o-aminobenzamide-based histone deacetylase (HDAC) inhibitors, among which the representative compd. I exhibited potent inhibitory activity against class I HDACs.  In this study, we report the development of more potent hydrazide-based class I selective HDAC inhibitors using II as a lead.  Representative compd. 13b showed a mixed, slow, and tight binding inhibition mechanism for HDAC1, 2, and 3.  The most potent compd. 13e exhibited low nanomolar IC50s toward HDAC1, 2, and 3 and could down-regulate HDAC6 in acute myeloid leukemia MV4-11 cells.  The EC50 of 13e against MV4-11 cells was 34.7 nM, which is 26 times lower than its parent compd. 11a.  In vitro responses to 13e vary significantly and interestingly based on cell type: in p53 wild-type MV4-11 cells, 13e induced cell death via apoptosis and G1/S cell cycle arrest, which is likely mediated by a p53-dependent pathway, while in p53-null PC-3 cells, 13e caused G2/M arrest and inhibited cell proliferation without inducing caspase-3-dependent apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNn9M1ceDMg7Vg90H21EOLACvtfcHk0lifYZ373prw5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKrs7w%253D&md5=36fcd594770688e5dcbbdbd3c8619b89</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00136%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DInks%26aufirst%3DE.%2BS.%26aulast%3DHimes%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DChou%26aufirst%3DC.%2BJ.%26atitle%3DClass%2520I%2520HDAC%2520inhibitors%2520display%2520different%2520antitumor%2520mechanism%2520in%2520leukemia%2520and%2520prostatic%2520cancer%2520cells%2520depending%2520on%2520their%2520p53%2520status%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2589%26epage%3D2603%26doi%3D10.1021%2Facs.jmedchem.8b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osko, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayana
Reddy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Exploring structural determinants of inhibitor affinity and selectivity in complexes with histone deacetylase 6</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01540</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01540" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit12jsr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=295-308&author=J.+D.+Oskoauthor=N.+J.+Porterauthor=P.+A.+Narayana%0AReddyauthor=Y.-C.+Xiaoauthor=J.+Rokkaauthor=M.+Jungauthor=J.+M.+Hookerauthor=J.+M.+Salvinoauthor=D.+W.+Christianson&title=Exploring+structural+determinants+of+inhibitor+affinity+and+selectivity+in+complexes+with+histone+deacetylase+6&doi=10.1021%2Facs.jmedchem.9b01540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6</span></div><div class="casAuthors">Osko, Jeremy D.; Porter, Nicholas J.; Narayana Reddy, Poli Adi; Xiao, You-Cai; Rokka, Johanna; Jung, Manfred; Hooker, Jacob M.; Salvino, Joseph M.; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">295-308</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of histone deacetylase 6 (HDAC6) has emerged as a promising therapeutic strategy for the treatment of cancer, chemotherapy-induced peripheral neuropathy, and neurodegenerative disease.  The recent X-ray crystal structure detn. of HDAC6 enables an understanding of structural features directing affinity and selectivity in the active site.  Here, we present the X-ray crystal structures of five HDAC6-inhibitor complexes that illuminate key mol. features of the inhibitor linker and capping groups that facilitate and differentiate binding to HDAC6.  In particular, arom. and heteroarom. linkers nestle within an arom. cleft defined by F583 and F643, and different arom. linkers direct the capping group toward shallow pockets defined by the L1 loop, the L2 loop, or somewhere in between these pockets.  These results expand our understanding of factors contributing to the selective inhibition of HDAC6, particularly regarding interactions that can be targeted in the region of the L2 pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBosfiCC-DubVg90H21EOLACvtfcHk0lifYZ373prw5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit12jsr3N&md5=0ebd3729b8a0ed03629c4ecca475b02e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01540%26sid%3Dliteratum%253Aachs%26aulast%3DOsko%26aufirst%3DJ.%2BD.%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DNarayana%2BReddy%26aufirst%3DP.%2BA.%26aulast%3DXiao%26aufirst%3DY.-C.%26aulast%3DRokka%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DExploring%2520structural%2520determinants%2520of%2520inhibitor%2520affinity%2520and%2520selectivity%2520in%2520complexes%2520with%2520histone%2520deacetylase%25206%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D295%26epage%3D308%26doi%3D10.1021%2Facs.jmedchem.9b01540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahendran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breslow, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christianson, D. W.</span></span> <span> </span><span class="NLM_article-title">Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">13459</span>– <span class="NLM_lpage">13464</span>, <span class="refDoi"> DOI: 10.1073/pnas.1718823114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1073%2Fpnas.1718823114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29203661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=13459-13464&author=N.+J.+Porterauthor=A.+Mahendranauthor=R.+Breslowauthor=D.+W.+Christianson&title=Unusual+zinc-binding+mode+of+HDAC6-selective+hydroxamate+inhibitors&doi=10.1073%2Fpnas.1718823114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors</span></div><div class="casAuthors">Porter, Nicholas J.; Mahendran, Adaickapillai; Breslow, Ronald; Christianson, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">13459-13464</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) regulate myriad cellular processes by catalyzing the hydrolysis of acetyl-L-lysine residues in histone and nonhistone proteins.  The Zn2+-dependent class IIb enzyme HDAC6 regulates microtubule function by deacetylating α-tubulin, which suppresses microtubule dynamics and leads to cell cycle arrest and apoptosis.  Accordingly, HDAC6 is a target for the development of selective inhibitors that might be useful in new therapeutic approaches for the treatment of cancer, neurodegenerative diseases, and other disorders.  Here, we present high-resoln. structures of catalytic domain 2 from Danio rerio HDAC6 (henceforth simply "HDAC6") complexed with compds. that selectively inhibit HDAC6 while maintaining nanomolar inhibitory potency: N-hydroxy-4-((N(2-hydroxyethyl)-2-phenylacetamido)methyl)-benzamide (HPB), ACY-1215 (Ricolinostat), and ACY-1083.  These structures reveal that an unusual monodentate Zn2+ coordination mode is exploited by sterically bulky HDAC6-selective phenylhydroxamate inhibitors.  We addnl. report the ultrahigh-resoln. structure of the HDAC6-trichostatin A complex, which reveals two Zn2+-binding conformers for the inhibitor: a major conformer (70%) with canonical bidentate hydroxamate-Zn2+ coordination geometry and a minor conformer (30%) with monodentate hydroxamate-Zn2+ coordination geometry, reflecting a free energy difference of only 0.5 kcal/mol.  The minor conformer is not visible in lower resoln. structure detns.  Structural comparisons of HDAC6-inhibitor complexes with class I HDACs suggest active site features that contribute to the isoenzyme selectivity obsd. in biochem. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0oUH1X_04p7Vg90H21EOLACvtfcHk0lgdT4WyUIadFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgsrbI&md5=07180756239eac4891642cf59a2e6992</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1718823114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1718823114%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DN.%2BJ.%26aulast%3DMahendran%26aufirst%3DA.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DChristianson%26aufirst%3DD.%2BW.%26atitle%3DUnusual%2520zinc-binding%2520mode%2520of%2520HDAC6-selective%2520hydroxamate%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D13459%26epage%3D13464%26doi%3D10.1073%2Fpnas.1718823114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarpe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duzer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazitschek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirstea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canavese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, N.</span></span> <span> </span><span class="NLM_article-title">Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">2579</span>– <span class="NLM_lpage">2589</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-10-387365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1182%2Fblood-2011-10-387365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=22262760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2579-2589&author=L.+Santoauthor=T.+Hideshimaauthor=A.+L.+Kungauthor=J.+C.+Tsengauthor=D.+Tamangauthor=M.+Yangauthor=M.+Jarpeauthor=J.+H.+van+Duzerauthor=R.+Mazitschekauthor=W.+C.+Ogierauthor=D.+Cirsteaauthor=S.+Rodigauthor=H.+Edaauthor=T.+Scullenauthor=M.+Canaveseauthor=J.+Bradnerauthor=K.+C.+Andersonauthor=S.+S.+Jonesauthor=N.+Raje&title=Preclinical+activity%2C+pharmacodynamic%2C+and+pharmacokinetic+properties+of+a+selective+HDAC6+inhibitor%2C+ACY-1215%2C+in+combination+with+bortezomib+in+multiple+myeloma&doi=10.1182%2Fblood-2011-10-387365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma</span></div><div class="casAuthors">Santo, Loredana; Hideshima, Teru; Kung, Andrew L.; Tseng, Jen-Chieh; Tamang, David; Yang, Min; Jarpe, Matthew; van Duzer, John H.; Mazitschek, Ralph; Ogier, Walter C.; Cirstea, Diana; Rodig, Scott; Eda, Homare; Scullen, Tyler; Canavese, Miriam; Bradner, James; Anderson, Kenneth C.; Jones, Simon S.; Raje, Noopur</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2579-2589</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) enzymic activity has been linked to the transcription of DNA in cancers including multiple myeloma (MM).  Therefore, HDAC inhibitors used alone and in combination are being actively studied as novel therapies in MM.  In the present study, we investigated the preclin. activity of ACY-1215, an HDAC6-selective inhibitor, alone and in combination with bortezomib in MM.  Low doses of ACY-1215 combined with bortezomib triggered synergistic anti-MM activity, resulting in protracted endoplasmic reticulum stress and apoptosis via activation of caspase-3, caspase-8, and caspase-9 and poly (ADP) ribosome polymerase.  In vivo, the anti-MM activity of ACY-1215 in combination with bortezomib was confirmed using 2 different xenograft SCID mouse models: human MM injected s.c. (the plasmacytoma model) and luciferase-expressing human MM injected i.v. (the disseminated MM model).  Tumor growth was significantly delayed and overall survival was significantly prolonged in animals treated with the combination therapy.  Pharmacokinetic data showed peak plasma levels of ACY-1215 at 4 h after treatment coincident with an increase in acetylated α-tubulin, a marker of HDAC6 inhibition, by immunohistochem. and Western blot anal.  These studies provide preclin. rationale for acetylated α-tubulin use as a pharmacodynamic biomarker in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoelmsk1wo_LVg90H21EOLACvtfcHk0lgdT4WyUIadFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOntb4%253D&md5=094298bdd3d5b91c7060d8b294857846</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-10-387365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-10-387365%26sid%3Dliteratum%253Aachs%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DTseng%26aufirst%3DJ.%2BC.%26aulast%3DTamang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DJarpe%26aufirst%3DM.%26aulast%3Dvan%2BDuzer%26aufirst%3DJ.%2BH.%26aulast%3DMazitschek%26aufirst%3DR.%26aulast%3DOgier%26aufirst%3DW.%2BC.%26aulast%3DCirstea%26aufirst%3DD.%26aulast%3DRodig%26aufirst%3DS.%26aulast%3DEda%26aufirst%3DH.%26aulast%3DScullen%26aufirst%3DT.%26aulast%3DCanavese%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DRaje%26aufirst%3DN.%26atitle%3DPreclinical%2520activity%252C%2520pharmacodynamic%252C%2520and%2520pharmacokinetic%2520properties%2520of%2520a%2520selective%2520HDAC6%2520inhibitor%252C%2520ACY-1215%252C%2520in%2520combination%2520with%2520bortezomib%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2579%26epage%3D2589%26doi%3D10.1182%2Fblood-2011-10-387365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neudert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">DSX: a knowledge-based scoring function for the assessment of protein-ligand complexes</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2731</span>– <span class="NLM_lpage">2745</span>, <span class="refDoi"> DOI: 10.1021/ci200274q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200274q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ggtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2731-2745&author=G.+Neudertauthor=G.+Klebe&title=DSX%3A+a+knowledge-based+scoring+function+for+the+assessment+of+protein-ligand+complexes&doi=10.1021%2Fci200274q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">DSX: A Knowledge-Based Scoring Function for the Assessment of Protein-Ligand Complexes</span></div><div class="casAuthors">Neudert, Gerd; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2731-2745</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We introduce the new knowledge-based scoring function DSX that consists of distance-dependent pair potentials, novel torsion angle potentials, and newly defined solvent accessible surface-dependent potentials.  DSX pair potentials are based on the statistical formalism of DrugScore, extended by a much more specialized set of atom types.  The original DrugScore-like ref. state is rather unstable with respect to modifications in the used atom types.  Therefore, an important method to overcome this problem and to allow for robust results when deriving pair potentials for arbitrary sets of atom types is presented.  A validation based on a carefully prepd. test set is shown, enabling direct comparison to the majority of other popular scoring functions.  Here, DSX features superior performance with respect to docking- and ranking power and runtime requirements.  Furthermore, the beneficial combination with torsion angle-dependent and desolvation-dependent potentials is demonstrated.  DSX is robust, flexible, and capable of working together with special features of popular docking engines, e.g., flexible protein residues in AutoDock or GOLD.  The program is freely available to the scientific community and can be downloaded from our Web site www.agklebe.de.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvQyrP7qPi5bVg90H21EOLACvtfcHk0lgdT4WyUIadFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ggtb3K&md5=c90af0aa9af9ae15d458d9ba759163bb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fci200274q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200274q%26sid%3Dliteratum%253Aachs%26aulast%3DNeudert%26aufirst%3DG.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DDSX%253A%2520a%2520knowledge-based%2520scoring%2520function%2520for%2520the%2520assessment%2520of%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2731%26epage%3D2745%26doi%3D10.1021%2Fci200274q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, J. P. F.</span></span> <span> </span><span class="NLM_article-title">Glutathione and thioredoxin dependent systems in neurodegenerative disease: what can be learned from reverse genetics in mice</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">738</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2013.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.neuint.2013.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=23333338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=738-749&author=M.+Conradauthor=J.+Schickauthor=J.+P.+F.+Angeli&title=Glutathione+and+thioredoxin+dependent+systems+in+neurodegenerative+disease%3A+what+can+be+learned+from+reverse+genetics+in+mice&doi=10.1016%2Fj.neuint.2013.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione and thioredoxin dependent systems in neurodegenerative disease: What can be learned from reverse genetics in mice</span></div><div class="casAuthors">Conrad, Marcus; Schick, Joel; Angeli, Jose Pedro Friedmann</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">738-749</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is a major common hallmark of many neurodegenerative disease such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and stroke.  Novel concepts in our understanding of oxidative stress indicate that a perturbed redox circuitry could be strongly linked with the onset of such diseases.  In this respect, glutathione and thioredoxin dependent antioxidant enzymes play a central role as key regulators due to the fact that a slight dysfunction of any of these enzymes leads to sustained reactive oxygen species (ROS) prodn.  Apart from their classical role as ROS scavengers, some of these enzymes are also able to control post-translational modifications.  Therefore, efficient control of ROS prodn. and reversibility of post-translational modifications are crit. as improper control of such events may lead to the activation of pathol. redox circuits that eventually culminate in neuronal cell death.  To dissect the apparently opposing functions of ROS in cell physiol. and pathophysiol., a proper working toolkit is mandatory.  In vivo modeling is an abs. requirement due to the complexity of redox signaling systems that often contradict data obtained from in vitro approaches.  Hence, inducible/conditional knockout mouse models for key redox enzymes are emerging as powerful tools to perturb redox circuitries in a temporal and spatial manner.  In this review we address the basics of ROS generation, chem. and detoxification as well as examples in where applications of mouse models of important enzymes have been successfully applied in the study of neurodegenerative processes.  We also highlight the importance of new models to overcome present tech. limitations in order to advance in the study of redox processes in the role of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCUAZhQc1wbVg90H21EOLACvtfcHk0limdR6ER7qSbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ylt7g%253D&md5=d60ecf990c569709840303865afd172b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DConrad%26aufirst%3DM.%26aulast%3DSchick%26aufirst%3DJ.%26aulast%3DAngeli%26aufirst%3DJ.%2BP.%2BF.%26atitle%3DGlutathione%2520and%2520thioredoxin%2520dependent%2520systems%2520in%2520neurodegenerative%2520disease%253A%2520what%2520can%2520be%2520learned%2520from%2520reverse%2520genetics%2520in%2520mice%26jtitle%3DNeurochem.%2520Int.%26date%3D2013%26volume%3D62%26spage%3D738%26epage%3D749%26doi%3D10.1016%2Fj.neuint.2013.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span> <span> </span><span class="NLM_article-title">Biological metals and Alzheimer’s disease: implications for therapeutics and diagnostics</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.pneurobio.2010.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=20444428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1-18&author=J.+A.+Duceauthor=A.+I.+Bush&title=Biological+metals+and+Alzheimer%E2%80%99s+disease%3A+implications+for+therapeutics+and+diagnostics&doi=10.1016%2Fj.pneurobio.2010.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics</span></div><div class="casAuthors">Duce, James A.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-18</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The equil. of metal ions is crit. for many physiol. functions, particularly in the central nervous system, where metals are essential for development and maintenance of enzymic activities, mitochondrial function, myelination, neurotransmission as well as learning and memory.  Due to their importance, cells have evolved complex machinery for controlling metal-ion homeostasis.  However, disruption of these mechanisms, or absorption of detrimental metals with no known biol. function, alter the ionic balance and can result in a disease state, including several neurodegenerative disorders such as Alzheimer's disease.  Understanding the complex structural and functional interactions of metal ions with the various intracellular and extracellular components of the central nervous system, under normal conditions and during neurodegeneration, is essential for the development of effective therapies.  Accordingly, assisting the balance of metal ions back to homeostatic levels has been proposed as a disease-modifying therapeutic strategy for Alzheimer's disease as well as other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHRXNaNohExLVg90H21EOLACvtfcHk0limdR6ER7qSbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVKmtbk%253D&md5=2aa9da17774b3da9f6118f0ce3f122ae</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DBiological%2520metals%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520therapeutics%2520and%2520diagnostics%26jtitle%3DProg.%2520Neurobiol.%26date%3D2010%26volume%3D92%26spage%3D1%26epage%3D18%26doi%3D10.1016%2Fj.pneurobio.2010.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, B.</span></span> <span> </span><span class="NLM_article-title">Metal ions in Alzheimer’s disease: a key role or not?</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2026</span>– <span class="NLM_lpage">2035</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.9b00248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.9b00248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlShs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=2026-2035&author=Y.+Liuauthor=M.+Nguyenauthor=A.+Robertauthor=B.+Meunier&title=Metal+ions+in+Alzheimer%E2%80%99s+disease%3A+a+key+role+or+not%3F&doi=10.1021%2Facs.accounts.9b00248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Metal Ions in Alzheimer's Disease: A Key Role or Not?</span></div><div class="casAuthors">Liu, Yan; Nguyen, Michel; Robert, Anne; Meunier, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2026-2035</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Despite tremendous research efforts in universities and pharmaceutical companies, effective drugs are still lacking for the treatment of Alzheimer's disease (AD).  The biochem. mechanisms of this devastating neurodegenerative disease have not yet been clearly understood.  Besides a small percentage of cases with early onset disease having a genetic origin (<5%, familial AD), most cases develop in the elderly as a sporadic form due to multiple and complex parameters of aging.  Consequently, AD is spreading in all countries with a long life expectancy.  AD is characterized by deposition of senile plaques made of β-amyloid proteins (Aβ) and by hyperphosphorylation of tau proteins, which have been considered as the main drug targets up to now.  However, antibodies targeting amyloid aggregates, as well as enzyme inhibitors aiming to modify the amyloid precursor protein processing, have failed to improve cognition in clin. trials.  Thus, to set up effective drugs, it is urgent to enlarge the panel of drug targets.  Evidence of the link between AD and redox metal dysregulation has also been supported by post-mortem analyses of amyloid plaques, which revealed accumulation of copper, iron, and zinc by 5.7, 2.8, and 3.1 times, resp., the levels obsd. in normal brains.  Copper-amyloid complexes, in the presence of endogenous reductants, are able to catalyze the redn. of dioxygen and to produce reduced, reactive oxygen species (ROS), leading to neuron death.  The possibility of using metal chelators to regenerate normal trafficking of metal ions has been considered as a promising strategy in order to reduce the redox stress lethal for neurons.  However, most attempts to use metal chelators as therapeutic agents have been limited to existing mols. available from the shelves.  Very few chelators have resulted from a rational design aiming to create drugs with a safety profile and able to cross the blood-brain barrier after an oral administration.  In the human body, metals are handled by a sophisticated protein network to strictly control their transport and reactivity.  Abnormal concns. of certain metals may lead to pathol. events due to misaccumulation and irregular reactivity.  Consequently, therapeutic attempts to restore metal homeostasis should carefully take into account the coordination chem. specificities of the concerned redox-active metal ions.  This Account is focused on the role of the main biol. redox-active transition metals, iron and copper.  For iron, the recent debate on the possible role of magnetite in AD pathogenesis is presented.  The section devoted to copper is focused on the design of specific copper chelators as drug candidates able to regulate copper homeostasis and to reduce the oxidative damage responsible for the neuron death obsd. in AD brains.  A short survey on non-redox-active metal ions is also included at the beginning, such as aluminum and its controversial role in AD and zinc which is a key metal ion in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkifxcw4n0LVg90H21EOLACvtfcHk0limdR6ER7qSbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlShs7%252FO&md5=1b5557cc504fe48a31223b39ed765b4f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.9b00248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.9b00248%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DA.%26aulast%3DMeunier%26aufirst%3DB.%26atitle%3DMetal%2520ions%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520key%2520role%2520or%2520not%253F%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2019%26volume%3D52%26spage%3D2026%26epage%3D2035%26doi%3D10.1021%2Facs.accounts.9b00248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span> <span> </span><span class="NLM_article-title">Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease</span>. <i>Ann. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">136</span>, <span class="refDoi"> DOI: 10.3978/j.issn.2305-5839.2015.03.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.3978%2Fj.issn.2305-5839.2015.03.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=26207229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFequrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=136&author=W.-Y.+Wangauthor=M.-S.+Tanauthor=J.-T.+Yuauthor=L.+Tan&title=Role+of+pro-inflammatory+cytokines+released+from+microglia+in+Alzheimer%E2%80%99s+disease&doi=10.3978%2Fj.issn.2305-5839.2015.03.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease</span></div><div class="casAuthors">Wang, Wen-Ying; Tan, Meng-Shan; Yu, Jin-Tai; Tan, Lan</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Translational Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">136/1-136/15</span>CODEN:
                <span class="NLM_cas:coden">ATMNDX</span>;
        ISSN:<span class="NLM_cas:issn">2305-5847</span>.
    
            (<span class="NLM_cas:orgname">AME Publishing Co.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain, which is characterized by the formation of extracellular amyloid plaques (or senile plaques) and intracellular neurofibrillary tangles.  However, increasing evidences demonstrated that neuroinflammatory changes, including chronic microgliosis are key pathol. components of AD.  Microglia, the resident immune cells of the brain, is constantly survey the microenvironment under physiol. conditions.  In AD, deposition of β-amyliod (Aβ) peptide initiates a spectrum of cerebral neuroinflammation mediated by activating microglia.  Activated microglia may play a potentially detrimental role by eliciting the expression of pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) influencing the surrounding brain tissue.  Emerging studies have demonstrated that up-regulation of pro-inflammatory cytokines play multiple roles in both neurodegeneration and neuroprotection.  Understanding the pro-inflammatory cytokines signaling pathways involved in the regulation of AD is crucial to the development of strategies for therapy.  This review will discuss the mechanisms and important role of pro-inflammatory cytokines in the pathogenesis of AD, and the ongoing drug targeting pro-inflammatory cytokine for therapeutic modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrydEyb_SUzbbVg90H21EOLACvtfcHk0lhwLepqACcRVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFequrk%253D&md5=21894d5d8de838c4137bfc5ebcd35218</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2305-5839.2015.03.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2305-5839.2015.03.49%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.-Y.%26aulast%3DTan%26aufirst%3DM.-S.%26aulast%3DYu%26aufirst%3DJ.-T.%26aulast%3DTan%26aufirst%3DL.%26atitle%3DRole%2520of%2520pro-inflammatory%2520cytokines%2520released%2520from%2520microglia%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Transl.%2520Med.%26date%3D2015%26volume%3D3%26spage%3D136%26doi%3D10.3978%2Fj.issn.2305-5839.2015.03.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Privat, A.</span></span> <span> </span><span class="NLM_article-title">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>706</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(95)01032-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2F0006-8993%2895%2901032-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=8822355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=706&publication_year=1996&pages=181-193&author=T.+Mauriceauthor=B.+P.+Lockhartauthor=A.+Privat&title=Amnesia+induced+in+mice+by+centrally+administered+%CE%B2-amyloid+peptides+involves+cholinergic+dysfunction&doi=10.1016%2F0006-8993%2895%2901032-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction</span></div><div class="casAuthors">Maurice, Tangui; Lockhart, Brian P.; Privat, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">706</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-93</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Substantial evidences suggest that the increased cerebral deposition, and neurotoxic action of the β-amyloid peptide, the major constituent of senile plaques, may represent the underlying cause of the cognitive deficits obsd. in Alzheimer's disease.  Herein, the authors attempted to verify this hypothesis by inducing a potential Alzheimer's-type amnesia after direct intracerebroventricular administration of aggregated β25-35-amyloid peptide in mice.  In this aim, amnesic capacities were evaluated after 6 to 13 days, using spontaneous alternation in the Y-maze, step-down type passive avoidance and place learning in a water-maze.  Pre-training administration of aggregated β25-35 peptide induced dose-dependent decreases in both alternation behavior and passive avoidance, at doses of 3 and 9 nmol/mouse.  A reduced but still significant impairment was obsd. when the peptide was not aggregated, or 'aged', by preincubation for 4 days at 37°.  The β1-28 peptide, at 3 nmol/mouse, also induced a marked decrease in step-down latency.  Post-training, but not pre-retention, administration of β25-35 peptide also significantly impaired learning.  The beneficial effects of cholinergic agents on β25-35-induced amnesia was examd. using the cholinesterase inhibitor tacrine (THA, 1.3 and 4.3 μmol/kg i.p.) and the nicotinic receptor agonist (-)-nicotine (NIC, 0.06 and 0.2 μmol/kg i.p.).  Both drugs induced a dose-dependent abrogation of the β25-35-induced decreases in alternation behavior and passive avoidance.  Furthermore, THA, at 1.3 μmol/kg, and NIC, at 0.2 μmol/kg, also reversed the β25-35-induced impairment of place learning and retention in the water-maze.  Histol. examn. of Cresyl violet-stained brain sections indicated a moderate but significant cell loss within the frontoparietal cortex and the hippocampal formation of mice treated with aged β25-35 peptide (9 nmol).  Examn. of Congo red-stained sections in the same animals demonstrated the presence of numerous amyloid deposits throughout these brain areas.  These results confirm that the deposition of β-amyloid peptide in the brain is in some way related to impairment of learning and cholinergic degeneration and suggest that the [25-35] fragment of the β-amyloid protein, sufficient to induce neuronal death in cultures, also induces an Alzheimer's-type amnesia in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsjUgNl1iVLVg90H21EOLACvtfcHk0lhwLepqACcRVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xns1yitQ%253D%253D&md5=5a0465719e2a405fcc1c6aae31ad0367</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2895%2901032-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252895%252901032-7%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DLockhart%26aufirst%3DB.%2BP.%26aulast%3DPrivat%26aufirst%3DA.%26atitle%3DAmnesia%2520induced%2520in%2520mice%2520by%2520centrally%2520administered%2520%25CE%25B2-amyloid%2520peptides%2520involves%2520cholinergic%2520dysfunction%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D706%26spage%3D181%26epage%3D193%26doi%3D10.1016%2F0006-8993%2895%2901032-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkeis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Dual-acting cholinesterase-human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9078</span>– <span class="NLM_lpage">9102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9078-9102&author=M.+Scheinerauthor=D.+Dollesauthor=S.+Guneschauthor=M.+Hoffmannauthor=M.+Nabissiauthor=O.+Marinelliauthor=M.+Naldiauthor=M.+Bartoliniauthor=S.+Petrallaauthor=E.+Poetaauthor=B.+Montiauthor=C.+Falkeisauthor=M.+Viethauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=R.+Maitraauthor=T.+Mauriceauthor=M.+Decker&title=Dual-acting+cholinesterase-human+cannabinoid+receptor+2+ligands+show+pronounced+neuroprotection+in+vitro+and+overadditive+and+disease-modifying+neuroprotective+effects+in+vivo&doi=10.1021%2Facs.jmedchem.9b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo</span></div><div class="casAuthors">Scheiner, Matthias; Dolles, Dominik; Gunesch, Sandra; Hoffmann, Matthias; Nabissi, Massimo; Marinelli, Oliviero; Naldi, Marina; Bartolini, Manuela; Petralla, Sabrina; Poeta, Eleonora; Monti, Barbara; Falkeis, Christina; Vieth, Michael; Huebner, Harald; Gmeiner, Peter; Maitra, Rangan; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9078-9102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a series of 14 hybrid mols. out of the cholinesterase (ChE) inhibitor tacrine and a benzimidazole-based human cannabinoid receptor subtype 2 (hCB2R) agonist and investigated them in vitro and in vivo.  The compds. are potent ChE inhibitors, and for the most promising hybrids, the mechanism of human acetylcholinesterase (hAChE) inhibition as well as their ability to interfere with AChE-induced aggregation of β-amyloid (Aβ), and Aβ self-aggregation was assessed.  All hybrids were evaluated for affinity and selectivity for hCB1R and hCB2R.  To ensure that the hybrids retained their agonist character, the expression of cAMP-regulated genes was quantified, and potency and efficacy were detd.  Addnl., the effects of the hybrids on microglia activation and neuroprotection on HT-22 cells were investigated.  The most promising in vitro hybrids showed pronounced neuroprotection in an Alzheimer's mouse model at low dosage (0.1 mg/kg, i.p.), lacking hepatotoxicity even at high dose (3 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRfz6xatTXLVg90H21EOLACvtfcHk0lhwLepqACcRVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM&md5=f0148c8ba51a2d0cbe83a26bb388a446</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DPoeta%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DFalkeis%26aufirst%3DC.%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDual-acting%2520cholinesterase-human%2520cannabinoid%2520receptor%25202%2520ligands%2520show%2520pronounced%2520neuroprotection%2520in%2520vitro%2520and%2520overadditive%2520and%2520disease-modifying%2520neuroprotective%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9078%26epage%3D9102%26doi%3D10.1021%2Facs.jmedchem.9b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer’s disease mouse model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9116</span>– <span class="NLM_lpage">9140</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9116-9140&author=M.+Hoffmannauthor=C.+Stillerauthor=E.+Endresauthor=M.+Scheinerauthor=S.+Guneschauthor=C.+Sotrifferauthor=T.+Mauriceauthor=M.+Decker&title=Highly+selective+butyrylcholinesterase+inhibitors+with+tunable+duration+of+action+by+chemical+modification+of+transferable+carbamate+units+exhibit+pronounced+neuroprotective+effect+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1021%2Facs.jmedchem.9b01012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Hoffmann, Matthias; Stiller, Carina; Endres, Erik; Scheiner, Matthias; Gunesch, Sandra; Sotriffer, Christoph; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9116-9140</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the carbamate structure of pseudo-irreversible butyrylcholinesterase (BChE) inhibitors was optimized with regard to a longer binding to the enzyme.  A set of compds. bearing different heterocycles (e.g., morpholine, tetrahydroisoquinoline, benzimidazole, piperidine) and alkylene spacers (2 to 10 methylene groups between carbamate and heterocycle) in the carbamate residue was synthesized and characterized in vitro for their binding affinity, binding kinetics, and carbamate hydrolysis.  These novel BChE inhibitors are highly selective for hBChE over human acetycholinesterase (hAChE), yielding short-, medium-, and long-acting nanomolar hBChE inhibitors (with a half-life of the carbamoylated enzyme ranging from 1 to 28 h).  The inhibitors show neuroprotective properties in a murine hippocampal cell line and a pharmacol. mouse model of Alzheimer's disease (AD), suggesting a significant benefit of BChE inhibition for a disease-modifying treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXA4e0pcqAhrVg90H21EOLACvtfcHk0lg_1gszTEcyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO&md5=458d5ab7ffce4864702a39d981b6dc29</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01012%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DStiller%26aufirst%3DC.%26aulast%3DEndres%26aufirst%3DE.%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DHighly%2520selective%2520butyrylcholinesterase%2520inhibitors%2520with%2520tunable%2520duration%2520of%2520action%2520by%2520chemical%2520modification%2520of%2520transferable%2520carbamate%2520units%2520exhibit%2520pronounced%2520neuroprotective%2520effect%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9116%26epage%3D9140%26doi%3D10.1021%2Facs.jmedchem.9b01012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouchet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstenn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span> <span> </span><span class="NLM_article-title">Anti-amnesic and neuroprotective effects of fluoroethylnormemantine in a pharmacological mouse model of Alzheimer’s disease</span>. <i>Int. J. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1093/ijnp/pyaa075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1093%2Fijnp%2Fpyaa075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=32977336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A280%3ADC%252BB3s%252FjsFOktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2021&pages=142-157&author=S.+Coulyauthor=M.+Denusauthor=M.+Bouchetauthor=G.+Rubinstennauthor=T.+Maurice&title=Anti-amnesic+and+neuroprotective+effects+of+fluoroethylnormemantine+in+a+pharmacological+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fijnp%2Fpyaa075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Couly Simon; Denus Morgane; Bouchet Melanie; Maurice Tangui; Rubinstenn Gilles</div><div class="citationInfo"><span class="NLM_cas:title">The international journal of neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-157</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Current therapies in Alzheimer's disease (AD), including Memantine, have proven to be only symptomatic but not curative or disease modifying.  Fluoroethylnormemantine (FENM) is a structural analogue of Memantine, functionalized with a fluorine group that allowed its use as a positron emission tomography tracer.  We here analyzed FENM neuroprotective potential in a pharmacological model of AD compared with Memantine.  METHODS:  Swiss mice were treated intracerebroventricularly with aggregated Aβ 25-35 peptide and examined after 1 week in a battery of memory tests (spontaneous alternation, passive avoidance, object recognition, place learning in the water-maze, topographic memory in the Hamlet).  Toxicity induced in the mouse hippocampus or cortex was analyzed biochemically or morphologically.  RESULTS:  Both Memantine and FENM showed symptomatic anti-amnesic effects in Aβ 25-35-treated mice.  Interestingly, FENM was not amnesic when tested alone at 10 mg/kg, contrarily to Memantine.  Drugs injected once per day prevented Aβ 25-35-induced memory deficits, oxidative stress (lipid peroxidation, cytochrome c release), inflammation (interleukin-6, tumor necrosis factor-α increases; glial fibrillary acidic protein and Iba1 immunoreactivity in the hippocampus and cortex), and apoptosis and cell loss (Bcl-2-associated X/B-cell lymphoma 2 ratio; cell loss in the hippocampus CA1 area).  However, FENM effects were more robust than observed with Memantine, with significant attenuations vs the Aβ 25-35-treated group.  CONCLUSIONS:  FENM therefore appeared as a potent neuroprotective drug in an AD model, with a superior efficacy compared with Memantine and an absence of direct amnesic effect at higher doses.  These results open the possibility to use the compound at more relevant dosages than those actually proposed in Memantine treatment for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMr7FgOxQEcBLDWw4HIq2sfW6udTcc2ebQeNY77CgNAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s%252FjsFOktw%253D%253D&md5=6e674d4e52a7c8391391204544166af4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1093%2Fijnp%2Fpyaa075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fijnp%252Fpyaa075%26sid%3Dliteratum%253Aachs%26aulast%3DCouly%26aufirst%3DS.%26aulast%3DDenus%26aufirst%3DM.%26aulast%3DBouchet%26aufirst%3DM.%26aulast%3DRubinstenn%26aufirst%3DG.%26aulast%3DMaurice%26aufirst%3DT.%26atitle%3DAnti-amnesic%2520and%2520neuroprotective%2520effects%2520of%2520fluoroethylnormemantine%2520in%2520a%2520pharmacological%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2021%26volume%3D24%26spage%3D142%26epage%3D157%26doi%3D10.1093%2Fijnp%2Fpyaa075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heltweg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span> <span> </span><span class="NLM_article-title">In vitro assays for the determination of histone deacetylase activity</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2005.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.ymeth.2005.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=16087348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1ahs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2005&pages=332-337&author=B.+Heltwegauthor=J.+Trappauthor=M.+Jung&title=In+vitro+assays+for+the+determination+of+histone+deacetylase+activity&doi=10.1016%2Fj.ymeth.2005.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro assays for the determination of histone deacetylase activity</span></div><div class="casAuthors">Heltweg, Birgit; Trapp, Johannes; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-337</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Histone deacetylases are important regulators of transcription and an emerging target for anticancer drugs.  We present an overview over various assay formats that include radiolabeled histones, oligopeptides, and small mols. as substrates.  The advantages and disadvantages of the various formats in terms of, e.g., substrate availability, throughput or subtype selectivity are discussed.  Detailed procedures for various assay types that can be used for different problems, such as library screening or fluorescent inhibitor testing, are given.  We present a new protocol for a simple high-throughput assay for NAD+-dependent (class III) histone deacetylases, also termed sirtuins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEetxUXugzbbVg90H21EOLACvtfcHk0lg_1gszTEcyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1ahs74%253D&md5=acdab3410a71c11ba6a2835d1e7378c0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2005.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2005.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DHeltweg%26aufirst%3DB.%26aulast%3DTrapp%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520assays%2520for%2520the%2520determination%2520of%2520histone%2520deacetylase%2520activity%26jtitle%3DMethods%26date%3D2005%26volume%3D36%26spage%3D332%26epage%3D337%26doi%3D10.1016%2Fj.ymeth.2005.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lg_1gszTEcyZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonk, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartshorn, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. D.</span></span> <span> </span><span class="NLM_article-title">Improved protein–ligand docking using GOLD</span>. <i>Proteins: Struct., Funct., Bioinf.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1002/prot.10465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1002%2Fprot.10465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=12910460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+protein%E2%80%93ligand+docking+using+GOLD&doi=10.1002%2Fprot.10465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Improved protein-ligand docking using GOLD</span></div><div class="casAuthors">Verdonk, Marcel L.; Cole, Jason C.; Hartshorn, Michael J.; Murray, Christopher W.; Taylor, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">PSFGEY</span>;
        ISSN:<span class="NLM_cas:issn">0887-3585</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The Chemscore function was implemented as a scoring function for the protein-ligand docking program GOLD, and its performance compared to the original Goldscore function and two consensus docking protocols, "Goldscore-CS" and "Chemscore-GS," in terms of docking accuracy, prediction of binding affinities, and speed.  In the "Goldscore-CS" protocol, dockings produced with the Goldscore function are scored and ranked with the Chemscore function; in the "Chemscore-GS" protocol, dockings produced with the Chemscore function are scored and ranked with the Goldscore function.  Comparisons were made for a "clean" set of 224 protein-ligand complexes, and for two subsets of this set, one for which the ligands are "drug-like," the other for which they are "fragment-like.".  For "drug-like" and "fragment-like" ligands, the docking accuracies obtained with Chemscore and Goldscore functions are similar.  For larger ligands, Goldscore gives superior results.  Docking with the Chemscore function is up to three times faster than docking with the Goldscore function.  Both combined docking protocols give significant improvements in docking accuracy over the use of the Goldscore or Chemscore function alone.  "Goldscore-CS" gives success rates of up to 81% (top-ranked GOLD soln. within 2.0 Å of the exptl. binding mode) for the "clean list," but at the cost of long search times.  For most virtual screening applications, "Chemscore-GS" seems optimal; search settings that give docking speeds of around 0.25-1.3 min/compd. have success rates of about 78% for "drug-like" compds. and 85% for "fragment-like" compds.  In terms of producing binding energy ests., the Goldscore function appears to perform better than the Chemscore function and the two consensus protocols, particularly for faster search settings.  Even at docking speeds of around 1-2 min/compd., the Goldscore function predicts binding energies with a std. deviation of ∼10.5 kJ/mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKKgOct_CAcbVg90H21EOLACvtfcHk0libSJ88RvMVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGrsLg%253D&md5=73a627d99dab6de1ae364c8e8e5f0fea</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fprot.10465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.10465%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520protein%25E2%2580%2593ligand%2520docking%2520using%2520GOLD%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623%26doi%3D10.1002%2Fprot.10465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. K.</span></span> <span> </span><span class="NLM_article-title">DPPH antioxidant assay revisited</span>. <i>Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1202</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.foodchem.2008.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.foodchem.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1202-1205&author=O.+P.+Sharmaauthor=T.+K.+Bhat&title=DPPH+antioxidant+assay+revisited&doi=10.1016%2Fj.foodchem.2008.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">DPPH antioxidant assay revisited</span></div><div class="casAuthors">Sharma, Om P.; Bhat, Tej K.</div><div class="citationInfo"><span class="NLM_cas:title">Food Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1202-1205</span>CODEN:
                <span class="NLM_cas:coden">FOCHDJ</span>;
        ISSN:<span class="NLM_cas:issn">0308-8146</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Scavenging of DPPH free radical is the basis of a common antioxidant assay.  A no. of protocols have been followed for this assay resulting in variation in the results of different labs.  We present a perspective of the protocols followed by different workers with incongruity in their results and recommend a std. procedure within the sensitivity range of spectrophotometry.  Three common std. antioxidants viz. ascorbic acid, BHT and Pr gallate have been used in this study.  The IC50 values for ascorbic acid and Pr gallate were 11.8 μM and 4.4 μM in methanol and 11.5 μM and 4.7 μM in buffered methanol as reaction medium, resp.  The free radical scavenging by BHT was markedly influenced by the reaction medium.  The IC50 values were 60.0 μM and 9.7 μM when the reaction was done in methanol and buffered methanol, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKousJor6cObVg90H21EOLACvtfcHk0libSJ88RvMVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWjsbrK&md5=23ff778dd3e2a174133b430f933301a3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.foodchem.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.foodchem.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DO.%2BP.%26aulast%3DBhat%26aufirst%3DT.%2BK.%26atitle%3DDPPH%2520antioxidant%2520assay%2520revisited%26jtitle%3DFood%2520Chem.%26date%3D2009%26volume%3D113%26spage%3D1202%26epage%3D1205%26doi%3D10.1016%2Fj.foodchem.2008.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampsch-Woodill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R. L.</span></span> <span> </span><span class="NLM_article-title">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4619</span>– <span class="NLM_lpage">4626</span>, <span class="refDoi"> DOI: 10.1021/jf010586o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+validation+of+an+improved+oxygen+radical+absorbance+capacity+assay+using+fluorescein+as+the+fluorescent+probe&doi=10.1021%2Fjf010586o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0libSJ88RvMVAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520an%2520improved%2520oxygen%2520radical%2520absorbance%2520capacity%2520assay%2520using%2520fluorescein%2520as%2520the%2520fluorescent%2520probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26spage%3D4619%26epage%3D4626%26doi%3D10.1021%2Fjf010586o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dávalos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Cordovés, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomé, B.</span></span> <span> </span><span class="NLM_article-title">Extending applicability of the oxygen radical absorbance capacity (ORAC–fluorescein) assay</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1021/jf0305231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&author=A.+D%C3%A1valosauthor=C.+G%C3%B3mez-Cordov%C3%A9sauthor=B.+Bartolom%C3%A9&title=Extending+applicability+of+the+oxygen+radical+absorbance+capacity+%28ORAC%E2%80%93fluorescein%29+assay&doi=10.1021%2Fjf0305231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC-Fluorescein) Assay</span></div><div class="casAuthors">Davalos, Alberto; Gomez-Cordoves, Carmen; Bartolome, Begona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ORAC-fluorescein (ORAC-FL) method recently validated using automatic liq. handling systems has been adapted to manual handling and using a conventional fluorescence microplate reader.  As calcd. for Trolox, the precision of the method was <3.0, expressed as percent coeff. of variation.  The accuracy of the method was <2.3, expressed as percent variation of the mean.  The detection and quantification limits were those corresponding to 0.5- and 1-μM Trolox std. solns., resp.  The method has been applied to 10 pure compds. (benzoic and cinnamic acids and aldehydes, flavonoids, and butylated hydroxyanisole), to 30 white, rose, and bottled- and oak-aged red wines, and to 7 com. dietary antioxidant supplements.  All samples exhibited a good linear response with concn.  As seen by other methodologies, the chem. structure of a compd. dets. its antioxidant activity (ORAC-FL value).  Of particular interest were the results with oak-aged red wines from different vintages (1989-2002) that confirm influence of vintage, but not origin of the oak, in the antioxidant activity of wines from the same variety.  Dietary antioxidant supplements presented a great variability (170-fold difference) in their antioxidant potency.  This work proves applicability of the ORAC-FL assay in evaluating the antioxidant activity of diverse food samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MQ8zab9ce7Vg90H21EOLACvtfcHk0lit2cObV7_Dpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsl2isL4%253D&md5=c08c16818b9c32fc87b46570b26544f9</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A1valos%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Cordov%25C3%25A9s%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DExtending%2520applicability%2520of%2520the%2520oxygen%2520radical%2520absorbance%2520capacity%2520%2528ORAC%25E2%2580%2593fluorescein%2529%2520assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26spage%3D48%26epage%3D54%26doi%3D10.1021%2Fjf0305231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarenga Brizola, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granato, D.</span></span> <span> </span><span class="NLM_article-title">High-throughput assay comparison and standardization for metal chelating capacity screening: A proposal and application</span>. <i>Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/j.foodchem.2016.07.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.foodchem.2016.07.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=27507505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ahs7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2017&pages=515-522&author=J.+S.+Santosauthor=V.+R.+Alvarenga+Brizolaauthor=D.+Granato&title=High-throughput+assay+comparison+and+standardization+for+metal+chelating+capacity+screening%3A+A+proposal+and+application&doi=10.1016%2Fj.foodchem.2016.07.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput assay comparison and standardization for metal chelating capacity screening: A proposal and application</span></div><div class="casAuthors">Santos, Janio Sousa; Alvarenga Brizola, Vitor Rafael; Granato, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Food Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">515-522</span>CODEN:
                <span class="NLM_cas:coden">FOCHDJ</span>;
        ISSN:<span class="NLM_cas:issn">0308-8146</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aiming to standardize the exptl. protocols to assess the ability to chelate Fe2+ and Cu2+ using 96-well microplates, we analyzed Brazilian coffees (n = 20) as a study-case in relation to their antioxidant activity using conventional methods (DPPH and FRAP assays) and correlated the results with the total phenolic content (TPC) using bivariate and multivariate statistical approaches.  Complementarily, we assessed the repeatability, reproducibility, recovery, and linearity of both methods.  Data showed that the proposed assays presented a good repeatability and reproducibility (<7% RSD) and mean recovery values of 96.66% and 98.91% for the iron and copper assays, resp.  Both methods were linear in the range of 0-100 mg EDTA equiv./L.  Cu2+-chelating ability was significantly correlated to FRAP, DPPH, and TPC, while sparse (p < 0.05) correlations were obtained with Fe2+-chelating ability.  Overall, both micro assays can be used to assess the ability of plant-based exts. to chelate Fe2+ and Cu2+in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzN3-RTiFq4LVg90H21EOLACvtfcHk0lit2cObV7_Dpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ahs7nF&md5=d031983e0ebbd4e761086c06390010ec</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.foodchem.2016.07.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.foodchem.2016.07.091%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DJ.%2BS.%26aulast%3DAlvarenga%2BBrizola%26aufirst%3DV.%2BR.%26aulast%3DGranato%26aufirst%3DD.%26atitle%3DHigh-throughput%2520assay%2520comparison%2520and%2520standardization%2520for%2520metal%2520chelating%2520capacity%2520screening%253A%2520A%2520proposal%2520and%2520application%26jtitle%3DFood%2520Chem.%26date%3D2017%26volume%3D214%26spage%3D515%26epage%3D522%26doi%3D10.1016%2Fj.foodchem.2016.07.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tvrdý, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlíčková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercolini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mladěnka, P.</span></span> <span> </span><span class="NLM_article-title">A simple, cheap but reliable method for evaluation of zinc chelating properties</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2018.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=10.1016%2Fj.bioorg.2018.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=29421704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFais7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2018&pages=287-292&author=M.+C.+Catapanoauthor=V.+Tvrd%C3%BDauthor=J.+Karl%C3%AD%C4%8Dkov%C3%A1author=L.+Mercoliniauthor=P.+Mlad%C4%9Bnka&title=A+simple%2C+cheap+but+reliable+method+for+evaluation+of+zinc+chelating+properties&doi=10.1016%2Fj.bioorg.2018.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A simple, cheap but reliable method for evaluation of zinc chelating properties</span></div><div class="casAuthors">Catapano, Maria Carmen; Tvrdy, Vaclav; Karlickova, Jana; Mercolini, Laura; Mladenka, Premysl</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">287-292</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Zinc is an essential trace element.  Both its lack and excess are assocd. with pathol. states.  The former is more common and can ensue from the excessive treatment with clin. used iron/copper chelators.  The aim of this work was to prep. a reliable, rapid and cheap method for the screening of zinc chelation.  Spectrophotometric assessment using a known zinc indicator dithizone was selected.  Initial screening performed by comparison of spectra of dithizone and its complex with zinc suggested 530 and 570nm as suitable wavelengths for detn. of zinc at pH 4.5 while 540 and 590nm for pH 5.5-7.5.  Addnl. research showed the lower wavelengths to be more suitable.  The sensitivity of the method was always bellow 1μM with good linearity relationship between absorbance and zinc concn.  The method suitability was confirmed by use of two known zinc chelators, EDTA and N,N,N',N'-tetrakis(2-pyridylmethyl)-1,2-ethylenediamine (TPEN).  This method represents a sufficiently precise method for zinc chelation screening usable at pathophysiol. relevant pH conditions.  Such method can be employed for both screening of novel zinc chelators and for testing affinity of other metal chelators for zinc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGratUaOy8CxYLVg90H21EOLACvtfcHk0lit2cObV7_Dpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFais7o%253D&md5=77678e7f351a4bc01ea2ffeef9b50f20</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DCatapano%26aufirst%3DM.%2BC.%26aulast%3DTvrd%25C3%25BD%26aufirst%3DV.%26aulast%3DKarl%25C3%25AD%25C4%258Dkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DMercolini%26aufirst%3DL.%26aulast%3DMlad%25C4%259Bnka%26aufirst%3DP.%26atitle%3DA%2520simple%252C%2520cheap%2520but%2520reliable%2520method%2520for%2520evaluation%2520of%2520zinc%2520chelating%2520properties%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D77%26spage%3D287%26epage%3D292%26doi%3D10.1016%2Fj.bioorg.2018.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DVM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DVM','PDB','6DVM'); return false;">PDB: 6DVM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01940">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16244"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01940?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01940</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC-chromatograms of target compounds, details of computational docking, metal chelation, neuroprotection against oxytosis and ATP depletion, and weight of animals during <i>in vivo</i> studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_002.csv">CVS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_001.pdf">jm0c01940_si_001.pdf (1.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01940/suppl_file/jm0c01940_si_002.csv">jm0c01940_si_002.csv (3.99 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01940&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01940%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01940" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ce2b3ee2196f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
